Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   colorectal cancer
  

Disease ID 1034
Disease colorectal cancer
Definition
A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.
Synonym
cancer of large bowel
cancer of large intestine
cancer of the large bowel
cancer of the large intestine
carcinoma colorectal
carcinoma of large bowel
carcinoma of large intestine
carcinoma of the large bowel
carcinoma of the large intestine
carcinoma, colorectal
carcinomas, colorectal
colorectal cancer, nos
colorectal carcinoma
colorectal carcinomas
crc
large bowel cancer
large bowel carcinoma
large intestine cancer
large intestine carcinoma
OMIM
DOID
UMLS
C0009402
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:196)
C0494165  |  liver metastases  |  110
C0494165  |  liver metastasis  |  105
C1333990  |  lynch syndrome  |  51
C0021390  |  inflammatory bowel disease  |  49
C0009324  |  ulcerative colitis  |  45
C0021831  |  bowel disease  |  42
C0009319  |  colitis  |  35
C0011847  |  diabetes  |  32
C0494165  |  hepatic metastases  |  26
C0028754  |  obesity  |  26
C0948303  |  peritoneal carcinoma  |  26
C0494165  |  hepatic metastasis  |  25
C0153676  |  pulmonary metastases  |  13
C0686619  |  lymph node metastases  |  13
C0011860  |  type 2 diabetes  |  11
C0442874  |  neuropathy  |  10
C0011849  |  diabetes mellitus  |  10
C0001430  |  adenoma  |  8
C0153676  |  pulmonary metastasis  |  8
C0011570  |  depression  |  8
C0024623  |  gastric cancer  |  7
C0007102  |  colon cancer  |  7
C0031117  |  peripheral neuropathy  |  7
C0008311  |  cholangitis  |  6
C0008313  |  sclerosing cholangitis  |  6
C0948265  |  metabolic syndrome  |  6
C0021843  |  intestinal obstruction  |  6
C0153676  |  lung metastasis  |  6
C0566602  |  primary sclerosing cholangitis  |  6
C0032580  |  adenomatous polyposis  |  6
C0153676  |  lung metastases  |  6
C0220650  |  brain metastases  |  6
C0021390  |  inflammatory bowel diseases  |  5
C0010346  |  crohn's disease  |  5
C0006142  |  breast cancer  |  5
C0242379  |  lung cancer  |  5
C0023895  |  liver disease  |  5
C0032580  |  familial adenomatous polyposis  |  5
C0242172  |  pelvic inflammatory disease  |  4
C0001418  |  adenocarcinoma  |  4
C0002871  |  anaemia  |  4
C0021843  |  bowel obstruction  |  4
C0011860  |  type 2 diabetes mellitus  |  4
C0015230  |  rash  |  4
C1302401  |  colorectal adenoma  |  4
C0376358  |  prostate cancer  |  4
C0003467  |  anxiety  |  4
C0011991  |  diarrhea  |  3
C0036323  |  schistosomiasis  |  3
C0162429  |  malnutrition  |  3
C0002871  |  anemia  |  3
C0028754  |  adiposity  |  3
C0017154  |  atrophic gastritis  |  3
C0023903  |  liver tumor  |  3
C0024623  |  stomach cancer  |  3
C0027947  |  neutropenia  |  3
C0040053  |  thrombosis  |  3
C1258215  |  ileus  |  3
C0010418  |  cryptosporidiosis  |  3
C0021845  |  intestinal perforation  |  2
C0025202  |  melanoma  |  2
C0156147  |  crohn's colitis  |  2
C1333990  |  hereditary nonpolyposis colorectal cancer  |  2
C0005684  |  bladder cancer  |  2
C0020538  |  hypertension  |  2
C0153687  |  skin metastasis  |  2
C0012739  |  disseminated intravascular coagulation  |  2
C0153687  |  skin metastases  |  2
C0021400  |  influenza  |  2
C0004763  |  barrett's esophagus  |  2
C0033953  |  sexual dysfunction  |  2
C0007222  |  cardiovascular diseases  |  2
C0162871  |  abdominal aortic aneurysm  |  2
C0220650  |  brain metastasis  |  2
C0008350  |  gallstones  |  2
C0268132  |  dihydropyrimidine dehydrogenase deficiency  |  2
C0003486  |  aortic aneurysm  |  2
C1568868  |  oral mucositis  |  2
C0007102  |  colonic cancer  |  2
C0042373  |  vascular diseases  |  2
C0007222  |  cardiovascular disease  |  2
C0007113  |  rectal carcinoma  |  2
C0040034  |  thrombocytopenia  |  2
C0007113  |  rectal cancer  |  2
C0017152  |  gastritis  |  2
C0868908  |  pancolitis  |  2
C0009806  |  constipation  |  2
C0042373  |  vascular disease  |  2
C0022661  |  chronic kidney disease  |  2
C0685938  |  gastrointestinal cancer  |  2
C0007847  |  cervical cancer  |  1
C0155626  |  acute myocardial infarction  |  1
C0023890  |  liver cirrhosis  |  1
C0152013  |  lung adenocarcinoma  |  1
C1153706  |  endometrial adenocarcinoma  |  1
C0270612  |  leukoencephalopathy  |  1
C0007130  |  mucinous carcinoma  |  1
C0020676  |  hypothyroidism  |  1
C0023903  |  liver cancer  |  1
C0162429  |  undernutrition  |  1
C0019294  |  inguinal hernias  |  1
C0041341  |  tuberous sclerosis complex  |  1
C0022104  |  irritable bowel  |  1
C0023903  |  hepatic tumor  |  1
C0017178  |  gastrointestinal disorder  |  1
C0036341  |  schizophrenia  |  1
C0162316  |  iron deficiency anemia  |  1
C0011991  |  diarrhoea  |  1
C0023530  |  leukopenia  |  1
C0007102  |  colon cancers  |  1
C0020538  |  high blood pressure  |  1
C0023890  |  cirrhosis  |  1
C0022354  |  obstructive jaundice  |  1
C0003873  |  rheumatoid arthritis  |  1
C0024299  |  lymphoma  |  1
C0018799  |  heart disease  |  1
C0009402  |  colorectal carcinoma  |  1
C0019348  |  herpes simplex  |  1
C0022116  |  ischemia  |  1
C0042769  |  virus infection  |  1
C0206702  |  klatskin tumor  |  1
C0026846  |  muscle wasting  |  1
C0159069  |  impaired glucose tolerance  |  1
C0042870  |  vitamin d defic  |  1
C0035435  |  rheumatic disease  |  1
C0206062  |  interstitial lung disease  |  1
C0040128  |  thyroid disease  |  1
C0017178  |  gastrointestinal disorders  |  1
C0851578  |  sleep disorders  |  1
C0019151  |  hepatic encephalopathy  |  1
C0022104  |  irritable bowel syndrome  |  1
C0023895  |  liver diseases  |  1
C0042214  |  vaccinia  |  1
C0027022  |  myeloproliferative neoplasms  |  1
C0022658  |  kidney disease  |  1
C0011860  |  type ii diabetes  |  1
C0025202  |  malignant melanoma  |  1
C0003864  |  arthritis  |  1
C0030354  |  papilloma  |  1
C0020541  |  portal hypertension  |  1
C0334480  |  pleomorphic rhabdomyosarcoma  |  1
C0029401  |  paget disease  |  1
C0032580  |  polyposis coli  |  1
C0012739  |  disseminated intravascular coagulation (dic)  |  1
C0004153  |  atherosclerosis  |  1
C1828108  |  myh-associated polyposis  |  1
C0027051  |  myocardial infarct  |  1
C0011860  |  type ii diabetes mellitus  |  1
C0685938  |  digestive cancer  |  1
C0038362  |  stomatitis  |  1
C0007131  |  non-small cell lung cancer  |  1
C1565489  |  renal insufficiency  |  1
C0017665  |  membranous nephropathy  |  1
C0007114  |  skin cancers  |  1
C0019294  |  inguinal hernia  |  1
C0007114  |  skin cancer  |  1
C0032580  |  adenomatous polyposis coli  |  1
C0007117  |  basal cell carcinoma  |  1
C0002874  |  aplastic anemia  |  1
C0007130  |  mucinous carcinomas  |  1
C0854178  |  adrenal metastases  |  1
C0878544  |  cardiomyopathies  |  1
C0376545  |  hematological malignancies  |  1
C0022658  |  nephropathy  |  1
C0042870  |  vitamin d deficiency  |  1
C0685938  |  gi cancer  |  1
C0019196  |  hepatitis c  |  1
C0268132  |  dpd deficiency  |  1
C0014859  |  esophageal cancer  |  1
C0014122  |  infectious endocarditis  |  1
C1140680  |  ovarian cancer  |  1
C0018621  |  hay fever  |  1
C0497327  |  dementia  |  1
C0032001  |  pituitary apoplexy  |  1
C0398623  |  hypercoagulable state  |  1
C0019158  |  hepatitis  |  1
C0021933  |  intussusception  |  1
C0302592  |  cervical ca  |  1
C0024115  |  lung disease  |  1
C0014118  |  endocarditis  |  1
C0034885  |  rectal neoplasms  |  1
C0035412  |  rhabdomyosarcoma  |  1
C1140680  |  ovarian ca  |  1
C0036503  |  sebaceous neoplasm  |  1
C0149925  |  small cell lung cancer  |  1
C0018995  |  hemochromatosis  |  1
C0023473  |  chronic myeloid leukemia  |  1
C0026986  |  myelodysplastic syndrome  |  1
C0152018  |  esophageal carcinoma  |  1
C0027051  |  myocardial infarction  |  1
C0023418  |  leukemia  |  1
C0153662  |  abdominal cancer  |  1
C0041313  |  hepatic tuberculosis  |  1
C0006625  |  cachexia  |  1
C0004096  |  asthma  |  1
C0023470  |  myeloid leukemia  |  1
Curated Gene(Waiting for update.)
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:399)
5243  |  ABCB1  |  infer
4363  |  ABCC1  |  infer
1244  |  ABCC2  |  infer
8714  |  ABCC3  |  infer
9429  |  ABCG2  |  infer
1636  |  ACE  |  infer
100  |  ADA  |  infer
103  |  ADAR  |  infer
124  |  ADH1A  |  infer
125  |  ADH1B  |  infer
126  |  ADH1C  |  infer
9370  |  ADIPOQ  |  infer
51094  |  ADIPOR1  |  infer
154  |  ADRB2  |  infer
155  |  ADRB3  |  infer
191  |  AHCY  |  infer
196  |  AHR  |  infer
11216  |  AKAP10  |  infer
10142  |  AKAP9  |  infer
207  |  AKT1  |  infer
10840  |  ALDH1L1  |  infer
217  |  ALDH2  |  infer
239  |  ALOX12  |  infer
240  |  ALOX5  |  infer
262  |  AMD1  |  infer
270  |  AMPD1  |  infer
324  |  APC  |  infer
328  |  APEX1  |  infer
348  |  APOE  |  infer
115761  |  ARL11  |  infer
10973  |  ASCC3  |  infer
9140  |  ATG12  |  infer
55102  |  ATG2B  |  infer
9474  |  ATG5  |  infer
285973  |  ATG9B  |  infer
471  |  ATIC  |  infer
472  |  ATM  |  infer
6790  |  AURKA  |  infer
8312  |  AXIN1  |  infer
8313  |  AXIN2  |  infer
25805  |  BAMBI  |  infer
598  |  BCL2L1  |  infer
635  |  BHMT  |  infer
637  |  BID  |  infer
332  |  BIRC5  |  infer
641  |  BLM  |  infer
649  |  BMP1  |  infer
650  |  BMP2  |  infer
652  |  BMP4  |  infer
659  |  BMPR2  |  infer
673  |  BRAF  |  infer
672  |  BRCA1  |  infer
675  |  BRCA2  |  infer
8945  |  BTRC  |  infer
765  |  CA6  |  infer
11132  |  CAPN10  |  infer
22900  |  CARD8  |  infer
843  |  CASP10  |  infer
836  |  CASP3  |  infer
839  |  CASP6  |  infer
840  |  CASP7  |  infer
841  |  CASP8  |  infer
842  |  CASP9  |  infer
846  |  CASR  |  infer
847  |  CAT  |  infer
857  |  CAV1  |  infer
875  |  CBS  |  infer
6346  |  CCL1  |  infer
6347  |  CCL2  |  infer
595  |  CCND1  |  infer
902  |  CCNH  |  infer
929  |  CD14  |  infer
940  |  CD28  |  infer
948  |  CD36  |  infer
10849  |  CD3EAP  |  infer
942  |  CD86  |  infer
999  |  CDH1  |  infer
1001  |  CDH3  |  infer
1026  |  CDKN1A  |  infer
1029  |  CDKN2A  |  infer
1030  |  CDKN2B  |  infer
1045  |  CDX2  |  infer
8824  |  CES2  |  infer
1111  |  CHEK1  |  infer
11200  |  CHEK2  |  infer
4261  |  CIITA  |  infer
1268  |  CNR1  |  infer
1301  |  COL11A1  |  infer
1312  |  COMT  |  infer
51200  |  CPA4  |  infer
1401  |  CRP  |  infer
1457  |  CSNK2A1  |  infer
1493  |  CTLA4  |  infer
1499  |  CTNNB1  |  infer
1508  |  CTSB  |  infer
8029  |  CUBN  |  infer
6376  |  CX3CL1  |  infer
6387  |  CXCL12  |  infer
6374  |  CXCL5  |  infer
7852  |  CXCR4  |  infer
1535  |  CYBA  |  infer
1583  |  CYP11A1  |  infer
1586  |  CYP17A1  |  infer
1588  |  CYP19A1  |  infer
1543  |  CYP1A1  |  infer
1544  |  CYP1A2  |  infer
1545  |  CYP1B1  |  infer
1548  |  CYP2A6  |  infer
1557  |  CYP2C19  |  infer
1558  |  CYP2C8  |  infer
1559  |  CYP2C9  |  infer
1565  |  CYP2D6  |  infer
1571  |  CYP2E1  |  infer
54905  |  CYP2W1  |  infer
1576  |  CYP3A4  |  infer
1577  |  CYP3A5  |  infer
1581  |  CYP7A1  |  infer
51339  |  DACT1  |  infer
1612  |  DAPK1  |  infer
1630  |  DCC  |  infer
1687  |  DFNA5  |  infer
1719  |  DHFR  |  infer
170506  |  DHX36  |  infer
27122  |  DKK3  |  infer
9231  |  DLG5  |  infer
1786  |  DNMT1  |  infer
1788  |  DNMT3A  |  infer
1789  |  DNMT3B  |  infer
1806  |  DPYD  |  infer
1813  |  DRD2  |  infer
1814  |  DRD3  |  infer
1815  |  DRD4  |  infer
1870  |  E2F2  |  infer
1950  |  EGF  |  infer
1956  |  EGFR  |  infer
79813  |  EHMT1  |  infer
10919  |  EHMT2  |  infer
8667  |  EIF3H  |  infer
2048  |  EPHB2  |  infer
2052  |  EPHX1  |  infer
2053  |  EPHX2  |  infer
2064  |  ERBB2  |  infer
2066  |  ERBB4  |  infer
2067  |  ERCC1  |  infer
2068  |  ERCC2  |  infer
2071  |  ERCC3  |  infer
2072  |  ERCC4  |  infer
2073  |  ERCC5  |  infer
2074  |  ERCC6  |  infer
2099  |  ESR1  |  infer
2100  |  ESR2  |  infer
2104  |  ESRRG  |  infer
9156  |  EXO1  |  infer
2147  |  F2  |  infer
2153  |  F5  |  infer
2169  |  FABP2  |  infer
55603  |  FAM46A  |  infer
2189  |  FANCG  |  infer
355  |  FAS  |  infer
356  |  FASLG  |  infer
2209  |  FCGR1A  |  infer
2212  |  FCGR2A  |  infer
2214  |  FCGR3A  |  infer
2249  |  FGF4  |  infer
2321  |  FLT1  |  infer
2328  |  FMO3  |  infer
2346  |  FOLH1  |  infer
2348  |  FOLR1  |  infer
2356  |  FPGS  |  infer
2487  |  FRZB  |  infer
5045  |  FURIN  |  infer
2618  |  GART  |  infer
8836  |  GGH  |  infer
2688  |  GH1  |  infer
51738  |  GHRL  |  infer
2693  |  GHSR  |  infer
2694  |  GIF  |  infer
2737  |  GLI3  |  infer
2778  |  GNAS  |  infer
2876  |  GPX1  |  infer
2879  |  GPX4  |  infer
26585  |  GREM1  |  infer
2938  |  GSTA1  |  infer
2939  |  GSTA2  |  infer
2941  |  GSTA4  |  infer
2944  |  GSTM1  |  infer
2946  |  GSTM2  |  infer
2947  |  GSTM3  |  infer
2950  |  GSTP1  |  infer
2952  |  GSTT1  |  infer
2953  |  GSTT2  |  infer
9734  |  HDAC9  |  infer
3077  |  HFE  |  infer
3090  |  HIC1  |  infer
3091  |  HIF1A  |  infer
3117  |  HLA-DQA1  |  infer
3119  |  HLA-DQB1  |  infer
3123  |  HLA-DRB1  |  infer
3156  |  HMGCR  |  infer
3248  |  HPGD  |  infer
3265  |  HRAS  |  infer
3294  |  HSD17B2  |  infer
3293  |  HSD17B3  |  infer
3383  |  ICAM1  |  infer
3458  |  IFNG  |  infer
3479  |  IGF1  |  infer
3480  |  IGF1R  |  infer
3484  |  IGFBP1  |  infer
3486  |  IGFBP3  |  infer
3551  |  IKBKB  |  infer
3586  |  IL10  |  infer
3592  |  IL12A  |  infer
3593  |  IL12B  |  infer
3606  |  IL18  |  infer
3552  |  IL1A  |  infer
3553  |  IL1B  |  infer
3557  |  IL1RN  |  infer
3565  |  IL4  |  infer
3566  |  IL4R  |  infer
3569  |  IL6  |  infer
3621  |  ING1  |  infer
3624  |  INHBA  |  infer
3630  |  INS  |  infer
3643  |  INSR  |  infer
3667  |  IRS1  |  infer
8660  |  IRS2  |  infer
3673  |  ITGA2  |  infer
3690  |  ITGB3  |  infer
3791  |  KDR  |  infer
22914  |  KLRK1  |  infer
3845  |  KRAS  |  infer
3938  |  LCT  |  infer
3952  |  LEP  |  infer
3953  |  LEPR  |  infer
3980  |  LIG3  |  infer
3990  |  LIPC  |  infer
4049  |  LTA  |  infer
4052  |  LTBP1  |  infer
8425  |  LTBP4  |  infer
4126  |  MANBA  |  infer
6416  |  MAP2K4  |  infer
10982  |  MAPRE2  |  infer
10747  |  MASP2  |  infer
4144  |  MAT2A  |  infer
4153  |  MBL2  |  infer
4160  |  MC4R  |  infer
4192  |  MDK  |  infer
4193  |  MDM2  |  infer
4255  |  MGMT  |  infer
4257  |  MGST1  |  infer
100507436  |  MICA  |  infer
4292  |  MLH1  |  infer
27030  |  MLH3  |  infer
4312  |  MMP1  |  infer
4313  |  MMP2  |  infer
4314  |  MMP3  |  infer
4316  |  MMP7  |  infer
4318  |  MMP9  |  infer
22915  |  MMRN1  |  infer
4353  |  MPO  |  infer
4360  |  MRC1  |  infer
4436  |  MSH2  |  infer
4437  |  MSH3  |  infer
2956  |  MSH6  |  infer
4512  |  MT-CO1  |  infer
4513  |  MT-CO2  |  infer
4522  |  MTHFD1  |  infer
4524  |  MTHFR  |  infer
10588  |  MTHFS  |  infer
4548  |  MTR  |  infer
4552  |  MTRR  |  infer
4595  |  MUTYH  |  infer
4609  |  MYC  |  infer
4619  |  MYH1  |  infer
53904  |  MYO3A  |  infer
9  |  NAT1  |  infer
10  |  NAT2  |  infer
4683  |  NBN  |  infer
10397  |  NDRG1  |  infer
4790  |  NFKB1  |  infer
4792  |  NFKBIA  |  infer
51701  |  NLK  |  infer
4830  |  NME1  |  infer
10392  |  NOD1  |  infer
64127  |  NOD2  |  infer
4846  |  NOS3  |  infer
1728  |  NQO1  |  infer
10062  |  NR1H3  |  infer
8856  |  NR1I2  |  infer
2908  |  NR3C1  |  infer
4893  |  NRAS  |  infer
4521  |  NUDT1  |  infer
4953  |  ODC1  |  infer
4968  |  OGG1  |  infer
142  |  PARP1  |  infer
5111  |  PCNA  |  infer
80380  |  PDCD1LG2  |  infer
5241  |  PGR  |  infer
5290  |  PIK3CA  |  infer
5320  |  PLA2G2A  |  infer
5328  |  PLAU  |  infer
5338  |  PLD2  |  infer
5378  |  PMS1  |  infer
5395  |  PMS2  |  infer
5423  |  POLB  |  infer
5444  |  PON1  |  infer
5450  |  POU2AF1  |  infer
5467  |  PPARD  |  infer
5468  |  PPARG  |  infer
10891  |  PPARGC1A  |  infer
10848  |  PPP1R13L  |  infer
5506  |  PPP1R3A  |  infer
7799  |  PRDM2  |  infer
5621  |  PRNP  |  infer
5698  |  PSMB9  |  infer
5728  |  PTEN  |  infer
5742  |  PTGS1  |  infer
5743  |  PTGS2  |  infer
5795  |  PTPRJ  |  infer
26108  |  PYGO1  |  infer
56852  |  RAD18  |  infer
5887  |  RAD23B  |  infer
5888  |  RAD51  |  infer
5925  |  RB1  |  infer
56729  |  RETN  |  infer
5981  |  RFC1  |  infer
85415  |  RHPN2  |  infer
8737  |  RIPK1  |  infer
80010  |  RMI1  |  infer
6035  |  RNASE1  |  infer
6041  |  RNASEL  |  infer
6052  |  RNR1  |  infer
6053  |  RNR2  |  infer
56475  |  RPRM  |  infer
50484  |  RRM2B  |  infer
6256  |  RXRA  |  infer
79048  |  SECISBP2  |  infer
6401  |  SELE  |  infer
6403  |  SELP  |  infer
5265  |  SERPINA1  |  infer
5054  |  SERPINE1  |  infer
5176  |  SERPINF1  |  infer
6423  |  SFRP2  |  infer
6424  |  SFRP4  |  infer
6470  |  SHMT1  |  infer
6555  |  SLC10A2  |  infer
6573  |  SLC19A1  |  infer
6583  |  SLC22A4  |  infer
6584  |  SLC22A5  |  infer
6532  |  SLC6A4  |  infer
4092  |  SMAD7  |  infer
57154  |  SMURF1  |  infer
6648  |  SOD2  |  infer
6817  |  SULT1A1  |  infer
6799  |  SULT1A2  |  infer
50840  |  TAS2R14  |  infer
10716  |  TBR1  |  infer
6932  |  TCF7  |  infer
6934  |  TCF7L2  |  infer
6948  |  TCN2  |  infer
7037  |  TFRC  |  infer
7040  |  TGFB1  |  infer
7046  |  TGFBR1  |  infer
7048  |  TGFBR2  |  infer
7057  |  THBS1  |  infer
7088  |  TLE1  |  infer
7097  |  TLR2  |  infer
7099  |  TLR4  |  infer
7124  |  TNF  |  infer
8797  |  TNFRSF10A  |  infer
8795  |  TNFRSF10B  |  infer
7157  |  TP53  |  infer
7161  |  TP73  |  infer
7172  |  TPMT  |  infer
7272  |  TTK  |  infer
10587  |  TXNRD2  |  infer
7298  |  TYMS  |  infer
7361  |  UGT1A  |  infer
54658  |  UGT1A1  |  infer
54578  |  UGT1A6  |  infer
54577  |  UGT1A7  |  infer
54576  |  UGT1A8  |  infer
54600  |  UGT1A9  |  infer
7372  |  UMPS  |  infer
7421  |  VDR  |  infer
7422  |  VEGFA  |  infer
11197  |  WIF1  |  infer
8840  |  WISP1  |  infer
8838  |  WISP3  |  infer
7482  |  WNT2B  |  infer
7486  |  WRN  |  infer
7507  |  XPA  |  infer
7508  |  XPC  |  infer
7515  |  XRCC1  |  infer
7516  |  XRCC2  |  infer
7517  |  XRCC3  |  infer
7518  |  XRCC4  |  infer
7520  |  XRCC5  |  infer
7428  |  VHL  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:4361)
84740  |  AFAP1-AS1  |  DISEASES
84740  |  AFAP1-AS1  |  DISEASES
100885775  |  BANCR  |  DISEASES
100885775  |  BANCR  |  DISEASES
101669762  |  BLACAT1  |  DISEASES
101669762  |  BLACAT1  |  DISEASES
100270680  |  CASC11  |  DISEASES
100270680  |  CASC11  |  DISEASES
255082  |  CASC2  |  DISEASES
255082  |  CASC2  |  DISEASES
727677  |  CASC8  |  DISEASES
727677  |  CASC8  |  DISEASES
100507056  |  CCAT1  |  DISEASES
100507056  |  CCAT1  |  DISEASES
101805488  |  CCAT2  |  DISEASES
101805488  |  CCAT2  |  DISEASES
643911  |  CRNDE  |  DISEASES
643911  |  CRNDE  |  DISEASES
100131796  |  DACOR1  |  DISEASES
100131796  |  DACOR1  |  DISEASES
57291  |  DANCR  |  DISEASES
57291  |  DANCR  |  DISEASES
101927125  |  ELFN1-AS1  |  DISEASES
101927125  |  ELFN1-AS1  |  DISEASES
6405  |  SEMA3F  |  DISEASES
6405  |  SEMA3F  |  DISEASES
1595  |  CYP51A1  |  DISEASES
1595  |  CYP51A1  |  DISEASES
10083  |  USH1C  |  DISEASES
10083  |  USH1C  |  DISEASES
5898  |  RALA  |  DISEASES
5898  |  RALA  |  DISEASES
1856  |  DVL2  |  DISEASES
1856  |  DVL2  |  DISEASES
1087  |  CEACAM7  |  DISEASES
1087  |  CEACAM7  |  DISEASES
3675  |  ITGA3  |  DISEASES
3675  |  ITGA3  |  DISEASES
1407  |  CRY1  |  DISEASES
1407  |  CRY1  |  DISEASES
928  |  CD9  |  DISEASES
928  |  CD9  |  DISEASES
4257  |  MGST1  |  DISEASES
4257  |  MGST1  |  DISEASES
4830  |  NME1  |  DISEASES
4830  |  NME1  |  DISEASES
2067  |  ERCC1  |  DISEASES
2067  |  ERCC1  |  DISEASES
9052  |  GPRC5A  |  DISEASES
9052  |  GPRC5A  |  DISEASES
54860  |  MS4A12  |  DISEASES
54860  |  MS4A12  |  DISEASES
5662  |  PSD  |  DISEASES
5662  |  PSD  |  DISEASES
6591  |  SNAI2  |  DISEASES
6591  |  SNAI2  |  DISEASES
1015  |  CDH17  |  DISEASES
1015  |  CDH17  |  DISEASES
54480  |  CHPF2  |  DISEASES
54480  |  CHPF2  |  DISEASES
65078  |  RTN4R  |  DISEASES
65078  |  RTN4R  |  DISEASES
1634  |  DCN  |  DISEASES
1634  |  DCN  |  DISEASES
140689  |  CBLN4  |  DISEASES
140689  |  CBLN4  |  DISEASES
43847  |  KLK14  |  DISEASES
43847  |  KLK14  |  DISEASES
23030  |  KDM4B  |  DISEASES
23030  |  KDM4B  |  DISEASES
634  |  CEACAM1  |  DISEASES
634  |  CEACAM1  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
9319  |  TRIP13  |  DISEASES
9319  |  TRIP13  |  DISEASES
54474  |  KRT20  |  DISEASES
54474  |  KRT20  |  DISEASES
6480  |  ST6GAL1  |  DISEASES
6480  |  ST6GAL1  |  DISEASES
9817  |  KEAP1  |  DISEASES
9817  |  KEAP1  |  DISEASES
7145  |  TNS1  |  DISEASES
7145  |  TNS1  |  DISEASES
4804  |  NGFR  |  DISEASES
4804  |  NGFR  |  DISEASES
9423  |  NTN1  |  DISEASES
9423  |  NTN1  |  DISEASES
30009  |  TBX21  |  DISEASES
30009  |  TBX21  |  DISEASES
5607  |  MAP2K5  |  DISEASES
5607  |  MAP2K5  |  DISEASES
26281  |  FGF20  |  DISEASES
26281  |  FGF20  |  DISEASES
51208  |  CLDN18  |  DISEASES
51208  |  CLDN18  |  DISEASES
2191  |  FAP  |  DISEASES
2191  |  FAP  |  DISEASES
55437  |  STRADB  |  DISEASES
55437  |  STRADB  |  DISEASES
4680  |  CEACAM6  |  DISEASES
4680  |  CEACAM6  |  DISEASES
3294  |  HSD17B2  |  DISEASES
3294  |  HSD17B2  |  DISEASES
3691  |  ITGB4  |  DISEASES
3691  |  ITGB4  |  DISEASES
23645  |  PPP1R15A  |  DISEASES
23645  |  PPP1R15A  |  DISEASES
28954  |  REM1  |  DISEASES
28954  |  REM1  |  DISEASES
3902  |  LAG3  |  DISEASES
3902  |  LAG3  |  DISEASES
7023  |  TFAP4  |  DISEASES
7023  |  TFAP4  |  DISEASES
8646  |  CHRD  |  DISEASES
8646  |  CHRD  |  DISEASES
1947  |  EFNB1  |  DISEASES
1947  |  EFNB1  |  DISEASES
2099  |  ESR1  |  DISEASES
2099  |  ESR1  |  DISEASES
2940  |  GSTA3  |  DISEASES
2940  |  GSTA3  |  DISEASES
7414  |  VCL  |  DISEASES
7414  |  VCL  |  DISEASES
23411  |  SIRT1  |  DISEASES
23411  |  SIRT1  |  DISEASES
1943  |  EFNA2  |  DISEASES
1943  |  EFNA2  |  DISEASES
4616  |  GADD45B  |  DISEASES
4616  |  GADD45B  |  DISEASES
6300  |  MAPK12  |  DISEASES
6300  |  MAPK12  |  DISEASES
4320  |  MMP11  |  DISEASES
4320  |  MMP11  |  DISEASES
4282  |  MIF  |  DISEASES
4282  |  MIF  |  DISEASES
2953  |  GSTT2  |  DISEASES
2953  |  GSTT2  |  DISEASES
10291  |  SF3A1  |  DISEASES
10291  |  SF3A1  |  DISEASES
5594  |  MAPK1  |  DISEASES
5594  |  MAPK1  |  DISEASES
6948  |  TCN2  |  DISEASES
6948  |  TCN2  |  DISEASES
50487  |  PLA2G3  |  DISEASES
50487  |  PLA2G3  |  DISEASES
7494  |  XBP1  |  DISEASES
7494  |  XBP1  |  DISEASES
3162  |  HMOX1  |  DISEASES
3162  |  HMOX1  |  DISEASES
4174  |  MCM5  |  DISEASES
4174  |  MCM5  |  DISEASES
50  |  ACO2  |  DISEASES
50  |  ACO2  |  DISEASES
3002  |  GZMB  |  DISEASES
3002  |  GZMB  |  DISEASES
1113  |  CHGA  |  DISEASES
1113  |  CHGA  |  DISEASES
328  |  APEX1  |  DISEASES
328  |  APEX1  |  DISEASES
4792  |  NFKBIA  |  DISEASES
4792  |  NFKBIA  |  DISEASES
1591  |  CYP24A1  |  DISEASES
1591  |  CYP24A1  |  DISEASES
6790  |  AURKA  |  DISEASES
6790  |  AURKA  |  DISEASES
4605  |  MYBL2  |  DISEASES
4605  |  MYBL2  |  DISEASES
57167  |  SALL4  |  DISEASES
57167  |  SALL4  |  DISEASES
28231  |  SLCO4A1  |  DISEASES
28231  |  SLCO4A1  |  DISEASES
79444  |  BIRC7  |  DISEASES
79444  |  BIRC7  |  DISEASES
1917  |  EEF1A2  |  DISEASES
1917  |  EEF1A2  |  DISEASES
5753  |  PTK6  |  DISEASES
5753  |  PTK6  |  DISEASES
1457  |  CSNK2A1  |  DISEASES
1457  |  CSNK2A1  |  DISEASES
55612  |  FERMT1  |  DISEASES
55612  |  FERMT1  |  DISEASES
191  |  AHCY  |  DISEASES
191  |  AHCY  |  DISEASES
57136  |  APMAP  |  DISEASES
57136  |  APMAP  |  DISEASES
6880  |  TAF9  |  DISEASES
6880  |  TAF9  |  DISEASES
25878  |  MXRA5  |  DISEASES
25878  |  MXRA5  |  DISEASES
5716  |  PSMD10  |  DISEASES
5716  |  PSMD10  |  DISEASES
10857  |  PGRMC1  |  DISEASES
10857  |  PGRMC1  |  DISEASES
9506  |  PAGE4  |  DISEASES
9506  |  PAGE4  |  DISEASES
7076  |  TIMP1  |  DISEASES
7076  |  TIMP1  |  DISEASES
479  |  ATP12A  |  DISEASES
479  |  ATP12A  |  DISEASES
10562  |  OLFM4  |  DISEASES
10562  |  OLFM4  |  DISEASES
4913  |  NTHL1  |  DISEASES
4913  |  NTHL1  |  DISEASES
4313  |  MMP2  |  DISEASES
4313  |  MMP2  |  DISEASES
23594  |  ORC6  |  DISEASES
23594  |  ORC6  |  DISEASES
6367  |  CCL22  |  DISEASES
6367  |  CCL22  |  DISEASES
4324  |  MMP15  |  DISEASES
4324  |  MMP15  |  DISEASES
4350  |  MPG  |  DISEASES
4350  |  MPG  |  DISEASES
10273  |  STUB1  |  DISEASES
10273  |  STUB1  |  DISEASES
343  |  AQP8  |  DISEASES
343  |  AQP8  |  DISEASES
1445  |  CSK  |  DISEASES
1445  |  CSK  |  DISEASES
51285  |  RASL12  |  DISEASES
51285  |  RASL12  |  DISEASES
171177  |  RHOV  |  DISEASES
171177  |  RHOV  |  DISEASES
1666  |  DECR1  |  DISEASES
1666  |  DECR1  |  DISEASES
6422  |  SFRP1  |  DISEASES
6422  |  SFRP1  |  DISEASES
5327  |  PLAT  |  DISEASES
5327  |  PLAT  |  DISEASES
27121  |  DKK4  |  DISEASES
27121  |  DKK4  |  DISEASES
3646  |  EIF3E  |  DISEASES
3646  |  EIF3E  |  DISEASES
8797  |  TNFRSF10A  |  DISEASES
8797  |  TNFRSF10A  |  DISEASES
8857  |  FCGBP  |  DISEASES
8857  |  FCGBP  |  DISEASES
27120  |  DKKL1  |  DISEASES
27120  |  DKKL1  |  DISEASES
56729  |  RETN  |  DISEASES
56729  |  RETN  |  DISEASES
166  |  AES  |  DISEASES
166  |  AES  |  DISEASES
7040  |  TGFB1  |  DISEASES
7040  |  TGFB1  |  DISEASES
973  |  CD79A  |  DISEASES
973  |  CD79A  |  DISEASES
7087  |  ICAM5  |  DISEASES
7087  |  ICAM5  |  DISEASES
1048  |  CEACAM5  |  DISEASES
1048  |  CEACAM5  |  DISEASES
9545  |  RAB3D  |  DISEASES
9545  |  RAB3D  |  DISEASES
828  |  CAPS  |  DISEASES
828  |  CAPS  |  DISEASES
23094  |  SIPA1L3  |  DISEASES
23094  |  SIPA1L3  |  DISEASES
3082  |  HGF  |  DISEASES
3082  |  HGF  |  DISEASES
7980  |  TFPI2  |  DISEASES
7980  |  TFPI2  |  DISEASES
10135  |  NAMPT  |  DISEASES
10135  |  NAMPT  |  DISEASES
3202  |  HOXA5  |  DISEASES
3202  |  HOXA5  |  DISEASES
1577  |  CYP3A5  |  DISEASES
1577  |  CYP3A5  |  DISEASES
5054  |  SERPINE1  |  DISEASES
5054  |  SERPINE1  |  DISEASES
56913  |  C1GALT1  |  DISEASES
56913  |  C1GALT1  |  DISEASES
7431  |  VIM  |  DISEASES
7431  |  VIM  |  DISEASES
657  |  BMPR1A  |  DISEASES
657  |  BMPR1A  |  DISEASES
4353  |  MPO  |  DISEASES
4353  |  MPO  |  DISEASES
1440  |  CSF3  |  DISEASES
1440  |  CSF3  |  DISEASES
7473  |  WNT3  |  DISEASES
7473  |  WNT3  |  DISEASES
6198  |  RPS6KB1  |  DISEASES
6198  |  RPS6KB1  |  DISEASES
708  |  C1QBP  |  DISEASES
708  |  C1QBP  |  DISEASES
11216  |  AKAP10  |  DISEASES
11216  |  AKAP10  |  DISEASES
1655  |  DDX5  |  DISEASES
1655  |  DDX5  |  DISEASES
6347  |  CCL2  |  DISEASES
6347  |  CCL2  |  DISEASES
6928  |  HNF1B  |  DISEASES
6928  |  HNF1B  |  DISEASES
4619  |  MYH1  |  DISEASES
4619  |  MYH1  |  DISEASES
7448  |  VTN  |  DISEASES
7448  |  VTN  |  DISEASES
27346  |  TMEM97  |  DISEASES
27346  |  TMEM97  |  DISEASES
80157  |  CWH43  |  DISEASES
4790  |  NFKB1  |  DISEASES
4790  |  NFKB1  |  DISEASES
3558  |  IL2  |  DISEASES
3558  |  IL2  |  DISEASES
3732  |  CD82  |  DISEASES
3732  |  CD82  |  DISEASES
3312  |  HSPA8  |  DISEASES
3312  |  HSPA8  |  DISEASES
595  |  CCND1  |  DISEASES
595  |  CCND1  |  DISEASES
329  |  BIRC2  |  DISEASES
329  |  BIRC2  |  DISEASES
4254  |  KITLG  |  DISEASES
4254  |  KITLG  |  DISEASES
9733  |  SART3  |  DISEASES
9733  |  SART3  |  DISEASES
5829  |  PXN  |  DISEASES
5829  |  PXN  |  DISEASES
969  |  CD69  |  DISEASES
969  |  CD69  |  DISEASES
1594  |  CYP27B1  |  DISEASES
1594  |  CYP27B1  |  DISEASES
2735  |  GLI1  |  DISEASES
2735  |  GLI1  |  DISEASES
10566  |  AKAP3  |  DISEASES
10566  |  AKAP3  |  DISEASES
1027  |  CDKN1B  |  DISEASES
1027  |  CDKN1B  |  DISEASES
55507  |  GPRC5D  |  DISEASES
55507  |  GPRC5D  |  DISEASES
79785  |  RERGL  |  DISEASES
79785  |  RERGL  |  DISEASES
11211  |  FZD10  |  DISEASES
11211  |  FZD10  |  DISEASES
3458  |  IFNG  |  DISEASES
3458  |  IFNG  |  DISEASES
2597  |  GAPDH  |  DISEASES
2597  |  GAPDH  |  DISEASES
84519  |  ACRBP  |  DISEASES
84519  |  ACRBP  |  DISEASES
2026  |  ENO2  |  DISEASES
2026  |  ENO2  |  DISEASES
113246  |  C12orf57  |  DISEASES
113246  |  C12orf57  |  DISEASES
79923  |  NANOG  |  DISEASES
79923  |  NANOG  |  DISEASES
3945  |  LDHB  |  DISEASES
3945  |  LDHB  |  DISEASES
55907  |  CMAS  |  DISEASES
55907  |  CMAS  |  DISEASES
25842  |  ASF1A  |  DISEASES
25842  |  ASF1A  |  DISEASES
1432  |  MAPK14  |  DISEASES
1432  |  MAPK14  |  DISEASES
11329  |  STK38  |  DISEASES
11329  |  STK38  |  DISEASES
55776  |  SAYSD1  |  DISEASES
55776  |  SAYSD1  |  DISEASES
135152  |  B3GAT2  |  DISEASES
135152  |  B3GAT2  |  DISEASES
5754  |  PTK7  |  DISEASES
5754  |  PTK7  |  DISEASES
11044  |  PAPD7  |  DISEASES
11044  |  PAPD7  |  DISEASES
1611  |  DAP  |  DISEASES
1611  |  DAP  |  DISEASES
1839  |  HBEGF  |  DISEASES
1839  |  HBEGF  |  DISEASES
4015  |  LOX  |  DISEASES
4015  |  LOX  |  DISEASES
6678  |  SPARC  |  DISEASES
6678  |  SPARC  |  DISEASES
56121  |  PCDHB15  |  DISEASES
56121  |  PCDHB15  |  DISEASES
3565  |  IL4  |  DISEASES
3565  |  IL4  |  DISEASES
6500  |  SKP1  |  DISEASES
6500  |  SKP1  |  DISEASES
1044  |  CDX1  |  DISEASES
1044  |  CDX1  |  DISEASES
4292  |  MLH1  |  DISEASES
4292  |  MLH1  |  DISEASES
1894  |  ECT2  |  DISEASES
1894  |  ECT2  |  DISEASES
10641  |  NPRL2  |  DISEASES
10641  |  NPRL2  |  DISEASES
7372  |  UMPS  |  DISEASES
7372  |  UMPS  |  DISEASES
4436  |  MSH2  |  DISEASES
4436  |  MSH2  |  DISEASES
10297  |  APC2  |  DISEASES
10297  |  APC2  |  DISEASES
374291  |  NDUFS7  |  DISEASES
374291  |  NDUFS7  |  DISEASES
1796  |  DOK1  |  DISEASES
1796  |  DOK1  |  DISEASES
5967  |  REG1A  |  DISEASES
5967  |  REG1A  |  DISEASES
3485  |  IGFBP2  |  DISEASES
3485  |  IGFBP2  |  DISEASES
3488  |  IGFBP5  |  DISEASES
3488  |  IGFBP5  |  DISEASES
7475  |  WNT6  |  DISEASES
7475  |  WNT6  |  DISEASES
3398  |  ID2  |  DISEASES
3398  |  ID2  |  DISEASES
4953  |  ODC1  |  DISEASES
4953  |  ODC1  |  DISEASES
2956  |  MSH6  |  DISEASES
2956  |  MSH6  |  DISEASES
2023  |  ENO1  |  DISEASES
2023  |  ENO1  |  DISEASES
1179  |  CLCA1  |  DISEASES
1179  |  CLCA1  |  DISEASES
607  |  BCL9  |  DISEASES
607  |  BCL9  |  DISEASES
7799  |  PRDM2  |  DISEASES
7799  |  PRDM2  |  DISEASES
10352  |  WARS2  |  DISEASES
10352  |  WARS2  |  DISEASES
6402  |  SELL  |  DISEASES
6402  |  SELL  |  DISEASES
1509  |  CTSD  |  DISEASES
1509  |  CTSD  |  DISEASES
4317  |  MMP8  |  DISEASES
4317  |  MMP8  |  DISEASES
335  |  APOA1  |  DISEASES
335  |  APOA1  |  DISEASES
7276  |  TTR  |  DISEASES
7276  |  TTR  |  DISEASES
9429  |  ABCG2  |  DISEASES
9429  |  ABCG2  |  DISEASES
81932  |  HDHD3  |  DISEASES
81932  |  HDHD3  |  DISEASES
7043  |  TGFB3  |  DISEASES
7043  |  TGFB3  |  DISEASES
23433  |  RHOQ  |  DISEASES
23433  |  RHOQ  |  DISEASES
3218  |  HOXB8  |  DISEASES
3218  |  HOXB8  |  DISEASES
3217  |  HOXB7  |  DISEASES
3217  |  HOXB7  |  DISEASES
1843  |  DUSP1  |  DISEASES
1843  |  DUSP1  |  DISEASES
4360  |  MRC1  |  DISEASES
4360  |  MRC1  |  DISEASES
1958  |  EGR1  |  DISEASES
1958  |  EGR1  |  DISEASES
7976  |  FZD3  |  DISEASES
7976  |  FZD3  |  DISEASES
1846  |  DUSP4  |  DISEASES
1846  |  DUSP4  |  DISEASES
847  |  CAT  |  DISEASES
847  |  CAT  |  DISEASES
8743  |  TNFSF10  |  DISEASES
8743  |  TNFSF10  |  DISEASES
2946  |  GSTM2  |  DISEASES
2946  |  GSTM2  |  DISEASES
92  |  ACVR2A  |  DISEASES
92  |  ACVR2A  |  DISEASES
2322  |  FLT3  |  DISEASES
2322  |  FLT3  |  DISEASES
3624  |  INHBA  |  DISEASES
3624  |  INHBA  |  DISEASES
7291  |  TWIST1  |  DISEASES
7291  |  TWIST1  |  DISEASES
7374  |  UNG  |  DISEASES
7374  |  UNG  |  DISEASES
84292  |  WDR83  |  DISEASES
84292  |  WDR83  |  DISEASES
5335  |  PLCG1  |  DISEASES
5335  |  PLCG1  |  DISEASES
57403  |  RAB22A  |  DISEASES
57403  |  RAB22A  |  DISEASES
5740  |  PTGIS  |  DISEASES
5740  |  PTGIS  |  DISEASES
6615  |  SNAI1  |  DISEASES
6615  |  SNAI1  |  DISEASES
27189  |  IL17C  |  DISEASES
27189  |  IL17C  |  DISEASES
27076  |  LYPD3  |  DISEASES
27076  |  LYPD3  |  DISEASES
1088  |  CEACAM8  |  DISEASES
1088  |  CEACAM8  |  DISEASES
1026  |  CDKN1A  |  DISEASES
1026  |  CDKN1A  |  DISEASES
6659  |  SOX4  |  DISEASES
6659  |  SOX4  |  DISEASES
2069  |  EREG  |  DISEASES
2069  |  EREG  |  DISEASES
4502  |  MT2A  |  DISEASES
4502  |  MT2A  |  DISEASES
2806  |  GOT2  |  DISEASES
2806  |  GOT2  |  DISEASES
56848  |  SPHK2  |  DISEASES
56848  |  SPHK2  |  DISEASES
9271  |  PIWIL1  |  DISEASES
9271  |  PIWIL1  |  DISEASES
6555  |  SLC10A2  |  DISEASES
6555  |  SLC10A2  |  DISEASES
1948  |  EFNB2  |  DISEASES
1948  |  EFNB2  |  DISEASES
3659  |  IRF1  |  DISEASES
652  |  BMP4  |  DISEASES
652  |  BMP4  |  DISEASES
5732  |  PTGER2  |  DISEASES
5732  |  PTGER2  |  DISEASES
6662  |  SOX9  |  DISEASES
6662  |  SOX9  |  DISEASES
51081  |  MRPS7  |  DISEASES
51081  |  MRPS7  |  DISEASES
8744  |  TNFSF9  |  DISEASES
8744  |  TNFSF9  |  DISEASES
2354  |  FOSB  |  DISEASES
2354  |  FOSB  |  DISEASES
7408  |  VASP  |  DISEASES
7408  |  VASP  |  DISEASES
994  |  CDC25B  |  DISEASES
994  |  CDC25B  |  DISEASES
11034  |  DSTN  |  DISEASES
11034  |  DSTN  |  DISEASES
2867  |  FFAR2  |  DISEASES
2867  |  FFAR2  |  DISEASES
1236  |  CCR7  |  DISEASES
1236  |  CCR7  |  DISEASES
83596  |  BCL2L12  |  DISEASES
83596  |  BCL2L12  |  DISEASES
7355  |  SLC35A2  |  DISEASES
7355  |  SLC35A2  |  DISEASES
9787  |  DLGAP5  |  DISEASES
9787  |  DLGAP5  |  DISEASES
7103  |  TSPAN8  |  DISEASES
7103  |  TSPAN8  |  DISEASES
390892  |  OR7A10  |  DISEASES
390892  |  OR7A10  |  DISEASES
26664  |  OR7C1  |  DISEASES
26664  |  OR7C1  |  DISEASES
7429  |  VIL1  |  DISEASES
7429  |  VIL1  |  DISEASES
3315  |  HSPB1  |  DISEASES
3315  |  HSPB1  |  DISEASES
2678  |  GGT1  |  DISEASES
2678  |  GGT1  |  DISEASES
2952  |  GSTT1  |  DISEASES
2952  |  GSTT1  |  DISEASES
22933  |  SIRT2  |  DISEASES
22933  |  SIRT2  |  DISEASES
3236  |  HOXD10  |  DISEASES
3236  |  HOXD10  |  DISEASES
54567  |  DLL4  |  DISEASES
54567  |  DLL4  |  DISEASES
51421  |  AMOTL2  |  DISEASES
51421  |  AMOTL2  |  DISEASES
8930  |  MBD4  |  DISEASES
8930  |  MBD4  |  DISEASES
4654  |  MYOD1  |  DISEASES
4654  |  MYOD1  |  DISEASES
968  |  CD68  |  DISEASES
968  |  CD68  |  DISEASES
84817  |  TXNDC17  |  DISEASES
84817  |  TXNDC17  |  DISEASES
79148  |  MMP28  |  DISEASES
79148  |  MMP28  |  DISEASES
6351  |  CCL4  |  DISEASES
6351  |  CCL4  |  DISEASES
8840  |  WISP1  |  DISEASES
8840  |  WISP1  |  DISEASES
81890  |  QTRT1  |  DISEASES
81890  |  QTRT1  |  DISEASES
112399  |  EGLN3  |  DISEASES
112399  |  EGLN3  |  DISEASES
4738  |  NEDD8  |  DISEASES
4738  |  NEDD8  |  DISEASES
5908  |  RAP1B  |  DISEASES
5908  |  RAP1B  |  DISEASES
417  |  ART1  |  DISEASES
417  |  ART1  |  DISEASES
9426  |  CDY2A  |  DISEASES
9426  |  CDY2A  |  DISEASES
3630  |  INS  |  DISEASES
3630  |  INS  |  DISEASES
239  |  ALOX12  |  DISEASES
239  |  ALOX12  |  DISEASES
5894  |  RAF1  |  DISEASES
5894  |  RAF1  |  DISEASES
1890  |  TYMP  |  DISEASES
1890  |  TYMP  |  DISEASES
80317  |  ZKSCAN3  |  DISEASES
80317  |  ZKSCAN3  |  DISEASES
3852  |  KRT5  |  DISEASES
83878  |  USHBP1  |  DISEASES
83878  |  USHBP1  |  DISEASES
2527  |  FUT5  |  DISEASES
2527  |  FUT5  |  DISEASES
2056  |  EPO  |  DISEASES
2056  |  EPO  |  DISEASES
9518  |  GDF15  |  DISEASES
9518  |  GDF15  |  DISEASES
1571  |  CYP2E1  |  DISEASES
1571  |  CYP2E1  |  DISEASES
140628  |  GATA5  |  DISEASES
140628  |  GATA5  |  DISEASES
3911  |  LAMA5  |  DISEASES
3911  |  LAMA5  |  DISEASES
11047  |  ADRM1  |  DISEASES
11047  |  ADRM1  |  DISEASES
10155  |  TRIM28  |  DISEASES
10155  |  TRIM28  |  DISEASES
1968  |  EIF2S3  |  DISEASES
1968  |  EIF2S3  |  DISEASES
4294  |  MAP3K10  |  DISEASES
4294  |  MAP3K10  |  DISEASES
83667  |  SESN2  |  DISEASES
83667  |  SESN2  |  DISEASES
9590  |  AKAP12  |  DISEASES
9590  |  AKAP12  |  DISEASES
9113  |  LATS1  |  DISEASES
9113  |  LATS1  |  DISEASES
9584  |  RBM39  |  DISEASES
9584  |  RBM39  |  DISEASES
51659  |  GINS2  |  DISEASES
51659  |  GINS2  |  DISEASES
9476  |  NAPSA  |  DISEASES
9476  |  NAPSA  |  DISEASES
47  |  ACLY  |  DISEASES
47  |  ACLY  |  DISEASES
84951  |  TNS4  |  DISEASES
84951  |  TNS4  |  DISEASES
8431  |  NR0B2  |  DISEASES
8431  |  NR0B2  |  DISEASES
79727  |  LIN28A  |  DISEASES
79727  |  LIN28A  |  DISEASES
85415  |  RHPN2  |  DISEASES
85415  |  RHPN2  |  DISEASES
3958  |  LGALS3  |  DISEASES
3958  |  LGALS3  |  DISEASES
90592  |  ZNF700  |  DISEASES
90592  |  ZNF700  |  DISEASES
65249  |  ZSWIM4  |  DISEASES
65249  |  ZSWIM4  |  DISEASES
6382  |  SDC1  |  DISEASES
6382  |  SDC1  |  DISEASES
23647  |  ARFIP2  |  DISEASES
55037  |  PTCD3  |  DISEASES
55037  |  PTCD3  |  DISEASES
8864  |  PER2  |  DISEASES
8864  |  PER2  |  DISEASES
10902  |  BRD8  |  DISEASES
10902  |  BRD8  |  DISEASES
182  |  JAG1  |  DISEASES
182  |  JAG1  |  DISEASES
1401  |  CRP  |  DISEASES
1401  |  CRP  |  DISEASES
23743  |  BHMT2  |  DISEASES
23743  |  BHMT2  |  DISEASES
8170  |  SLC14A2  |  DISEASES
8170  |  SLC14A2  |  DISEASES
1131  |  CHRM3  |  DISEASES
1131  |  CHRM3  |  DISEASES
1116  |  CHI3L1  |  DISEASES
1116  |  CHI3L1  |  DISEASES
9201  |  DCLK1  |  DISEASES
9201  |  DCLK1  |  DISEASES
4922  |  NTS  |  DISEASES
4922  |  NTS  |  DISEASES
3845  |  KRAS  |  DISEASES
3845  |  KRAS  |  DISEASES
10526  |  IPO8  |  DISEASES
10526  |  IPO8  |  DISEASES
759  |  CA1  |  DISEASES
759  |  CA1  |  DISEASES
10894  |  LYVE1  |  DISEASES
10894  |  LYVE1  |  DISEASES
1965  |  EIF2S1  |  DISEASES
1965  |  EIF2S1  |  DISEASES
157310  |  PEBP4  |  DISEASES
157310  |  PEBP4  |  DISEASES
27299  |  ADAMDEC1  |  DISEASES
27299  |  ADAMDEC1  |  DISEASES
891  |  CCNB1  |  DISEASES
891  |  CCNB1  |  DISEASES
10752  |  CHL1  |  DISEASES
10752  |  CHL1  |  DISEASES
83998  |  REG4  |  DISEASES
83998  |  REG4  |  DISEASES
2949  |  GSTM5  |  DISEASES
2949  |  GSTM5  |  DISEASES
2947  |  GSTM3  |  DISEASES
2947  |  GSTM3  |  DISEASES
4853  |  NOTCH2  |  DISEASES
4853  |  NOTCH2  |  DISEASES
2922  |  GRP  |  DISEASES
2922  |  GRP  |  DISEASES
902  |  CCNH  |  DISEASES
902  |  CCNH  |  DISEASES
91768  |  CABLES1  |  DISEASES
91768  |  CABLES1  |  DISEASES
10599  |  SLCO1B1  |  DISEASES
10599  |  SLCO1B1  |  DISEASES
2346  |  FOLH1  |  DISEASES
2346  |  FOLH1  |  DISEASES
6947  |  TCN1  |  DISEASES
6947  |  TCN1  |  DISEASES
5156  |  PDGFRA  |  DISEASES
5156  |  PDGFRA  |  DISEASES
22873  |  DZIP1  |  DISEASES
22873  |  DZIP1  |  DISEASES
324  |  APC  |  DISEASES
324  |  APC  |  DISEASES
301  |  ANXA1  |  DISEASES
301  |  ANXA1  |  DISEASES
8728  |  ADAM19  |  DISEASES
8728  |  ADAM19  |  DISEASES
4440  |  MSI1  |  DISEASES
4440  |  MSI1  |  DISEASES
4907  |  NT5E  |  DISEASES
4907  |  NT5E  |  DISEASES
79056  |  PRRG4  |  DISEASES
79056  |  PRRG4  |  DISEASES
1019  |  CDK4  |  DISEASES
1019  |  CDK4  |  DISEASES
80326  |  WNT10A  |  DISEASES
80326  |  WNT10A  |  DISEASES
1593  |  CYP27A1  |  DISEASES
1593  |  CYP27A1  |  DISEASES
10643  |  IGF2BP3  |  DISEASES
10643  |  IGF2BP3  |  DISEASES
3569  |  IL6  |  DISEASES
3569  |  IL6  |  DISEASES
10241  |  CALCOCO2  |  DISEASES
10241  |  CALCOCO2  |  DISEASES
4836  |  NMT1  |  DISEASES
4836  |  NMT1  |  DISEASES
6426  |  SRSF1  |  DISEASES
6426  |  SRSF1  |  DISEASES
6366  |  CCL21  |  DISEASES
6366  |  CCL21  |  DISEASES
8737  |  RIPK1  |  DISEASES
8737  |  RIPK1  |  DISEASES
5460  |  POU5F1  |  DISEASES
5460  |  POU5F1  |  DISEASES
7097  |  TLR2  |  DISEASES
7097  |  TLR2  |  DISEASES
8836  |  GGH  |  DISEASES
8836  |  GGH  |  DISEASES
23213  |  SULF1  |  DISEASES
23213  |  SULF1  |  DISEASES
4316  |  MMP7  |  DISEASES
4316  |  MMP7  |  DISEASES
4322  |  MMP13  |  DISEASES
4322  |  MMP13  |  DISEASES
7057  |  THBS1  |  DISEASES
7057  |  THBS1  |  DISEASES
56924  |  PAK6  |  DISEASES
56924  |  PAK6  |  DISEASES
102  |  ADAM10  |  DISEASES
102  |  ADAM10  |  DISEASES
1588  |  CYP19A1  |  DISEASES
1588  |  CYP19A1  |  DISEASES
1545  |  CYP1B1  |  DISEASES
1545  |  CYP1B1  |  DISEASES
1559  |  CYP2C9  |  DISEASES
1559  |  CYP2C9  |  DISEASES
51196  |  PLCE1  |  DISEASES
51196  |  PLCE1  |  DISEASES
23314  |  SATB2  |  DISEASES
23314  |  SATB2  |  DISEASES
580  |  BARD1  |  DISEASES
580  |  BARD1  |  DISEASES
9360  |  PPIG  |  DISEASES
9360  |  PPIG  |  DISEASES
3685  |  ITGAV  |  DISEASES
3685  |  ITGAV  |  DISEASES
2984  |  GUCY2C  |  DISEASES
2984  |  GUCY2C  |  DISEASES
28234  |  SLCO1B3  |  DISEASES
28234  |  SLCO1B3  |  DISEASES
11213  |  IRAK3  |  DISEASES
11213  |  IRAK3  |  DISEASES
894  |  CCND2  |  DISEASES
894  |  CCND2  |  DISEASES
4069  |  LYZ  |  DISEASES
4069  |  LYZ  |  DISEASES
5037  |  PEBP1  |  DISEASES
5037  |  PEBP1  |  DISEASES
4040  |  LRP6  |  DISEASES
4040  |  LRP6  |  DISEASES
4001  |  LMNB1  |  DISEASES
4001  |  LMNB1  |  DISEASES
9956  |  HS3ST2  |  DISEASES
9956  |  HS3ST2  |  DISEASES
9891  |  NUAK1  |  DISEASES
9891  |  NUAK1  |  DISEASES
7450  |  VWF  |  DISEASES
7450  |  VWF  |  DISEASES
5629  |  PROX1  |  DISEASES
5629  |  PROX1  |  DISEASES
23326  |  USP22  |  DISEASES
23326  |  USP22  |  DISEASES
6095  |  RORA  |  DISEASES
6095  |  RORA  |  DISEASES
1800  |  DPEP1  |  DISEASES
1800  |  DPEP1  |  DISEASES
8140  |  SLC7A5  |  DISEASES
8140  |  SLC7A5  |  DISEASES
8099  |  CDK2AP1  |  DISEASES
8099  |  CDK2AP1  |  DISEASES
217  |  ALDH2  |  DISEASES
217  |  ALDH2  |  DISEASES
999  |  CDH1  |  DISEASES
999  |  CDH1  |  DISEASES
5159  |  PDGFRB  |  DISEASES
5159  |  PDGFRB  |  DISEASES
54962  |  TIPIN  |  DISEASES
54962  |  TIPIN  |  DISEASES
4756  |  NEO1  |  DISEASES
4756  |  NEO1  |  DISEASES
2324  |  FLT4  |  DISEASES
2324  |  FLT4  |  DISEASES
3690  |  ITGB3  |  DISEASES
3690  |  ITGB3  |  DISEASES
506  |  ATP5B  |  DISEASES
506  |  ATP5B  |  DISEASES
23531  |  MMD  |  DISEASES
23531  |  MMD  |  DISEASES
57509  |  MTUS1  |  DISEASES
57509  |  MTUS1  |  DISEASES
4173  |  MCM4  |  DISEASES
57045  |  TWSG1  |  DISEASES
57045  |  TWSG1  |  DISEASES
4092  |  SMAD7  |  DISEASES
4092  |  SMAD7  |  DISEASES
4087  |  SMAD2  |  DISEASES
4087  |  SMAD2  |  DISEASES
312  |  ANXA13  |  DISEASES
312  |  ANXA13  |  DISEASES
7528  |  YY1  |  DISEASES
7528  |  YY1  |  DISEASES
81671  |  VMP1  |  DISEASES
81671  |  VMP1  |  DISEASES
63922  |  CHTF18  |  DISEASES
63922  |  CHTF18  |  DISEASES
8312  |  AXIN1  |  DISEASES
8312  |  AXIN1  |  DISEASES
1387  |  CREBBP  |  DISEASES
1387  |  CREBBP  |  DISEASES
2294  |  FOXF1  |  DISEASES
2294  |  FOXF1  |  DISEASES
6416  |  MAP2K4  |  DISEASES
6416  |  MAP2K4  |  DISEASES
6558  |  SLC12A2  |  DISEASES
6558  |  SLC12A2  |  DISEASES
2201  |  FBN2  |  DISEASES
2201  |  FBN2  |  DISEASES
23361  |  ZNF629  |  DISEASES
23361  |  ZNF629  |  DISEASES
9368  |  SLC9A3R1  |  DISEASES
9368  |  SLC9A3R1  |  DISEASES
495  |  ATP4A  |  DISEASES
495  |  ATP4A  |  DISEASES
898  |  CCNE1  |  DISEASES
898  |  CCNE1  |  DISEASES
23239  |  PHLPP1  |  DISEASES
23239  |  PHLPP1  |  DISEASES
5465  |  PPARA  |  DISEASES
5465  |  PPARA  |  DISEASES
8503  |  PIK3R3  |  DISEASES
8503  |  PIK3R3  |  DISEASES
5052  |  PRDX1  |  DISEASES
5052  |  PRDX1  |  DISEASES
7077  |  TIMP2  |  DISEASES
7077  |  TIMP2  |  DISEASES
3959  |  LGALS3BP  |  DISEASES
3959  |  LGALS3BP  |  DISEASES
25939  |  SAMHD1  |  DISEASES
25939  |  SAMHD1  |  DISEASES
7515  |  XRCC1  |  DISEASES
7515  |  XRCC1  |  DISEASES
1871  |  E2F3  |  DISEASES
1871  |  E2F3  |  DISEASES
6487  |  ST3GAL3  |  DISEASES
6487  |  ST3GAL3  |  DISEASES
10156  |  RASA4  |  DISEASES
10156  |  RASA4  |  DISEASES
10552  |  ARPC1A  |  DISEASES
10552  |  ARPC1A  |  DISEASES
5605  |  MAP2K2  |  DISEASES
5605  |  MAP2K2  |  DISEASES
1434  |  CSE1L  |  DISEASES
1434  |  CSE1L  |  DISEASES
5595  |  MAPK3  |  DISEASES
5595  |  MAPK3  |  DISEASES
5338  |  PLD2  |  DISEASES
5338  |  PLD2  |  DISEASES
1109  |  AKR1C4  |  DISEASES
1109  |  AKR1C4  |  DISEASES
54487  |  DGCR8  |  DISEASES
54487  |  DGCR8  |  DISEASES
6855  |  SYP  |  DISEASES
6855  |  SYP  |  DISEASES
2033  |  EP300  |  DISEASES
2033  |  EP300  |  DISEASES
3552  |  IL1A  |  DISEASES
3552  |  IL1A  |  DISEASES
3553  |  IL1B  |  DISEASES
3553  |  IL1B  |  DISEASES
4854  |  NOTCH3  |  DISEASES
4854  |  NOTCH3  |  DISEASES
330  |  BIRC3  |  DISEASES
330  |  BIRC3  |  DISEASES
1991  |  ELANE  |  DISEASES
1991  |  ELANE  |  DISEASES
25927  |  CNRIP1  |  DISEASES
25927  |  CNRIP1  |  DISEASES
9014  |  TAF1B  |  DISEASES
9014  |  TAF1B  |  DISEASES
25884  |  CHRDL2  |  DISEASES
25884  |  CHRDL2  |  DISEASES
9828  |  ARHGEF17  |  DISEASES
9828  |  ARHGEF17  |  DISEASES
10714  |  POLD3  |  DISEASES
10714  |  POLD3  |  DISEASES
6403  |  SELP  |  DISEASES
6403  |  SELP  |  DISEASES
2034  |  EPAS1  |  DISEASES
2034  |  EPAS1  |  DISEASES
4072  |  EPCAM  |  DISEASES
4072  |  EPCAM  |  DISEASES
440275  |  EIF2AK4  |  DISEASES
3574  |  IL7  |  DISEASES
3574  |  IL7  |  DISEASES
390  |  RND3  |  DISEASES
390  |  RND3  |  DISEASES
55850  |  USE1  |  DISEASES
55850  |  USE1  |  DISEASES
3791  |  KDR  |  DISEASES
3791  |  KDR  |  DISEASES
5290  |  PIK3CA  |  DISEASES
5290  |  PIK3CA  |  DISEASES
23301  |  EHBP1  |  DISEASES
23301  |  EHBP1  |  DISEASES
10664  |  CTCF  |  DISEASES
10664  |  CTCF  |  DISEASES
1001  |  CDH3  |  DISEASES
1001  |  CDH3  |  DISEASES
1656  |  DDX6  |  DISEASES
1656  |  DDX6  |  DISEASES
4162  |  MCAM  |  DISEASES
4162  |  MCAM  |  DISEASES
60482  |  SLC5A7  |  DISEASES
60482  |  SLC5A7  |  DISEASES
10382  |  TUBB4A  |  DISEASES
10382  |  TUBB4A  |  DISEASES
3918  |  LAMC2  |  DISEASES
3918  |  LAMC2  |  DISEASES
3938  |  LCT  |  DISEASES
3938  |  LCT  |  DISEASES
10874  |  NMU  |  DISEASES
10874  |  NMU  |  DISEASES
941  |  CD80  |  DISEASES
941  |  CD80  |  DISEASES
7531  |  YWHAE  |  DISEASES
7531  |  YWHAE  |  DISEASES
57575  |  PCDH10  |  DISEASES
57575  |  PCDH10  |  DISEASES
64579  |  NDST4  |  DISEASES
64579  |  NDST4  |  DISEASES
374  |  AREG  |  DISEASES
374  |  AREG  |  DISEASES
59067  |  IL21  |  DISEASES
59067  |  IL21  |  DISEASES
2247  |  FGF2  |  DISEASES
2247  |  FGF2  |  DISEASES
3589  |  IL11  |  DISEASES
3589  |  IL11  |  DISEASES
658  |  BMPR1B  |  DISEASES
658  |  BMPR1B  |  DISEASES
7474  |  WNT5A  |  DISEASES
7474  |  WNT5A  |  DISEASES
6774  |  STAT3  |  DISEASES
6774  |  STAT3  |  DISEASES
84961  |  FBXL20  |  DISEASES
84961  |  FBXL20  |  DISEASES
4552  |  MTRR  |  DISEASES
4552  |  MTRR  |  DISEASES
1788  |  DNMT3A  |  DISEASES
1788  |  DNMT3A  |  DISEASES
8626  |  TP63  |  DISEASES
8626  |  TP63  |  DISEASES
53834  |  FGFRL1  |  DISEASES
53834  |  FGFRL1  |  DISEASES
3383  |  ICAM1  |  DISEASES
3383  |  ICAM1  |  DISEASES
306  |  ANXA3  |  DISEASES
306  |  ANXA3  |  DISEASES
28990  |  ASTE1  |  DISEASES
28990  |  ASTE1  |  DISEASES
11343  |  MGLL  |  DISEASES
11343  |  MGLL  |  DISEASES
4171  |  MCM2  |  DISEASES
4171  |  MCM2  |  DISEASES
64083  |  GOLPH3  |  DISEASES
64083  |  GOLPH3  |  DISEASES
1462  |  VCAN  |  DISEASES
1462  |  VCAN  |  DISEASES
4437  |  MSH3  |  DISEASES
4437  |  MSH3  |  DISEASES
80315  |  CPEB4  |  DISEASES
80315  |  CPEB4  |  DISEASES
8614  |  STC2  |  DISEASES
8614  |  STC2  |  DISEASES
839  |  CASP6  |  DISEASES
839  |  CASP6  |  DISEASES
51176  |  LEF1  |  DISEASES
51176  |  LEF1  |  DISEASES
1950  |  EGF  |  DISEASES
1950  |  EGF  |  DISEASES
9061  |  PAPSS1  |  DISEASES
9061  |  PAPSS1  |  DISEASES
64374  |  SIL1  |  DISEASES
64374  |  SIL1  |  DISEASES
7416  |  VDAC1  |  DISEASES
7416  |  VDAC1  |  DISEASES
5307  |  PITX1  |  DISEASES
5307  |  PITX1  |  DISEASES
57510  |  XPO5  |  DISEASES
57510  |  XPO5  |  DISEASES
8829  |  NRP1  |  DISEASES
8829  |  NRP1  |  DISEASES
1390  |  CREM  |  DISEASES
1390  |  CREM  |  DISEASES
320  |  APBA1  |  DISEASES
320  |  APBA1  |  DISEASES
5423  |  POLB  |  DISEASES
5423  |  POLB  |  DISEASES
7472  |  WNT2  |  DISEASES
7472  |  WNT2  |  DISEASES
311  |  ANXA11  |  DISEASES
311  |  ANXA11  |  DISEASES
25824  |  PRDX5  |  DISEASES
25824  |  PRDX5  |  DISEASES
127  |  ADH4  |  DISEASES
127  |  ADH4  |  DISEASES
27074  |  LAMP3  |  DISEASES
27074  |  LAMP3  |  DISEASES
51083  |  GAL  |  DISEASES
51083  |  GAL  |  DISEASES
1119  |  CHKA  |  DISEASES
1119  |  CHKA  |  DISEASES
5243  |  ABCB1  |  DISEASES
5243  |  ABCB1  |  DISEASES
6717  |  SRI  |  DISEASES
6717  |  SRI  |  DISEASES
1021  |  CDK6  |  DISEASES
1021  |  CDK6  |  DISEASES
5218  |  CDK14  |  DISEASES
5218  |  CDK14  |  DISEASES
7458  |  EIF4H  |  DISEASES
7458  |  EIF4H  |  DISEASES
29999  |  FSCN3  |  DISEASES
29999  |  FSCN3  |  DISEASES
5395  |  PMS2  |  DISEASES
5395  |  PMS2  |  DISEASES
3189  |  HNRNPH3  |  DISEASES
3189  |  HNRNPH3  |  DISEASES
6585  |  SLIT1  |  DISEASES
6585  |  SLIT1  |  DISEASES
6425  |  SFRP5  |  DISEASES
6425  |  SFRP5  |  DISEASES
24148  |  PRPF6  |  DISEASES
24148  |  PRPF6  |  DISEASES
7078  |  TIMP3  |  DISEASES
7078  |  TIMP3  |  DISEASES
939  |  CD27  |  DISEASES
939  |  CD27  |  DISEASES
8549  |  LGR5  |  DISEASES
8549  |  LGR5  |  DISEASES
374462  |  PTPRQ  |  DISEASES
374462  |  PTPRQ  |  DISEASES
4060  |  LUM  |  DISEASES
4060  |  LUM  |  DISEASES
1017  |  CDK2  |  DISEASES
1017  |  CDK2  |  DISEASES
2065  |  ERBB3  |  DISEASES
2065  |  ERBB3  |  DISEASES
5925  |  RB1  |  DISEASES
5925  |  RB1  |  DISEASES
2252  |  FGF7  |  DISEASES
2252  |  FGF7  |  DISEASES
597  |  BCL2A1  |  DISEASES
597  |  BCL2A1  |  DISEASES
3480  |  IGF1R  |  DISEASES
3480  |  IGF1R  |  DISEASES
11057  |  ABHD2  |  DISEASES
11057  |  ABHD2  |  DISEASES
4240  |  MFGE8  |  DISEASES
4240  |  MFGE8  |  DISEASES
5045  |  FURIN  |  DISEASES
5045  |  FURIN  |  DISEASES
8826  |  IQGAP1  |  DISEASES
8826  |  IQGAP1  |  DISEASES
3687  |  ITGAX  |  DISEASES
3687  |  ITGAX  |  DISEASES
85407  |  NKD1  |  DISEASES
85407  |  NKD1  |  DISEASES
283927  |  NUDT7  |  DISEASES
283927  |  NUDT7  |  DISEASES
81631  |  MAP1LC3B  |  DISEASES
81631  |  MAP1LC3B  |  DISEASES
284086  |  NEK8  |  DISEASES
284086  |  NEK8  |  DISEASES
1000  |  CDH2  |  DISEASES
1000  |  CDH2  |  DISEASES
2627  |  GATA6  |  DISEASES
2627  |  GATA6  |  DISEASES
7157  |  TP53  |  DISEASES
7157  |  TP53  |  DISEASES
55520  |  ELAC1  |  DISEASES
55520  |  ELAC1  |  DISEASES
2064  |  ERBB2  |  DISEASES
2064  |  ERBB2  |  DISEASES
3487  |  IGFBP4  |  DISEASES
3487  |  IGFBP4  |  DISEASES
207  |  AKT1  |  DISEASES
207  |  AKT1  |  DISEASES
126147  |  NTN5  |  DISEASES
126147  |  NTN5  |  DISEASES
114783  |  LMTK3  |  DISEASES
114783  |  LMTK3  |  DISEASES
9032  |  TM4SF5  |  DISEASES
9032  |  TM4SF5  |  DISEASES
49856  |  WRAP73  |  DISEASES
49856  |  WRAP73  |  DISEASES
5686  |  PSMA5  |  DISEASES
5686  |  PSMA5  |  DISEASES
84432  |  PROK1  |  DISEASES
84432  |  PROK1  |  DISEASES
2212  |  FCGR2A  |  DISEASES
2212  |  FCGR2A  |  DISEASES
6282  |  S100A11  |  DISEASES
6282  |  S100A11  |  DISEASES
29956  |  CERS2  |  DISEASES
29956  |  CERS2  |  DISEASES
55204  |  GOLPH3L  |  DISEASES
55204  |  GOLPH3L  |  DISEASES
7483  |  WNT9A  |  DISEASES
7483  |  WNT9A  |  DISEASES
2052  |  EPHX1  |  DISEASES
2052  |  EPHX1  |  DISEASES
388  |  RHOB  |  DISEASES
388  |  RHOB  |  DISEASES
805  |  CALM2  |  DISEASES
805  |  CALM2  |  DISEASES
23671  |  TMEFF2  |  DISEASES
23671  |  TMEFF2  |  DISEASES
890  |  CCNA2  |  DISEASES
890  |  CCNA2  |  DISEASES
6423  |  SFRP2  |  DISEASES
6423  |  SFRP2  |  DISEASES
6502  |  SKP2  |  DISEASES
6502  |  SKP2  |  DISEASES
9180  |  OSMR  |  DISEASES
9180  |  OSMR  |  DISEASES
5295  |  PIK3R1  |  DISEASES
5295  |  PIK3R1  |  DISEASES
1404  |  HAPLN1  |  DISEASES
1404  |  HAPLN1  |  DISEASES
5921  |  RASA1  |  DISEASES
5921  |  RASA1  |  DISEASES
8817  |  FGF18  |  DISEASES
8817  |  FGF18  |  DISEASES
10667  |  FARS2  |  DISEASES
10667  |  FARS2  |  DISEASES
4594  |  MUT  |  DISEASES
4594  |  MUT  |  DISEASES
6581  |  SLC22A3  |  DISEASES
6581  |  SLC22A3  |  DISEASES
1956  |  EGFR  |  DISEASES
1956  |  EGFR  |  DISEASES
3484  |  IGFBP1  |  DISEASES
3484  |  IGFBP1  |  DISEASES
5723  |  PSPH  |  DISEASES
5723  |  PSPH  |  DISEASES
2041  |  EPHA1  |  DISEASES
2041  |  EPHA1  |  DISEASES
56548  |  CHST7  |  DISEASES
56548  |  CHST7  |  DISEASES
4841  |  NONO  |  DISEASES
4841  |  NONO  |  DISEASES
10395  |  DLC1  |  DISEASES
10395  |  DLC1  |  DISEASES
8795  |  TNFRSF10B  |  DISEASES
8795  |  TNFRSF10B  |  DISEASES
84296  |  GINS4  |  DISEASES
84296  |  GINS4  |  DISEASES
340419  |  RSPO2  |  DISEASES
340419  |  RSPO2  |  DISEASES
56169  |  GSDMC  |  DISEASES
56169  |  GSDMC  |  DISEASES
1030  |  CDKN2B  |  DISEASES
1030  |  CDKN2B  |  DISEASES
3439  |  IFNA1  |  DISEASES
3439  |  IFNA1  |  DISEASES
4915  |  NTRK2  |  DISEASES
4915  |  NTRK2  |  DISEASES
3934  |  LCN2  |  DISEASES
3934  |  LCN2  |  DISEASES
4851  |  NOTCH1  |  DISEASES
4851  |  NOTCH1  |  DISEASES
79741  |  CCDC7  |  DISEASES
79741  |  CCDC7  |  DISEASES
196743  |  PAOX  |  DISEASES
196743  |  PAOX  |  DISEASES
2620  |  GAS2  |  DISEASES
2620  |  GAS2  |  DISEASES
5058  |  PAK1  |  DISEASES
5058  |  PAK1  |  DISEASES
472  |  ATM  |  DISEASES
472  |  ATM  |  DISEASES
6768  |  ST14  |  DISEASES
6768  |  ST14  |  DISEASES
9219  |  MTA2  |  DISEASES
9219  |  MTA2  |  DISEASES
6876  |  TAGLN  |  DISEASES
6876  |  TAGLN  |  DISEASES
81928  |  CABLES2  |  DISEASES
81928  |  CABLES2  |  DISEASES
1848  |  DUSP6  |  DISEASES
1848  |  DUSP6  |  DISEASES
27250  |  PDCD4  |  DISEASES
27250  |  PDCD4  |  DISEASES
7424  |  VEGFC  |  DISEASES
7424  |  VEGFC  |  DISEASES
10666  |  CD226  |  DISEASES
10666  |  CD226  |  DISEASES
220047  |  CCDC83  |  DISEASES
220047  |  CCDC83  |  DISEASES
341032  |  C11orf53  |  DISEASES
341032  |  C11orf53  |  DISEASES
3606  |  IL18  |  DISEASES
3606  |  IL18  |  DISEASES
5805  |  PTS  |  DISEASES
5805  |  PTS  |  DISEASES
23657  |  SLC7A11  |  DISEASES
23657  |  SLC7A11  |  DISEASES
3948  |  LDHC  |  DISEASES
3948  |  LDHC  |  DISEASES
196463  |  PLBD2  |  DISEASES
196463  |  PLBD2  |  DISEASES
4613  |  MYCN  |  DISEASES
4613  |  MYCN  |  DISEASES
5281  |  PIGF  |  DISEASES
5281  |  PIGF  |  DISEASES
2180  |  ACSL1  |  DISEASES
2180  |  ACSL1  |  DISEASES
7082  |  TJP1  |  DISEASES
7082  |  TJP1  |  DISEASES
55294  |  FBXW7  |  DISEASES
55294  |  FBXW7  |  DISEASES
57105  |  CYSLTR2  |  DISEASES
57105  |  CYSLTR2  |  DISEASES
115761  |  ARL11  |  DISEASES
115761  |  ARL11  |  DISEASES
498  |  ATP5A1  |  DISEASES
498  |  ATP5A1  |  DISEASES
83439  |  TCF7L1  |  DISEASES
83439  |  TCF7L1  |  DISEASES
2321  |  FLT1  |  DISEASES
2321  |  FLT1  |  DISEASES
10413  |  YAP1  |  DISEASES
10413  |  YAP1  |  DISEASES
2697  |  GJA1  |  DISEASES
2697  |  GJA1  |  DISEASES
3672  |  ITGA1  |  DISEASES
3672  |  ITGA1  |  DISEASES
347732  |  CATSPER3  |  DISEASES
347732  |  CATSPER3  |  DISEASES
651  |  BMP3  |  DISEASES
651  |  BMP3  |  DISEASES
3087  |  HHEX  |  DISEASES
3087  |  HHEX  |  DISEASES
5801  |  PTPRR  |  DISEASES
5801  |  PTPRR  |  DISEASES
3694  |  ITGB6  |  DISEASES
3694  |  ITGB6  |  DISEASES
6317  |  SERPINB3  |  DISEASES
7345  |  UCHL1  |  DISEASES
7345  |  UCHL1  |  DISEASES
252969  |  NEIL2  |  DISEASES
252969  |  NEIL2  |  DISEASES
89780  |  WNT3A  |  DISEASES
89780  |  WNT3A  |  DISEASES
221357  |  GSTA5  |  DISEASES
221357  |  GSTA5  |  DISEASES
126731  |  CCSAP  |  DISEASES
126731  |  CCSAP  |  DISEASES
55760  |  DHX32  |  DISEASES
55760  |  DHX32  |  DISEASES
118611  |  C10orf90  |  DISEASES
118611  |  C10orf90  |  DISEASES
351  |  APP  |  DISEASES
351  |  APP  |  DISEASES
8714  |  ABCC3  |  DISEASES
8714  |  ABCC3  |  DISEASES
27123  |  DKK2  |  DISEASES
27123  |  DKK2  |  DISEASES
760  |  CA2  |  DISEASES
760  |  CA2  |  DISEASES
389  |  RHOC  |  DISEASES
389  |  RHOC  |  DISEASES
231  |  AKR1B1  |  DISEASES
231  |  AKR1B1  |  DISEASES
843  |  CASP10  |  DISEASES
843  |  CASP10  |  DISEASES
8324  |  FZD7  |  DISEASES
8324  |  FZD7  |  DISEASES
1436  |  CSF1R  |  DISEASES
1436  |  CSF1R  |  DISEASES
10  |  NAT2  |  DISEASES
10  |  NAT2  |  DISEASES
2776  |  GNAQ  |  DISEASES
2776  |  GNAQ  |  DISEASES
11197  |  WIF1  |  DISEASES
11197  |  WIF1  |  DISEASES
1633  |  DCK  |  DISEASES
1633  |  DCK  |  DISEASES
27163  |  NAAA  |  DISEASES
57188  |  ADAMTSL3  |  DISEASES
57188  |  ADAMTSL3  |  DISEASES
9073  |  CLDN8  |  DISEASES
9073  |  CLDN8  |  DISEASES
7074  |  TIAM1  |  DISEASES
7074  |  TIAM1  |  DISEASES
2528  |  FUT6  |  DISEASES
2528  |  FUT6  |  DISEASES
135228  |  CD109  |  DISEASES
135228  |  CD109  |  DISEASES
4838  |  NODAL  |  DISEASES
4838  |  NODAL  |  DISEASES
56965  |  PARP6  |  DISEASES
56965  |  PARP6  |  DISEASES
701  |  BUB1B  |  DISEASES
701  |  BUB1B  |  DISEASES
6750  |  SST  |  DISEASES
6750  |  SST  |  DISEASES
6529  |  SLC6A1  |  DISEASES
6529  |  SLC6A1  |  DISEASES
5468  |  PPARG  |  DISEASES
5468  |  PPARG  |  DISEASES
8321  |  FZD1  |  DISEASES
8321  |  FZD1  |  DISEASES
3156  |  HMGCR  |  DISEASES
3156  |  HMGCR  |  DISEASES
3815  |  KIT  |  DISEASES
3815  |  KIT  |  DISEASES
9133  |  CCNB2  |  DISEASES
9133  |  CCNB2  |  DISEASES
26060  |  APPL1  |  DISEASES
26060  |  APPL1  |  DISEASES
673  |  BRAF  |  DISEASES
673  |  BRAF  |  DISEASES
114793  |  FMNL2  |  DISEASES
114793  |  FMNL2  |  DISEASES
1844  |  DUSP2  |  DISEASES
1844  |  DUSP2  |  DISEASES
4690  |  NCK1  |  DISEASES
4690  |  NCK1  |  DISEASES
8365  |  HIST1H4H  |  DISEASES
8365  |  HIST1H4H  |  DISEASES
909  |  CD1A  |  DISEASES
909  |  CD1A  |  DISEASES
90737  |  PAGE5  |  DISEASES
90737  |  PAGE5  |  DISEASES
1013  |  CDH15  |  DISEASES
1013  |  CDH15  |  DISEASES
10361  |  NPM2  |  DISEASES
10361  |  NPM2  |  DISEASES
3588  |  IL10RB  |  DISEASES
3588  |  IL10RB  |  DISEASES
6781  |  STC1  |  DISEASES
6781  |  STC1  |  DISEASES
10481  |  HOXB13  |  DISEASES
10481  |  HOXB13  |  DISEASES
10642  |  IGF2BP1  |  DISEASES
10642  |  IGF2BP1  |  DISEASES
3099  |  HK2  |  DISEASES
3099  |  HK2  |  DISEASES
11189  |  CELF3  |  DISEASES
11189  |  CELF3  |  DISEASES
653689  |  GSTT2B  |  DISEASES
653689  |  GSTT2B  |  DISEASES
1636  |  ACE  |  DISEASES
1636  |  ACE  |  DISEASES
10417  |  SPON2  |  DISEASES
10417  |  SPON2  |  DISEASES
1487  |  CTBP1  |  DISEASES
1487  |  CTBP1  |  DISEASES
5304  |  PIP  |  DISEASES
808  |  CALM3  |  DISEASES
808  |  CALM3  |  DISEASES
2063  |  NR2F6  |  DISEASES
2063  |  NR2F6  |  DISEASES
7032  |  TFF2  |  DISEASES
7032  |  TFF2  |  DISEASES
7031  |  TFF1  |  DISEASES
7031  |  TFF1  |  DISEASES
7109  |  TRAPPC10  |  DISEASES
7109  |  TRAPPC10  |  DISEASES
643  |  CXCR5  |  DISEASES
643  |  CXCR5  |  DISEASES
79671  |  NLRX1  |  DISEASES
79671  |  NLRX1  |  DISEASES
55585  |  UBE2Q1  |  DISEASES
55585  |  UBE2Q1  |  DISEASES
729230  |  CCR2  |  DISEASES
729230  |  CCR2  |  DISEASES
1234  |  CCR5  |  DISEASES
1234  |  CCR5  |  DISEASES
2264  |  FGFR4  |  DISEASES
2264  |  FGFR4  |  DISEASES
5731  |  PTGER1  |  DISEASES
5731  |  PTGER1  |  DISEASES
114757  |  CYGB  |  DISEASES
114757  |  CYGB  |  DISEASES
6352  |  CCL5  |  DISEASES
6352  |  CCL5  |  DISEASES
581  |  BAX  |  DISEASES
581  |  BAX  |  DISEASES
3856  |  KRT8  |  DISEASES
3856  |  KRT8  |  DISEASES
6777  |  STAT5B  |  DISEASES
6777  |  STAT5B  |  DISEASES
3071  |  NCKAP1L  |  DISEASES
3071  |  NCKAP1L  |  DISEASES
3678  |  ITGA5  |  DISEASES
3678  |  ITGA5  |  DISEASES
7471  |  WNT1  |  DISEASES
7471  |  WNT1  |  DISEASES
362  |  AQP5  |  DISEASES
362  |  AQP5  |  DISEASES
160622  |  GRASP  |  DISEASES
160622  |  GRASP  |  DISEASES
246  |  ALOX15  |  DISEASES
246  |  ALOX15  |  DISEASES
58191  |  CXCL16  |  DISEASES
58191  |  CXCL16  |  DISEASES
1973  |  EIF4A1  |  DISEASES
1973  |  EIF4A1  |  DISEASES
4917  |  NTN3  |  DISEASES
4917  |  NTN3  |  DISEASES
10825  |  NEU3  |  DISEASES
10825  |  NEU3  |  DISEASES
6159  |  RPL29  |  DISEASES
6159  |  RPL29  |  DISEASES
4041  |  LRP5  |  DISEASES
4041  |  LRP5  |  DISEASES
374946  |  DRAXIN  |  DISEASES
374946  |  DRAXIN  |  DISEASES
10630  |  PDPN  |  DISEASES
10630  |  PDPN  |  DISEASES
7412  |  VCAM1  |  DISEASES
7412  |  VCAM1  |  DISEASES
23528  |  ZNF281  |  DISEASES
23528  |  ZNF281  |  DISEASES
2215  |  FCGR3B  |  DISEASES
2215  |  FCGR3B  |  DISEASES
5966  |  REL  |  DISEASES
3754  |  KCNF1  |  DISEASES
3754  |  KCNF1  |  DISEASES
2487  |  FRZB  |  DISEASES
2487  |  FRZB  |  DISEASES
3625  |  INHBB  |  DISEASES
3625  |  INHBB  |  DISEASES
27306  |  HPGDS  |  DISEASES
27306  |  HPGDS  |  DISEASES
9076  |  CLDN1  |  DISEASES
9076  |  CLDN1  |  DISEASES
1293  |  COL6A3  |  DISEASES
1293  |  COL6A3  |  DISEASES
3490  |  IGFBP7  |  DISEASES
3490  |  IGFBP7  |  DISEASES
3577  |  CXCR1  |  DISEASES
3577  |  CXCR1  |  DISEASES
27148  |  STK36  |  DISEASES
27148  |  STK36  |  DISEASES
3549  |  IHH  |  DISEASES
3549  |  IHH  |  DISEASES
57650  |  KIAA1524  |  DISEASES
57650  |  KIAA1524  |  DISEASES
84666  |  RETNLB  |  DISEASES
84666  |  RETNLB  |  DISEASES
50852  |  TRAT1  |  DISEASES
50852  |  TRAT1  |  DISEASES
56648  |  EIF5A2  |  DISEASES
56648  |  EIF5A2  |  DISEASES
2168  |  FABP1  |  DISEASES
2168  |  FABP1  |  DISEASES
152185  |  SPICE1  |  DISEASES
152185  |  SPICE1  |  DISEASES
213  |  ALB  |  DISEASES
213  |  ALB  |  DISEASES
6374  |  CXCL5  |  DISEASES
6374  |  CXCL5  |  DISEASES
6259  |  RYK  |  DISEASES
6259  |  RYK  |  DISEASES
64866  |  CDCP1  |  DISEASES
64866  |  CDCP1  |  DISEASES
7123  |  CLEC3B  |  DISEASES
7123  |  CLEC3B  |  DISEASES
1230  |  CCR1  |  DISEASES
1230  |  CCR1  |  DISEASES
6997  |  TDGF1  |  DISEASES
6997  |  TDGF1  |  DISEASES
23173  |  METAP1  |  DISEASES
23173  |  METAP1  |  DISEASES
4486  |  MST1R  |  DISEASES
4486  |  MST1R  |  DISEASES
4085  |  MAD2L1  |  DISEASES
4085  |  MAD2L1  |  DISEASES
308  |  ANXA5  |  DISEASES
308  |  ANXA5  |  DISEASES
3248  |  HPGD  |  DISEASES
3248  |  HPGD  |  DISEASES
3600  |  IL15  |  DISEASES
3600  |  IL15  |  DISEASES
3673  |  ITGA2  |  DISEASES
3673  |  ITGA2  |  DISEASES
2151  |  F2RL2  |  DISEASES
2151  |  F2RL2  |  DISEASES
6228  |  RPS23  |  DISEASES
6228  |  RPS23  |  DISEASES
4724  |  NDUFS4  |  DISEASES
4724  |  NDUFS4  |  DISEASES
6690  |  SPINK1  |  DISEASES
6690  |  SPINK1  |  DISEASES
9607  |  CARTPT  |  DISEASES
7098  |  TLR3  |  DISEASES
7098  |  TLR3  |  DISEASES
94234  |  FOXQ1  |  DISEASES
94234  |  FOXQ1  |  DISEASES
85409  |  NKD2  |  DISEASES
85409  |  NKD2  |  DISEASES
1437  |  CSF2  |  DISEASES
1437  |  CSF2  |  DISEASES
3313  |  HSPA9  |  DISEASES
3313  |  HSPA9  |  DISEASES
26872  |  STEAP1  |  DISEASES
26872  |  STEAP1  |  DISEASES
6469  |  SHH  |  DISEASES
6469  |  SHH  |  DISEASES
64321  |  SOX17  |  DISEASES
64321  |  SOX17  |  DISEASES
114788  |  CSMD3  |  DISEASES
114788  |  CSMD3  |  DISEASES
216  |  ALDH1A1  |  DISEASES
216  |  ALDH1A1  |  DISEASES
55582  |  KIF27  |  DISEASES
55582  |  KIF27  |  DISEASES
360  |  AQP3  |  DISEASES
360  |  AQP3  |  DISEASES
115825  |  WDFY2  |  DISEASES
115825  |  WDFY2  |  DISEASES
7486  |  WRN  |  DISEASES
7486  |  WRN  |  DISEASES
57447  |  NDRG2  |  DISEASES
57447  |  NDRG2  |  DISEASES
340706  |  VWA2  |  DISEASES
340706  |  VWA2  |  DISEASES
143689  |  PIWIL4  |  DISEASES
143689  |  PIWIL4  |  DISEASES
10818  |  FRS2  |  DISEASES
10818  |  FRS2  |  DISEASES
10576  |  CCT2  |  DISEASES
3611  |  ILK  |  DISEASES
3611  |  ILK  |  DISEASES
5055  |  SERPINB2  |  DISEASES
5055  |  SERPINB2  |  DISEASES
1381  |  CRABP1  |  DISEASES
1381  |  CRABP1  |  DISEASES
338339  |  CLEC4D  |  DISEASES
338339  |  CLEC4D  |  DISEASES
23423  |  TMED3  |  DISEASES
23423  |  TMED3  |  DISEASES
6236  |  RRAD  |  DISEASES
6236  |  RRAD  |  DISEASES
7184  |  HSP90B1  |  DISEASES
7184  |  HSP90B1  |  DISEASES
4314  |  MMP3  |  DISEASES
4314  |  MMP3  |  DISEASES
4837  |  NNMT  |  DISEASES
4837  |  NNMT  |  DISEASES
290  |  ANPEP  |  DISEASES
290  |  ANPEP  |  DISEASES
5347  |  PLK1  |  DISEASES
5347  |  PLK1  |  DISEASES
6778  |  STAT6  |  DISEASES
6778  |  STAT6  |  DISEASES
54948  |  MRPL16  |  DISEASES
54948  |  MRPL16  |  DISEASES
7529  |  YWHAB  |  DISEASES
7529  |  YWHAB  |  DISEASES
26585  |  GREM1  |  DISEASES
26585  |  GREM1  |  DISEASES
22974  |  TPX2  |  DISEASES
22974  |  TPX2  |  DISEASES
124872  |  B4GALNT2  |  DISEASES
124872  |  B4GALNT2  |  DISEASES
5245  |  PHB  |  DISEASES
5245  |  PHB  |  DISEASES
64127  |  NOD2  |  DISEASES
64127  |  NOD2  |  DISEASES
915  |  CD3D  |  DISEASES
915  |  CD3D  |  DISEASES
6786  |  STIM1  |  DISEASES
6786  |  STIM1  |  DISEASES
6240  |  RRM1  |  DISEASES
6240  |  RRM1  |  DISEASES
64122  |  FN3K  |  DISEASES
64122  |  FN3K  |  DISEASES
762  |  CA4  |  DISEASES
762  |  CA4  |  DISEASES
29123  |  ANKRD11  |  DISEASES
29123  |  ANKRD11  |  DISEASES
1548  |  CYP2A6  |  DISEASES
1548  |  CYP2A6  |  DISEASES
558  |  AXL  |  DISEASES
558  |  AXL  |  DISEASES
84798  |  C19orf48  |  DISEASES
84798  |  C19orf48  |  DISEASES
3816  |  KLK1  |  DISEASES
3816  |  KLK1  |  DISEASES
51129  |  ANGPTL4  |  DISEASES
51129  |  ANGPTL4  |  DISEASES
3489  |  IGFBP6  |  DISEASES
3489  |  IGFBP6  |  DISEASES
147741  |  ZNF560  |  DISEASES
147741  |  ZNF560  |  DISEASES
7001  |  PRDX2  |  DISEASES
7001  |  PRDX2  |  DISEASES
332  |  BIRC5  |  DISEASES
332  |  BIRC5  |  DISEASES
7083  |  TK1  |  DISEASES
7083  |  TK1  |  DISEASES
8772  |  FADD  |  DISEASES
8772  |  FADD  |  DISEASES
55872  |  PBK  |  DISEASES
55872  |  PBK  |  DISEASES
84168  |  ANTXR1  |  DISEASES
84168  |  ANTXR1  |  DISEASES
55106  |  SLFN12  |  DISEASES
55106  |  SLFN12  |  DISEASES
11079  |  RER1  |  DISEASES
11079  |  RER1  |  DISEASES
3960  |  LGALS4  |  DISEASES
3960  |  LGALS4  |  DISEASES
4255  |  MGMT  |  DISEASES
4255  |  MGMT  |  DISEASES
474  |  ATOH1  |  DISEASES
474  |  ATOH1  |  DISEASES
133418  |  EMB  |  DISEASES
133418  |  EMB  |  DISEASES
5604  |  MAP2K1  |  DISEASES
5604  |  MAP2K1  |  DISEASES
9839  |  ZEB2  |  DISEASES
9839  |  ZEB2  |  DISEASES
699  |  BUB1  |  DISEASES
699  |  BUB1  |  DISEASES
598  |  BCL2L1  |  DISEASES
598  |  BCL2L1  |  DISEASES
116844  |  LRG1  |  DISEASES
116844  |  LRG1  |  DISEASES
8313  |  AXIN2  |  DISEASES
8313  |  AXIN2  |  DISEASES
3479  |  IGF1  |  DISEASES
3479  |  IGF1  |  DISEASES
140453  |  MUC17  |  DISEASES
140453  |  MUC17  |  DISEASES
2990  |  GUSB  |  DISEASES
2990  |  GUSB  |  DISEASES
5734  |  PTGER4  |  DISEASES
5734  |  PTGER4  |  DISEASES
6795  |  AURKC  |  DISEASES
6795  |  AURKC  |  DISEASES
3603  |  IL16  |  DISEASES
3603  |  IL16  |  DISEASES
3308  |  HSPA4  |  DISEASES
3308  |  HSPA4  |  DISEASES
8841  |  HDAC3  |  DISEASES
8841  |  HDAC3  |  DISEASES
10648  |  SCGB1D1  |  DISEASES
10648  |  SCGB1D1  |  DISEASES
4144  |  MAT2A  |  DISEASES
4144  |  MAT2A  |  DISEASES
140738  |  TMEM37  |  DISEASES
140738  |  TMEM37  |  DISEASES
347169  |  OR1B1  |  DISEASES
347169  |  OR1B1  |  DISEASES
54578  |  UGT1A6  |  DISEASES
54578  |  UGT1A6  |  DISEASES
3688  |  ITGB1  |  DISEASES
3688  |  ITGB1  |  DISEASES
51181  |  DCXR  |  DISEASES
51181  |  DCXR  |  DISEASES
8988  |  HSPB3  |  DISEASES
8988  |  HSPB3  |  DISEASES
257019  |  FRMD3  |  DISEASES
257019  |  FRMD3  |  DISEASES
993  |  CDC25A  |  DISEASES
993  |  CDC25A  |  DISEASES
3643  |  INSR  |  DISEASES
3643  |  INSR  |  DISEASES
1493  |  CTLA4  |  DISEASES
1493  |  CTLA4  |  DISEASES
23246  |  BOP1  |  DISEASES
23246  |  BOP1  |  DISEASES
4071  |  TM4SF1  |  DISEASES
4071  |  TM4SF1  |  DISEASES
7764  |  ZNF217  |  DISEASES
7764  |  ZNF217  |  DISEASES
1281  |  COL3A1  |  DISEASES
1281  |  COL3A1  |  DISEASES
388969  |  C2orf68  |  DISEASES
388969  |  C2orf68  |  DISEASES
10663  |  CXCR6  |  DISEASES
10663  |  CXCR6  |  DISEASES
3038  |  HAS3  |  DISEASES
3038  |  HAS3  |  DISEASES
171558  |  PTCRA  |  DISEASES
171558  |  PTCRA  |  DISEASES
2194  |  FASN  |  DISEASES
2194  |  FASN  |  DISEASES
54463  |  FAM134B  |  DISEASES
54463  |  FAM134B  |  DISEASES
1495  |  CTNNA1  |  DISEASES
1495  |  CTNNA1  |  DISEASES
79905  |  TMC7  |  DISEASES
79905  |  TMC7  |  DISEASES
54658  |  UGT1A1  |  DISEASES
54658  |  UGT1A1  |  DISEASES
3667  |  IRS1  |  DISEASES
3667  |  IRS1  |  DISEASES
3596  |  IL13  |  DISEASES
3596  |  IL13  |  DISEASES
1602  |  DACH1  |  DISEASES
1602  |  DACH1  |  DISEASES
201931  |  TMEM192  |  DISEASES
201931  |  TMEM192  |  DISEASES
6726  |  SRP9  |  DISEASES
6726  |  SRP9  |  DISEASES
5579  |  PRKCB  |  DISEASES
5579  |  PRKCB  |  DISEASES
1051  |  CEBPB  |  DISEASES
1051  |  CEBPB  |  DISEASES
4992  |  OR1F1  |  DISEASES
4992  |  OR1F1  |  DISEASES
2237  |  FEN1  |  DISEASES
2237  |  FEN1  |  DISEASES
10678  |  B3GNT2  |  DISEASES
10678  |  B3GNT2  |  DISEASES
2525  |  FUT3  |  DISEASES
2525  |  FUT3  |  DISEASES
3627  |  CXCL10  |  DISEASES
3627  |  CXCL10  |  DISEASES
8436  |  SDPR  |  DISEASES
8436  |  SDPR  |  DISEASES
649  |  BMP1  |  DISEASES
649  |  BMP1  |  DISEASES
1469  |  CST1  |  DISEASES
1469  |  CST1  |  DISEASES
7104  |  TM4SF4  |  DISEASES
7104  |  TM4SF4  |  DISEASES
29100  |  TMEM208  |  DISEASES
29100  |  TMEM208  |  DISEASES
6579  |  SLCO1A2  |  DISEASES
214  |  ALCAM  |  DISEASES
214  |  ALCAM  |  DISEASES
11162  |  NUDT6  |  DISEASES
11162  |  NUDT6  |  DISEASES
2353  |  FOS  |  DISEASES
2353  |  FOS  |  DISEASES
4430  |  MYO1B  |  DISEASES
4430  |  MYO1B  |  DISEASES
51029  |  DESI2  |  DISEASES
51029  |  DESI2  |  DISEASES
4968  |  OGG1  |  DISEASES
4968  |  OGG1  |  DISEASES
125  |  ADH1B  |  DISEASES
125  |  ADH1B  |  DISEASES
8493  |  PPM1D  |  DISEASES
8493  |  PPM1D  |  DISEASES
6373  |  CXCL11  |  DISEASES
6373  |  CXCL11  |  DISEASES
3037  |  HAS2  |  DISEASES
3037  |  HAS2  |  DISEASES
6383  |  SDC2  |  DISEASES
6383  |  SDC2  |  DISEASES
112398  |  EGLN2  |  DISEASES
112398  |  EGLN2  |  DISEASES
26532  |  OR10H3  |  DISEASES
26532  |  OR10H3  |  DISEASES
1473  |  CST5  |  DISEASES
1473  |  CST5  |  DISEASES
3622  |  ING2  |  DISEASES
3622  |  ING2  |  DISEASES
9451  |  EIF2AK3  |  DISEASES
9451  |  EIF2AK3  |  DISEASES
54498  |  SMOX  |  DISEASES
54498  |  SMOX  |  DISEASES
57521  |  RPTOR  |  DISEASES
57521  |  RPTOR  |  DISEASES
4176  |  MCM7  |  DISEASES
4176  |  MCM7  |  DISEASES
10116  |  FEM1B  |  DISEASES
10116  |  FEM1B  |  DISEASES
126669  |  SHE  |  DISEASES
126669  |  SHE  |  DISEASES
794  |  CALB2  |  DISEASES
794  |  CALB2  |  DISEASES
54205  |  CYCS  |  DISEASES
54205  |  CYCS  |  DISEASES
51162  |  EGFL7  |  DISEASES
51162  |  EGFL7  |  DISEASES
27087  |  B3GAT1  |  DISEASES
27087  |  B3GAT1  |  DISEASES
29785  |  CYP2S1  |  DISEASES
29785  |  CYP2S1  |  DISEASES
57124  |  CD248  |  DISEASES
57124  |  CD248  |  DISEASES
2348  |  FOLR1  |  DISEASES
2348  |  FOLR1  |  DISEASES
4323  |  MMP14  |  DISEASES
4323  |  MMP14  |  DISEASES
84294  |  UTP23  |  DISEASES
84294  |  UTP23  |  DISEASES
197259  |  MLKL  |  DISEASES
197259  |  MLKL  |  DISEASES
6199  |  RPS6KB2  |  DISEASES
6199  |  RPS6KB2  |  DISEASES
991  |  CDC20  |  DISEASES
991  |  CDC20  |  DISEASES
8637  |  EIF4EBP3  |  DISEASES
8637  |  EIF4EBP3  |  DISEASES
2147  |  F2  |  DISEASES
2147  |  F2  |  DISEASES
9940  |  DLEC1  |  DISEASES
9940  |  DLEC1  |  DISEASES
5897  |  RAG2  |  DISEASES
5897  |  RAG2  |  DISEASES
23333  |  DPY19L1  |  DISEASES
23333  |  DPY19L1  |  DISEASES
9575  |  CLOCK  |  DISEASES
9575  |  CLOCK  |  DISEASES
51206  |  GP6  |  DISEASES
51206  |  GP6  |  DISEASES
6363  |  CCL19  |  DISEASES
6363  |  CCL19  |  DISEASES
24146  |  CLDN15  |  DISEASES
24146  |  CLDN15  |  DISEASES
81029  |  WNT5B  |  DISEASES
81029  |  WNT5B  |  DISEASES
6573  |  SLC19A1  |  DISEASES
6573  |  SLC19A1  |  DISEASES
5340  |  PLG  |  DISEASES
5340  |  PLG  |  DISEASES
6596  |  HLTF  |  DISEASES
6596  |  HLTF  |  DISEASES
5653  |  KLK6  |  DISEASES
5653  |  KLK6  |  DISEASES
9134  |  CCNE2  |  DISEASES
9134  |  CCNE2  |  DISEASES
3219  |  HOXB9  |  DISEASES
3219  |  HOXB9  |  DISEASES
7534  |  YWHAZ  |  DISEASES
7534  |  YWHAZ  |  DISEASES
51316  |  PLAC8  |  DISEASES
51316  |  PLAC8  |  DISEASES
7015  |  TERT  |  DISEASES
7015  |  TERT  |  DISEASES
3964  |  LGALS8  |  DISEASES
3964  |  LGALS8  |  DISEASES
1072  |  CFL1  |  DISEASES
1072  |  CFL1  |  DISEASES
3265  |  HRAS  |  DISEASES
3265  |  HRAS  |  DISEASES
6868  |  ADAM17  |  DISEASES
6868  |  ADAM17  |  DISEASES
947  |  CD34  |  DISEASES
947  |  CD34  |  DISEASES
10393  |  ANAPC10  |  DISEASES
10393  |  ANAPC10  |  DISEASES
54905  |  CYP2W1  |  DISEASES
54905  |  CYP2W1  |  DISEASES
8061  |  FOSL1  |  DISEASES
8061  |  FOSL1  |  DISEASES
8793  |  TNFRSF10D  |  DISEASES
8793  |  TNFRSF10D  |  DISEASES
8815  |  BANF1  |  DISEASES
8815  |  BANF1  |  DISEASES
9610  |  RIN1  |  DISEASES
9610  |  RIN1  |  DISEASES
8704  |  B4GALT2  |  DISEASES
8704  |  B4GALT2  |  DISEASES
284433  |  OR10H5  |  DISEASES
284433  |  OR10H5  |  DISEASES
81839  |  VANGL1  |  DISEASES
81839  |  VANGL1  |  DISEASES
84826  |  SFT2D3  |  DISEASES
84826  |  SFT2D3  |  DISEASES
5467  |  PPARD  |  DISEASES
5467  |  PPARD  |  DISEASES
5598  |  MAPK7  |  DISEASES
5598  |  MAPK7  |  DISEASES
836  |  CASP3  |  DISEASES
836  |  CASP3  |  DISEASES
7423  |  VEGFB  |  DISEASES
7423  |  VEGFB  |  DISEASES
358  |  AQP1  |  DISEASES
358  |  AQP1  |  DISEASES
6578  |  SLCO2A1  |  DISEASES
6578  |  SLCO2A1  |  DISEASES
147687  |  ZNF417  |  DISEASES
147687  |  ZNF417  |  DISEASES
5519  |  PPP2R1B  |  DISEASES
5519  |  PPP2R1B  |  DISEASES
5883  |  RAD9A  |  DISEASES
5883  |  RAD9A  |  DISEASES
2944  |  GSTM1  |  DISEASES
2944  |  GSTM1  |  DISEASES
57474  |  ZNF490  |  DISEASES
57474  |  ZNF490  |  DISEASES
8658  |  TNKS  |  DISEASES
8658  |  TNKS  |  DISEASES
5655  |  KLK10  |  DISEASES
5655  |  KLK10  |  DISEASES
9156  |  EXO1  |  DISEASES
9156  |  EXO1  |  DISEASES
84868  |  HAVCR2  |  DISEASES
84868  |  HAVCR2  |  DISEASES
55279  |  ZNF654  |  DISEASES
55279  |  ZNF654  |  DISEASES
56667  |  MUC13  |  DISEASES
56667  |  MUC13  |  DISEASES
5319  |  PLA2G1B  |  DISEASES
5319  |  PLA2G1B  |  DISEASES
8639  |  AOC3  |  DISEASES
79102  |  RNF26  |  DISEASES
79102  |  RNF26  |  DISEASES
8837  |  CFLAR  |  DISEASES
8837  |  CFLAR  |  DISEASES
3952  |  LEP  |  DISEASES
3952  |  LEP  |  DISEASES
835  |  CASP2  |  DISEASES
835  |  CASP2  |  DISEASES
3172  |  HNF4A  |  DISEASES
3172  |  HNF4A  |  DISEASES
404217  |  CTXN1  |  DISEASES
404217  |  CTXN1  |  DISEASES
5591  |  PRKDC  |  DISEASES
5591  |  PRKDC  |  DISEASES
653499  |  LGALS7B  |  DISEASES
653499  |  LGALS7B  |  DISEASES
80818  |  ZNF436  |  DISEASES
80818  |  ZNF436  |  DISEASES
8877  |  SPHK1  |  DISEASES
8877  |  SPHK1  |  DISEASES
10657  |  KHDRBS1  |  DISEASES
10657  |  KHDRBS1  |  DISEASES
117196  |  MRGPRX4  |  DISEASES
117196  |  MRGPRX4  |  DISEASES
3090  |  HIC1  |  DISEASES
3090  |  HIC1  |  DISEASES
354  |  KLK3  |  DISEASES
354  |  KLK3  |  DISEASES
9448  |  MAP4K4  |  DISEASES
9448  |  MAP4K4  |  DISEASES
998  |  CDC42  |  DISEASES
998  |  CDC42  |  DISEASES
285  |  ANGPT2  |  DISEASES
285  |  ANGPT2  |  DISEASES
27122  |  DKK3  |  DISEASES
27122  |  DKK3  |  DISEASES
5430  |  POLR2A  |  DISEASES
5430  |  POLR2A  |  DISEASES
1909  |  EDNRA  |  DISEASES
1909  |  EDNRA  |  DISEASES
1191  |  CLU  |  DISEASES
1191  |  CLU  |  DISEASES
254042  |  METAP1D  |  DISEASES
254042  |  METAP1D  |  DISEASES
30835  |  CD209  |  DISEASES
30835  |  CD209  |  DISEASES
7298  |  TYMS  |  DISEASES
7298  |  TYMS  |  DISEASES
901  |  CCNG2  |  DISEASES
901  |  CCNG2  |  DISEASES
3936  |  LCP1  |  DISEASES
3936  |  LCP1  |  DISEASES
3234  |  HOXD8  |  DISEASES
3234  |  HOXD8  |  DISEASES
1604  |  CD55  |  DISEASES
1604  |  CD55  |  DISEASES
8560  |  DEGS1  |  DISEASES
8560  |  DEGS1  |  DISEASES
23512  |  SUZ12  |  DISEASES
23512  |  SUZ12  |  DISEASES
220441  |  RNF152  |  DISEASES
220441  |  RNF152  |  DISEASES
10170  |  DHRS9  |  DISEASES
10170  |  DHRS9  |  DISEASES
4233  |  MET  |  DISEASES
4233  |  MET  |  DISEASES
4762  |  NEUROG1  |  DISEASES
4762  |  NEUROG1  |  DISEASES
9400  |  RECQL5  |  DISEASES
9400  |  RECQL5  |  DISEASES
196500  |  PIANP  |  DISEASES
196500  |  PIANP  |  DISEASES
8824  |  CES2  |  DISEASES
8824  |  CES2  |  DISEASES
5930  |  RBBP6  |  DISEASES
5930  |  RBBP6  |  DISEASES
9475  |  ROCK2  |  DISEASES
9475  |  ROCK2  |  DISEASES
2529  |  FUT7  |  DISEASES
2529  |  FUT7  |  DISEASES
4691  |  NCL  |  DISEASES
4691  |  NCL  |  DISEASES
4684  |  NCAM1  |  DISEASES
4684  |  NCAM1  |  DISEASES
10808  |  HSPH1  |  DISEASES
10808  |  HSPH1  |  DISEASES
6470  |  SHMT1  |  DISEASES
6470  |  SHMT1  |  DISEASES
58492  |  ZNF77  |  DISEASES
58492  |  ZNF77  |  DISEASES
10419  |  PRMT5  |  DISEASES
10419  |  PRMT5  |  DISEASES
2814  |  GP5  |  DISEASES
8490  |  RGS5  |  DISEASES
8490  |  RGS5  |  DISEASES
91662  |  NLRP12  |  DISEASES
91662  |  NLRP12  |  DISEASES
6819  |  SULT1C2  |  DISEASES
6819  |  SULT1C2  |  DISEASES
3579  |  CXCR2  |  DISEASES
3579  |  CXCR2  |  DISEASES
1728  |  NQO1  |  DISEASES
1728  |  NQO1  |  DISEASES
10397  |  NDRG1  |  DISEASES
10397  |  NDRG1  |  DISEASES
8834  |  TMEM11  |  DISEASES
8834  |  TMEM11  |  DISEASES
80381  |  CD276  |  DISEASES
80381  |  CD276  |  DISEASES
2146  |  EZH2  |  DISEASES
2146  |  EZH2  |  DISEASES
5315  |  PKM  |  DISEASES
5315  |  PKM  |  DISEASES
8289  |  ARID1A  |  DISEASES
8289  |  ARID1A  |  DISEASES
27436  |  EML4  |  DISEASES
27436  |  EML4  |  DISEASES
9370  |  ADIPOQ  |  DISEASES
9370  |  ADIPOQ  |  DISEASES
811  |  CALR  |  DISEASES
811  |  CALR  |  DISEASES
6863  |  TAC1  |  DISEASES
6863  |  TAC1  |  DISEASES
149233  |  IL23R  |  DISEASES
149233  |  IL23R  |  DISEASES
162517  |  FBXO39  |  DISEASES
162517  |  FBXO39  |  DISEASES
131566  |  DCBLD2  |  DISEASES
131566  |  DCBLD2  |  DISEASES
7156  |  TOP3A  |  DISEASES
7156  |  TOP3A  |  DISEASES
995  |  CDC25C  |  DISEASES
995  |  CDC25C  |  DISEASES
10611  |  PDLIM5  |  DISEASES
10611  |  PDLIM5  |  DISEASES
2118  |  ETV4  |  DISEASES
2118  |  ETV4  |  DISEASES
347736  |  NME9  |  DISEASES
347736  |  NME9  |  DISEASES
6817  |  SULT1A1  |  DISEASES
6817  |  SULT1A1  |  DISEASES
79075  |  DSCC1  |  DISEASES
79075  |  DSCC1  |  DISEASES
3039  |  HBA1  |  DISEASES
3039  |  HBA1  |  DISEASES
7284  |  TUFM  |  DISEASES
7284  |  TUFM  |  DISEASES
5426  |  POLE  |  DISEASES
5426  |  POLE  |  DISEASES
4312  |  MMP1  |  DISEASES
4312  |  MMP1  |  DISEASES
2274  |  FHL2  |  DISEASES
2274  |  FHL2  |  DISEASES
4238  |  MFAP3  |  DISEASES
4238  |  MFAP3  |  DISEASES
923  |  CD6  |  DISEASES
923  |  CD6  |  DISEASES
27079  |  RPUSD2  |  DISEASES
27079  |  RPUSD2  |  DISEASES
8243  |  SMC1A  |  DISEASES
8243  |  SMC1A  |  DISEASES
55600  |  ITLN1  |  DISEASES
55600  |  ITLN1  |  DISEASES
6657  |  SOX2  |  DISEASES
6657  |  SOX2  |  DISEASES
57491  |  AHRR  |  DISEASES
57491  |  AHRR  |  DISEASES
79039  |  DDX54  |  DISEASES
79039  |  DDX54  |  DISEASES
2535  |  FZD2  |  DISEASES
2535  |  FZD2  |  DISEASES
977  |  CD151  |  DISEASES
977  |  CD151  |  DISEASES
3309  |  HSPA5  |  DISEASES
3309  |  HSPA5  |  DISEASES
8408  |  ULK1  |  DISEASES
8408  |  ULK1  |  DISEASES
1555  |  CYP2B6  |  DISEASES
1555  |  CYP2B6  |  DISEASES
29841  |  GRHL1  |  DISEASES
29841  |  GRHL1  |  DISEASES
7525  |  YES1  |  DISEASES
7525  |  YES1  |  DISEASES
9235  |  IL32  |  DISEASES
9235  |  IL32  |  DISEASES
2932  |  GSK3B  |  DISEASES
2932  |  GSK3B  |  DISEASES
6794  |  STK11  |  DISEASES
6794  |  STK11  |  DISEASES
3200  |  HOXA3  |  DISEASES
3200  |  HOXA3  |  DISEASES
148266  |  ZNF569  |  DISEASES
148266  |  ZNF569  |  DISEASES
5241  |  PGR  |  DISEASES
5241  |  PGR  |  DISEASES
1303  |  COL12A1  |  DISEASES
1303  |  COL12A1  |  DISEASES
3927  |  LASP1  |  DISEASES
3927  |  LASP1  |  DISEASES
4670  |  HNRNPM  |  DISEASES
4670  |  HNRNPM  |  DISEASES
27430  |  MAT2B  |  DISEASES
27430  |  MAT2B  |  DISEASES
7481  |  WNT11  |  DISEASES
7481  |  WNT11  |  DISEASES
55748  |  CNDP2  |  DISEASES
55748  |  CNDP2  |  DISEASES
80230  |  RUFY1  |  DISEASES
80230  |  RUFY1  |  DISEASES
3326  |  HSP90AB1  |  DISEASES
3326  |  HSP90AB1  |  DISEASES
5366  |  PMAIP1  |  DISEASES
5366  |  PMAIP1  |  DISEASES
9622  |  KLK4  |  DISEASES
9622  |  KLK4  |  DISEASES
5663  |  PSEN1  |  DISEASES
5663  |  PSEN1  |  DISEASES
2303  |  FOXC2  |  DISEASES
2303  |  FOXC2  |  DISEASES
8454  |  CUL1  |  DISEASES
8454  |  CUL1  |  DISEASES
122525  |  C14orf28  |  DISEASES
122525  |  C14orf28  |  DISEASES
4843  |  NOS2  |  DISEASES
4843  |  NOS2  |  DISEASES
633  |  BGN  |  DISEASES
633  |  BGN  |  DISEASES
1435  |  CSF1  |  DISEASES
1435  |  CSF1  |  DISEASES
339390  |  CLEC4G  |  DISEASES
339390  |  CLEC4G  |  DISEASES
5034  |  P4HB  |  DISEASES
5034  |  P4HB  |  DISEASES
26333  |  OR7A17  |  DISEASES
26333  |  OR7A17  |  DISEASES
3714  |  JAG2  |  DISEASES
3714  |  JAG2  |  DISEASES
9241  |  NOG  |  DISEASES
9241  |  NOG  |  DISEASES
84876  |  ORAI1  |  DISEASES
84876  |  ORAI1  |  DISEASES
84864  |  MINA  |  DISEASES
84864  |  MINA  |  DISEASES
346389  |  MACC1  |  DISEASES
346389  |  MACC1  |  DISEASES
1789  |  DNMT3B  |  DISEASES
1789  |  DNMT3B  |  DISEASES
221937  |  FOXK1  |  DISEASES
221937  |  FOXK1  |  DISEASES
1946  |  EFNA5  |  DISEASES
1946  |  EFNA5  |  DISEASES
9501  |  RPH3AL  |  DISEASES
9501  |  RPH3AL  |  DISEASES
752  |  FMNL1  |  DISEASES
752  |  FMNL1  |  DISEASES
3855  |  KRT7  |  DISEASES
3855  |  KRT7  |  DISEASES
6667  |  SP1  |  DISEASES
6667  |  SP1  |  DISEASES
50616  |  IL22  |  DISEASES
50616  |  IL22  |  DISEASES
8651  |  SOCS1  |  DISEASES
8651  |  SOCS1  |  DISEASES
596  |  BCL2  |  DISEASES
596  |  BCL2  |  DISEASES
1670  |  DEFA5  |  DISEASES
1670  |  DEFA5  |  DISEASES
121006  |  FAM186A  |  DISEASES
121006  |  FAM186A  |  DISEASES
7378  |  UPP1  |  DISEASES
7378  |  UPP1  |  DISEASES
1915  |  EEF1A1  |  DISEASES
1915  |  EEF1A1  |  DISEASES
842  |  CASP9  |  DISEASES
842  |  CASP9  |  DISEASES
91057  |  CCDC34  |  DISEASES
9021  |  SOCS3  |  DISEASES
9021  |  SOCS3  |  DISEASES
5155  |  PDGFB  |  DISEASES
5155  |  PDGFB  |  DISEASES
8590  |  OR6A2  |  DISEASES
8590  |  OR6A2  |  DISEASES
3953  |  LEPR  |  DISEASES
3953  |  LEPR  |  DISEASES
9798  |  IST1  |  DISEASES
9798  |  IST1  |  DISEASES
115908  |  CTHRC1  |  DISEASES
115908  |  CTHRC1  |  DISEASES
6900  |  CNTN2  |  DISEASES
6900  |  CNTN2  |  DISEASES
8519  |  IFITM1  |  DISEASES
8519  |  IFITM1  |  DISEASES
10539  |  GLRX3  |  DISEASES
10539  |  GLRX3  |  DISEASES
4978  |  OPCML  |  DISEASES
4978  |  OPCML  |  DISEASES
926  |  CD8B  |  DISEASES
926  |  CD8B  |  DISEASES
7490  |  WT1  |  DISEASES
7490  |  WT1  |  DISEASES
2520  |  GAST  |  DISEASES
2520  |  GAST  |  DISEASES
5797  |  PTPRM  |  DISEASES
5797  |  PTPRM  |  DISEASES
83482  |  SCRT1  |  DISEASES
83482  |  SCRT1  |  DISEASES
6401  |  SELE  |  DISEASES
6401  |  SELE  |  DISEASES
253143  |  PRR14L  |  DISEASES
253143  |  PRR14L  |  DISEASES
942  |  CD86  |  DISEASES
942  |  CD86  |  DISEASES
2049  |  EPHB3  |  DISEASES
2049  |  EPHB3  |  DISEASES
199221  |  DZIP1L  |  DISEASES
199221  |  DZIP1L  |  DISEASES
220  |  ALDH1A3  |  DISEASES
220  |  ALDH1A3  |  DISEASES
11156  |  PTP4A3  |  DISEASES
11156  |  PTP4A3  |  DISEASES
430  |  ASCL2  |  DISEASES
430  |  ASCL2  |  DISEASES
5915  |  RARB  |  DISEASES
5915  |  RARB  |  DISEASES
55794  |  DDX28  |  DISEASES
55794  |  DDX28  |  DISEASES
5727  |  PTCH1  |  DISEASES
5727  |  PTCH1  |  DISEASES
1485  |  CTAG1B  |  DISEASES
1485  |  CTAG1B  |  DISEASES
8663  |  EIF3C  |  DISEASES
8663  |  EIF3C  |  DISEASES
339221  |  ENPP7  |  DISEASES
339221  |  ENPP7  |  DISEASES
1233  |  CCR4  |  DISEASES
1233  |  CCR4  |  DISEASES
90249  |  UNC5A  |  DISEASES
90249  |  UNC5A  |  DISEASES
60529  |  ALX4  |  DISEASES
60529  |  ALX4  |  DISEASES
2185  |  PTK2B  |  DISEASES
2185  |  PTK2B  |  DISEASES
29796  |  UQCR10  |  DISEASES
29796  |  UQCR10  |  DISEASES
4088  |  SMAD3  |  DISEASES
4088  |  SMAD3  |  DISEASES
9939  |  RBM8A  |  DISEASES
9939  |  RBM8A  |  DISEASES
10287  |  RGS19  |  DISEASES
10287  |  RGS19  |  DISEASES
3916  |  LAMP1  |  DISEASES
3916  |  LAMP1  |  DISEASES
80864  |  EGFL8  |  DISEASES
80864  |  EGFL8  |  DISEASES
64976  |  MRPL40  |  DISEASES
64976  |  MRPL40  |  DISEASES
9230  |  RAB11B  |  DISEASES
9230  |  RAB11B  |  DISEASES
9112  |  MTA1  |  DISEASES
9112  |  MTA1  |  DISEASES
6472  |  SHMT2  |  DISEASES
6472  |  SHMT2  |  DISEASES
5600  |  MAPK11  |  DISEASES
5600  |  MAPK11  |  DISEASES
682  |  BSG  |  DISEASES
682  |  BSG  |  DISEASES
2124  |  EVI2B  |  DISEASES
2124  |  EVI2B  |  DISEASES
6182  |  MRPL12  |  DISEASES
6182  |  MRPL12  |  DISEASES
10057  |  ABCC5  |  DISEASES
10057  |  ABCC5  |  DISEASES
5641  |  LGMN  |  DISEASES
5641  |  LGMN  |  DISEASES
10013  |  HDAC6  |  DISEASES
10013  |  HDAC6  |  DISEASES
138802  |  OR13C8  |  DISEASES
138802  |  OR13C8  |  DISEASES
2152  |  F3  |  DISEASES
2152  |  F3  |  DISEASES
54490  |  UGT2B28  |  DISEASES
54490  |  UGT2B28  |  DISEASES
27445  |  PCLO  |  DISEASES
27445  |  PCLO  |  DISEASES
219699  |  UNC5B  |  DISEASES
219699  |  UNC5B  |  DISEASES
2626  |  GATA4  |  DISEASES
2626  |  GATA4  |  DISEASES
120227  |  CYP2R1  |  DISEASES
120227  |  CYP2R1  |  DISEASES
4494  |  MT1F  |  DISEASES
4494  |  MT1F  |  DISEASES
5133  |  PDCD1  |  DISEASES
5133  |  PDCD1  |  DISEASES
51738  |  GHRL  |  DISEASES
51738  |  GHRL  |  DISEASES
3320  |  HSP90AA1  |  DISEASES
3320  |  HSP90AA1  |  DISEASES
957  |  ENTPD5  |  DISEASES
957  |  ENTPD5  |  DISEASES
123264  |  SLC51B  |  DISEASES
123264  |  SLC51B  |  DISEASES
283149  |  BCL9L  |  DISEASES
283149  |  BCL9L  |  DISEASES
23451  |  SF3B1  |  DISEASES
23451  |  SF3B1  |  DISEASES
887  |  CCKBR  |  DISEASES
887  |  CCKBR  |  DISEASES
2938  |  GSTA1  |  DISEASES
2938  |  GSTA1  |  DISEASES
885  |  CCK  |  DISEASES
885  |  CCK  |  DISEASES
3607  |  FOXK2  |  DISEASES
3607  |  FOXK2  |  DISEASES
8856  |  NR1I2  |  DISEASES
8856  |  NR1I2  |  DISEASES
9075  |  CLDN2  |  DISEASES
9075  |  CLDN2  |  DISEASES
25788  |  RAD54B  |  DISEASES
25788  |  RAD54B  |  DISEASES
1984  |  EIF5A  |  DISEASES
1984  |  EIF5A  |  DISEASES
283  |  ANG  |  DISEASES
283  |  ANG  |  DISEASES
468  |  ATF4  |  DISEASES
468  |  ATF4  |  DISEASES
1058  |  CENPA  |  DISEASES
1058  |  CENPA  |  DISEASES
9547  |  CXCL14  |  DISEASES
9547  |  CXCL14  |  DISEASES
80323  |  CCDC68  |  DISEASES
80323  |  CCDC68  |  DISEASES
57820  |  CCNB1IP1  |  DISEASES
57820  |  CCNB1IP1  |  DISEASES
112744  |  IL17F  |  DISEASES
112744  |  IL17F  |  DISEASES
51339  |  DACT1  |  DISEASES
51339  |  DACT1  |  DISEASES
60528  |  ELAC2  |  DISEASES
60528  |  ELAC2  |  DISEASES
2042  |  EPHA3  |  DISEASES
2042  |  EPHA3  |  DISEASES
10554  |  AGPAT1  |  DISEASES
10554  |  AGPAT1  |  DISEASES
83714  |  NRIP2  |  DISEASES
83714  |  NRIP2  |  DISEASES
9166  |  EBAG9  |  DISEASES
9166  |  EBAG9  |  DISEASES
3932  |  LCK  |  DISEASES
3932  |  LCK  |  DISEASES
1576  |  CYP3A4  |  DISEASES
1576  |  CYP3A4  |  DISEASES
3091  |  HIF1A  |  DISEASES
3091  |  HIF1A  |  DISEASES
92140  |  MTDH  |  DISEASES
92140  |  MTDH  |  DISEASES
23462  |  HEY1  |  DISEASES
23462  |  HEY1  |  DISEASES
6622  |  SNCA  |  DISEASES
5269  |  SERPINB6  |  DISEASES
5269  |  SERPINB6  |  DISEASES
23583  |  SMUG1  |  DISEASES
23583  |  SMUG1  |  DISEASES
55704  |  CCDC88A  |  DISEASES
55704  |  CCDC88A  |  DISEASES
147923  |  ZNF420  |  DISEASES
147923  |  ZNF420  |  DISEASES
7430  |  EZR  |  DISEASES
7430  |  EZR  |  DISEASES
395  |  ARHGAP6  |  DISEASES
395  |  ARHGAP6  |  DISEASES
203068  |  TUBB  |  DISEASES
203068  |  TUBB  |  DISEASES
2885  |  GRB2  |  DISEASES
2885  |  GRB2  |  DISEASES
6175  |  RPLP0  |  DISEASES
6175  |  RPLP0  |  DISEASES
65999  |  LRRC61  |  DISEASES
65999  |  LRRC61  |  DISEASES
6201  |  RPS7  |  DISEASES
6201  |  RPS7  |  DISEASES
3266  |  ERAS  |  DISEASES
3266  |  ERAS  |  DISEASES
857  |  CAV1  |  DISEASES
857  |  CAV1  |  DISEASES
6540  |  SLC6A13  |  DISEASES
6540  |  SLC6A13  |  DISEASES
5329  |  PLAUR  |  DISEASES
5329  |  PLAUR  |  DISEASES
63826  |  SRR  |  DISEASES
63826  |  SRR  |  DISEASES
4521  |  NUDT1  |  DISEASES
4521  |  NUDT1  |  DISEASES
2309  |  FOXO3  |  DISEASES
2309  |  FOXO3  |  DISEASES
2182  |  ACSL4  |  DISEASES
2182  |  ACSL4  |  DISEASES
2261  |  FGFR3  |  DISEASES
2261  |  FGFR3  |  DISEASES
29102  |  DROSHA  |  DISEASES
29102  |  DROSHA  |  DISEASES
4602  |  MYB  |  DISEASES
4602  |  MYB  |  DISEASES
7100  |  TLR5  |  DISEASES
7100  |  TLR5  |  DISEASES
966  |  CD59  |  DISEASES
966  |  CD59  |  DISEASES
23677  |  SH3BP4  |  DISEASES
23677  |  SH3BP4  |  DISEASES
29800  |  ZDHHC1  |  DISEASES
29800  |  ZDHHC1  |  DISEASES
10524  |  KAT5  |  DISEASES
10524  |  KAT5  |  DISEASES
1978  |  EIF4EBP1  |  DISEASES
1978  |  EIF4EBP1  |  DISEASES
5781  |  PTPN11  |  DISEASES
5781  |  PTPN11  |  DISEASES
2810  |  SFN  |  DISEASES
2810  |  SFN  |  DISEASES
59277  |  NTN4  |  DISEASES
59277  |  NTN4  |  DISEASES
3167  |  HMX2  |  DISEASES
3167  |  HMX2  |  DISEASES
5764  |  PTN  |  DISEASES
5764  |  PTN  |  DISEASES
5747  |  PTK2  |  DISEASES
5747  |  PTK2  |  DISEASES
10164  |  CHST4  |  DISEASES
10164  |  CHST4  |  DISEASES
6776  |  STAT5A  |  DISEASES
6776  |  STAT5A  |  DISEASES
55969  |  C20orf24  |  DISEASES
55969  |  C20orf24  |  DISEASES
23708  |  GSPT2  |  DISEASES
23708  |  GSPT2  |  DISEASES
4089  |  SMAD4  |  DISEASES
4089  |  SMAD4  |  DISEASES
51094  |  ADIPOR1  |  DISEASES
51094  |  ADIPOR1  |  DISEASES
3178  |  HNRNPA1  |  DISEASES
3178  |  HNRNPA1  |  DISEASES
1544  |  CYP1A2  |  DISEASES
1544  |  CYP1A2  |  DISEASES
93099  |  DMKN  |  DISEASES
93099  |  DMKN  |  DISEASES
1508  |  CTSB  |  DISEASES
1508  |  CTSB  |  DISEASES
2272  |  FHIT  |  DISEASES
2272  |  FHIT  |  DISEASES
6692  |  SPINT1  |  DISEASES
6692  |  SPINT1  |  DISEASES
10350  |  ABCA9  |  DISEASES
10350  |  ABCA9  |  DISEASES
2066  |  ERBB4  |  DISEASES
2066  |  ERBB4  |  DISEASES
2305  |  FOXM1  |  DISEASES
2305  |  FOXM1  |  DISEASES
9536  |  PTGES  |  DISEASES
9536  |  PTGES  |  DISEASES
1364  |  CLDN4  |  DISEASES
1364  |  CLDN4  |  DISEASES
81551  |  STMN4  |  DISEASES
81551  |  STMN4  |  DISEASES
10193  |  RNF41  |  DISEASES
10193  |  RNF41  |  DISEASES
159296  |  NKX2-3  |  DISEASES
159296  |  NKX2-3  |  DISEASES
5962  |  RDX  |  DISEASES
5962  |  RDX  |  DISEASES
27111  |  SDCBP2  |  DISEASES
27111  |  SDCBP2  |  DISEASES
108  |  ADCY2  |  DISEASES
108  |  ADCY2  |  DISEASES
3146  |  HMGB1  |  DISEASES
3146  |  HMGB1  |  DISEASES
3716  |  JAK1  |  DISEASES
3716  |  JAK1  |  DISEASES
8360  |  HIST1H4D  |  DISEASES
8360  |  HIST1H4D  |  DISEASES
9474  |  ATG5  |  DISEASES
9474  |  ATG5  |  DISEASES
10317  |  B3GALT5  |  DISEASES
10317  |  B3GALT5  |  DISEASES
7517  |  XRCC3  |  DISEASES
7517  |  XRCC3  |  DISEASES
864  |  RUNX3  |  DISEASES
864  |  RUNX3  |  DISEASES
23405  |  DICER1  |  DISEASES
23405  |  DICER1  |  DISEASES
10252  |  SPRY1  |  DISEASES
10252  |  SPRY1  |  DISEASES
54575  |  UGT1A10  |  DISEASES
54575  |  UGT1A10  |  DISEASES
2100  |  ESR2  |  DISEASES
2100  |  ESR2  |  DISEASES
1003  |  CDH5  |  DISEASES
1003  |  CDH5  |  DISEASES
3605  |  IL17A  |  DISEASES
3605  |  IL17A  |  DISEASES
54914  |  FOCAD  |  DISEASES
54914  |  FOCAD  |  DISEASES
467  |  ATF3  |  DISEASES
467  |  ATF3  |  DISEASES
389421  |  LIN28B  |  DISEASES
389421  |  LIN28B  |  DISEASES
1499  |  CTNNB1  |  DISEASES
1499  |  CTNNB1  |  DISEASES
875  |  CBS  |  DISEASES
875  |  CBS  |  DISEASES
5757  |  PTMA  |  DISEASES
5757  |  PTMA  |  DISEASES
80279  |  CDK5RAP3  |  DISEASES
80279  |  CDK5RAP3  |  DISEASES
84236  |  RHBDD1  |  DISEASES
84236  |  RHBDD1  |  DISEASES
8073  |  PTP4A2  |  DISEASES
8073  |  PTP4A2  |  DISEASES
9232  |  PTTG1  |  DISEASES
9232  |  PTTG1  |  DISEASES
81848  |  SPRY4  |  DISEASES
81848  |  SPRY4  |  DISEASES
3516  |  RBPJ  |  DISEASES
3516  |  RBPJ  |  DISEASES
80142  |  PTGES2  |  DISEASES
80142  |  PTGES2  |  DISEASES
57556  |  SEMA6A  |  DISEASES
57556  |  SEMA6A  |  DISEASES
1869  |  E2F1  |  DISEASES
1869  |  E2F1  |  DISEASES
766  |  CA7  |  DISEASES
766  |  CA7  |  DISEASES
8326  |  FZD9  |  DISEASES
8326  |  FZD9  |  DISEASES
56937  |  PMEPA1  |  DISEASES
56937  |  PMEPA1  |  DISEASES
1852  |  DUSP9  |  DISEASES
1852  |  DUSP9  |  DISEASES
1811  |  SLC26A3  |  DISEASES
1811  |  SLC26A3  |  DISEASES
114770  |  PGLYRP2  |  DISEASES
114770  |  PGLYRP2  |  DISEASES
55556  |  ENOSF1  |  DISEASES
55556  |  ENOSF1  |  DISEASES
6122  |  RPL3  |  DISEASES
6122  |  RPL3  |  DISEASES
6157  |  RPL27A  |  DISEASES
6157  |  RPL27A  |  DISEASES
302  |  ANXA2  |  DISEASES
302  |  ANXA2  |  DISEASES
2879  |  GPX4  |  DISEASES
2879  |  GPX4  |  DISEASES
5562  |  PRKAA1  |  DISEASES
5562  |  PRKAA1  |  DISEASES
6275  |  S100A4  |  DISEASES
6275  |  S100A4  |  DISEASES
8294  |  HIST1H4I  |  DISEASES
8294  |  HIST1H4I  |  DISEASES
127255  |  LRRIQ3  |  DISEASES
127255  |  LRRIQ3  |  DISEASES
10533  |  ATG7  |  DISEASES
10533  |  ATG7  |  DISEASES
6925  |  TCF4  |  DISEASES
6925  |  TCF4  |  DISEASES
2534  |  FYN  |  DISEASES
2534  |  FYN  |  DISEASES
27044  |  SND1  |  DISEASES
27044  |  SND1  |  DISEASES
54600  |  UGT1A9  |  DISEASES
54600  |  UGT1A9  |  DISEASES
2335  |  FN1  |  DISEASES
2335  |  FN1  |  DISEASES
7080  |  NKX2-1  |  DISEASES
7080  |  NKX2-1  |  DISEASES
131920  |  TMEM207  |  DISEASES
131920  |  TMEM207  |  DISEASES
64218  |  SEMA4A  |  DISEASES
64218  |  SEMA4A  |  DISEASES
8363  |  HIST1H4J  |  DISEASES
8363  |  HIST1H4J  |  DISEASES
8650  |  NUMB  |  DISEASES
8650  |  NUMB  |  DISEASES
79661  |  NEIL1  |  DISEASES
79661  |  NEIL1  |  DISEASES
94086  |  HSPB9  |  DISEASES
94086  |  HSPB9  |  DISEASES
122704  |  MRPL52  |  DISEASES
122704  |  MRPL52  |  DISEASES
2070  |  EYA4  |  DISEASES
2070  |  EYA4  |  DISEASES
23111  |  SPG20  |  DISEASES
23111  |  SPG20  |  DISEASES
100506658  |  OCLN  |  DISEASES
100506658  |  OCLN  |  DISEASES
147495  |  APCDD1  |  DISEASES
147495  |  APCDD1  |  DISEASES
7453  |  WARS  |  DISEASES
7453  |  WARS  |  DISEASES
80781  |  COL18A1  |  DISEASES
80781  |  COL18A1  |  DISEASES
8295  |  TRRAP  |  DISEASES
8295  |  TRRAP  |  DISEASES
3359  |  HTR3A  |  DISEASES
3359  |  HTR3A  |  DISEASES
8871  |  SYNJ2  |  DISEASES
8871  |  SYNJ2  |  DISEASES
22841  |  RAB11FIP2  |  DISEASES
22841  |  RAB11FIP2  |  DISEASES
331  |  XIAP  |  DISEASES
331  |  XIAP  |  DISEASES
5979  |  RET  |  DISEASES
5979  |  RET  |  DISEASES
2073  |  ERCC5  |  DISEASES
2073  |  ERCC5  |  DISEASES
355  |  FAS  |  DISEASES
355  |  FAS  |  DISEASES
27030  |  MLH3  |  DISEASES
27030  |  MLH3  |  DISEASES
5265  |  SERPINA1  |  DISEASES
5265  |  SERPINA1  |  DISEASES
56164  |  STK31  |  DISEASES
56164  |  STK31  |  DISEASES
5358  |  PLS3  |  DISEASES
5358  |  PLS3  |  DISEASES
3240  |  HP  |  DISEASES
3240  |  HP  |  DISEASES
8368  |  HIST1H4L  |  DISEASES
8368  |  HIST1H4L  |  DISEASES
54766  |  BTG4  |  DISEASES
54766  |  BTG4  |  DISEASES
8510  |  MMP23B  |  DISEASES
8510  |  MMP23B  |  DISEASES
51155  |  HN1  |  DISEASES
51155  |  HN1  |  DISEASES
51710  |  ZNF44  |  DISEASES
51710  |  ZNF44  |  DISEASES
51703  |  ACSL5  |  DISEASES
51703  |  ACSL5  |  DISEASES
7405  |  UVRAG  |  DISEASES
7405  |  UVRAG  |  DISEASES
55544  |  RBM38  |  DISEASES
55544  |  RBM38  |  DISEASES
122786  |  FRMD6  |  DISEASES
122786  |  FRMD6  |  DISEASES
10142  |  AKAP9  |  DISEASES
10142  |  AKAP9  |  DISEASES
23035  |  PHLPP2  |  DISEASES
23035  |  PHLPP2  |  DISEASES
10616  |  RBCK1  |  DISEASES
10616  |  RBCK1  |  DISEASES
5906  |  RAP1A  |  DISEASES
5906  |  RAP1A  |  DISEASES
5789  |  PTPRD  |  DISEASES
5789  |  PTPRD  |  DISEASES
10507  |  SEMA4D  |  DISEASES
10507  |  SEMA4D  |  DISEASES
11065  |  UBE2C  |  DISEASES
11065  |  UBE2C  |  DISEASES
5284  |  PIGR  |  DISEASES
5284  |  PIGR  |  DISEASES
6288  |  SAA1  |  DISEASES
6288  |  SAA1  |  DISEASES
284654  |  RSPO1  |  DISEASES
284654  |  RSPO1  |  DISEASES
5733  |  PTGER3  |  DISEASES
5733  |  PTGER3  |  DISEASES
1822  |  ATN1  |  DISEASES
1822  |  ATN1  |  DISEASES
4100  |  MAGEA1  |  DISEASES
4100  |  MAGEA1  |  DISEASES
84870  |  RSPO3  |  DISEASES
84870  |  RSPO3  |  DISEASES
6477  |  SIAH1  |  DISEASES
6477  |  SIAH1  |  DISEASES
3187  |  HNRNPH1  |  DISEASES
3187  |  HNRNPH1  |  DISEASES
55124  |  PIWIL2  |  DISEASES
55124  |  PIWIL2  |  DISEASES
3683  |  ITGAL  |  DISEASES
3683  |  ITGAL  |  DISEASES
3084  |  NRG1  |  DISEASES
3084  |  NRG1  |  DISEASES
8794  |  TNFRSF10C  |  DISEASES
8794  |  TNFRSF10C  |  DISEASES
5725  |  PTBP1  |  DISEASES
5725  |  PTBP1  |  DISEASES
3482  |  IGF2R  |  DISEASES
3482  |  IGF2R  |  DISEASES
801  |  CALM1  |  DISEASES
801  |  CALM1  |  DISEASES
2980  |  GUCA2A  |  DISEASES
2980  |  GUCA2A  |  DISEASES
1108  |  CHD4  |  DISEASES
1108  |  CHD4  |  DISEASES
11186  |  RASSF1  |  DISEASES
11186  |  RASSF1  |  DISEASES
79602  |  ADIPOR2  |  DISEASES
79602  |  ADIPOR2  |  DISEASES
4745  |  NELL1  |  DISEASES
4745  |  NELL1  |  DISEASES
3663  |  IRF5  |  DISEASES
3663  |  IRF5  |  DISEASES
253260  |  RICTOR  |  DISEASES
253260  |  RICTOR  |  DISEASES
60  |  ACTB  |  DISEASES
60  |  ACTB  |  DISEASES
23032  |  USP33  |  DISEASES
23032  |  USP33  |  DISEASES
283160  |  OR8D2  |  DISEASES
283160  |  OR8D2  |  DISEASES
728378  |  POTEF  |  DISEASES
728378  |  POTEF  |  DISEASES
8362  |  HIST1H4K  |  DISEASES
8362  |  HIST1H4K  |  DISEASES
493  |  ATP2B4  |  DISEASES
493  |  ATP2B4  |  DISEASES
9586  |  CREB5  |  DISEASES
9586  |  CREB5  |  DISEASES
4097  |  MAFG  |  DISEASES
4097  |  MAFG  |  DISEASES
10987  |  COPS5  |  DISEASES
10987  |  COPS5  |  DISEASES
10505  |  SEMA4F  |  DISEASES
10505  |  SEMA4F  |  DISEASES
54955  |  C1orf109  |  DISEASES
54955  |  C1orf109  |  DISEASES
6597  |  SMARCA4  |  DISEASES
6597  |  SMARCA4  |  DISEASES
121504  |  HIST4H4  |  DISEASES
121504  |  HIST4H4  |  DISEASES
1612  |  DAPK1  |  DISEASES
1612  |  DAPK1  |  DISEASES
23567  |  ZNF346  |  DISEASES
23567  |  ZNF346  |  DISEASES
2050  |  EPHB4  |  DISEASES
2050  |  EPHB4  |  DISEASES
6714  |  SRC  |  DISEASES
6714  |  SRC  |  DISEASES
10298  |  PAK4  |  DISEASES
10298  |  PAK4  |  DISEASES
83694  |  RPS6KL1  |  DISEASES
83694  |  RPS6KL1  |  DISEASES
53841  |  CDHR5  |  DISEASES
53841  |  CDHR5  |  DISEASES
1969  |  EPHA2  |  DISEASES
1969  |  EPHA2  |  DISEASES
841  |  CASP8  |  DISEASES
841  |  CASP8  |  DISEASES
405  |  ARNT  |  DISEASES
405  |  ARNT  |  DISEASES
10004  |  NAALADL1  |  DISEASES
10004  |  NAALADL1  |  DISEASES
2526  |  FUT4  |  DISEASES
2526  |  FUT4  |  DISEASES
8323  |  FZD6  |  DISEASES
8323  |  FZD6  |  DISEASES
6364  |  CCL20  |  DISEASES
6364  |  CCL20  |  DISEASES
56980  |  PRDM10  |  DISEASES
56980  |  PRDM10  |  DISEASES
7048  |  TGFBR2  |  DISEASES
7048  |  TGFBR2  |  DISEASES
8913  |  CACNA1G  |  DISEASES
8913  |  CACNA1G  |  DISEASES
9332  |  CD163  |  DISEASES
9332  |  CD163  |  DISEASES
56474  |  CTPS2  |  DISEASES
56474  |  CTPS2  |  DISEASES
11199  |  ANXA10  |  DISEASES
11199  |  ANXA10  |  DISEASES
2547  |  XRCC6  |  DISEASES
2547  |  XRCC6  |  DISEASES
7516  |  XRCC2  |  DISEASES
7516  |  XRCC2  |  DISEASES
122773  |  KLHDC1  |  DISEASES
122773  |  KLHDC1  |  DISEASES
55503  |  TRPV6  |  DISEASES
55503  |  TRPV6  |  DISEASES
1786  |  DNMT1  |  DISEASES
1786  |  DNMT1  |  DISEASES
57016  |  AKR1B10  |  DISEASES
57016  |  AKR1B10  |  DISEASES
9179  |  AP4M1  |  DISEASES
9179  |  AP4M1  |  DISEASES
1999  |  ELF3  |  DISEASES
6832  |  SUPV3L1  |  DISEASES
6832  |  SUPV3L1  |  DISEASES
6539  |  SLC6A12  |  DISEASES
6539  |  SLC6A12  |  DISEASES
4192  |  MDK  |  DISEASES
4192  |  MDK  |  DISEASES
7004  |  TEAD4  |  DISEASES
7004  |  TEAD4  |  DISEASES
1454  |  CSNK1E  |  DISEASES
1454  |  CSNK1E  |  DISEASES
8359  |  HIST1H4A  |  DISEASES
8359  |  HIST1H4A  |  DISEASES
51150  |  SDF4  |  DISEASES
51150  |  SDF4  |  DISEASES
340578  |  DCAF12L2  |  DISEASES
340578  |  DCAF12L2  |  DISEASES
79690  |  GAL3ST4  |  DISEASES
79690  |  GAL3ST4  |  DISEASES
5697  |  PYY  |  DISEASES
5697  |  PYY  |  DISEASES
7037  |  TFRC  |  DISEASES
7037  |  TFRC  |  DISEASES
2114  |  ETS2  |  DISEASES
2114  |  ETS2  |  DISEASES
4478  |  MSN  |  DISEASES
4478  |  MSN  |  DISEASES
3164  |  NR4A1  |  DISEASES
3164  |  NR4A1  |  DISEASES
3135  |  HLA-G  |  DISEASES
3135  |  HLA-G  |  DISEASES
1366  |  CLDN7  |  DISEASES
1366  |  CLDN7  |  DISEASES
5599  |  MAPK8  |  DISEASES
5599  |  MAPK8  |  DISEASES
8367  |  HIST1H4E  |  DISEASES
8367  |  HIST1H4E  |  DISEASES
4311  |  MME  |  DISEASES
4311  |  MME  |  DISEASES
1066  |  CES1  |  DISEASES
1066  |  CES1  |  DISEASES
1803  |  DPP4  |  DISEASES
1803  |  DPP4  |  DISEASES
6241  |  RRM2  |  DISEASES
6241  |  RRM2  |  DISEASES
1565  |  CYP2D6  |  DISEASES
1565  |  CYP2D6  |  DISEASES
9361  |  LONP1  |  DISEASES
9361  |  LONP1  |  DISEASES
7707  |  ZNF148  |  DISEASES
7707  |  ZNF148  |  DISEASES
54106  |  TLR9  |  DISEASES
54106  |  TLR9  |  DISEASES
578  |  BAK1  |  DISEASES
578  |  BAK1  |  DISEASES
140803  |  TRPM6  |  DISEASES
140803  |  TRPM6  |  DISEASES
58484  |  NLRC4  |  DISEASES
58484  |  NLRC4  |  DISEASES
4916  |  NTRK3  |  DISEASES
4916  |  NTRK3  |  DISEASES
10848  |  PPP1R13L  |  DISEASES
10848  |  PPP1R13L  |  DISEASES
7169  |  TPM2  |  DISEASES
7169  |  TPM2  |  DISEASES
6772  |  STAT1  |  DISEASES
6772  |  STAT1  |  DISEASES
6935  |  ZEB1  |  DISEASES
6935  |  ZEB1  |  DISEASES
4512  |  MT-CO1  |  DISEASES
4512  |  MT-CO1  |  DISEASES
7150  |  TOP1  |  DISEASES
7150  |  TOP1  |  DISEASES
4860  |  PNP  |  DISEASES
4860  |  PNP  |  DISEASES
9819  |  TSC22D2  |  DISEASES
9819  |  TSC22D2  |  DISEASES
2475  |  MTOR  |  DISEASES
2475  |  MTOR  |  DISEASES
219927  |  MRPL21  |  DISEASES
219927  |  MRPL21  |  DISEASES
9848  |  MFAP3L  |  DISEASES
9848  |  MFAP3L  |  DISEASES
2736  |  GLI2  |  DISEASES
2736  |  GLI2  |  DISEASES
5742  |  PTGS1  |  DISEASES
5742  |  PTGS1  |  DISEASES
919  |  CD247  |  DISEASES
919  |  CD247  |  DISEASES
54739  |  XAF1  |  DISEASES
54739  |  XAF1  |  DISEASES
800  |  CALD1  |  DISEASES
800  |  CALD1  |  DISEASES
9760  |  TOX  |  DISEASES
9760  |  TOX  |  DISEASES
4283  |  CXCL9  |  DISEASES
4283  |  CXCL9  |  DISEASES
8556  |  CDC14A  |  DISEASES
8556  |  CDC14A  |  DISEASES
4514  |  MT-CO3  |  DISEASES
4514  |  MT-CO3  |  DISEASES
8863  |  PER3  |  DISEASES
8863  |  PER3  |  DISEASES
56259  |  CTNNBL1  |  DISEASES
56259  |  CTNNBL1  |  DISEASES
9444  |  QKI  |  DISEASES
9444  |  QKI  |  DISEASES
3880  |  KRT19  |  DISEASES
3880  |  KRT19  |  DISEASES
8678  |  BECN1  |  DISEASES
8678  |  BECN1  |  DISEASES
1870  |  E2F2  |  DISEASES
1870  |  E2F2  |  DISEASES
23038  |  WDTC1  |  DISEASES
23038  |  WDTC1  |  DISEASES
10806  |  SDCCAG8  |  DISEASES
10806  |  SDCCAG8  |  DISEASES
4548  |  MTR  |  DISEASES
4548  |  MTR  |  DISEASES
54583  |  EGLN1  |  DISEASES
54583  |  EGLN1  |  DISEASES
58480  |  RHOU  |  DISEASES
58480  |  RHOU  |  DISEASES
28514  |  DLL1  |  DISEASES
28514  |  DLL1  |  DISEASES
116841  |  SNAP47  |  DISEASES
116841  |  SNAP47  |  DISEASES
7058  |  THBS2  |  DISEASES
7058  |  THBS2  |  DISEASES
142  |  PARP1  |  DISEASES
142  |  PARP1  |  DISEASES
11221  |  DUSP10  |  DISEASES
11221  |  DUSP10  |  DISEASES
2058  |  EPRS  |  DISEASES
2058  |  EPRS  |  DISEASES
7042  |  TGFB2  |  DISEASES
7042  |  TGFB2  |  DISEASES
6582  |  SLC22A2  |  DISEASES
6582  |  SLC22A2  |  DISEASES
51514  |  DTL  |  DISEASES
51514  |  DTL  |  DISEASES
25896  |  INTS7  |  DISEASES
25896  |  INTS7  |  DISEASES
4751  |  NEK2  |  DISEASES
4751  |  NEK2  |  DISEASES
3664  |  IRF6  |  DISEASES
3664  |  IRF6  |  DISEASES
1378  |  CR1  |  DISEASES
1378  |  CR1  |  DISEASES
6648  |  SOD2  |  DISEASES
6648  |  SOD2  |  DISEASES
729533  |  FAM72A  |  DISEASES
729533  |  FAM72A  |  DISEASES
3814  |  KISS1  |  DISEASES
3814  |  KISS1  |  DISEASES
7432  |  VIP  |  DISEASES
7432  |  VIP  |  DISEASES
23345  |  SYNE1  |  DISEASES
23345  |  SYNE1  |  DISEASES
10765  |  KDM5B  |  DISEASES
10765  |  KDM5B  |  DISEASES
59352  |  LGR6  |  DISEASES
59352  |  LGR6  |  DISEASES
80328  |  ULBP2  |  DISEASES
80328  |  ULBP2  |  DISEASES
2494  |  NR5A2  |  DISEASES
2494  |  NR5A2  |  DISEASES
5788  |  PTPRC  |  DISEASES
5788  |  PTPRC  |  DISEASES
3075  |  CFH  |  DISEASES
3075  |  CFH  |  DISEASES
23328  |  SASH1  |  DISEASES
23328  |  SASH1  |  DISEASES
5743  |  PTGS2  |  DISEASES
5743  |  PTGS2  |  DISEASES
7175  |  TPR  |  DISEASES
7175  |  TPR  |  DISEASES
6041  |  RNASEL  |  DISEASES
6041  |  RNASEL  |  DISEASES
27101  |  CACYBP  |  DISEASES
27101  |  CACYBP  |  DISEASES
356  |  FASLG  |  DISEASES
356  |  FASLG  |  DISEASES
6446  |  SGK1  |  DISEASES
6446  |  SGK1  |  DISEASES
10223  |  GPA33  |  DISEASES
10223  |  GPA33  |  DISEASES
84944  |  MAEL  |  DISEASES
84944  |  MAEL  |  DISEASES
8876  |  VNN1  |  DISEASES
8876  |  VNN1  |  DISEASES
11266  |  DUSP12  |  DISEASES
11266  |  DUSP12  |  DISEASES
2214  |  FCGR3A  |  DISEASES
2214  |  FCGR3A  |  DISEASES
6391  |  SDHC  |  DISEASES
6391  |  SDHC  |  DISEASES
1490  |  CTGF  |  DISEASES
1490  |  CTGF  |  DISEASES
257106  |  ARHGAP30  |  DISEASES
257106  |  ARHGAP30  |  DISEASES
7391  |  USF1  |  DISEASES
7391  |  USF1  |  DISEASES
57216  |  VANGL2  |  DISEASES
57216  |  VANGL2  |  DISEASES
383  |  ARG1  |  DISEASES
383  |  ARG1  |  DISEASES
8407  |  TAGLN2  |  DISEASES
8407  |  TAGLN2  |  DISEASES
9447  |  AIM2  |  DISEASES
9447  |  AIM2  |  DISEASES
6708  |  SPTA1  |  DISEASES
6708  |  SPTA1  |  DISEASES
911  |  CD1C  |  DISEASES
911  |  CD1C  |  DISEASES
912  |  CD1D  |  DISEASES
912  |  CD1D  |  DISEASES
2117  |  ETV3  |  DISEASES
2117  |  ETV3  |  DISEASES
3068  |  HDGF  |  DISEASES
3068  |  HDGF  |  DISEASES
5796  |  PTPRK  |  DISEASES
5796  |  PTPRK  |  DISEASES
4582  |  MUC1  |  DISEASES
4582  |  MUC1  |  DISEASES
55974  |  SLC50A1  |  DISEASES
55974  |  SLC50A1  |  DISEASES
1942  |  EFNA1  |  DISEASES
1942  |  EFNA1  |  DISEASES
1944  |  EFNA3  |  DISEASES
1944  |  EFNA3  |  DISEASES
3570  |  IL6R  |  DISEASES
3570  |  IL6R  |  DISEASES
6098  |  ROS1  |  DISEASES
6098  |  ROS1  |  DISEASES
7170  |  TPM3  |  DISEASES
7170  |  TPM3  |  DISEASES
4082  |  MARCKS  |  DISEASES
4082  |  MARCKS  |  DISEASES
664  |  BNIP3  |  DISEASES
664  |  BNIP3  |  DISEASES
256536  |  TCERG1L  |  DISEASES
256536  |  TCERG1L  |  DISEASES
4288  |  MKI67  |  DISEASES
4288  |  MKI67  |  DISEASES
6273  |  S100A2  |  DISEASES
6273  |  S100A2  |  DISEASES
6277  |  S100A6  |  DISEASES
6277  |  S100A6  |  DISEASES
6279  |  S100A8  |  DISEASES
6279  |  S100A8  |  DISEASES
6280  |  S100A9  |  DISEASES
6280  |  S100A9  |  DISEASES
56647  |  BCCIP  |  DISEASES
56647  |  BCCIP  |  DISEASES
9184  |  BUB3  |  DISEASES
9184  |  BUB3  |  DISEASES
5710  |  PSMD4  |  DISEASES
5710  |  PSMD4  |  DISEASES
262  |  AMD1  |  DISEASES
262  |  AMD1  |  DISEASES
1755  |  DMBT1  |  DISEASES
1755  |  DMBT1  |  DISEASES
10500  |  SEMA6C  |  DISEASES
10500  |  SEMA6C  |  DISEASES
1520  |  CTSS  |  DISEASES
1520  |  CTSS  |  DISEASES
256380  |  SCML4  |  DISEASES
256380  |  SCML4  |  DISEASES
4170  |  MCL1  |  DISEASES
4170  |  MCL1  |  DISEASES
8349  |  HIST2H2BE  |  DISEASES
8349  |  HIST2H2BE  |  DISEASES
554313  |  HIST2H4B  |  DISEASES
554313  |  HIST2H4B  |  DISEASES
10973  |  ASCC3  |  DISEASES
10973  |  ASCC3  |  DISEASES
8370  |  HIST2H4A  |  DISEASES
8370  |  HIST2H4A  |  DISEASES
2209  |  FCGR1A  |  DISEASES
2209  |  FCGR1A  |  DISEASES
2045  |  EPHA7  |  DISEASES
2045  |  EPHA7  |  DISEASES
840  |  CASP7  |  DISEASES
840  |  CASP7  |  DISEASES
6885  |  MAP3K7  |  DISEASES
6885  |  MAP3K7  |  DISEASES
3158  |  HMGCS2  |  DISEASES
3158  |  HMGCS2  |  DISEASES
54834  |  GDAP2  |  DISEASES
54834  |  GDAP2  |  DISEASES
79679  |  VTCN1  |  DISEASES
79679  |  VTCN1  |  DISEASES
914  |  CD2  |  DISEASES
914  |  CD2  |  DISEASES
8732  |  RNGTT  |  DISEASES
8732  |  RNGTT  |  DISEASES
965  |  CD58  |  DISEASES
965  |  CD58  |  DISEASES
1268  |  CNR1  |  DISEASES
1268  |  CNR1  |  DISEASES
4893  |  NRAS  |  DISEASES
4893  |  NRAS  |  DISEASES
23036  |  ZNF292  |  DISEASES
23036  |  ZNF292  |  DISEASES
1847  |  DUSP5  |  DISEASES
1847  |  DUSP5  |  DISEASES
8517  |  IKBKG  |  DISEASES
8517  |  IKBKG  |  DISEASES
6566  |  SLC16A1  |  DISEASES
6566  |  SLC16A1  |  DISEASES
7482  |  WNT2B  |  DISEASES
7482  |  WNT2B  |  DISEASES
4199  |  ME1  |  DISEASES
4199  |  ME1  |  DISEASES
7162  |  TPBG  |  DISEASES
7162  |  TPBG  |  DISEASES
2010  |  EMD  |  DISEASES
2010  |  EMD  |  DISEASES
51684  |  SUFU  |  DISEASES
51684  |  SUFU  |  DISEASES
8277  |  TKTL1  |  DISEASES
8277  |  TKTL1  |  DISEASES
8771  |  TNFRSF6B  |  DISEASES
8771  |  TNFRSF6B  |  DISEASES
10451  |  VAV3  |  DISEASES
10451  |  VAV3  |  DISEASES
1301  |  COL11A1  |  DISEASES
1301  |  COL11A1  |  DISEASES
8945  |  BTRC  |  DISEASES
8945  |  BTRC  |  DISEASES
1806  |  DPYD  |  DISEASES
1806  |  DPYD  |  DISEASES
10660  |  LBX1  |  DISEASES
10660  |  LBX1  |  DISEASES
1266  |  CNN3  |  DISEASES
1266  |  CNN3  |  DISEASES
343099  |  CCDC18  |  DISEASES
343099  |  CCDC18  |  DISEASES
4102  |  MAGEA3  |  DISEASES
4102  |  MAGEA3  |  DISEASES
6125  |  RPL5  |  DISEASES
6125  |  RPL5  |  DISEASES
1147  |  CHUK  |  DISEASES
1147  |  CHUK  |  DISEASES
1244  |  ABCC2  |  DISEASES
1244  |  ABCC2  |  DISEASES
55257  |  MRGBP  |  DISEASES
55257  |  MRGBP  |  DISEASES
4923  |  NTSR1  |  DISEASES
4923  |  NTSR1  |  DISEASES
2258  |  FGF13  |  DISEASES
2258  |  FGF13  |  DISEASES
23566  |  LPAR3  |  DISEASES
23566  |  LPAR3  |  DISEASES
959  |  CD40LG  |  DISEASES
959  |  CD40LG  |  DISEASES
80019  |  UBTD1  |  DISEASES
80019  |  UBTD1  |  DISEASES
5688  |  PSMA7  |  DISEASES
5688  |  PSMA7  |  DISEASES
2941  |  GSTA4  |  DISEASES
2941  |  GSTA4  |  DISEASES
1647  |  GADD45A  |  DISEASES
1647  |  GADD45A  |  DISEASES
116154  |  PHACTR3  |  DISEASES
116154  |  PHACTR3  |  DISEASES
10023  |  FRAT1  |  DISEASES
10023  |  FRAT1  |  DISEASES
2778  |  GNAS  |  DISEASES
2778  |  GNAS  |  DISEASES
1791  |  DNTT  |  DISEASES
1791  |  DNTT  |  DISEASES
953  |  ENTPD1  |  DISEASES
953  |  ENTPD1  |  DISEASES
3725  |  JUN  |  DISEASES
3725  |  JUN  |  DISEASES
4070  |  TACSTD2  |  DISEASES
4070  |  TACSTD2  |  DISEASES
55165  |  CEP55  |  DISEASES
55165  |  CEP55  |  DISEASES
3755  |  KCNG1  |  DISEASES
3755  |  KCNG1  |  DISEASES
2030  |  SLC29A1  |  DISEASES
2030  |  SLC29A1  |  DISEASES
9334  |  B4GALT5  |  DISEASES
9334  |  B4GALT5  |  DISEASES
387700  |  SLC16A12  |  DISEASES
387700  |  SLC16A12  |  DISEASES
5728  |  PTEN  |  DISEASES
5728  |  PTEN  |  DISEASES
10103  |  TSPAN1  |  DISEASES
10103  |  TSPAN1  |  DISEASES
6130  |  RPL7A  |  DISEASES
6130  |  RPL7A  |  DISEASES
6623  |  SNCG  |  DISEASES
6623  |  SNCG  |  DISEASES
51249  |  TMEM69  |  DISEASES
51249  |  TMEM69  |  DISEASES
26301  |  GBGT1  |  DISEASES
26301  |  GBGT1  |  DISEASES
5900  |  RALGDS  |  DISEASES
5900  |  RALGDS  |  DISEASES
7422  |  VEGFA  |  DISEASES
7422  |  VEGFA  |  DISEASES
4595  |  MUTYH  |  DISEASES
4595  |  MUTYH  |  DISEASES
112858  |  TP53RK  |  DISEASES
112858  |  TP53RK  |  DISEASES
1263  |  PLK3  |  DISEASES
1263  |  PLK3  |  DISEASES
11004  |  KIF2C  |  DISEASES
11004  |  KIF2C  |  DISEASES
64405  |  CDH22  |  DISEASES
64405  |  CDH22  |  DISEASES
958  |  CD40  |  DISEASES
958  |  CD40  |  DISEASES
128209  |  KLF17  |  DISEASES
128209  |  KLF17  |  DISEASES
4318  |  MMP9  |  DISEASES
4318  |  MMP9  |  DISEASES
25  |  ABL1  |  DISEASES
25  |  ABL1  |  DISEASES
9682  |  KDM4A  |  DISEASES
9682  |  KDM4A  |  DISEASES
375759  |  C9orf50  |  DISEASES
375759  |  C9orf50  |  DISEASES
389792  |  IER5L  |  DISEASES
389792  |  IER5L  |  DISEASES
89845  |  ABCC10  |  DISEASES
89845  |  ABCC10  |  DISEASES
4904  |  YBX1  |  DISEASES
4904  |  YBX1  |  DISEASES
2981  |  GUCA2B  |  DISEASES
2981  |  GUCA2B  |  DISEASES
10864  |  SLC22A7  |  DISEASES
10864  |  SLC22A7  |  DISEASES
2021  |  ENDOG  |  DISEASES
2021  |  ENDOG  |  DISEASES
5328  |  PLAU  |  DISEASES
5328  |  PLAU  |  DISEASES
158931  |  TCEAL6  |  DISEASES
158931  |  TCEAL6  |  DISEASES
6789  |  STK4  |  DISEASES
6789  |  STK4  |  DISEASES
10953  |  TOMM34  |  DISEASES
10953  |  TOMM34  |  DISEASES
27035  |  NOX1  |  DISEASES
27035  |  NOX1  |  DISEASES
896  |  CCND3  |  DISEASES
896  |  CCND3  |  DISEASES
11122  |  PTPRT  |  DISEASES
11122  |  PTPRT  |  DISEASES
2022  |  ENG  |  DISEASES
2022  |  ENG  |  DISEASES
5464  |  PPA1  |  DISEASES
5464  |  PPA1  |  DISEASES
339488  |  TFAP2E  |  DISEASES
339488  |  TFAP2E  |  DISEASES
2356  |  FPGS  |  DISEASES
2356  |  FPGS  |  DISEASES
10800  |  CYSLTR1  |  DISEASES
10800  |  CYSLTR1  |  DISEASES
5230  |  PGK1  |  DISEASES
5230  |  PGK1  |  DISEASES
139596  |  UPRT  |  DISEASES
139596  |  UPRT  |  DISEASES
54657  |  UGT1A4  |  DISEASES
54657  |  UGT1A4  |  DISEASES
54579  |  UGT1A5  |  DISEASES
54579  |  UGT1A5  |  DISEASES
23452  |  ANGPTL2  |  DISEASES
23452  |  ANGPTL2  |  DISEASES
54577  |  UGT1A7  |  DISEASES
54577  |  UGT1A7  |  DISEASES
54576  |  UGT1A8  |  DISEASES
54576  |  UGT1A8  |  DISEASES
3065  |  HDAC1  |  DISEASES
3065  |  HDAC1  |  DISEASES
80312  |  TET1  |  DISEASES
80312  |  TET1  |  DISEASES
23637  |  RABGAP1  |  DISEASES
23637  |  RABGAP1  |  DISEASES
220202  |  ATOH7  |  DISEASES
220202  |  ATOH7  |  DISEASES
2833  |  CXCR3  |  DISEASES
2833  |  CXCR3  |  DISEASES
8473  |  OGT  |  DISEASES
8473  |  OGT  |  DISEASES
2934  |  GSN  |  DISEASES
2934  |  GSN  |  DISEASES
80114  |  BICC1  |  DISEASES
80114  |  BICC1  |  DISEASES
22943  |  DKK1  |  DISEASES
22943  |  DKK1  |  DISEASES
7099  |  TLR4  |  DISEASES
7099  |  TLR4  |  DISEASES
25803  |  SPDEF  |  DISEASES
25803  |  SPDEF  |  DISEASES
1317  |  SLC31A1  |  DISEASES
1317  |  SLC31A1  |  DISEASES
91544  |  UBXN11  |  DISEASES
91544  |  UBXN11  |  DISEASES
240  |  ALOX5  |  DISEASES
240  |  ALOX5  |  DISEASES
55454  |  CSGALNACT2  |  DISEASES
55454  |  CSGALNACT2  |  DISEASES
7295  |  TXN  |  DISEASES
7295  |  TXN  |  DISEASES
5774  |  PTPN3  |  DISEASES
5774  |  PTPN3  |  DISEASES
1896  |  EDA  |  DISEASES
1896  |  EDA  |  DISEASES
659  |  BMPR2  |  DISEASES
659  |  BMPR2  |  DISEASES
2048  |  EPHB2  |  DISEASES
2048  |  EPHB2  |  DISEASES
8518  |  IKBKAP  |  DISEASES
8518  |  IKBKAP  |  DISEASES
9314  |  KLF4  |  DISEASES
9314  |  KLF4  |  DISEASES
367  |  AR  |  DISEASES
367  |  AR  |  DISEASES
8325  |  FZD8  |  DISEASES
8325  |  FZD8  |  DISEASES
84557  |  MAP1LC3A  |  DISEASES
84557  |  MAP1LC3A  |  DISEASES
5698  |  PSMB9  |  DISEASES
5698  |  PSMB9  |  DISEASES
5696  |  PSMB8  |  DISEASES
5696  |  PSMB8  |  DISEASES
7046  |  TGFBR1  |  DISEASES
7046  |  TGFBR1  |  DISEASES
79695  |  GALNT12  |  DISEASES
79695  |  GALNT12  |  DISEASES
4855  |  NOTCH4  |  DISEASES
4855  |  NOTCH4  |  DISEASES
978  |  CDA  |  DISEASES
978  |  CDA  |  DISEASES
55450  |  CAMK2N1  |  DISEASES
55450  |  CAMK2N1  |  DISEASES
5320  |  PLA2G2A  |  DISEASES
5320  |  PLA2G2A  |  DISEASES
7507  |  XPA  |  DISEASES
7507  |  XPA  |  DISEASES
3014  |  H2AFX  |  DISEASES
3014  |  H2AFX  |  DISEASES
51154  |  MRTO4  |  DISEASES
51154  |  MRTO4  |  DISEASES
8555  |  CDC14B  |  DISEASES
8555  |  CDC14B  |  DISEASES
22927  |  HABP4  |  DISEASES
22927  |  HABP4  |  DISEASES
25805  |  BAMBI  |  DISEASES
25805  |  BAMBI  |  DISEASES
10919  |  EHMT2  |  DISEASES
10919  |  EHMT2  |  DISEASES
2159  |  F10  |  DISEASES
2159  |  F10  |  DISEASES
22919  |  MAPRE1  |  DISEASES
22919  |  MAPRE1  |  DISEASES
3376  |  IARS  |  DISEASES
3376  |  IARS  |  DISEASES
3303  |  HSPA1A  |  DISEASES
3303  |  HSPA1A  |  DISEASES
4920  |  ROR2  |  DISEASES
4920  |  ROR2  |  DISEASES
23013  |  SPEN  |  DISEASES
23013  |  SPEN  |  DISEASES
3621  |  ING1  |  DISEASES
3621  |  ING1  |  DISEASES
1164  |  CKS2  |  DISEASES
1164  |  CKS2  |  DISEASES
3055  |  HCK  |  DISEASES
3055  |  HCK  |  DISEASES
8660  |  IRS2  |  DISEASES
8660  |  IRS2  |  DISEASES
93081  |  TEX30  |  DISEASES
93081  |  TEX30  |  DISEASES
3397  |  ID1  |  DISEASES
3397  |  ID1  |  DISEASES
50943  |  FOXP3  |  DISEASES
50943  |  FOXP3  |  DISEASES
100507436  |  MICA  |  DISEASES
100507436  |  MICA  |  DISEASES
7133  |  TNFRSF1B  |  DISEASES
3190  |  HNRNPK  |  DISEASES
3190  |  HNRNPK  |  DISEASES
1041  |  CDSN  |  DISEASES
1041  |  CDSN  |  DISEASES
5355  |  PLP2  |  DISEASES
5355  |  PLP2  |  DISEASES
256297  |  PTF1A  |  DISEASES
256297  |  PTF1A  |  DISEASES
7091  |  TLE4  |  DISEASES
7091  |  TLE4  |  DISEASES
2017  |  CTTN  |  DISEASES
2017  |  CTTN  |  DISEASES
29968  |  PSAT1  |  DISEASES
29968  |  PSAT1  |  DISEASES
4524  |  MTHFR  |  DISEASES
4524  |  MTHFR  |  DISEASES
3133  |  HLA-E  |  DISEASES
3133  |  HLA-E  |  DISEASES
648  |  BMI1  |  DISEASES
648  |  BMI1  |  DISEASES
2650  |  GCNT1  |  DISEASES
2650  |  GCNT1  |  DISEASES
6668  |  SP2  |  DISEASES
5935  |  RBM3  |  DISEASES
5935  |  RBM3  |  DISEASES
3105  |  HLA-A  |  DISEASES
3105  |  HLA-A  |  DISEASES
10257  |  ABCC4  |  DISEASES
10257  |  ABCC4  |  DISEASES
10537  |  UBD  |  DISEASES
10537  |  UBD  |  DISEASES
10253  |  SPRY2  |  DISEASES
10253  |  SPRY2  |  DISEASES
7056  |  THBD  |  DISEASES
7056  |  THBD  |  DISEASES
8366  |  HIST1H4B  |  DISEASES
8366  |  HIST1H4B  |  DISEASES
3604  |  TNFRSF9  |  DISEASES
3604  |  TNFRSF9  |  DISEASES
688  |  KLF5  |  DISEASES
688  |  KLF5  |  DISEASES
219  |  ALDH1B1  |  DISEASES
219  |  ALDH1B1  |  DISEASES
8361  |  HIST1H4F  |  DISEASES
8361  |  HIST1H4F  |  DISEASES
22894  |  DIS3  |  DISEASES
22894  |  DIS3  |  DISEASES
8364  |  HIST1H4C  |  DISEASES
8364  |  HIST1H4C  |  DISEASES
54626  |  HES2  |  DISEASES
54626  |  HES2  |  DISEASES
390992  |  HES3  |  DISEASES
8434  |  RECK  |  DISEASES
8434  |  RECK  |  DISEASES
4609  |  MYC  |  DISEASES
4609  |  MYC  |  DISEASES
51754  |  TMEM8B  |  DISEASES
51754  |  TMEM8B  |  DISEASES
9397  |  NMT2  |  DISEASES
9397  |  NMT2  |  DISEASES
7161  |  TP73  |  DISEASES
7161  |  TP73  |  DISEASES
768  |  CA9  |  DISEASES
768  |  CA9  |  DISEASES
388585  |  HES5  |  DISEASES
388585  |  HES5  |  DISEASES
5420  |  PODXL  |  DISEASES
5420  |  PODXL  |  DISEASES
6354  |  CCL7  |  DISEASES
6354  |  CCL7  |  DISEASES
3963  |  LGALS7  |  DISEASES
3963  |  LGALS7  |  DISEASES
196441  |  ZFC3H1  |  DISEASES
196441  |  ZFC3H1  |  DISEASES
650  |  BMP2  |  DISEASES
650  |  BMP2  |  DISEASES
1855  |  DVL1  |  DISEASES
1855  |  DVL1  |  DISEASES
4897  |  NRCAM  |  DISEASES
4897  |  NRCAM  |  DISEASES
9308  |  CD83  |  DISEASES
9308  |  CD83  |  DISEASES
55366  |  LGR4  |  DISEASES
55366  |  LGR4  |  DISEASES
7293  |  TNFRSF4  |  DISEASES
7293  |  TNFRSF4  |  DISEASES
6303  |  SAT1  |  DISEASES
6303  |  SAT1  |  DISEASES
2625  |  GATA3  |  DISEASES
10549  |  PRDX4  |  DISEASES
10549  |  PRDX4  |  DISEASES
28984  |  RGCC  |  DISEASES
28984  |  RGCC  |  DISEASES
168400  |  DDX53  |  DISEASES
168400  |  DDX53  |  DISEASES
1906  |  EDN1  |  DISEASES
1906  |  EDN1  |  DISEASES
9770  |  RASSF2  |  DISEASES
9770  |  RASSF2  |  DISEASES
1874  |  E2F4  |  DISEASES
1874  |  E2F4  |  DISEASES
4739  |  NEDD9  |  DISEASES
4739  |  NEDD9  |  DISEASES
257240  |  KLHL34  |  DISEASES
257240  |  KLHL34  |  DISEASES
6197  |  RPS6KA3  |  DISEASES
6197  |  RPS6KA3  |  DISEASES
387921  |  NHLRC3  |  DISEASES
387921  |  NHLRC3  |  DISEASES
7905  |  REEP5  |  DISEASES
7905  |  REEP5  |  DISEASES
9521  |  EEF1E1  |  DISEASES
9521  |  EEF1E1  |  DISEASES
1543  |  CYP1A1  |  DISEASES
1543  |  CYP1A1  |  DISEASES
10631  |  POSTN  |  DISEASES
10631  |  POSTN  |  DISEASES
5209  |  PFKFB3  |  DISEASES
5209  |  PFKFB3  |  DISEASES
7010  |  TEK  |  DISEASES
7010  |  TEK  |  DISEASES
57228  |  SMAGP  |  DISEASES
57228  |  SMAGP  |  DISEASES
675  |  BRCA2  |  DISEASES
675  |  BRCA2  |  DISEASES
3440  |  IFNA2  |  DISEASES
3440  |  IFNA2  |  DISEASES
79339  |  OR51B4  |  DISEASES
79339  |  OR51B4  |  DISEASES
3456  |  IFNB1  |  DISEASES
3456  |  IFNB1  |  DISEASES
2925  |  GRPR  |  DISEASES
2925  |  GRPR  |  DISEASES
6194  |  RPS6  |  DISEASES
6194  |  RPS6  |  DISEASES
284390  |  ZNF763  |  DISEASES
284390  |  ZNF763  |  DISEASES
79724  |  ZNF768  |  DISEASES
79724  |  ZNF768  |  DISEASES
689  |  BTF3  |  DISEASES
689  |  BTF3  |  DISEASES
665  |  BNIP3L  |  DISEASES
665  |  BNIP3L  |  DISEASES
7114  |  TMSB4X  |  DISEASES
7114  |  TMSB4X  |  DISEASES
51284  |  TLR7  |  DISEASES
51284  |  TLR7  |  DISEASES
5884  |  RAD17  |  DISEASES
5884  |  RAD17  |  DISEASES
2762  |  GMDS  |  DISEASES
2762  |  GMDS  |  DISEASES
357  |  SHROOM2  |  DISEASES
357  |  SHROOM2  |  DISEASES
340481  |  ZDHHC21  |  DISEASES
340481  |  ZDHHC21  |  DISEASES
1854  |  DUT  |  DISEASES
1854  |  DUT  |  DISEASES
1045  |  CDX2  |  DISEASES
1045  |  CDX2  |  DISEASES
3486  |  IGFBP3  |  DISEASES
3486  |  IGFBP3  |  DISEASES
11082  |  ESM1  |  DISEASES
11082  |  ESM1  |  DISEASES
6443  |  SGCB  |  DISEASES
6443  |  SGCB  |  DISEASES
90865  |  IL33  |  DISEASES
90865  |  IL33  |  DISEASES
79958  |  DENND1C  |  DISEASES
79958  |  DENND1C  |  DISEASES
140901  |  STK35  |  DISEASES
140901  |  STK35  |  DISEASES
1024  |  CDK8  |  DISEASES
1024  |  CDK8  |  DISEASES
29126  |  CD274  |  DISEASES
29126  |  CD274  |  DISEASES
3717  |  JAK2  |  DISEASES
3717  |  JAK2  |  DISEASES
7158  |  TP53BP1  |  DISEASES
7158  |  TP53BP1  |  DISEASES
23600  |  AMACR  |  DISEASES
23600  |  AMACR  |  DISEASES
6624  |  FSCN1  |  DISEASES
6624  |  FSCN1  |  DISEASES
9037  |  SEMA5A  |  DISEASES
9037  |  SEMA5A  |  DISEASES
60312  |  AFAP1  |  DISEASES
60312  |  AFAP1  |  DISEASES
11200  |  CHEK2  |  DISEASES
11200  |  CHEK2  |  DISEASES
26524  |  LATS2  |  DISEASES
26524  |  LATS2  |  DISEASES
5888  |  RAD51  |  DISEASES
5888  |  RAD51  |  DISEASES
5268  |  SERPINB5  |  DISEASES
5268  |  SERPINB5  |  DISEASES
2706  |  GJB2  |  DISEASES
2706  |  GJB2  |  DISEASES
203611  |  CDY2B  |  DISEASES
203611  |  CDY2B  |  DISEASES
6736  |  SRY  |  DISEASES
6736  |  SRY  |  DISEASES
2878  |  GPX3  |  DISEASES
2878  |  GPX3  |  DISEASES
3875  |  KRT18  |  DISEASES
3875  |  KRT18  |  DISEASES
286077  |  FAM83H  |  DISEASES
286077  |  FAM83H  |  DISEASES
64754  |  SMYD3  |  DISEASES
64754  |  SMYD3  |  DISEASES
238  |  ALK  |  DISEASES
238  |  ALK  |  DISEASES
26046  |  LTN1  |  DISEASES
26046  |  LTN1  |  DISEASES
2877  |  GPX2  |  DISEASES
2877  |  GPX2  |  DISEASES
727936  |  GXYLT2  |  DISEASES
727936  |  GXYLT2  |  DISEASES
406  |  ARNTL  |  DISEASES
406  |  ARNTL  |  DISEASES
338442  |  HCAR2  |  DISEASES
338442  |  HCAR2  |  DISEASES
5462  |  POU5F1B  |  DISEASES
5462  |  POU5F1B  |  DISEASES
5650  |  KLK7  |  DISEASES
5650  |  KLK7  |  DISEASES
11009  |  IL24  |  DISEASES
11009  |  IL24  |  DISEASES
2068  |  ERCC2  |  DISEASES
2068  |  ERCC2  |  DISEASES
208  |  AKT2  |  DISEASES
208  |  AKT2  |  DISEASES
7520  |  XRCC5  |  DISEASES
7520  |  XRCC5  |  DISEASES
51347  |  TAOK3  |  DISEASES
51347  |  TAOK3  |  DISEASES
2113  |  ETS1  |  DISEASES
2113  |  ETS1  |  DISEASES
7187  |  TRAF3  |  DISEASES
7187  |  TRAF3  |  DISEASES
6996  |  TDG  |  DISEASES
6996  |  TDG  |  DISEASES
51466  |  EVL  |  DISEASES
51466  |  EVL  |  DISEASES
2051  |  EPHB6  |  DISEASES
2051  |  EPHB6  |  DISEASES
143187  |  VTI1A  |  DISEASES
143187  |  VTI1A  |  DISEASES
55240  |  STEAP3  |  DISEASES
55240  |  STEAP3  |  DISEASES
838  |  CASP5  |  DISEASES
838  |  CASP5  |  DISEASES
654364  |  NME1-NME2  |  DISEASES
654364  |  NME1-NME2  |  DISEASES
4831  |  NME2  |  DISEASES
4831  |  NME2  |  DISEASES
10018  |  BCL2L11  |  DISEASES
10018  |  BCL2L11  |  DISEASES
440603  |  BCL2L15  |  DISEASES
440603  |  BCL2L15  |  DISEASES
164832  |  LONRF2  |  DISEASES
164832  |  LONRF2  |  DISEASES
152404  |  IGSF11  |  DISEASES
152404  |  IGSF11  |  DISEASES
9801  |  MRPL19  |  DISEASES
9801  |  MRPL19  |  DISEASES
3161  |  HMMR  |  DISEASES
3161  |  HMMR  |  DISEASES
2172  |  FABP6  |  DISEASES
2172  |  FABP6  |  DISEASES
56954  |  NIT2  |  DISEASES
56954  |  NIT2  |  DISEASES
7026  |  NR2F2  |  DISEASES
7026  |  NR2F2  |  DISEASES
5627  |  PROS1  |  DISEASES
5627  |  PROS1  |  DISEASES
65009  |  NDRG4  |  DISEASES
65009  |  NDRG4  |  DISEASES
307  |  ANXA4  |  DISEASES
307  |  ANXA4  |  DISEASES
2719  |  GPC3  |  DISEASES
2719  |  GPC3  |  DISEASES
79633  |  FAT4  |  DISEASES
79633  |  FAT4  |  DISEASES
140467  |  ZNF358  |  DISEASES
140467  |  ZNF358  |  DISEASES
51520  |  LARS  |  DISEASES
51520  |  LARS  |  DISEASES
9560  |  CCL4L2  |  DISEASES
9560  |  CCL4L2  |  DISEASES
4501  |  MT1X  |  DISEASES
4501  |  MT1X  |  DISEASES
10265  |  IRX5  |  DISEASES
10265  |  IRX5  |  DISEASES
64400  |  AKTIP  |  DISEASES
64400  |  AKTIP  |  DISEASES
98  |  ACYP2  |  DISEASES
98  |  ACYP2  |  DISEASES
5530  |  PPP3CA  |  DISEASES
5530  |  PPP3CA  |  DISEASES
6696  |  SPP1  |  DISEASES
6696  |  SPP1  |  DISEASES
1365  |  CLDN3  |  DISEASES
1365  |  CLDN3  |  DISEASES
146540  |  ZNF785  |  DISEASES
146540  |  ZNF785  |  DISEASES
983  |  CDK1  |  DISEASES
983  |  CDK1  |  DISEASES
27297  |  CRCP  |  DISEASES
27297  |  CRCP  |  DISEASES
3965  |  LGALS9  |  DISEASES
3965  |  LGALS9  |  DISEASES
11180  |  WDR6  |  DISEASES
11180  |  WDR6  |  DISEASES
685  |  BTC  |  DISEASES
685  |  BTC  |  DISEASES
2919  |  CXCL1  |  DISEASES
2919  |  CXCL1  |  DISEASES
51074  |  APIP  |  DISEASES
51074  |  APIP  |  DISEASES
174  |  AFP  |  DISEASES
174  |  AFP  |  DISEASES
6387  |  CXCL12  |  DISEASES
6387  |  CXCL12  |  DISEASES
5744  |  PTHLH  |  DISEASES
5744  |  PTHLH  |  DISEASES
2737  |  GLI3  |  DISEASES
2737  |  GLI3  |  DISEASES
83989  |  FAM172A  |  DISEASES
83989  |  FAM172A  |  DISEASES
115560  |  ZNF501  |  DISEASES
115560  |  ZNF501  |  DISEASES
9245  |  GCNT3  |  DISEASES
9245  |  GCNT3  |  DISEASES
137872  |  ADHFE1  |  DISEASES
137872  |  ADHFE1  |  DISEASES
116135  |  LRRC3B  |  DISEASES
116135  |  LRRC3B  |  DISEASES
51147  |  ING4  |  DISEASES
51147  |  ING4  |  DISEASES
3676  |  ITGA4  |  DISEASES
3676  |  ITGA4  |  DISEASES
4780  |  NFE2L2  |  DISEASES
4780  |  NFE2L2  |  DISEASES
80148  |  PQLC1  |  DISEASES
80148  |  PQLC1  |  DISEASES
386683  |  KRTAP12-3  |  DISEASES
386683  |  KRTAP12-3  |  DISEASES
5609  |  MAP2K7  |  DISEASES
5609  |  MAP2K7  |  DISEASES
2047  |  EPHB1  |  DISEASES
2047  |  EPHB1  |  DISEASES
729857  |  RGPD2  |  DISEASES
729857  |  RGPD2  |  DISEASES
91694  |  LONRF1  |  DISEASES
91694  |  LONRF1  |  DISEASES
4599  |  MX1  |  DISEASES
4599  |  MX1  |  DISEASES
2950  |  GSTP1  |  DISEASES
2950  |  GSTP1  |  DISEASES
7478  |  WNT8A  |  DISEASES
7478  |  WNT8A  |  DISEASES
1500  |  CTNND1  |  DISEASES
1500  |  CTNND1  |  DISEASES
4363  |  ABCC1  |  DISEASES
4363  |  ABCC1  |  DISEASES
387267  |  KRTAP5-4  |  DISEASES
387267  |  KRTAP5-4  |  DISEASES
6093  |  ROCK1  |  DISEASES
6093  |  ROCK1  |  DISEASES
10410  |  IFITM3  |  DISEASES
10410  |  IFITM3  |  DISEASES
1654  |  DDX3X  |  DISEASES
1654  |  DDX3X  |  DISEASES
23028  |  KDM1A  |  DISEASES
23028  |  KDM1A  |  DISEASES
5596  |  MAPK4  |  DISEASES
5596  |  MAPK4  |  DISEASES
1826  |  DSCAM  |  DISEASES
1826  |  DSCAM  |  DISEASES
388795  |  EFCAB8  |  DISEASES
388795  |  EFCAB8  |  DISEASES
81669  |  CCNL2  |  DISEASES
81669  |  CCNL2  |  DISEASES
10747  |  MASP2  |  DISEASES
10747  |  MASP2  |  DISEASES
24144  |  TFIP11  |  DISEASES
24144  |  TFIP11  |  DISEASES
8091  |  HMGA2  |  DISEASES
8091  |  HMGA2  |  DISEASES
5970  |  RELA  |  DISEASES
5970  |  RELA  |  DISEASES
9170  |  LPAR2  |  DISEASES
9170  |  LPAR2  |  DISEASES
5672  |  PSG4  |  DISEASES
5672  |  PSG4  |  DISEASES
7514  |  XPO1  |  DISEASES
7514  |  XPO1  |  DISEASES
2160  |  F11  |  DISEASES
2160  |  F11  |  DISEASES
137970  |  UNC5D  |  DISEASES
137970  |  UNC5D  |  DISEASES
1994  |  ELAVL1  |  DISEASES
1994  |  ELAVL1  |  DISEASES
55714  |  TENM3  |  DISEASES
55714  |  TENM3  |  DISEASES
54894  |  RNF43  |  DISEASES
54894  |  RNF43  |  DISEASES
55083  |  KIF26B  |  DISEASES
55083  |  KIF26B  |  DISEASES
28996  |  HIPK2  |  DISEASES
28996  |  HIPK2  |  DISEASES
2909  |  ARHGAP35  |  DISEASES
2909  |  ARHGAP35  |  DISEASES
728441  |  GGT2  |  DISEASES
728441  |  GGT2  |  DISEASES
6611  |  SMS  |  DISEASES
6611  |  SMS  |  DISEASES
7018  |  TF  |  DISEASES
7018  |  TF  |  DISEASES
25983  |  NGDN  |  DISEASES
25983  |  NGDN  |  DISEASES
4163  |  MCC  |  DISEASES
4163  |  MCC  |  DISEASES
89958  |  SAPCD2  |  DISEASES
89958  |  SAPCD2  |  DISEASES
29072  |  SETD2  |  DISEASES
29072  |  SETD2  |  DISEASES
7852  |  CXCR4  |  DISEASES
7852  |  CXCR4  |  DISEASES
3655  |  ITGA6  |  DISEASES
3655  |  ITGA6  |  DISEASES
57703  |  CWC22  |  DISEASES
57703  |  CWC22  |  DISEASES
5861  |  RAB1A  |  DISEASES
5861  |  RAB1A  |  DISEASES
26648  |  OR7E24  |  DISEASES
26648  |  OR7E24  |  DISEASES
2641  |  GCG  |  DISEASES
2641  |  GCG  |  DISEASES
1385  |  CREB1  |  DISEASES
1385  |  CREB1  |  DISEASES
1111  |  CHEK1  |  DISEASES
1111  |  CHEK1  |  DISEASES
6744  |  SSFA2  |  DISEASES
6744  |  SSFA2  |  DISEASES
9805  |  SCRN1  |  DISEASES
9805  |  SCRN1  |  DISEASES
1630  |  DCC  |  DISEASES
1630  |  DCC  |  DISEASES
5601  |  MAPK9  |  DISEASES
5601  |  MAPK9  |  DISEASES
5349  |  FXYD3  |  DISEASES
5349  |  FXYD3  |  DISEASES
90353  |  CTU1  |  DISEASES
90353  |  CTU1  |  DISEASES
6336  |  SCN10A  |  DISEASES
6336  |  SCN10A  |  DISEASES
4495  |  MT1G  |  DISEASES
4495  |  MT1G  |  DISEASES
10551  |  AGR2  |  DISEASES
10551  |  AGR2  |  DISEASES
9564  |  BCAR1  |  DISEASES
9564  |  BCAR1  |  DISEASES
3718  |  JAK3  |  DISEASES
3718  |  JAK3  |  DISEASES
3481  |  IGF2  |  DISEASES
3481  |  IGF2  |  DISEASES
164714  |  TTLL8  |  DISEASES
164714  |  TTLL8  |  DISEASES
55743  |  CHFR  |  DISEASES
55743  |  CHFR  |  DISEASES
9058  |  SLC13A2  |  DISEASES
9058  |  SLC13A2  |  DISEASES
26086  |  GPSM1  |  DISEASES
26086  |  GPSM1  |  DISEASES
6222  |  RPS18  |  DISEASES
6222  |  RPS18  |  DISEASES
2260  |  FGFR1  |  DISEASES
2260  |  FGFR1  |  DISEASES
57448  |  BIRC6  |  DISEASES
57448  |  BIRC6  |  DISEASES
27244  |  SESN1  |  DISEASES
27244  |  SESN1  |  DISEASES
8399  |  PLA2G10  |  DISEASES
8399  |  PLA2G10  |  DISEASES
197  |  AHSG  |  DISEASES
197  |  AHSG  |  DISEASES
85458  |  DIXDC1  |  DISEASES
85458  |  DIXDC1  |  DISEASES
90589  |  ZNF625  |  DISEASES
90589  |  ZNF625  |  DISEASES
57224  |  NHSL1  |  DISEASES
57224  |  NHSL1  |  DISEASES
5783  |  PTPN13  |  DISEASES
5783  |  PTPN13  |  DISEASES
1029  |  CDKN2A  |  DISEASES
1029  |  CDKN2A  |  DISEASES
23705  |  CADM1  |  DISEASES
23705  |  CADM1  |  DISEASES
26354  |  GNL3  |  DISEASES
26354  |  GNL3  |  DISEASES
1719  |  DHFR  |  DISEASES
1719  |  DHFR  |  DISEASES
10725  |  NFAT5  |  DISEASES
10725  |  NFAT5  |  DISEASES
720  |  C4A  |  DISEASES
720  |  C4A  |  DISEASES
7155  |  TOP2B  |  DISEASES
7155  |  TOP2B  |  DISEASES
1875  |  E2F5  |  DISEASES
1875  |  E2F5  |  DISEASES
56616  |  DIABLO  |  DISEASES
56616  |  DIABLO  |  DISEASES
960  |  CD44  |  DISEASES
960  |  CD44  |  DISEASES
7124  |  TNF  |  DISEASES
7124  |  TNF  |  DISEASES
3491  |  CYR61  |  DISEASES
3491  |  CYR61  |  DISEASES
3106  |  HLA-B  |  DISEASES
3106  |  HLA-B  |  DISEASES
23043  |  TNIK  |  DISEASES
23043  |  TNIK  |  DISEASES
6304  |  SATB1  |  DISEASES
6304  |  SATB1  |  DISEASES
5795  |  PTPRJ  |  DISEASES
5795  |  PTPRJ  |  DISEASES
387  |  RHOA  |  DISEASES
387  |  RHOA  |  DISEASES
159371  |  SLC35G1  |  DISEASES
159371  |  SLC35G1  |  DISEASES
64785  |  GINS3  |  DISEASES
64785  |  GINS3  |  DISEASES
4615  |  MYD88  |  DISEASES
4615  |  MYD88  |  DISEASES
5706  |  PSMC6  |  DISEASES
5706  |  PSMC6  |  DISEASES
7465  |  WEE1  |  DISEASES
7465  |  WEE1  |  DISEASES
55353  |  LAPTM4B  |  DISEASES
55353  |  LAPTM4B  |  DISEASES
55611  |  OTUB1  |  DISEASES
55611  |  OTUB1  |  DISEASES
400986  |  ANKRD36C  |  DISEASES
400986  |  ANKRD36C  |  DISEASES
8831  |  SYNGAP1  |  DISEASES
8831  |  SYNGAP1  |  DISEASES
10178  |  TENM1  |  DISEASES
27113  |  BBC3  |  DISEASES
27113  |  BBC3  |  DISEASES
6892  |  TAPBP  |  DISEASES
6892  |  TAPBP  |  DISEASES
117581  |  TWIST2  |  DISEASES
117581  |  TWIST2  |  DISEASES
7086  |  TKT  |  DISEASES
7086  |  TKT  |  DISEASES
388372  |  CCL4L1  |  DISEASES
388372  |  CCL4L1  |  DISEASES
255919  |  CNEP1R1  |  DISEASES
255919  |  CNEP1R1  |  DISEASES
54845  |  ESRP1  |  DISEASES
54845  |  ESRP1  |  DISEASES
8633  |  UNC5C  |  DISEASES
8633  |  UNC5C  |  DISEASES
5424  |  POLD1  |  DISEASES
5424  |  POLD1  |  DISEASES
284111  |  SLC13A5  |  DISEASES
284111  |  SLC13A5  |  DISEASES
2195  |  FAT1  |  DISEASES
2195  |  FAT1  |  DISEASES
5378  |  PMS1  |  DISEASES
5378  |  PMS1  |  DISEASES
1408  |  CRY2  |  DISEASES
1408  |  CRY2  |  DISEASES
4588  |  MUC6  |  DISEASES
4588  |  MUC6  |  DISEASES
2876  |  GPX1  |  DISEASES
2876  |  GPX1  |  DISEASES
8522  |  GAS7  |  DISEASES
8522  |  GAS7  |  DISEASES
64854  |  USP46  |  DISEASES
64854  |  USP46  |  DISEASES
9351  |  SLC9A3R2  |  DISEASES
9351  |  SLC9A3R2  |  DISEASES
9266  |  CYTH2  |  DISEASES
9266  |  CYTH2  |  DISEASES
1012  |  CDH13  |  DISEASES
1012  |  CDH13  |  DISEASES
1154  |  CISH  |  DISEASES
1154  |  CISH  |  DISEASES
834  |  CASP1  |  DISEASES
834  |  CASP1  |  DISEASES
2263  |  FGFR2  |  DISEASES
2263  |  FGFR2  |  DISEASES
3925  |  STMN1  |  DISEASES
3925  |  STMN1  |  DISEASES
6424  |  SFRP4  |  DISEASES
6424  |  SFRP4  |  DISEASES
64283  |  ARHGEF28  |  DISEASES
64283  |  ARHGEF28  |  DISEASES
7153  |  TOP2A  |  DISEASES
7153  |  TOP2A  |  DISEASES
3586  |  IL10  |  DISEASES
3586  |  IL10  |  DISEASES
55635  |  DEPDC1  |  DISEASES
55635  |  DEPDC1  |  DISEASES
55355  |  HJURP  |  DISEASES
55355  |  HJURP  |  DISEASES
4583  |  MUC2  |  DISEASES
4583  |  MUC2  |  DISEASES
8842  |  PROM1  |  DISEASES
8842  |  PROM1  |  DISEASES
721  |  C4B  |  DISEASES
721  |  C4B  |  DISEASES
56649  |  TMPRSS4  |  DISEASES
56649  |  TMPRSS4  |  DISEASES
6513  |  SLC2A1  |  DISEASES
6513  |  SLC2A1  |  DISEASES
4753  |  NELL2  |  DISEASES
4753  |  NELL2  |  DISEASES
10201  |  NME6  |  DISEASES
10201  |  NME6  |  DISEASES
170506  |  DHX36  |  DISEASES
170506  |  DHX36  |  DISEASES
4193  |  MDM2  |  DISEASES
4193  |  MDM2  |  DISEASES
6092  |  ROBO2  |  DISEASES
6092  |  ROBO2  |  DISEASES
3077  |  HFE  |  DISEASES
3077  |  HFE  |  DISEASES
4585  |  MUC4  |  DISEASES
4585  |  MUC4  |  DISEASES
8260  |  NAA10  |  DISEASES
8260  |  NAA10  |  DISEASES
1496  |  CTNNA2  |  DISEASES
1496  |  CTNNA2  |  DISEASES
3712  |  IVD  |  DISEASES
3712  |  IVD  |  DISEASES
5515  |  PPP2CA  |  DISEASES
5515  |  PPP2CA  |  DISEASES
672  |  BRCA1  |  DISEASES
672  |  BRCA1  |  DISEASES
79012  |  CAMKV  |  DISEASES
79012  |  CAMKV  |  DISEASES
6256  |  RXRA  |  DISEASES
6256  |  RXRA  |  DISEASES
1316  |  KLF6  |  DISEASES
1316  |  KLF6  |  DISEASES
222659  |  PXT1  |  DISEASES
222659  |  PXT1  |  DISEASES
30816  |  ERVW-1  |  DISEASES
30816  |  ERVW-1  |  DISEASES
5447  |  POR  |  DISEASES
5447  |  POR  |  DISEASES
51227  |  PIGP  |  DISEASES
51227  |  PIGP  |  DISEASES
2939  |  GSTA2  |  DISEASES
2939  |  GSTA2  |  DISEASES
846  |  CASR  |  DISEASES
846  |  CASR  |  DISEASES
6091  |  ROBO1  |  DISEASES
6091  |  ROBO1  |  DISEASES
51389  |  RWDD1  |  DISEASES
51389  |  RWDD1  |  DISEASES
813  |  CALU  |  DISEASES
813  |  CALU  |  DISEASES
58494  |  JAM2  |  DISEASES
58494  |  JAM2  |  DISEASES
573  |  BAG1  |  DISEASES
573  |  BAG1  |  DISEASES
7019  |  TFAM  |  DISEASES
7019  |  TFAM  |  DISEASES
114818  |  KLHL29  |  DISEASES
114818  |  KLHL29  |  DISEASES
7511  |  XPNPEP1  |  DISEASES
7511  |  XPNPEP1  |  DISEASES
6949  |  TCOF1  |  DISEASES
6949  |  TCOF1  |  DISEASES
1452  |  CSNK1A1  |  DISEASES
1452  |  CSNK1A1  |  DISEASES
2638  |  GC  |  DISEASES
2638  |  GC  |  DISEASES
22993  |  HMGXB3  |  DISEASES
22993  |  HMGXB3  |  DISEASES
56034  |  PDGFC  |  DISEASES
56034  |  PDGFC  |  DISEASES
9353  |  SLIT2  |  DISEASES
9353  |  SLIT2  |  DISEASES
51428  |  DDX41  |  DISEASES
51428  |  DDX41  |  DISEASES
8635  |  RNASET2  |  DISEASES
8635  |  RNASET2  |  DISEASES
285782  |  CAGE1  |  DISEASES
285782  |  CAGE1  |  DISEASES
1977  |  EIF4E  |  DISEASES
1977  |  EIF4E  |  DISEASES
6196  |  RPS6KA2  |  DISEASES
6196  |  RPS6KA2  |  DISEASES
2920  |  CXCL2  |  DISEASES
2920  |  CXCL2  |  DISEASES
2994  |  GYPB  |  DISEASES
2994  |  GYPB  |  DISEASES
114907  |  FBXO32  |  DISEASES
114907  |  FBXO32  |  DISEASES
23484  |  LEPROTL1  |  DISEASES
23484  |  LEPROTL1  |  DISEASES
284  |  ANGPT1  |  DISEASES
284  |  ANGPT1  |  DISEASES
137075  |  CLDN23  |  DISEASES
137075  |  CLDN23  |  DISEASES
9788  |  MTSS1  |  DISEASES
9788  |  MTSS1  |  DISEASES
127540  |  HMGB4  |  DISEASES
127540  |  HMGB4  |  DISEASES
374899  |  ZNF829  |  DISEASES
374899  |  ZNF829  |  DISEASES
6224  |  RPS20  |  DISEASES
6224  |  RPS20  |  DISEASES
8667  |  EIF3H  |  DISEASES
8667  |  EIF3H  |  DISEASES
6586  |  SLIT3  |  DISEASES
6586  |  SLIT3  |  DISEASES
3066  |  HDAC2  |  DISEASES
3066  |  HDAC2  |  DISEASES
3620  |  IDO1  |  DISEASES
3620  |  IDO1  |  DISEASES
3551  |  IKBKB  |  DISEASES
3551  |  IKBKB  |  DISEASES
7033  |  TFF3  |  DISEASES
7033  |  TFF3  |  DISEASES
4914  |  NTRK1  |  DISEASES
4914  |  NTRK1  |  DISEASES
7178  |  TPT1  |  DISEASES
7178  |  TPT1  |  DISEASES
59351  |  PBOV1  |  DISEASES
59351  |  PBOV1  |  DISEASES
8322  |  FZD4  |  DISEASES
8322  |  FZD4  |  DISEASES
22827  |  PUF60  |  DISEASES
22827  |  PUF60  |  DISEASES
7296  |  TXNRD1  |  DISEASES
7296  |  TXNRD1  |  DISEASES
441381  |  LRRC24  |  DISEASES
441381  |  LRRC24  |  DISEASES
192134  |  B3GNT6  |  DISEASES
192134  |  B3GNT6  |  DISEASES
6195  |  RPS6KA1  |  DISEASES
6195  |  RPS6KA1  |  DISEASES
4586  |  MUC5AC  |  DISEASES
4586  |  MUC5AC  |  DISEASES
493861  |  EID3  |  DISEASES
493861  |  EID3  |  DISEASES
51399  |  TRAPPC4  |  DISEASES
51399  |  TRAPPC4  |  DISEASES
727897  |  MUC5B  |  DISEASES
727897  |  MUC5B  |  DISEASES
930  |  CD19  |  DISEASES
930  |  CD19  |  DISEASES
9414  |  TJP2  |  DISEASES
9414  |  TJP2  |  DISEASES
3684  |  ITGAM  |  DISEASES
3684  |  ITGAM  |  DISEASES
10071  |  MUC12  |  DISEASES
10071  |  MUC12  |  DISEASES
4090  |  SMAD5  |  DISEASES
4090  |  SMAD5  |  DISEASES
91  |  ACVR1B  |  DISEASES
91  |  ACVR1B  |  DISEASES
9  |  NAT1  |  DISEASES
9  |  NAT1  |  DISEASES
586  |  BCAT1  |  DISEASES
586  |  BCAT1  |  DISEASES
132864  |  CPEB2  |  DISEASES
132864  |  CPEB2  |  DISEASES
283848  |  CES4A  |  DISEASES
283848  |  CES4A  |  DISEASES
90485  |  ZNF835  |  DISEASES
90485  |  ZNF835  |  DISEASES
6934  |  TCF7L2  |  DISEASES
6934  |  TCF7L2  |  DISEASES
3939  |  LDHA  |  DISEASES
3939  |  LDHA  |  DISEASES
160728  |  SLC5A8  |  DISEASES
160728  |  SLC5A8  |  DISEASES
84667  |  HES7  |  DISEASES
84667  |  HES7  |  DISEASES
5125  |  PCSK5  |  DISEASES
5125  |  PCSK5  |  DISEASES
11153  |  FICD  |  DISEASES
11153  |  FICD  |  DISEASES
6141  |  RPL18  |  DISEASES
6141  |  RPL18  |  DISEASES
7421  |  VDR  |  DISEASES
7421  |  VDR  |  DISEASES
8972  |  MGAM  |  DISEASES
8972  |  MGAM  |  DISEASES
1649  |  DDIT3  |  DISEASES
1649  |  DDIT3  |  DISEASES
100381270  |  ZBED6  |  DISEASES
100381270  |  ZBED6  |  DISEASES
317  |  APAF1  |  DISEASES
317  |  APAF1  |  DISEASES
5726  |  TAS2R38  |  DISEASES
5726  |  TAS2R38  |  DISEASES
4522  |  MTHFD1  |  DISEASES
4522  |  MTHFD1  |  DISEASES
5228  |  PGF  |  DISEASES
5228  |  PGF  |  DISEASES
4293  |  MAP3K9  |  DISEASES
4293  |  MAP3K9  |  DISEASES
10381  |  TUBB3  |  DISEASES
10381  |  TUBB3  |  DISEASES
56963  |  RGMA  |  DISEASES
56963  |  RGMA  |  DISEASES
567  |  B2M  |  DISEASES
567  |  B2M  |  DISEASES
54742  |  LY6K  |  DISEASES
54742  |  LY6K  |  DISEASES
11245  |  GPR176  |  DISEASES
11245  |  GPR176  |  DISEASES
321  |  APBA2  |  DISEASES
321  |  APBA2  |  DISEASES
6642  |  SNX1  |  DISEASES
6642  |  SNX1  |  DISEASES
54749  |  EPDR1  |  DISEASES
54749  |  EPDR1  |  DISEASES
401207  |  C5orf63  |  DISEASES
401207  |  C5orf63  |  DISEASES
51741  |  WWOX  |  DISEASES
51741  |  WWOX  |  DISEASES
3316  |  HSPB2  |  DISEASES
3316  |  HSPB2  |  DISEASES
1506  |  CTRL  |  DISEASES
1506  |  CTRL  |  DISEASES
4927  |  NUP88  |  DISEASES
4927  |  NUP88  |  DISEASES
23186  |  RCOR1  |  DISEASES
23186  |  RCOR1  |  DISEASES
404266  |  HOXB-AS3  |  DISEASES
404266  |  HOXB-AS3  |  DISEASES
23059  |  CLUAP1  |  DISEASES
23059  |  CLUAP1  |  DISEASES
2232  |  FDXR  |  DISEASES
2232  |  FDXR  |  DISEASES
9212  |  AURKB  |  DISEASES
9212  |  AURKB  |  DISEASES
3292  |  HSD17B1  |  DISEASES
3292  |  HSD17B1  |  DISEASES
65982  |  ZSCAN18  |  DISEASES
65982  |  ZSCAN18  |  DISEASES
246734  |  NPCDR1  |  DISEASES
246734  |  NPCDR1  |  DISEASES
54938  |  SARS2  |  DISEASES
54938  |  SARS2  |  DISEASES
284307  |  ZIK1  |  DISEASES
284307  |  ZIK1  |  DISEASES
11012  |  KLK11  |  DISEASES
11012  |  KLK11  |  DISEASES
10856  |  RUVBL2  |  DISEASES
10856  |  RUVBL2  |  DISEASES
283932  |  FBXL19-AS1  |  DISEASES
283932  |  FBXL19-AS1  |  DISEASES
286467  |  FIRRE  |  DISEASES
286467  |  FIRRE  |  DISEASES
101060264  |  FOXP4-AS1  |  DISEASES
101060264  |  FOXP4-AS1  |  DISEASES
60674  |  GAS5  |  DISEASES
60674  |  GAS5  |  DISEASES
102723099  |  GHET1  |  DISEASES
102723099  |  GHET1  |  DISEASES
100124700  |  HOTAIR  |  DISEASES
100124700  |  HOTAIR  |  DISEASES
100316868  |  HOTTIP  |  DISEASES
100316868  |  HOTTIP  |  DISEASES
285943  |  HOXA-AS2  |  DISEASES
285943  |  HOXA-AS2  |  DISEASES
100506783  |  HOXD-AS2  |  DISEASES
100506783  |  HOXD-AS2  |  DISEASES
102723508  |  KANTR  |  DISEASES
102723508  |  KANTR  |  DISEASES
378805  |  LINC-PINT  |  DISEASES
378805  |  LINC-PINT  |  DISEASES
100861504  |  LINC00538  |  DISEASES
100861504  |  LINC00538  |  DISEASES
284998  |  LINC01114  |  DISEASES
284998  |  LINC01114  |  DISEASES
100505633  |  LINC01133  |  DISEASES
100505633  |  LINC01133  |  DISEASES
101927477  |  LINC01507  |  DISEASES
101927477  |  LINC01507  |  DISEASES
101926947  |  LINC01617  |  DISEASES
101926947  |  LINC01617  |  DISEASES
339929  |  LPP-AS2  |  DISEASES
339929  |  LPP-AS2  |  DISEASES
378938  |  MALAT1  |  DISEASES
378938  |  MALAT1  |  DISEASES
79104  |  MEG8  |  DISEASES
79104  |  MEG8  |  DISEASES
407975  |  MIR17HG  |  DISEASES
407975  |  MIR17HG  |  DISEASES
100302746  |  NCRUPAR  |  DISEASES
100302746  |  NCRUPAR  |  DISEASES
283131  |  NEAT1  |  DISEASES
283131  |  NEAT1  |  DISEASES
100652772  |  NNT-AS1  |  DISEASES
100652772  |  NNT-AS1  |  DISEASES
101154753  |  PANDAR  |  DISEASES
101154753  |  PANDAR  |  DISEASES
101867536  |  PRNCR1  |  DISEASES
101867536  |  PRNCR1  |  DISEASES
285456  |  RPL34-AS1  |  DISEASES
285456  |  RPL34-AS1  |  DISEASES
100289019  |  SLC25A25-AS1  |  DISEASES
100289019  |  SLC25A25-AS1  |  DISEASES
677803  |  SNORA15  |  DISEASES
677803  |  SNORA15  |  DISEASES
727676  |  SNORD118  |  DISEASES
727676  |  SNORD118  |  DISEASES
26807  |  SNORD43  |  DISEASES
26807  |  SNORD43  |  DISEASES
26806  |  SNORD44  |  DISEASES
26806  |  SNORD44  |  DISEASES
26801  |  SNORD48  |  DISEASES
26801  |  SNORD48  |  DISEASES
100642175  |  SPRY4-IT1  |  DISEASES
100642175  |  SPRY4-IT1  |  DISEASES
399972  |  ST3GAL4-AS1  |  DISEASES
399972  |  ST3GAL4-AS1  |  DISEASES
257000  |  TINCR  |  DISEASES
257000  |  TINCR  |  DISEASES
102800311  |  TP53COR1  |  DISEASES
102800311  |  TP53COR1  |  DISEASES
55000  |  TUG1  |  DISEASES
55000  |  TUG1  |  DISEASES
285194  |  TUSC7  |  DISEASES
285194  |  TUSC7  |  DISEASES
652995  |  UCA1  |  DISEASES
652995  |  UCA1  |  DISEASES
100133957  |  UXT-AS1  |  DISEASES
100133957  |  UXT-AS1  |  DISEASES
100128881  |  VPS9D1-AS1  |  DISEASES
100128881  |  VPS9D1-AS1  |  DISEASES
283050  |  ZMIZ1-AS1  |  DISEASES
283050  |  ZMIZ1-AS1  |  DISEASES
386758  |  ZNF582-AS1  |  DISEASES
386758  |  ZNF582-AS1  |  DISEASES
Locus(Waiting for update.)
Disease ID 1034
Disease colorectal cancer
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:5)
HP:0006716  |  Hereditary nonpolyposis colorectal carcinoma
HP:0006740  |  Transitional cell bladder carcinoma
HP:0006753  |  Stomach tumor
HP:0002891  |  Uterine leiomyosarcoma
HP:0005584  |  Renal cell carcinoma
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:128)
HP:0002664  |  Neoplasia  |  228
HP:0100279  |  Ulcerative colitis  |  45
HP:0002583  |  Colitis  |  34
HP:0001513  |  Obesity  |  26
HP:0000819  |  Diabetes mellitus  |  10
HP:0012126  |  Gastric cancer  |  9
HP:0000716  |  Depression  |  8
HP:0001907  |  Thromboembolic disease  |  7
HP:0009830  |  Peripheral neuritis  |  7
HP:0001903  |  Anemia  |  7
HP:0003003  |  Colon cancer  |  7
HP:0030151  |  Cholangitis  |  6
HP:0005214  |  Bowel obstruction  |  6
HP:0030731  |  Carcinoma  |  6
HP:0003002  |  Breast carcinoma  |  5
HP:0100280  |  Morbus Crohn  |  5
HP:0012378  |  Fatigue  |  5
HP:0002896  |  Liver cancer  |  4
HP:0012531  |  Pain  |  4
HP:0002573  |  Bloody diarrhea  |  4
HP:0001410  |  Decreased liver function  |  4
HP:0000855  |  Insulin resistance  |  4
HP:0012125  |  Prostate cancer  |  4
HP:0000739  |  Anxiety  |  4
HP:0100523  |  Hepatic abscess  |  4
HP:0000952  |  Yellow skin  |  4
HP:0000988  |  Exanthem  |  3
HP:0002595  |  Gastrointestinal atony  |  3
HP:0001824  |  Weight loss  |  3
HP:0001875  |  Neutropenia  |  3
HP:0002014  |  Diarrhea  |  3
HP:0004395  |  Malnutrition  |  3
HP:0004936  |  Blood clot in vein  |  3
HP:0012622  |  Chronic kidney disease  |  2
HP:0000718  |  Aggressive behaviour  |  2
HP:0004942  |  Aortic aneurysm  |  2
HP:0002019  |  Dyschezia  |  2
HP:0005263  |  Gastritis  |  2
HP:0100580  |  Barrett's esophagus  |  2
HP:0001397  |  Hepatic steatosis  |  2
HP:0011458  |  Abdominal symptom  |  2
HP:0000822  |  Hypertension  |  2
HP:0001081  |  Gallstones  |  2
HP:0100543  |  Cognitive deficits  |  2
HP:0100281  |  Chronic colitis  |  2
HP:0004953  |  Abdominal aortic aneurysm  |  2
HP:0005521  |  Disseminated intravascular coagulation  |  2
HP:0001873  |  Low platelet count  |  2
HP:0009725  |  Bladder neoplasm  |  2
HP:0002017  |  Nausea and vomiting  |  2
HP:0002013  |  Emesis  |  2
HP:0002018  |  Nausea  |  2
HP:0002861  |  Melanoma  |  2
HP:0005506  |  Chronic myeloid leukemia  |  1
HP:0100743  |  Rectal tumor  |  1
HP:0002621  |  Atherosclerosis  |  1
HP:0001891  |  Iron-deficiency anemia  |  1
HP:0100584  |  Endocarditis  |  1
HP:0001370  |  Rheumatoid arthritis  |  1
HP:0002527  |  Falls  |  1
HP:0012578  |  Membranous glomerulonephritis  |  1
HP:0003202  |  Neurogenic muscle atrophy, especially in the lower limbs  |  1
HP:0100758  |  Gangrene  |  1
HP:0001409  |  Portal hypertension  |  1
HP:0002576  |  Intussusception  |  1
HP:0001407  |  Hepatic cysts  |  1
HP:0005110  |  Atrial fibrillation  |  1
HP:0100033  |  Tic disorder  |  1
HP:0100896  |  Rectal polyps  |  1
HP:0002917  |  Low blood magnesium levels  |  1
HP:0000820  |  Thyroid abnormality  |  1
HP:0001974  |  Leukocytosis  |  1
HP:0002099  |  Asthma  |  1
HP:0100723  |  Gastrointestinal stroma tumor  |  1
HP:0004326  |  Cachexia  |  1
HP:0000833  |  Glucose intolerance  |  1
HP:0001658  |  Myocardial infarction  |  1
HP:0100512  |  Vitamin D deficiency  |  1
HP:0001945  |  Fever  |  1
HP:0001394  |  Hepatic cirrhosis  |  1
HP:0002625  |  Blood clot in a deep vein  |  1
HP:0001915  |  Aplastic anemia  |  1
HP:0000016  |  Urinary retention  |  1
HP:0009726  |  Renal neoplasm  |  1
HP:0000708  |  Behavioral problems  |  1
HP:0008069  |  Neoplasm of the skin  |  1
HP:0002480  |  Hepatic encephalopathy  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0200042  |  Skin ulcer  |  1
HP:0002863  |  Myelodysplastic syndrome  |  1
HP:0012175  |  Resistance to activated protein C  |  1
HP:0200063  |  Colorectal polyposis  |  1
HP:0030358  |  Non-small cell lung carcinoma  |  1
HP:0002584  |  Intestinal hemorrhage  |  1
HP:0012324  |  Myeloid leukemia  |  1
HP:0001882  |  Decreased blood leukocyte number  |  1
HP:0002859  |  Rhabdomyosarcoma  |  1
HP:0000821  |  Underactive thyroid  |  1
HP:0002253  |  Colonic diverticulosis  |  1
HP:0012115  |  Liver inflammation  |  1
HP:0002671  |  Basalioma  |  1
HP:0002617  |  Aneurysmal dilatation  |  1
HP:0001298  |  Encephalopathy  |  1
HP:0005305  |  Cerebral vein thrombosis  |  1
HP:0002352  |  Leukoencephalopathy  |  1
HP:0001892  |  Bleeding diathesis  |  1
HP:0011459  |  Esophageal carcinoma  |  1
HP:0002027  |  Abdominal pain  |  1
HP:0001909  |  Leukemia  |  1
HP:0002239  |  Gastrointestinal hemorrhage  |  1
HP:0006530  |  Interstitial lung disease  |  1
HP:0005978  |  Noninsulin dependent diabetes mellitus  |  1
HP:0000023  |  Inguinal hernia  |  1
HP:0000726  |  Dementia  |  1
HP:0030078  |  Lung adenocarcinoma  |  1
HP:0100753  |  Schizophrenia  |  1
HP:0001399  |  Liver failure  |  1
HP:0000112  |  Nephropathy  |  1
HP:0006859  |  Posterior leukoencephalopathy  |  1
HP:0030357  |  Small cell lung carcinoma  |  1
HP:0001260  |  Dysarthric speech  |  1
HP:0012740  |  Papilloma  |  1
HP:0011032  |  Abnormality of fluid regulation  |  1
HP:0002665  |  Lymphoma  |  1
HP:0100790  |  Hernia  |  1
HP:0010280  |  Stomatitis  |  1
HP:0001369  |  Arthritis  |  1
HP:0002904  |  High blood bilirubin levels  |  1
Disease ID 1034
Disease colorectal cancer
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:72)
C0494165  |  liver metastases  |  100
C0494165  |  liver metastasis  |  99
C1333990  |  lynch syndrome  |  51
C0009324  |  ulcerative colitis  |  44
C1332128  |  peritoneal carcinomatosis  |  26
C0494165  |  hepatic metastases  |  24
C0494165  |  hepatic metastasis  |  24
C0153676  |  pulmonary metastases  |  13
C0686619  |  lymph node metastases  |  13
C0346989  |  peritoneal metastases  |  11
C0442874  |  neuropathy  |  10
C0011570  |  depression  |  8
C0231303  |  distress  |  8
C0153676  |  pulmonary metastasis  |  7
C0024623  |  gastric cancer  |  7
C0031117  |  peripheral neuropathy  |  7
C0007102  |  colon cancer  |  7
C0153676  |  lung metastasis  |  6
C0206677  |  adenomatous polyps  |  5
C0153676  |  lung metastases  |  5
C0015672  |  fatigue  |  5
C0040038  |  thromboembolism  |  4
C0002871  |  anaemia  |  4
C0003467  |  anxiety  |  4
C0220650  |  brain metastases  |  4
C0021843  |  bowel obstruction  |  4
C0009450  |  infection  |  4
C0027947  |  neutropenia  |  3
C0162429  |  malnutrition  |  3
C0011991  |  diarrhea  |  3
C0023903  |  liver tumor  |  3
C0333516  |  tumor necrosis  |  3
C0235328  |  colonic obstruction  |  3
C1258215  |  ileus  |  3
C0549410  |  hand-foot syndrome  |  3
C0022346  |  jaundice  |  3
C0002871  |  anemia  |  3
C0010418  |  cryptosporidiosis  |  3
C0021311  |  infections  |  2
C0012739  |  disseminated intravascular coagulation  |  2
C0153687  |  skin metastases  |  2
C0029896  |  ent disease  |  2
C0036527  |  ovarian metastases  |  2
C0033953  |  sexual dysfunction  |  2
C0153687  |  skin metastasis  |  2
C1568868  |  oral mucositis  |  2
C0268132  |  dihydropyrimidine dehydrogenase deficiency  |  2
C0036527  |  ovarian metastasis  |  2
C0162871  |  abdominal aortic aneurysm  |  2
C0220650  |  brain metastasis  |  2
C0333983  |  hyperplastic polyp  |  1
C0009404  |  colorectal neoplasms  |  1
C0151723  |  hypomagnesemia  |  1
C0011991  |  diarrhoea  |  1
C2711227  |  steatohepatitis  |  1
C0024232  |  lymphatic metastasis  |  1
C0746883  |  febrile neutropenia  |  1
C0042870  |  vitamin d deficiency  |  1
C0032580  |  polyposis coli  |  1
C0021933  |  intussusception  |  1
C0149871  |  deep venous thrombosis  |  1
C0010823  |  cmv infection  |  1
C0002940  |  aneurysm  |  1
C0022354  |  obstructive jaundice  |  1
C1519670  |  tumor angiogenesis  |  1
C0850666  |  h. pylori infection  |  1
C1511789  |  desmoplastic reaction  |  1
C0021079  |  immune suppression  |  1
C0153687  |  cutaneous metastasis  |  1
C0235394  |  wasting  |  1
C1608408  |  malignant transformation  |  1
C0220650  |  brain secondaries  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:2124)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs102038532482227454575UGT1A10umls:C0009402BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014MROH2A2233778772AG,T
rs102038532482227454575UGT1A10umls:C1527249BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014MROH2A2233778772AG,T
rs10411210223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012RHPN21933041394CT
rs1041121022367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012RHPN21933041394CT
rs1041121019011631652BMP4umls:C0009402BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0038001862008RHPN21933041394CT
rs1041121022367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012RHPN21933041394CT
rs10411210223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012RHPN21933041394CT
rs1041121022367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012RHPN21933041394CT
rs104112102236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012RHPN21933041394CT
rs10411210223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012RHPN21933041394CT
rs1041121022367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012RHPN21933041394CT
rs104112102236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012RHPN21933041394CT
rs10411210223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012RHPN21933041394CT
rs104112101901163185415RHPN2umls:C1527249GAD[We identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).]0.1389362562008RHPN21933041394CT
rs1041121019011631652BMP4umls:C1527249BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0132683142008RHPN21933041394CT
rs1041121022367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012RHPN21933041394CT
rs1041121022367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012RHPN21933041394CT
rs104112101901163185415RHPN2umls:C1527249GWASCATWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.1389362562008RHPN21933041394CT
rs1041981224197146934TCF7L2umls:C1527249BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.1358631812012LTA;LOC100287329631573007CA
rs10419812241971454901CDKAL1umls:C0009402BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0002714422012LTA;LOC100287329631573007CA
rs1041981224197146934TCF7L2umls:C0009402BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0114005592012LTA;LOC100287329631573007CA
rs10419812241971454901CDKAL1umls:C1527249BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0002714422012LTA;LOC100287329631573007CA
rs1042522210515334193MDM2umls:C0009402BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.0057002792011TP53177676154GT,C
rs1042522173749547157TP53umls:C0009402BeFreeFew reports have investigated the association of two p53 polymorphisms (Arg72Pro and PIN3-A2) with colorectal cancer (CRC) risk, and no previous study has analyzed their role as susceptibility alleles for colorectal adenoma.0.0847340642006TP53177676154GT,C
rs1042522173749547157TP53umls:C1527249BeFreeFew reports have investigated the association of two p53 polymorphisms (Arg72Pro and PIN3-A2) with colorectal cancer (CRC) risk, and no previous study has analyzed their role as susceptibility alleles for colorectal adenoma.0.162006TP53177676154GT,C
rs1042522172242356041RNASELumls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0008143262007TP53177676154GT,C
rs1042522223939627157TP53umls:C1527249BeFreeAssociation of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.0.162011TP53177676154GT,C
rs1042522223939627157TP53umls:C0009402BeFreeAssociation of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.0.0847340642011TP53177676154GT,C
rs1042522210515337157TP53umls:C1527249BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.162011TP53177676154GT,C
rs1042522219711037515XRCC1umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0126818232011TP53177676154GT,C
rs1042522189883027157TP53umls:C0009402BeFreeThe p53 R72P genotype was identified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 78 consecutive colorectal cancer patients with liver metastases and 214 age- and sex-matched cases with nonmetastatic colorectal cancer.0.0847340642008TP53177676154GT,C
rs1042522219711037515XRCC1umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0623894952011TP53177676154GT,C
rs1042522219711037157TP53umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0847340642011TP53177676154GT,C
rs1042522163531347157TP53umls:C0009402BeFreeAge of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.0.0847340642006TP53177676154GT,C
rs1042522206158917157TP53umls:C1527249BeFreeTP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.0.162010TP53177676154GT,C
rs1042522172242357157TP53umls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.162007TP53177676154GT,C
rs1042522204497977157TP53umls:C1527249BeFreeTP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.0.162010TP53177676154GT,C
rs1042522231837477157TP53umls:C0009402BeFreeWe aimed to investigate the association between miR-34b/c rs4938723 and TP53 Arg72Pro polymorphisms and the risk of CRC.0.0847340642013TP53177676154GT,C
rs1042522172242357157TP53umls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0847340642007TP53177676154GT,C
rs1042522219711037157TP53umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.162011TP53177676154GT,C
rs1042522210515337157TP53umls:C0009402BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.0847340642011TP53177676154GT,C
rs1042522231837477157TP53umls:C1527249BeFreeWe aimed to investigate the association between miR-34b/c rs4938723 and TP53 Arg72Pro polymorphisms and the risk of CRC.0.162013TP53177676154GT,C
rs1042522204497977157TP53umls:C0009402BeFreeTP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.0.0847340642010TP53177676154GT,C
rs1042522163531347157TP53umls:C1527249BeFreeAge of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.0.162006TP53177676154GT,C
rs1042522206158917157TP53umls:C0009402BeFreeTP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.0.0847340642010TP53177676154GT,C
rs1042522211240377157TP53umls:C1527249BeFreeAssociation between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.0.162010TP53177676154GT,C
rs1042522210515334193MDM2umls:C1527249BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.0172639972011TP53177676154GT,C
rs1042522172242356041RNASELumls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0031813582007TP53177676154GT,C
rs1042522211240377157TP53umls:C0009402BeFreeAssociation between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.0.0847340642010TP53177676154GT,C
rs104548518362937841CASP8umls:C1527249BeFreeCASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.0.0111727242008CASP82201284866GC
rs104548518362937841CASP8umls:C0009402BeFreeCASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.0.0046145122008CASP82201284866GC
rs1045642235045255243ABCB1umls:C0009402BeFreeAssociation between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.0.0105862332013ABCB1787509329AT,G
rs1045642128945675243ABCB1umls:C0009402BeFreeMDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry.0.0105862332003ABCB1787509329AT,G
rs1045642235045255243ABCB1umls:C1527249BeFreeAssociation between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.0.0447345032013ABCB1787509329AT,G
rs10477812494122528ABOumls:C1527249BeFreeThe rs1047781 (chr19- FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9- ABO) was associated with the regional lymph metastasis in the CRC patients.0.0002714422014FUT2;LOC1054476451948703374AT
rs10477812494122528ABOumls:C0009402BeFreeThe rs1047781 (chr19- FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9- ABO) was associated with the regional lymph metastasis in the CRC patients.0.0002714422014FUT2;LOC1054476451948703374AT
rs1048943184091461543CYP1A1umls:C1527249BeFreeRelationship between genetic polymorphism of CYP1A1 at codon 462 (Ile462Val) in colorectal cancer.0.0715102362008CYP1A11574720644TG,C,A
rs1048943184091461543CYP1A1umls:C0009402BeFreeRelationship between genetic polymorphism of CYP1A1 at codon 462 (Ile462Val) in colorectal cancer.0.0073289312008CYP1A11574720644TG,C,A
rs1048943212460021543CYP1A1umls:C1527249BeFreeCYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.0.0715102362011CYP1A11574720644TG,C,A
rs1048943249394161543CYP1A1umls:C0009402BeFreeCYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients.0.0073289312014CYP1A11574720644TG,C,A
rs1048943212460021543CYP1A1umls:C0009402BeFreeCYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.0.0073289312011CYP1A11574720644TG,C,A
rs1048943249394161543CYP1A1umls:C1527249BeFreeCYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients.0.0715102362014CYP1A11574720644TG,C,A
rs104894521037106328APEX1umls:C0009402BeFreeCarriers of the APEX1 codon 51 Gln/His genotype had a reduced CRC risk compared with carriers of the Gln/Gln genotype (odds ratio (OR) = 0.15, 95% CI = 0.03-0.69, P = 0.015).0.0027144192010APEX1;OSGEP1420456008GC
rs1048945210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010APEX1;OSGEP1420456008GC
rs1048945210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010APEX1;OSGEP1420456008GC
rs1048945210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010APEX1;OSGEP1420456008GC
rs1048945210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010APEX1;OSGEP1420456008GC
rs104894521037106328APEX1umls:C1527249BeFreeCarriers of the APEX1 codon 51 Gln/His genotype had a reduced CRC risk compared with carriers of the Gln/Gln genotype (odds ratio (OR) = 0.15, 95% CI = 0.03-0.69, P = 0.015).0.0119111052010APEX1;OSGEP1420456008GC
rs1050547725302443727677CASC8umls:C0009402BeFreeGenome-wide association studies have identified the SNP rs10505477 and SNP rs1562430 in CASC8 were associated with risk of the colorectal cancer (CRC) and breast cancer, respectively.0.0002714422014CASC88127395198AG
rs10505477236775735460POU5F1umls:C0009402BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0019000932013CASC88127395198AG
rs10505477236775735460POU5F1umls:C1527249BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0019000932013CASC88127395198AG
rs10505477236775739734HDAC9umls:C0009402BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0016286512013CASC88127395198AG
rs1050547725302443727677CASC8umls:C1527249BeFreeGenome-wide association studies have identified the SNP rs10505477 and SNP rs1562430 in CASC8 were associated with risk of the colorectal cancer (CRC) and breast cancer, respectively.0.0002714422014CASC88127395198AG
rs10505477236775739734HDAC9umls:C1527249BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0039956832013CASC88127395198AG
rs1051208229392285894RAF1umls:C1527249BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0038001862012RAF1312584248GA
rs1051208229392283691ITGB4umls:C1527249BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0005428842012RAF1312584248GA
rs1051208229392285894RAF1umls:C0009402BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0038001862012RAF1312584248GA
rs1051208229392283691ITGB4umls:C0009402BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0005428842012RAF1312584248GA
rs105169020971123942CD86umls:C1527249BeFreePolymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.0.0031813582011INSR197116952TC
rs105169020971123942CD86umls:C0009402BeFreePolymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.0.0008143262011INSR197116952TC
rs1051740224157912052EPHX1umls:C1527249BeFreeWe investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates.0.0326715092013EPHX11225831932TC
rs1051740224157912052EPHX1umls:C0009402BeFreeWe investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates.0.0021715352013EPHX11225831932TC
rs1052133216953874968OGG1umls:C0009402BeFreeAssociation of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis.0.0062431632011OGG1;CAMK139757089CG
rs1052133180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007OGG1;CAMK139757089CG
rs1052133180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007OGG1;CAMK139757089CG
rs1052133252276624968OGG1umls:C0009402BeFreeAssociation of hOGG1 Ser326Cys polymorphism with colorectal cancer risk: an updated meta-analysis including 5235 cases and 8438 controls.0.0062431632013OGG1;CAMK139757089CG
rs1052133180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007OGG1;CAMK139757089CG
rs1052133180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007OGG1;CAMK139757089CG
rs1052133239753674968OGG1umls:C1527249BeFreeThe meta-analysis suggests that OGG1 rs1052133 polymorphism is significantly associated with the risk of colorectal cancer in Caucasian population.0.0296420412013OGG1;CAMK139757089CG
rs1052133218994424968OGG1umls:C1527249BeFreeDNA repair gene 8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri population.0.0296420412012OGG1;CAMK139757089CG
rs1052133253235814968OGG1umls:C0009402BeFreeIn subgroup analyses by cancer types, we found that the hOGG1 Ser326Cys polymorphism may increase hepatocellular cancer and colorectal cancer risks, but decrease the risk of oral cancer.0.0062431632014OGG1;CAMK139757089CG
rs1052133166090224968OGG1umls:C1527249BeFreePolymorphism OGG1 S326C was associated with an increased risk of colorectal cancer [odds ratio (OR), 2.3; 95% confidence interval (95% CI), 1.1-5.0], the risk being higher in younger individuals.0.0296420412006OGG1;CAMK139757089CG
rs1052133180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007OGG1;CAMK139757089CG
rs1052133159467954968OGG1umls:C1527249BeFreeGPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer.0.0296420412005OGG1;CAMK139757089CG
rs1052133179914924968OGG1umls:C1527249BeFreeThe analysis of binary genotype combinations showed increased colorectal cancer risk in individuals simultaneously homozygous for the variant alleles of APE1 Asn148Glu and hOGG1 Ser326Cys (OR: 6.37; 95% CI: 1.40-29.02; p=0.02).0.0296420412008OGG1;CAMK139757089CG
rs1052133252276624968OGG1umls:C1527249BeFreeAssociation of hOGG1 Ser326Cys polymorphism with colorectal cancer risk: an updated meta-analysis including 5235 cases and 8438 controls.0.0296420412013OGG1;CAMK139757089CG
rs1052133159467954968OGG1umls:C0009402BeFreeGPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer.0.0062431632005OGG1;CAMK139757089CG
rs1052133253235814968OGG1umls:C1527249BeFreeIn subgroup analyses by cancer types, we found that the hOGG1 Ser326Cys polymorphism may increase hepatocellular cancer and colorectal cancer risks, but decrease the risk of oral cancer.0.0296420412014OGG1;CAMK139757089CG
rs105213317991492328APEX1umls:C0009402BeFreeThe analysis of binary genotype combinations showed increased colorectal cancer risk in individuals simultaneously homozygous for the variant alleles of APE1 Asn148Glu and hOGG1 Ser326Cys (OR: 6.37; 95% CI: 1.40-29.02; p=0.02).0.0027144192008OGG1;CAMK139757089CG
rs105213317991492328APEX1umls:C1527249BeFreeThe analysis of binary genotype combinations showed increased colorectal cancer risk in individuals simultaneously homozygous for the variant alleles of APE1 Asn148Glu and hOGG1 Ser326Cys (OR: 6.37; 95% CI: 1.40-29.02; p=0.02).0.0119111052008OGG1;CAMK139757089CG
rs1052133218994424968OGG1umls:C0009402BeFreeDNA repair gene 8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri population.0.0062431632012OGG1;CAMK139757089CG
rs1052133166090224968OGG1umls:C0009402BeFreePolymorphism OGG1 S326C was associated with an increased risk of colorectal cancer [odds ratio (OR), 2.3; 95% confidence interval (95% CI), 1.1-5.0], the risk being higher in younger individuals.0.0062431632006OGG1;CAMK139757089CG
rs1052133179914924968OGG1umls:C0009402BeFreeThe analysis of binary genotype combinations showed increased colorectal cancer risk in individuals simultaneously homozygous for the variant alleles of APE1 Asn148Glu and hOGG1 Ser326Cys (OR: 6.37; 95% CI: 1.40-29.02; p=0.02).0.0062431632008OGG1;CAMK139757089CG
rs1052133216953874968OGG1umls:C1527249BeFreeAssociation of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis.0.0296420412011OGG1;CAMK139757089CG
rs1052133239753674968OGG1umls:C0009402BeFreeThe meta-analysis suggests that OGG1 rs1052133 polymorphism is significantly associated with the risk of colorectal cancer in Caucasian population.0.0062431632013OGG1;CAMK139757089CG
rs1052133225261534968OGG1umls:C1527249BeFreeMeta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.0.0296420412012OGG1;CAMK139757089CG
rs1052133180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007OGG1;CAMK139757089CG
rs1052133225261534968OGG1umls:C0009402BeFreeMeta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.0.0062431632012OGG1;CAMK139757089CG
rs1052918239405586929TCF3umls:C0009402BeFreeTargeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients.0.0010857672013TCF3191609670TC
rs1052918239405586892TAPBPumls:C1527249BeFreeFinally, we determined that rs3106189, localized to the 5' UTR of antigen presenting tapasin binding protein (TAPBP), and rs1052918, localized to the 3' UTR of transcription factor 3 (TCF3), were associated with overall survival of CRC patients.0.0002714422013TCF3191609670TC
rs1052918239405586892TAPBPumls:C0009402BeFreeFinally, we determined that rs3106189, localized to the 5' UTR of antigen presenting tapasin binding protein (TAPBP), and rs1052918, localized to the 3' UTR of transcription factor 3 (TCF3), were associated with overall survival of CRC patients.0.0002714422013TCF3191609670TC
rs1052918239405586929TCF3umls:C1527249BeFreeTargeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients.0.0010857672013TCF3191609670TC
rs1056836216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012CYP1B1238071060GC
rs1056836216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012CYP1B1238071060GC
rs1056836221902241545CYP1B1umls:C0009402BeFreeCYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.0.0032573022012CYP1B1238071060GC
rs1056836216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012CYP1B1238071060GC
rs10568362161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012CYP1B1238071060GC
rs1056836216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012CYP1B1238071060GC
rs10568362161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012CYP1B1238071060GC
rs1056836221902241545CYP1B1umls:C1527249BeFreeCYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.0.0298375382012CYP1B1238071060GC
rs10570352344161223405DICER1umls:C1527249BeFreeFinally, we observed that homozygous CC genotype of DICER1, rs1057035, was significantly associated with decreased risk of CRC (odds ratio = 0.49; 95% confidence interval: 0.25-0.95, P = 0.036) when compared to TT homozygote genotype; also, the C allele tended to have a protective effect (P = 0.072).0.0010857672013DICER11495087805TC
rs10570352344161223405DICER1umls:C0009402BeFreeFinally, we observed that homozygous CC genotype of DICER1, rs1057035, was significantly associated with decreased risk of CRC (odds ratio = 0.49; 95% confidence interval: 0.25-0.95, P = 0.036) when compared to TT homozygote genotype; also, the C allele tended to have a protective effect (P = 0.072).0.0010857672013DICER11495087805TC
rs1079566822367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012LOC105376400108659256GA
rs10795668223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012LOC105376400108659256GA
rs1079566822363440509ATP5C1umls:C0009402BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012LOC105376400108659256GA
rs1079566824968322894CCND2umls:C1527249BeFreeWe found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population.0.1205428842014LOC105376400108659256GA
rs1079566822367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012LOC105376400108659256GA
rs10795668223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012LOC105376400108659256GA
rs10795668223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012LOC105376400108659256GA
rs10795668238756894092SMAD7umls:C0009402BeFreeAmong the European CRC-susceptibility SNPs, rs4939827 in SMAD7 was associated with a significant decreased risk of Korean CRC (age-/gender-adjusted odds ratio [95% confidence interval]: additive model, 0.67 [95% CI, 0.47-0.95]; dominant model, 0.59 [95% CI, 0.39-0.91]). rs4779584 and rs10795668 were associated with CRC risk in females and males, respectively.0.0092290242013LOC105376400108659256GA
rs1079566822363440509ATP5C1umls:C1527249BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012LOC105376400108659256GA
rs10795668223634409787DLGAP5umls:C1527249BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012LOC105376400108659256GA
rs107956682236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012LOC105376400108659256GA
rs10795668223634409787DLGAP5umls:C0009402BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012LOC105376400108659256GA
rs1079566822367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012LOC105376400108659256GA
rs1079566822367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012LOC105376400108659256GA
rs10795668238756894092SMAD7umls:C1527249BeFreeAmong the European CRC-susceptibility SNPs, rs4939827 in SMAD7 was associated with a significant decreased risk of Korean CRC (age-/gender-adjusted odds ratio [95% confidence interval]: additive model, 0.67 [95% CI, 0.47-0.95]; dominant model, 0.59 [95% CI, 0.39-0.91]). rs4779584 and rs10795668 were associated with CRC risk in females and males, respectively.0.1623674712013LOC105376400108659256GA
rs1079566822367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012LOC105376400108659256GA
rs1079566824968322894CCND2umls:C0009402BeFreeWe found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population.0.0002714422014LOC105376400108659256GA
rs107956682236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012LOC105376400108659256GA
rs1079566822367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012LOC105376400108659256GA
rs10795668183729058667EIF3Humls:C0009402BeFreeIn addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P = 2.5 x 10(-13) overall; P = 6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P = 3.3 x 10(-18) overall; P = 9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H.0.0008143262008LOC105376400108659256GA
rs10795668223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012LOC105376400108659256GA
rs10795668183729058667EIF3Humls:C1527249BeFreeIn addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P = 2.5 x 10(-13) overall; P = 6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P = 3.3 x 10(-18) overall; P = 9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H.0.0102824542008LOC105376400108659256GA
rs1089124624256810120376COLCA2umls:C1527249BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.1210857672014COLCA2;COLCA111111299815AG
rs1089124624256810399948COLCA1umls:C1527249BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.1252769482014COLCA2;COLCA111111299815AG
rs1089124624256810341032C11orf53umls:C0009402BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0002714422014COLCA2;COLCA111111299815AG
rs1089124624256810120376COLCA2umls:C0009402BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0010857672014COLCA2;COLCA111111299815AG
rs1089124624256810399948COLCA1umls:C0009402BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0005428842014COLCA2;COLCA111111299815AG
rs1089124624256810341032C11orf53umls:C1527249BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0026384742014COLCA2;COLCA111111299815AG
rs10911251232665563915LAMC1umls:C1527249GWASCATIdentification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.0.122013LAMC11183112059AC
rs109292512482227454575UGT1A10umls:C1527249BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014UGT1A10;UGT1A82233637583AG
rs109292512482227454575UGT1A10umls:C0009402BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014UGT1A10;UGT1A82233637583AG
rs109365992097244055892MYNNumls:C1527249GWASCATMeta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.0.122010MYNN3169774313CT
rs109709852453604948ACO1umls:C1527249BeFreeHeme iron was positively associated with colorectal cancer among those with GG genotypes for ACO1 rs10970985 (ORQ4-Q 1 = 2.45, 95% CI 3.40-8.06, Ptrend = 0.004; Pinteraction = 0.05).0.0002714422014LOC105376014932453121CG
rs109709852453604948ACO1umls:C0009402BeFreeHeme iron was positively associated with colorectal cancer among those with GG genotypes for ACO1 rs10970985 (ORQ4-Q 1 = 2.45, 95% CI 3.40-8.06, Ptrend = 0.004; Pinteraction = 0.05).0.0002714422014LOC105376014932453121CG
rs11014993206105411457CSNK2A1umls:C0009402BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0008143262010MYO3A;LOC1053764581026194254TC
rs11014993206105411459CSNK2A2umls:C1527249BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0005428842010MYO3A;LOC1053764581026194254TC
rs110149932061054153904MYO3Aumls:C1527249BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0026384742010MYO3A;LOC1053764581026194254TC
rs110149932061054153904MYO3Aumls:C0009402BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0002714422010MYO3A;LOC1053764581026194254TC
rs11014993206105411459CSNK2A2umls:C0009402BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0005428842010MYO3A;LOC1053764581026194254TC
rs11014993206105411457CSNK2A1umls:C1527249BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0029099162010MYO3A;LOC1053764581026194254TC
rs11072508210814731544CYP1A2umls:C0009402BeFreeCYP1A2 rs11072508 was marginally significantly associated with CRC, where each copy of the T allele was associated with reduced risk (OR: 0.72, 95% CI: 0.58-0.88, P(trend) = 0.0017).0.0051573962011NA1574770056CT
rs11072508210814731544CYP1A2umls:C1527249BeFreeCYP1A2 rs11072508 was marginally significantly associated with CRC, where each copy of the T allele was associated with reduced risk (OR: 0.72, 95% CI: 0.58-0.88, P(trend) = 0.0017).0.0459398232011NA1574770056CT
rs11196172248362866934TCF7L2umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.1358631812014TCF7L210112967084GA
rs112445441253671983845KRASumls:C0009402BeFreeOur finding that KRAS codon 13 mutations (in particular G13D) are associated with inferior survival in BRAF wild-type CRCs in Chinese patients was not reported thus far.0.0823670322014KRAS1225245347CA,G,T
rs112445441256095771956EGFRumls:C1527249BeFreeKRAS MASI is a significant event in colorectal cancer, specifically associated with G13D mutation, and featuring a heterogeneous spatial distribution, that may have a role to predict the response to EGFR inhibitors.0.1081323492015KRAS1225245347CA,G,T
rs11244544125367198673BRAFumls:C1527249BeFreeOur finding that KRAS codon 13 mutations (in particular G13D) are associated with inferior survival in BRAF wild-type CRCs in Chinese patients was not reported thus far.0.2743750732014KRAS1225245347CA,G,T
rs112445441256095773845KRASumls:C0009402BeFreeKRAS MASI is a significant event in colorectal cancer, specifically associated with G13D mutation, and featuring a heterogeneous spatial distribution, that may have a role to predict the response to EGFR inhibitors.0.0823670322015KRAS1225245347CA,G,T
rs112445441232098131738DLDumls:C1527249BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0070574892012KRAS1225245347CA,G,T
rs112445441253594943845KRASumls:C0009402BeFreeWe compared the metastatic efficiency of KRas G12V (Kirsten rat sarcoma viral oncogene homolog with valine mutation at codon 12) and KRas G13D (Kirsten rat sarcoma viral oncogene homolog with aspartic mutation at codon 13) oncogenes in an orthotopic colorectal cancer (CRC) model.0.0823670322015KRAS1225245347CA,G,T
rs112445441209782593845KRASumls:C1527249BeFreeIn this analysis, use of cetuximab was associated with longer overall and progression-free survival among patients with chemotherapy-refractory colorectal cancer with p.G13D-mutated tumors than with other KRAS-mutated tumors.0.162010KRAS1225245347CA,G,T
rs1124454412320981360343FAM3Aumls:C1527249BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0070574892012KRAS1225245347CA,G,T
rs11244544123209813197257LDHDumls:C0009402BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0095004662012KRAS1225245347CA,G,T
rs112445441232098131738DLDumls:C0009402BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0095004662012KRAS1225245347CA,G,T
rs112445441256095771956EGFRumls:C0009402BeFreeKRAS MASI is a significant event in colorectal cancer, specifically associated with G13D mutation, and featuring a heterogeneous spatial distribution, that may have a role to predict the response to EGFR inhibitors.0.082015KRAS1225245347CA,G,T
rs112445441253594943845KRASumls:C1527249BeFreeWe compared the metastatic efficiency of KRas G12V (Kirsten rat sarcoma viral oncogene homolog with valine mutation at codon 12) and KRas G13D (Kirsten rat sarcoma viral oncogene homolog with aspartic mutation at codon 13) oncogenes in an orthotopic colorectal cancer (CRC) model.0.162015KRAS1225245347CA,G,T
rs112445441230150723845KRASumls:C1527249BeFreeKRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.0.162013KRAS1225245347CA,G,T
rs1124454412320981360343FAM3Aumls:C0009402BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0095004662012KRAS1225245347CA,G,T
rs112445441230150723845KRASumls:C0009402BeFreeKRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.0.0823670322013KRAS1225245347CA,G,T
rs112445441230150721956EGFRumls:C0009402BeFreeKRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.0.082013KRAS1225245347CA,G,T
rs112445441209782593845KRASumls:C0009402BeFreeIn this analysis, use of cetuximab was associated with longer overall and progression-free survival among patients with chemotherapy-refractory colorectal cancer with p.G13D-mutated tumors than with other KRAS-mutated tumors.0.0823670322010KRAS1225245347CA,G,T
rs11244544123209813197257LDHDumls:C1527249BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0070574892012KRAS1225245347CA,G,T
rs112445441253671983845KRASumls:C1527249BeFreeOur finding that KRAS codon 13 mutations (in particular G13D) are associated with inferior survival in BRAF wild-type CRCs in Chinese patients was not reported thus far.0.162014KRAS1225245347CA,G,T
rs112445441230150721956EGFRumls:C1527249BeFreeKRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.0.1081323492013KRAS1225245347CA,G,T
rs112445441256095773845KRASumls:C1527249BeFreeKRAS MASI is a significant event in colorectal cancer, specifically associated with G13D mutation, and featuring a heterogeneous spatial distribution, that may have a role to predict the response to EGFR inhibitors.0.162015KRAS1225245347CA,G,T
rs11244544125367198673BRAFumls:C0009402BeFreeOur finding that KRAS codon 13 mutations (in particular G13D) are associated with inferior survival in BRAF wild-type CRCs in Chinese patients was not reported thus far.0.0741036312014KRAS1225245347CA,G,T
rs1130409188235664595MUTYHumls:C1527249BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.1055276842008APEX1;OSGEP1420456995TA,G
rs1130409210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010APEX1;OSGEP1420456995TA,G
rs113040918823566328APEX1umls:C0009402BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.0027144192008APEX1;OSGEP1420456995TA,G
rs113040924254302328APEX1umls:C1527249BeFreeThe APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.0.0119111052013APEX1;OSGEP1420456995TA,G
rs1130409188235664595MUTYHumls:C0009402BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.0276870712008APEX1;OSGEP1420456995TA,G
rs113040925268610328APEX1umls:C0009402BeFreeEffect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.0.0027144192014APEX1;OSGEP1420456995TA,G
rs113040918823566328APEX1umls:C1527249BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.0119111052008APEX1;OSGEP1420456995TA,G
rs1130409252686104968OGG1umls:C1527249BeFreeEffect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.0.0296420412014APEX1;OSGEP1420456995TA,G
rs1130409210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010APEX1;OSGEP1420456995TA,G
rs1130409250246287515XRCC1umls:C1527249BeFreeAPE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.0.0623894952014APEX1;OSGEP1420456995TA,G
rs1130409250246287515XRCC1umls:C0009402BeFreeAPE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.0.0126818232014APEX1;OSGEP1420456995TA,G
rs113040925268610328APEX1umls:C1527249BeFreeEffect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.0.0119111052014APEX1;OSGEP1420456995TA,G
rs113040924254302328APEX1umls:C0009402BeFreeThe APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.0.0027144192013APEX1;OSGEP1420456995TA,G
rs113040925268610142PARP1umls:C1527249BeFreeEffect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.0.010629842014APEX1;OSGEP1420456995TA,G
rs1130409210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010APEX1;OSGEP1420456995TA,G
rs1130409252686104968OGG1umls:C0009402BeFreeEffect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.0.0062431632014APEX1;OSGEP1420456995TA,G
rs113040925268610142PARP1umls:C0009402BeFreeEffect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.0.0032573022014APEX1;OSGEP1420456995TA,G
rs1130409210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010APEX1;OSGEP1420456995TA,G
rs1131620199984498425LTBP4umls:C0009402BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0005428842010LTBP41940611963AG
rs1131620199984495045FURINumls:C0009402BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0005428842010LTBP41940611963AG
rs1131620199984498425LTBP4umls:C1527249BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0029099162010LTBP41940611963AG
rs11316201999844925805BAMBIumls:C1527249BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0029099162010LTBP41940611963AG
rs11316201999844925805BAMBIumls:C0009402BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0008143262010LTBP41940611963AG
rs1131620199984497046TGFBR1umls:C1527249BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0243650932010LTBP41940611963AG
rs1131620199984497046TGFBR1umls:C0009402BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0054288372010LTBP41940611963AG
rs1131620199984495045FURINumls:C1527249BeFreeThe observed statistically significant associations included a decreased CRC risk for TGFBR1 IVS7G+24A minor allele carriers (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53-0.97), less aggressive tumors with Dukes' stage A+B for carriers of LTBP4 Thr750Ala and BAMBI T-779A minor alleles (OR: 0.58, 95%CI: 0.36-0.93 and OR: 0.51, 95%CI: 0.29-0.89, respectively) and worse survival for FURIN C-229T heterozygotes (hazard ratio: 1.63, 95%CI: 1.08-2.46).0.0029099162010LTBP41940611963AG
rs11348802218428050673BRAFumls:C0009402BeFreeDetection of the V600E hotspot mutation in BRAF oncogene is extremely useful for the screening of hereditary non-polyposis colorectal cancer (Lynch's syndrome) and for the prediction of sensitivity to MEK inhibitors.0.0741036312008BRAF7140753336AT,G,C
rs11348802225549141673BRAFumls:C0009402BeFreeTo summarize the usefulness of several recently discovered immunohistochemical markers in the study of gastrointestinal and liver tumors; to suggest the most current and effective immunohistochemical panels addressing common diagnostic challenges for these tumors; to share practical experience and useful tips for human epidermal growth factor receptor 2 testing in gastric and gastroesophageal junction adenocarcinoma and v-raf murine sarcoma viral oncogene homolog B V600E immunohistochemistry in colorectal carcinoma.0.0741036312015BRAF7140753336AT,G,C
rs113488022242423313845KRASumls:C1527249BeFreemiRNA array analysis revealed that microRNA-31 (miR-31)-5p was the most up-regulated miRNA in CRCs with mutated BRAF (V600E) compared with CRCs possessing wild-type BRAF (including cases with KRAS mutation).0.162014BRAF7140753336AT,G,C
rs113488022188068305595MAPK3umls:C1527249BeFreeColorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.0.0029858612008BRAF7140753336AT,G,C
rs113488022238871576737TRIM21umls:C0009402BeFreeWe demonstrate that SSA-associated synchronous colorectal carcinomas have a striking predilection for elderly women, are associated with a favorable prognosis, and are MSI-H and BRAF V600E positive.0.0008143262013BRAF7140753336AT,G,C
rs11348802217942460673BRAFumls:C1527249BeFreeThe BRAF V600E mutation is associated with sporadic MSI-H colorectal cancers (CRCs) harboring hMLH1 methylation but not Lynch syndrome-related CRCs.0.2743750732008BRAF7140753336AT,G,C
rs113488022235498755291PIK3CBumls:C1527249BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0119434422013BRAF7140753336AT,G,C
rs11348802224768606673BRAFumls:C0009402BeFreeWe have prospectively studied a series of 1624 consecutive colorectal carcinomas with an algorithm including immunohistochemical analysis of mismatch repair proteins and molecular study of microsatellite instability and BRAF c.1799 T > A (p.V600E) gene mutations.0.0741036312014BRAF7140753336AT,G,C
rs11348802224833563673BRAFumls:C1527249BeFreeSince RAC1b has been associated with the BRAF(V600E) mutation, associated with poor prognosis in CRC, we evaluated the role of RAC1b expression as a predictor of chemotherapy efficacy in mCRC.0.2743750732014BRAF7140753336AT,G,C
rs11348802224248543673BRAFumls:C0009402BeFreeIn conclusion, miR-145 might be used as a therapeutic target in the treatment of colorectal cancer patients with BRAF V600E mutation.0.0741036312013BRAF7140753336AT,G,C
rs113488022206163665424POLD1umls:C1527249BeFreeThe use of COLD-PCR in apparently wild-type samples allowed us to identify 15 newly mutated CRCs (10 for KRAS and 5 for BRAF (V600E)), raising the percentage of mutated CRCs to 48.7% for KRAS and to 12.8% for BRAF (V600E).0.0019000932010BRAF7140753336AT,G,C
rs11348802225862899673BRAFumls:C1527249BeFreeBRAF V600E mutation in colorectal cancer is associated with right-sided tumours and iron deficiency anaemia.0.2743750732015BRAF7140753336AT,G,C
rs113488022188068305595MAPK3umls:C0009402BeFreeColorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.0.0032573022008BRAF7140753336AT,G,C
rs113488022228454801956EGFRumls:C0009402BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.082012BRAF7140753336AT,G,C
rs11348802224242331407035MIR31umls:C1527249BeFreemiRNA array analysis revealed that microRNA-31 (miR-31)-5p was the most up-regulated miRNA in CRCs with mutated BRAF (V600E) compared with CRCs possessing wild-type BRAF (including cases with KRAS mutation).0.0038001862014BRAF7140753336AT,G,C
rs11348802225624727673BRAFumls:C0009402BeFreeTo determine the prognostic significance of deficient mismatch repair (dMMR) and BRAF V600E in Thai sporadic colorectal cancer (CRC) patients.0.0741036312014BRAF7140753336AT,G,C
rs113488022247678623845KRASumls:C0009402BeFreeThe aim of our study was to test sebaceous neoplasms for V600E BRAF or KRAS mutations to determine if these mutations are associated with somatic or germline MMR defects, analogous to colorectal carcinomas.0.0823670322014BRAF7140753336AT,G,C
rs11348802220197478673BRAFumls:C0009402BeFreeThe aim of this study was to relate the CpG island methylator phenotype (CIMP; characterized by extensive promoter hypermethylation) to cancer-specific survival in colorectal cancer, taking into consideration relevant clinicopathologic factors, such as microsatellite instability (MSI) screening status and the BRAF V600E mutation.0.0741036312010BRAF7140753336AT,G,C
rs11348802223406774673BRAFumls:C1527249BeFreeThe V600E mutation of BRAF was initially described in 2002 and has been found at particularly high frequency in melanoma and certain subtypes of colorectal cancer.0.2743750732013BRAF7140753336AT,G,C
rs113488022255491412064ERBB2umls:C0009402BeFreeTo summarize the usefulness of several recently discovered immunohistochemical markers in the study of gastrointestinal and liver tumors; to suggest the most current and effective immunohistochemical panels addressing common diagnostic challenges for these tumors; to share practical experience and useful tips for human epidermal growth factor receptor 2 testing in gastric and gastroesophageal junction adenocarcinoma and v-raf murine sarcoma viral oncogene homolog B V600E immunohistochemistry in colorectal carcinoma.0.0138435352015BRAF7140753336AT,G,C
rs113488022179424604292MLH1umls:C1527249BeFreeThe BRAF V600E mutation is associated with sporadic MSI-H colorectal cancers (CRCs) harboring hMLH1 methylation but not Lynch syndrome-related CRCs.0.162008BRAF7140753336AT,G,C
rs11348802218096441673BRAFumls:C1527249BeFreeBRAF V600E mutation was analyzed in CRC patients with MMR deficiencies (microsatellite instability and/or lack of MLH1/MSH2 protein expression) in the EPICOLON population-based study.0.2743750732008BRAF7140753336AT,G,C
rs113488022262168407157TP53umls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.162015BRAF7140753336AT,G,C
rs11348802225280751673BRAFumls:C0009402BeFreeTumour DNA was extracted (formalin fixed, paraffin embedded, FFPE tissue) and pyrosequencing used to test for MLH1 promoter methylation and presence of the BRAF c.1799T>A, p.(Val600Glu) mutation 71 CRCs from individuals with pathogenic MLH1 mutations and 73 CRCs with sporadic MLH1 loss.0.0741036312015BRAF7140753336AT,G,C
rs113488022200272243490IGFBP7umls:C0009402BeFreeCIMP-specific inactivation of BRAF(V600E)-induced senescence and apoptosis pathways by IGFBP7 DNA hypermethylation might create a favorable context for the acquisition of BRAF(V600E) in CIMP+ colorectal cancer.0.0029858612009BRAF7140753336AT,G,C
rs113488022252807514292MLH1umls:C1527249BeFreeTumour DNA was extracted (formalin fixed, paraffin embedded, FFPE tissue) and pyrosequencing used to test for MLH1 promoter methylation and presence of the BRAF c.1799T>A, p.(Val600Glu) mutation 71 CRCs from individuals with pathogenic MLH1 mutations and 73 CRCs with sporadic MLH1 loss.0.162015BRAF7140753336AT,G,C
rs113488022233415442321FLT1umls:C0009402BeFreeWe used preclinical models of CRC to demonstrate (18)F-FLT PET as a sensitive predictor of response to (V600E)BRAF inhibitors.0.0029858612013BRAF7140753336AT,G,C
rs11348802224166180673BRAFumls:C0009402BeFreeThese results seem to indicate that Cdx2 may play a role in the serrated pathway to colorectal cancer as underlined by strong relationships with BRAF(V600E), CIMP-high and MMR-deficiency.0.0741036312013BRAF7140753336AT,G,C
rs113488022252807514292MLH1umls:C0009402BeFreeTumour DNA was extracted (formalin fixed, paraffin embedded, FFPE tissue) and pyrosequencing used to test for MLH1 promoter methylation and presence of the BRAF c.1799T>A, p.(Val600Glu) mutation 71 CRCs from individuals with pathogenic MLH1 mutations and 73 CRCs with sporadic MLH1 loss.0.0823670322015BRAF7140753336AT,G,C
rs113488022262168405290PIK3CAumls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0301300482015BRAF7140753336AT,G,C
rs11348802223887157811CALRumls:C0009402BeFreeWe demonstrate that SSA-associated synchronous colorectal carcinomas have a striking predilection for elderly women, are associated with a favorable prognosis, and are MSI-H and BRAF V600E positive.0.0010857672013BRAF7140753336AT,G,C
rs11348802225219500673BRAFumls:C1527249BeFreeThrough an RNAi screen, here we identify the transcriptional repressor MAFG as the pivotal factor required for MLH1 silencing and CIMP in CRCs containing BRAF(V600E).0.2743750732014BRAF7140753336AT,G,C
rs113488022157821184292MLH1umls:C1527249BeFreeThe detection of a positive BRAF-V600E mutation in a colorectal cancer suggests a sporadic origin of the disease and the absence of germline alterations of MLH1, MSH2 and also of MSH6.0.162005BRAF7140753336AT,G,C
rs113488022191901293845KRASumls:C0009402BeFreeDistinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.0.0823670322009BRAF7140753336AT,G,C
rs11348802219190129673BRAFumls:C0009402BeFreeDistinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.0.0741036312009BRAF7140753336AT,G,C
rs11348802225318602673BRAFumls:C1527249BeFreePerformance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.0.2743750732014BRAF7140753336AT,G,C
rs113488022228454802064ERBB2umls:C0009402BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.0138435352012BRAF7140753336AT,G,C
rs11348802217119056673BRAFumls:C0009402BeFreeSomatic BRAF-V600E mutations in familial colorectal cancer.0.0741036312006BRAF7140753336AT,G,C
rs11348802225624727673BRAFumls:C1527249BeFreeTo determine the prognostic significance of deficient mismatch repair (dMMR) and BRAF V600E in Thai sporadic colorectal cancer (CRC) patients.0.2743750732014BRAF7140753336AT,G,C
rs11348802225613750673BRAFumls:C1527249BeFreeWe hypothesized it would be more commonly methylated and inactivated in serrated pathway colorectal cancers that are hallmarked by a BRAF V600E mutation and a methylator phenotype, compared to traditional pathway cancers that are BRAF wild type.0.2743750732015BRAF7140753336AT,G,C
rs113488022157821184292MLH1umls:C0009402BeFreeThe detection of a positive BRAF-V600E mutation in a colorectal cancer suggests a sporadic origin of the disease and the absence of germline alterations of MLH1, MSH2 and also of MSH6.0.0823670322005BRAF7140753336AT,G,C
rs11348802226216840673BRAFumls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0741036312015BRAF7140753336AT,G,C
rs11348802223462926673BRAFumls:C1527249BeFreeFamily history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases.0.2743750732013BRAF7140753336AT,G,C
rs11348802221102416673BRAFumls:C0009402BeFreeWe previously reported the concurrent methylation of the mismatch repair gene MLH1 with a cluster of flanking genes in chromosome region 3p22 in sporadic colorectal carcinoma exhibiting microsatellite instability and the BRAF V600E mutation.0.0741036312011BRAF7140753336AT,G,C
rs113488022232510025293PIK3CDumls:C1527249BeFreeWe conducted comparative proteomic analysis of BRAF(V600E) melanoma and CRC cell lines, followed by correlation of phosphoinositide 3-kinase (PI3K) pathway activation and sensitivity to the vemurafenib analogue PLX4720.0.0124863262013BRAF7140753336AT,G,C
rs11348802221681432673BRAFumls:C0009402BeFreeAssociation between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients.0.0741036312012BRAF7140753336AT,G,C
rs113488022252195004097MAFGumls:C1527249BeFreeThrough an RNAi screen, here we identify the transcriptional repressor MAFG as the pivotal factor required for MLH1 silencing and CIMP in CRCs containing BRAF(V600E).0.0005428842014BRAF7140753336AT,G,C
rs113488022235498755291PIK3CBumls:C0009402BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0116722013BRAF7140753336AT,G,C
rs11348802215782118673BRAFumls:C0009402BeFreeThe detection of a positive BRAF-V600E mutation in a colorectal cancer suggests a sporadic origin of the disease and the absence of germline alterations of MLH1, MSH2 and also of MSH6.0.0741036312005BRAF7140753336AT,G,C
rs11348802217065421673BRAFumls:C1527249BeFreeDetection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.0.2743750732006BRAF7140753336AT,G,C
rs113488022200272243490IGFBP7umls:C1527249BeFreeCIMP-specific inactivation of BRAF(V600E)-induced senescence and apoptosis pathways by IGFBP7 DNA hypermethylation might create a favorable context for the acquisition of BRAF(V600E) in CIMP+ colorectal cancer.0.0027144192009BRAF7140753336AT,G,C
rs113488022232510025291PIK3CBumls:C1527249BeFreeWe conducted comparative proteomic analysis of BRAF(V600E) melanoma and CRC cell lines, followed by correlation of phosphoinositide 3-kinase (PI3K) pathway activation and sensitivity to the vemurafenib analogue PLX4720.0.0119434422013BRAF7140753336AT,G,C
rs11348802221681432673BRAFumls:C1527249BeFreeAssociation between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients.0.2743750732012BRAF7140753336AT,G,C
rs113488022235498755290PIK3CAumls:C0009402BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0301300482013BRAF7140753336AT,G,C
rs113488022235498755290PIK3CAumls:C1527249BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.1922696852013BRAF7140753336AT,G,C
rs113488022238809614292MLH1umls:C0009402BeFreeA correlation between MLH1 promoter methylation, specifically the 'C' region, and BRAF V600E status has been reported in CRC studies.0.0823670322015BRAF7140753336AT,G,C
rs1134880221880683010018BCL2L11umls:C0009402BeFreeColorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.0.0002714422008BRAF7140753336AT,G,C
rs113488022235498755294PIK3CGumls:C1527249BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0119434422013BRAF7140753336AT,G,C
rs11348802221516079673BRAFumls:C0009402BeFreeThus, large-scale KRAS mutation screening is needed for efficient patient management and in the future metastatic colorectal cancer genotyping might also include the detection of the BRAF V600E mutation, which is a very strong negative prognostic factor in colorectal cancer.0.0741036312011BRAF7140753336AT,G,C
rs113488022233415442321FLT1umls:C1527249BeFreeWe used preclinical models of CRC to demonstrate (18)F-FLT PET as a sensitive predictor of response to (V600E)BRAF inhibitors.0.0021715352013BRAF7140753336AT,G,C
rs113488022235498755293PIK3CDumls:C1527249BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0124863262013BRAF7140753336AT,G,C
rs113488022262168405624PROCumls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0518453982015BRAF7140753336AT,G,C
rs11348802222481281673BRAFumls:C0009402BeFreeBRAF V600E mutations were not identified in the early-onset colorectal carcinoma group.0.0741036312012BRAF7140753336AT,G,C
rs113488022214571624255MGMTumls:C0009402BeFreeKRAS codon 12/13 and 59/61 and BRAF V600E mutations, MSI, and MGMT and hMLH1 methylation and expression in 42 serrated adenocarcinomas and 17 serrated adenomas were compared with those in 59 non-serrated colorectal carcinomas (CRCs) and nine adenomas.0.0143864192011BRAF7140753336AT,G,C
rs113488022228454803845KRASumls:C0009402BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.0823670322012BRAF7140753336AT,G,C
rs1134880221880683010018BCL2L11umls:C1527249BeFreeColorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.0.0002714422008BRAF7140753336AT,G,C
rs11348802226216840324APCumls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.242015BRAF7140753336AT,G,C
rs113488022184280505609MAP2K7umls:C0009402BeFreeDetection of the V600E hotspot mutation in BRAF oncogene is extremely useful for the screening of hereditary non-polyposis colorectal cancer (Lynch's syndrome) and for the prediction of sensitivity to MEK inhibitors.0.0040716282008BRAF7140753336AT,G,C
rs11348802225862899673BRAFumls:C0009402BeFreeBRAF V600E mutation in colorectal cancer is associated with right-sided tumours and iron deficiency anaemia.0.0741036312015BRAF7140753336AT,G,C
rs113488022153426964436MSH2umls:C1527249BeFreeBRAF-V600E mutations were analysed by automatic sequencing in colorectal cancers from 206 sporadic cases with MSI-H and 111 HNPCC cases with known germline mutations in MLH1 and MSH2.0.143788842004BRAF7140753336AT,G,C
rs11348802224085553673BRAFumls:C0009402BeFreeUltra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.0.0741036312013BRAF7140753336AT,G,C
rs113488022204891144292MLH1umls:C0009402BeFreeThe aim of this study is to compare the utility of methylation analysis of MLH1 and BRAF V600E mutations for the selection of patients with MLH1 negative colorectal cancer for genetic testing.0.0823670322010BRAF7140753336AT,G,C
rs11348802223650027673BRAFumls:C1527249BeFreeDetection of the BRAF V600E mutation in colorectal cancer by immunohistochemistry is a viable alternative to molecular methods.0.2743750732013BRAF7140753336AT,G,C
rs113488022262168403845KRASumls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0823670322015BRAF7140753336AT,G,C
rs11348802224833563673BRAFumls:C0009402BeFreeSince RAC1b has been associated with the BRAF(V600E) mutation, associated with poor prognosis in CRC, we evaluated the role of RAC1b expression as a predictor of chemotherapy efficacy in mCRC.0.0741036312014BRAF7140753336AT,G,C
rs113488022262168403845KRASumls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.162015BRAF7140753336AT,G,C
rs113488022238809614292MLH1umls:C1527249BeFreeA correlation between MLH1 promoter methylation, specifically the 'C' region, and BRAF V600E status has been reported in CRC studies.0.162015BRAF7140753336AT,G,C
rs113488022215872587474WNT5Aumls:C1527249BeFreePromoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients.0.0021715352011BRAF7140753336AT,G,C
rs11348802223549875673BRAFumls:C1527249BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.2743750732013BRAF7140753336AT,G,C
rs11348802219190129673BRAFumls:C1527249BeFreeDistinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.0.2743750732009BRAF7140753336AT,G,C
rs11348802222210186673BRAFumls:C0009402BeFreeHigh-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer.0.0741036312012BRAF7140753336AT,G,C
rs11348802220616366100271691CRCS10umls:C1527249BeFreeThe use of COLD-PCR in apparently wild-type samples allowed us to identify 15 newly mutated CRCs (10 for KRAS and 5 for BRAF (V600E)), raising the percentage of mutated CRCs to 48.7% for KRAS and to 12.8% for BRAF (V600E).0.0002714422010BRAF7140753336AT,G,C
rs11348802226216840673BRAFumls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.2743750732015BRAF7140753336AT,G,C
rs11348802224767862673BRAFumls:C0009402BeFreeThe aim of our study was to test sebaceous neoplasms for V600E BRAF or KRAS mutations to determine if these mutations are associated with somatic or germline MMR defects, analogous to colorectal carcinomas.0.0741036312014BRAF7140753336AT,G,C
rs11348802224925223673BRAFumls:C0009402BeFreeWhen subclassified by combined BRAF V600E mutation and MMR status, loss of ARID1A expression was found most commonly in CRCs with the BRAF V600E mutated, MMR- deficient phenotype (58 of 232 cases, 25%, P < .01).0.0741036312014BRAF7140753336AT,G,C
rs11348802222314188673BRAFumls:C0009402BeFreeThe association of BRAF V600E mutation and the presence of the CpG island methylator phenotype (CIMP) and microsatellite instability (MSI) often confound analysis of BRAF mutation status and survival in colorectal carcinoma.0.0741036312012BRAF7140753336AT,G,C
rs11348802224248543673BRAFumls:C1527249BeFreeIn conclusion, miR-145 might be used as a therapeutic target in the treatment of colorectal cancer patients with BRAF V600E mutation.0.2743750732013BRAF7140753336AT,G,C
rs11348802222210186673BRAFumls:C1527249BeFreeHigh-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer.0.2743750732012BRAF7140753336AT,G,C
rs11348802225280751673BRAFumls:C1527249BeFreeTumour DNA was extracted (formalin fixed, paraffin embedded, FFPE tissue) and pyrosequencing used to test for MLH1 promoter methylation and presence of the BRAF c.1799T>A, p.(Val600Glu) mutation 71 CRCs from individuals with pathogenic MLH1 mutations and 73 CRCs with sporadic MLH1 loss.0.2743750732015BRAF7140753336AT,G,C
rs11348802223887157673BRAFumls:C0009402BeFreeWe demonstrate that SSA-associated synchronous colorectal carcinomas have a striking predilection for elderly women, are associated with a favorable prognosis, and are MSI-H and BRAF V600E positive.0.0741036312013BRAF7140753336AT,G,C
rs113488022184280505609MAP2K7umls:C1527249BeFreeDetection of the V600E hotspot mutation in BRAF oncogene is extremely useful for the screening of hereditary non-polyposis colorectal cancer (Lynch's syndrome) and for the prediction of sensitivity to MEK inhibitors.0.0038001862008BRAF7140753336AT,G,C
rs113488022215160793845KRASumls:C0009402BeFreeThus, large-scale KRAS mutation screening is needed for efficient patient management and in the future metastatic colorectal cancer genotyping might also include the detection of the BRAF V600E mutation, which is a very strong negative prognostic factor in colorectal cancer.0.0823670322011BRAF7140753336AT,G,C
rs113488022191901293845KRASumls:C1527249BeFreeDistinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.0.162009BRAF7140753336AT,G,C
rs11348802223341544673BRAFumls:C0009402BeFree3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.0.0741036312013BRAF7140753336AT,G,C
rs11348802224242331673BRAFumls:C1527249BeFreemiRNA array analysis revealed that microRNA-31 (miR-31)-5p was the most up-regulated miRNA in CRCs with mutated BRAF (V600E) compared with CRCs possessing wild-type BRAF (including cases with KRAS mutation).0.2743750732014BRAF7140753336AT,G,C
rs11348802221587258673BRAFumls:C1527249BeFreePromoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients.0.2743750732011BRAF7140753336AT,G,C
rs113488022201626683845KRASumls:C1527249BeFreeSpecific KRAS mutation is an informative prognostic factor in both sporadic and hereditary CRC and applied in an algorithm with BRAF(V600E) and MSI may identify sporadic CRC patients with poor clinical outcome.0.162010BRAF7140753336AT,G,C
rs11348802219213871673BRAFumls:C1527249BeFreeBRAF V600E is the predominantly occurring mutation of the cytoplasmic kinase BRAF, and, in colorectal cancer, its determination provides a diagnostic exclusion criterion for hereditary nonpolyposis colorectal cancer.0.2743750732009BRAF7140753336AT,G,C
rs11348802225744437673BRAFumls:C0009402BeFreeIn this review, clinicopathologic characteristics associated with BRAF-mutant tumors will be highlighted, and the prognostic and predictive implications of a BRAF V600E mutation will be discussed with a focus on melanoma, thyroid carcinoma and colorectal carcinoma.0.0741036312015BRAF7140753336AT,G,C
rs11348802224166180673BRAFumls:C1527249BeFreeThese results seem to indicate that Cdx2 may play a role in the serrated pathway to colorectal cancer as underlined by strong relationships with BRAF(V600E), CIMP-high and MMR-deficiency.0.2743750732013BRAF7140753336AT,G,C
rs113488022153426964292MLH1umls:C1527249BeFreeBRAF-V600E mutations were analysed by automatic sequencing in colorectal cancers from 206 sporadic cases with MSI-H and 111 HNPCC cases with known germline mutations in MLH1 and MSH2.0.162004BRAF7140753336AT,G,C
rs11348802220489114673BRAFumls:C1527249BeFreeThe aim of this study is to compare the utility of methylation analysis of MLH1 and BRAF V600E mutations for the selection of patients with MLH1 negative colorectal cancer for genetic testing.0.2743750732010BRAF7140753336AT,G,C
rs11348802223251002207AKT1umls:C1527249BeFreeWe show that activation of the PI3K/AKT pathway is a mechanism of both innate and acquired resistance to BRAF inhibitors in BRAF(V600E) CRC and suggest combinatorial approaches to improve outcomes in this poor prognosis subset of patients.0.0115960562013BRAF7140753336AT,G,C
rs11348802220197478673BRAFumls:C1527249BeFreeThe aim of this study was to relate the CpG island methylator phenotype (CIMP; characterized by extensive promoter hypermethylation) to cancer-specific survival in colorectal cancer, taking into consideration relevant clinicopathologic factors, such as microsatellite instability (MSI) screening status and the BRAF V600E mutation.0.2743750732010BRAF7140753336AT,G,C
rs113488022262168407157TP53umls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0847340642015BRAF7140753336AT,G,C
rs113488022235498755294PIK3CGumls:C0009402BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0119434422013BRAF7140753336AT,G,C
rs11348802224248543406937MIR145umls:C0009402BeFreeIn conclusion, miR-145 might be used as a therapeutic target in the treatment of colorectal cancer patients with BRAF V600E mutation.0.004343072013BRAF7140753336AT,G,C
rs11348802223553055673BRAFumls:C0009402BeFreeBRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.0.0741036312013BRAF7140753336AT,G,C
rs11348802223462926673BRAFumls:C0009402BeFreeFamily history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases.0.0741036312013BRAF7140753336AT,G,C
rs11348802221516079673BRAFumls:C1527249BeFreeThus, large-scale KRAS mutation screening is needed for efficient patient management and in the future metastatic colorectal cancer genotyping might also include the detection of the BRAF V600E mutation, which is a very strong negative prognostic factor in colorectal cancer.0.2743750732011BRAF7140753336AT,G,C
rs11348802220489114673BRAFumls:C0009402BeFreeThe aim of this study is to compare the utility of methylation analysis of MLH1 and BRAF V600E mutations for the selection of patients with MLH1 negative colorectal cancer for genetic testing.0.0741036312010BRAF7140753336AT,G,C
rs11348802218628431673BRAFumls:C1527249BeFreeEthnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.0.2743750732008BRAF7140753336AT,G,C
rs11348802218428050673BRAFumls:C1527249BeFreeDetection of the V600E hotspot mutation in BRAF oncogene is extremely useful for the screening of hereditary non-polyposis colorectal cancer (Lynch's syndrome) and for the prediction of sensitivity to MEK inhibitors.0.2743750732008BRAF7140753336AT,G,C
rs11348802224722974673BRAFumls:C0009402BeFreeVE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.0.0741036312014BRAF7140753336AT,G,C
rs11348802226216840324APCumls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0757322822015BRAF7140753336AT,G,C
rs113488022236577891956EGFRumls:C0009402BeFreeA point mutation (V600E) in the BRAF oncogene is a prognostic biomarker and may predict for nonresponse to anti-EGFR antibody therapy in patients with colorectal carcinoma.0.082013BRAF7140753336AT,G,C
rs11348802218591935673BRAFumls:C0009402BeFreeWe show MCC expression is dramatically decreased in many CRC cell lines and the distinct subset of sporadic CRC characterized by the CpG island methylator phenotype and BRAF(V600E) mutation due to promoter methylation as reported previously.0.0741036312008BRAF7140753336AT,G,C
rs113488022232510025290PIK3CAumls:C1527249BeFreeWe conducted comparative proteomic analysis of BRAF(V600E) melanoma and CRC cell lines, followed by correlation of phosphoinositide 3-kinase (PI3K) pathway activation and sensitivity to the vemurafenib analogue PLX4720.0.1922696852013BRAF7140753336AT,G,C
rs113488022204891144292MLH1umls:C1527249BeFreeThe aim of this study is to compare the utility of methylation analysis of MLH1 and BRAF V600E mutations for the selection of patients with MLH1 negative colorectal cancer for genetic testing.0.162010BRAF7140753336AT,G,C
rs11348802215342696673BRAFumls:C1527249BeFreeBRAF-V600E mutations were analysed by automatic sequencing in colorectal cancers from 206 sporadic cases with MSI-H and 111 HNPCC cases with known germline mutations in MLH1 and MSH2.0.2743750732004BRAF7140753336AT,G,C
rs11348802215782118673BRAFumls:C1527249BeFreeThe detection of a positive BRAF-V600E mutation in a colorectal cancer suggests a sporadic origin of the disease and the absence of germline alterations of MLH1, MSH2 and also of MSH6.0.2743750732005BRAF7140753336AT,G,C
rs113488022170654215894RAF1umls:C0009402BeFreeMutation V600E of BRAF, a kinase-encoding gene from the RAS/RAF/MAPK pathway, in colorectal carcinoma (CRC) suggests a sporadic origin of the disease, providing an exclusion criterion for hereditary nonpolyposis colorectal cancer.0.0038001862006BRAF7140753336AT,G,C
rs113488022201626683845KRASumls:C0009402BeFreeSpecific KRAS mutation is an informative prognostic factor in both sporadic and hereditary CRC and applied in an algorithm with BRAF(V600E) and MSI may identify sporadic CRC patients with poor clinical outcome.0.0823670322010BRAF7140753336AT,G,C
rs113488022232510025294PIK3CGumls:C1527249BeFreeWe conducted comparative proteomic analysis of BRAF(V600E) melanoma and CRC cell lines, followed by correlation of phosphoinositide 3-kinase (PI3K) pathway activation and sensitivity to the vemurafenib analogue PLX4720.0.0119434422013BRAF7140753336AT,G,C
rs11348802225176643673BRAFumls:C1527249BeFreeHigh prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer.0.2743750732014BRAF7140753336AT,G,C
rs1134880221706542122882ZHX2umls:C0009402BeFreeMutation V600E of BRAF, a kinase-encoding gene from the RAS/RAF/MAPK pathway, in colorectal carcinoma (CRC) suggests a sporadic origin of the disease, providing an exclusion criterion for hereditary nonpolyposis colorectal cancer.0.0019000932006BRAF7140753336AT,G,C
rs11348802218806830673BRAFumls:C1527249BeFreeColorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.0.2743750732008BRAF7140753336AT,G,C
rs113488022228454803845KRASumls:C1527249BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.162012BRAF7140753336AT,G,C
rs11348802223887306673BRAFumls:C0009402BeFreeThis improved classification of serrated lesions including immunohistochemical evaluation of BRAF V600E mutation may be the key to identify lesions with higher potential to progression into sessile serrated adenoma/polyp, and further to BRAF V600E-mutated colorectal cancer.0.0741036312013BRAF7140753336AT,G,C
rs11348802221587258673BRAFumls:C0009402BeFreePromoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients.0.0741036312011BRAF7140753336AT,G,C
rs11348802217545526673BRAFumls:C1527249BeFreeThe reference tumor group contained 28 HNPCC with proven germ-line mutations or positive Amsterdam I criteria (median age, 37 years) and loss of MLH1 expression, 14 sporadic MSI-H CRC tumors with loss of MLH1 expression and BRAF V600E mutation (median age, 80.5 years), and 16 sporadic MSS CRC (median age, 76.5 years).0.2743750732007BRAF7140753336AT,G,C
rs11348802218556776673BRAFumls:C0009402BeFreeIn addition, the combination of microsatellite instability testing, MLH1 promoter methylation analysis, and BRAF (V600E) mutation analysis can distinguish a sporadic colorectal cancer from one associated with HNPCC, helping to avoid costly molecular genetic testing for germline mutations in mismatch repair genes.0.0741036312008BRAF7140753336AT,G,C
rs113488022237925673845KRASumls:C0009402BeFreeIndeed, whereas the median overall survival (OS) of colorectal cancer (CRC) patients receiving standard-of-care therapy is approximately two years or more if their tumors express wild-type BRAF and wild-type KRAS, median OS is less than twelve months with tumors expressing V600E-mutant BRAF and wild-type KRAS.0.0823670322014BRAF7140753336AT,G,C
rs11348802223650027673BRAFumls:C0009402BeFreeBRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.0.0741036312013BRAF7140753336AT,G,C
rs11348802219289622673BRAFumls:C1527249BeFreeBRAF mutation (V600E) is found in MSI colorectal cancers.0.2743750732009BRAF7140753336AT,G,C
rs11348802225176643673BRAFumls:C0009402BeFreeHigh prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer.0.0741036312014BRAF7140753336AT,G,C
rs113488022252195004292MLH1umls:C1527249BeFreeThrough an RNAi screen, here we identify the transcriptional repressor MAFG as the pivotal factor required for MLH1 silencing and CIMP in CRCs containing BRAF(V600E).0.162014BRAF7140753336AT,G,C
rs113488022262168405290PIK3CAumls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.1922696852015BRAF7140753336AT,G,C
rs11348802223251002673BRAFumls:C1527249BeFreeWe show that activation of the PI3K/AKT pathway is a mechanism of both innate and acquired resistance to BRAF inhibitors in BRAF(V600E) CRC and suggest combinatorial approaches to improve outcomes in this poor prognosis subset of patients.0.2743750732013BRAF7140753336AT,G,C
rs113488022160156294292MLH1umls:C0009402BeFreeThe current data showed instead that the BRAF V599E mutation was associated only with a subgroup of colorectal carcinomas with MSI that were obtained from older patients without hereditary nonpolyposis colorectal carcinoma and showed epigenetic silencing of hMLH1.0.0823670322005BRAF7140753336AT,G,C
rs113488022237925673845KRASumls:C1527249BeFreeIndeed, whereas the median overall survival (OS) of colorectal cancer (CRC) patients receiving standard-of-care therapy is approximately two years or more if their tumors express wild-type BRAF and wild-type KRAS, median OS is less than twelve months with tumors expressing V600E-mutant BRAF and wild-type KRAS.0.162014BRAF7140753336AT,G,C
rs113488022228454802064ERBB2umls:C1527249BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.0153962422012BRAF7140753336AT,G,C
rs11348802223880961673BRAFumls:C0009402BeFreeA correlation between MLH1 promoter methylation, specifically the 'C' region, and BRAF V600E status has been reported in CRC studies.0.0741036312015BRAF7140753336AT,G,C
rs11348802224248543406937MIR145umls:C1527249BeFreeIn conclusion, miR-145 might be used as a therapeutic target in the treatment of colorectal cancer patients with BRAF V600E mutation.0.0040716282013BRAF7140753336AT,G,C
rs11348802223887306673BRAFumls:C1527249BeFreeThis improved classification of serrated lesions including immunohistochemical evaluation of BRAF V600E mutation may be the key to identify lesions with higher potential to progression into sessile serrated adenoma/polyp, and further to BRAF V600E-mutated colorectal cancer.0.2743750732013BRAF7140753336AT,G,C
rs11348802223553055673BRAFumls:C1527249BeFreeBRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.0.2743750732013BRAF7140753336AT,G,C
rs1134880222284548025ABL1umls:C0009402BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.0005428842012BRAF7140753336AT,G,C
rs1134880222284548025ABL1umls:C1527249BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.0005428842012BRAF7140753336AT,G,C
rs11348802225708741673BRAFumls:C1527249BeFreeThe patient with SSL as index lesions who developed CRC harbored V600E BRAF mutation in both index lesion and the carcinoma.0.2743750732014BRAF7140753336AT,G,C
rs11348802220635392673BRAFumls:C0009402BeFreeOptimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.0.0741036312011BRAF7140753336AT,G,C
rs113488022215160793845KRASumls:C1527249BeFreeThus, large-scale KRAS mutation screening is needed for efficient patient management and in the future metastatic colorectal cancer genotyping might also include the detection of the BRAF V600E mutation, which is a very strong negative prognostic factor in colorectal cancer.0.162011BRAF7140753336AT,G,C
rs113488022215872587474WNT5Aumls:C0009402BeFreePromoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients.0.0021715352011BRAF7140753336AT,G,C
rs113488022235498755293PIK3CDumls:C0009402BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0124863262013BRAF7140753336AT,G,C
rs11348802218591935673BRAFumls:C1527249BeFreeWe show MCC expression is dramatically decreased in many CRC cell lines and the distinct subset of sporadic CRC characterized by the CpG island methylator phenotype and BRAF(V600E) mutation due to promoter methylation as reported previously.0.2743750732008BRAF7140753336AT,G,C
rs11348802223406774673BRAFumls:C0009402BeFreeThe V600E mutation of BRAF was initially described in 2002 and has been found at particularly high frequency in melanoma and certain subtypes of colorectal cancer.0.0741036312013BRAF7140753336AT,G,C
rs11348802225613750673BRAFumls:C0009402BeFreeWe hypothesized it would be more commonly methylated and inactivated in serrated pathway colorectal cancers that are hallmarked by a BRAF V600E mutation and a methylator phenotype, compared to traditional pathway cancers that are BRAF wild type.0.0741036312015BRAF7140753336AT,G,C
rs11348802223657789673BRAFumls:C0009402BeFreeA point mutation (V600E) in the BRAF oncogene is a prognostic biomarker and may predict for nonresponse to anti-EGFR antibody therapy in patients with colorectal carcinoma.0.0741036312013BRAF7140753336AT,G,C
rs11348802219213871673BRAFumls:C0009402BeFreeBRAF V600E is the predominantly occurring mutation of the cytoplasmic kinase BRAF, and, in colorectal cancer, its determination provides a diagnostic exclusion criterion for hereditary nonpolyposis colorectal cancer.0.0741036312009BRAF7140753336AT,G,C
rs11348802217119056673BRAFumls:C1527249BeFreeSomatic BRAF-V600E mutations in familial colorectal cancer.0.2743750732006BRAF7140753336AT,G,C
rs11348802223341544673BRAFumls:C1527249BeFree3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.0.2743750732013BRAF7140753336AT,G,C
rs11348802217065421673BRAFumls:C0009402BeFreeDetection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.0.0741036312006BRAF7140753336AT,G,C
rs11348802218556776673BRAFumls:C1527249BeFreeIn addition, the combination of microsatellite instability testing, MLH1 promoter methylation analysis, and BRAF (V600E) mutation analysis can distinguish a sporadic colorectal cancer from one associated with HNPCC, helping to avoid costly molecular genetic testing for germline mutations in mismatch repair genes.0.2743750732008BRAF7140753336AT,G,C
rs11348802223549875673BRAFumls:C0009402BeFreeConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.0.0741036312013BRAF7140753336AT,G,C
rs113488022228454801956EGFRumls:C1527249BeFreeHere, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4-ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR-ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RARα for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia.0.1081323492012BRAF7140753336AT,G,C
rs113488022214571624292MLH1umls:C0009402BeFreeKRAS codon 12/13 and 59/61 and BRAF V600E mutations, MSI, and MGMT and hMLH1 methylation and expression in 42 serrated adenocarcinomas and 17 serrated adenomas were compared with those in 59 non-serrated colorectal carcinomas (CRCs) and nine adenomas.0.0823670322011BRAF7140753336AT,G,C
rs11348802218098337673BRAFumls:C0009402BeFreeBRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.0.0741036312008BRAF7140753336AT,G,C
rs11348802225318602673BRAFumls:C0009402BeFreePerformance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.0.0741036312014BRAF7140753336AT,G,C
rs11348802224921639673BRAFumls:C0009402BeFreeBRAF V600E immunohistochemistry is reliable in primary and metastatic colorectal carcinoma regardless of treatment status and shows high intratumoral homogeneity.0.0741036312014BRAF7140753336AT,G,C
rs11348802223880961673BRAFumls:C1527249BeFreeA correlation between MLH1 promoter methylation, specifically the 'C' region, and BRAF V600E status has been reported in CRC studies.0.2743750732015BRAF7140753336AT,G,C
rs113488022262168405426POLEumls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0019000932015BRAF7140753336AT,G,C
rs113488022262168405624PROCumls:C0009402BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0513025142015BRAF7140753336AT,G,C
rs113488022262168405426POLEumls:C1527249BeFreeCommonly observed alterations across sporadic CRCs have allowed classification into a (1) hypermutated group that includes defective DNA mismatch repair with microsatellite instability and POLE mutations in ∼15%, containing multiple frameshifted genes and BRAF(V600E); (2) nonhypermutated group with multiple somatic copy number alterations and aneuploidy in ∼85%, containing oncogenic activation of KRAS and PIK3CA and mutation and loss of heterozygosity of tumor suppressor genes, such as APC and TP53; (3) CpG island methylator phenotype CRCs in ∼20% that overlap greatly with microsatellite instability CRCs and some nonhypermutated CRCs; and (4) elevated microsatellite alterations at selected tetranucleotide repeats in ∼60% that associates with metastatic behavior in both hypermutated and nonhypermutated groups.0.0021715352015BRAF7140753336AT,G,C
rs11348802220635392673BRAFumls:C1527249BeFreeOptimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.0.2743750732011BRAF7140753336AT,G,C
rs11348802218806830673BRAFumls:C0009402BeFreeColorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.0.0741036312008BRAF7140753336AT,G,C
rs1136410180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007PARP11226367601AG
rs11364102420381625976TIPARPumls:C0009402BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0005428842013PARP11226367601AG
rs1136410242038164255MGMTumls:C0009402BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0143864192013PARP11226367601AG
rs1136410180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007PARP11226367601AG
rs1136410180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007PARP11226367601AG
rs1136410180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007PARP11226367601AG
rs1136410180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007PARP11226367601AG
rs1136410180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007PARP11226367601AG
rs1136410242038164255MGMTumls:C1527249BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0333226752013PARP11226367601AG
rs11364102420381625976TIPARPumls:C1527249BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0005428842013PARP11226367601AG
rs1143623244461826647SOD1umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0013572092014IL1B2112838252CG
rs1143623244461823586IL10umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0059717212014IL1B2112838252CG
rs1143623241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013IL1B2112838252CG
rs1143623244461826647SOD1umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0016286512014IL1B2112838252CG
rs1143623244461827099TLR4umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.004343072014IL1B2112838252CG
rs1143623244461823553IL1Bumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0174594942014IL1B2112838252CG
rs1143623244461823553IL1Bumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0032573022014IL1B2112838252CG
rs1143623244461823605IL17Aumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0054288372014IL1B2112838252CG
rs1143623241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013IL1B2112838252CG
rs1143623244461823605IL17Aumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0057002792014IL1B2112838252CG
rs1143623244461827099TLR4umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0082628082014IL1B2112838252CG
rs1143623244461823586IL10umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0128013752014IL1B2112838252CG
rs1143627241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013IL1B2112836810GA
rs1143627241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013IL1B2112836810GA
rs1143634231926173552IL1Aumls:C0009402BeFreeWe investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer.0.0010857672013IL1B2112832813GA
rs1143634245570623586IL10umls:C0009402BeFreeWe found that rs1143634 in the interleukin-1β (IL1B) gene and rs1800871 in the interleukin-10 (IL10) gene were associated with increased risk for CRC in the Han Chinese.0.0059717212015IL1B2112832813GA
rs1143634245570623586IL10umls:C1527249BeFreeWe found that rs1143634 in the interleukin-1β (IL1B) gene and rs1800871 in the interleukin-10 (IL10) gene were associated with increased risk for CRC in the Han Chinese.0.0128013752015IL1B2112832813GA
rs1143634231926173552IL1Aumls:C1527249BeFreeWe investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer.0.0058198312013IL1B2112832813GA
rs11536891197600277099TLR4umls:C1527249BeFreeTwo CRP haplotypes (global p = 0.04) and TLR4 tagSNPs (rs7873784, rs11536891), but not TLR4 haplotypes, were associated with colorectal cancer.0.0082628082009TLR49117717059TC
rs11536891197600277099TLR4umls:C0009402BeFreeTwo CRP haplotypes (global p = 0.04) and TLR4 tagSNPs (rs7873784, rs11536891), but not TLR4 haplotypes, were associated with colorectal cancer.0.004343072009TLR49117717059TC
rs11540654206158917157TP53umls:C0009402BeFreeTP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.0.0847340642010TP53177676040CT,G,A
rs11540654204497977157TP53umls:C0009402BeFreeTP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.0.0847340642010TP53177676040CT,G,A
rs11540654219711037157TP53umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0847340642011TP53177676040CT,G,A
rs11540654163531347157TP53umls:C1527249BeFreeAge of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.0.162006TP53177676040CT,G,A
rs11540654204497977157TP53umls:C1527249BeFreeTP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.0.162010TP53177676040CT,G,A
rs11540654231837477157TP53umls:C1527249BeFreeWe aimed to investigate the association between miR-34b/c rs4938723 and TP53 Arg72Pro polymorphisms and the risk of CRC.0.162013TP53177676040CT,G,A
rs11540654210515334193MDM2umls:C1527249BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.0172639972011TP53177676040CT,G,A
rs11540654211240377157TP53umls:C1527249BeFreeAssociation between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.0.162010TP53177676040CT,G,A
rs11540654173749547157TP53umls:C0009402BeFreeFew reports have investigated the association of two p53 polymorphisms (Arg72Pro and PIN3-A2) with colorectal cancer (CRC) risk, and no previous study has analyzed their role as susceptibility alleles for colorectal adenoma.0.0847340642006TP53177676040CT,G,A
rs11540654231837477157TP53umls:C0009402BeFreeWe aimed to investigate the association between miR-34b/c rs4938723 and TP53 Arg72Pro polymorphisms and the risk of CRC.0.0847340642013TP53177676040CT,G,A
rs11540654223939627157TP53umls:C1527249BeFreeAssociation of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.0.162011TP53177676040CT,G,A
rs11540654206158917157TP53umls:C1527249BeFreeTP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.0.162010TP53177676040CT,G,A
rs11540654223939627157TP53umls:C0009402BeFreeAssociation of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.0.0847340642011TP53177676040CT,G,A
rs11540654210515337157TP53umls:C1527249BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.162011TP53177676040CT,G,A
rs11540654211240377157TP53umls:C0009402BeFreeAssociation between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.0.0847340642010TP53177676040CT,G,A
rs11540654219711037157TP53umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.162011TP53177676040CT,G,A
rs11540654189883027157TP53umls:C0009402BeFreeThe p53 R72P genotype was identified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 78 consecutive colorectal cancer patients with liver metastases and 214 age- and sex-matched cases with nonmetastatic colorectal cancer.0.0847340642008TP53177676040CT,G,A
rs11540654172242356041RNASELumls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0031813582007TP53177676040CT,G,A
rs11540654219711037515XRCC1umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0623894952011TP53177676040CT,G,A
rs11540654210515334193MDM2umls:C0009402BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.0057002792011TP53177676040CT,G,A
rs11540654172242357157TP53umls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.162007TP53177676040CT,G,A
rs11540654173749547157TP53umls:C1527249BeFreeFew reports have investigated the association of two p53 polymorphisms (Arg72Pro and PIN3-A2) with colorectal cancer (CRC) risk, and no previous study has analyzed their role as susceptibility alleles for colorectal adenoma.0.162006TP53177676040CT,G,A
rs11540654172242356041RNASELumls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0008143262007TP53177676040CT,G,A
rs11540654163531347157TP53umls:C0009402BeFreeAge of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.0.0847340642006TP53177676040CT,G,A
rs11540654219711037515XRCC1umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0126818232011TP53177676040CT,G,A
rs11540654210515337157TP53umls:C0009402BeFreeTP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.0.0847340642011TP53177676040CT,G,A
rs11540654172242357157TP53umls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0847340642007TP53177676040CT,G,A
rs11568820240757991045CDX2umls:C1527249BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0134961492013NA1247908762CT
rs11568820240757991045CDX2umls:C0009402BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0122148842013NA1247908762CT
rs11609374110896919999CDH1umls:C0009402BeFreeThe E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.0.0076003722000CDH11668812144AG,T
rs11609374110896919999CDH1umls:C1527249BeFreeThe E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.0.1712927162000CDH11668812144AG,T
rs1161491324399071406938MIR146Aumls:C0009402BeFreeEffects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.0.0035287442013MIR196A21253991815CT
rs1161491324399071406938MIR146Aumls:C1527249BeFreeEffects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.0.0038001862013MIR196A21253991815CT
rs11615212782437376NR1H2umls:C1527249BeFreeTo summarize published data on the association between polymorphisms of NER genes (ERCC1 and ERCC2) and responses to oxaliplatin-based chemotherapies, we carried out a meta-analysis of gastric and colorectal cancer for commonly studied polymorphisms ERCC1 rs11615C>T and ERCC2 rs13181T>G.0.0013572092011ERCC11945420395AG
rs11615248616462072ERCC4umls:C1527249BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.005548392014ERCC11945420395AG
rs11615248616462072ERCC4umls:C0009402BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.0008143262014ERCC11945420395AG
rs11615212782437376NR1H2umls:C0009402BeFreeTo summarize published data on the association between polymorphisms of NER genes (ERCC1 and ERCC2) and responses to oxaliplatin-based chemotherapies, we carried out a meta-analysis of gastric and colorectal cancer for commonly studied polymorphisms ERCC1 rs11615C>T and ERCC2 rs13181T>G.0.0013572092011ERCC11945420395AG
rs116327152165508926585GREM1umls:C1527249BeFreeNear GREM1, we found using fine-mapping that the previously-identified association between tagSNP rs4779584 and CRC actually resulted from two independent signals represented by rs16969681 (P = 5.33×10(-8)) and rs11632715 (P = 2.30×10(-10)).0.1256243342011NA1532712046GA
rs116327152165508926585GREM1umls:C0009402BeFreeNear GREM1, we found using fine-mapping that the previously-identified association between tagSNP rs4779584 and CRC actually resulted from two independent signals represented by rs16969681 (P = 5.33×10(-8)) and rs11632715 (P = 2.30×10(-10)).0.0032573022011NA1532712046GA
rs11676348260713993579CXCR2umls:C0009402BeFreeThe minor allele (T) in SNP rs11676348, located downstream from CXCR2 that has been implicated in CRC progression, is associated with a lower risk of CRC, particularly tumors with a mucinous component, Crohn's-like reaction and MSI-high.0.0008143262015NA2218145423CT
rs11676348260713993579CXCR2umls:C1527249BeFreeThe minor allele (T) in SNP rs11676348, located downstream from CXCR2 that has been implicated in CRC progression, is associated with a lower risk of CRC, particularly tumors with a mucinous component, Crohn's-like reaction and MSI-high.0.0008143262015NA2218145423CT
rs11874392232751544092SMAD7umls:C0009402BeFreeSMAD7 rs11874392 presented consistently significant associations with a risk of CRC at both stages, with odds ratio = 1.41 (95% confidence interval = 1.21-1.63) using additive modes in combined analyses.0.0092290242013SMAD71848926786AT
rs11874392232751544092SMAD7umls:C1527249BeFreeSMAD7 rs11874392 presented consistently significant associations with a risk of CRC at both stages, with odds ratio = 1.41 (95% confidence interval = 1.21-1.63) using additive modes in combined analyses.0.1623674712013SMAD71848926786AT
rs120378792359330854741LEPROTumls:C1527249BeFreeLEPR rs12037879 only presented modestly increased colorectal cancer risk, with odds ratios of 1.41 (95% confidence interval [CI] 1.13-1.76) and 1.74 (95%CI 1.08-2.81) for GA and AA genotype when compared with GG genotype in combined population.0.0002714422013LEPR165477024GA
rs120378792359330854741LEPROTumls:C0009402BeFreeLEPR rs12037879 only presented modestly increased colorectal cancer risk, with odds ratios of 1.41 (95% confidence interval [CI] 1.13-1.76) and 1.74 (95%CI 1.08-2.81) for GA and AA genotype when compared with GG genotype in combined population.0.0002714422013LEPR165477024GA
rs12143459218813315207AKT1umls:C1527249BeFreeRecently, a rare activating mutation of AKT1 (E17K) has been reported in breast, ovarian, and colorectal cancers.0.0115960562008AKT114104780214CT
rs121913254234004514893NRASumls:C1527249BeFreeBevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation.0.0090771342013NRAS1114713909GT,C
rs121913254234004514893NRASumls:C0009402BeFreeBevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation.0.0067860472013NRAS1114713909GT,C
rs121913529253594943845KRASumls:C1527249BeFreeWe compared the metastatic efficiency of KRas G12V (Kirsten rat sarcoma viral oncogene homolog with valine mutation at codon 12) and KRas G13D (Kirsten rat sarcoma viral oncogene homolog with aspartic mutation at codon 13) oncogenes in an orthotopic colorectal cancer (CRC) model.0.162015KRAS1225245350CT,G,A
rs121913529253594943845KRASumls:C0009402BeFreeWe compared the metastatic efficiency of KRas G12V (Kirsten rat sarcoma viral oncogene homolog with valine mutation at codon 12) and KRas G13D (Kirsten rat sarcoma viral oncogene homolog with aspartic mutation at codon 13) oncogenes in an orthotopic colorectal cancer (CRC) model.0.0823670322015KRAS1225245350CT,G,A
rs1219135292320981360343FAM3Aumls:C0009402BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0095004662012KRAS1225245350CT,G,A
rs1219135292320981360343FAM3Aumls:C1527249BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0070574892012KRAS1225245350CT,G,A
rs121913529103981033845KRASumls:C0009402BeFreeRecent evidence associates the codon 12 valine-for-glycine (G12V) mutant Ki-Ras protein with higher stage and increased lethality of colorectal carcinomas, while the codon 12 aspartate-for-glycine (G12D) Ras mutation shows no such association.0.0823670321999KRAS1225245350CT,G,A
rs12191352923209813197257LDHDumls:C1527249BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0070574892012KRAS1225245350CT,G,A
rs121913529232098131738DLDumls:C0009402BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0095004662012KRAS1225245350CT,G,A
rs121913529232098131738DLDumls:C1527249BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0070574892012KRAS1225245350CT,G,A
rs12191352923209813197257LDHDumls:C0009402BeFreeKRAS was knocked-down in KRAS-mutant CRC cells (DLD-1(G13D) and SW480(G12V)) by small interfering RNAs (siRNA) and overexpressed in KRAS-wild-type CRC cells (COLO320DM) by KRAS-mutant vectors to generate paired CRC cells.0.0095004662012KRAS1225245350CT,G,A
rs1224100825105248143187VTI1Aumls:C1527249GWASCATTrans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.0.1205428842014VTI1A10112520943TC
rs12299841633272510327AKR1A1umls:C0009402BeFreeGenetic polymorphisms, aldehyde dehydrogenase (ALDH2) Glu487Lys and alcohol dehydrogenase 2 (ADH2) His47Arg, which have a strong impact on alcohol metabolism, are common in Japanese population but their significance for CRC carcinogenesis remains to be clarified in detail.0.0021715352006ADH1B499318162TC
rs122998416332725125ADH1Bumls:C1527249BeFreeA gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan.0.0158308432006ADH1B499318162TC
rs122998424552298125ADH1Bumls:C0009402BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0019000932015ADH1B499318162TC
rs12299841633272510327AKR1A1umls:C1527249BeFreeGenetic polymorphisms, aldehyde dehydrogenase (ALDH2) Glu487Lys and alcohol dehydrogenase 2 (ADH2) His47Arg, which have a strong impact on alcohol metabolism, are common in Japanese population but their significance for CRC carcinogenesis remains to be clarified in detail.0.0021715352006ADH1B499318162TC
rs1229984245522985468PPARGumls:C1527249BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0389906172015ADH1B499318162TC
rs122998424552298125ADH1Bumls:C1527249BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0158308432015ADH1B499318162TC
rs122998416332725217ALDH2umls:C1527249BeFreeA gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan.0.0248320322006ADH1B499318162TC
rs122998416332725125ADH1Bumls:C0009402BeFreeA gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan.0.0019000932006ADH1B499318162TC
rs122998416332725217ALDH2umls:C0009402BeFreeA gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan.0.0035287442006ADH1B499318162TC
rs1229984245522985468PPARGumls:C0009402BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0111291172015ADH1B499318162TC
rs12373250795148460TPST1umls:C1527249BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0002714422014ZG16B162832196GT
rs1237325079514124220ZG16Bumls:C0009402BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0005428842014ZG16B162832196GT
rs1237325079514124220ZG16Bumls:C1527249BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0005428842014ZG16B162832196GT
rs12373250795148460TPST1umls:C0009402BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0002714422014ZG16B162832196GT
rs1241239124836286101927324LINC01475umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014LINC014751099529178AG
rs126035262483628664359NXNumls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014NXN17897353TC
rs12654264204039971917EEF1A2umls:C0009402BeFreeCompared with nonusers, the unadjusted odds ratio of CRC among statin users with the A/A genotype of rs12654264 in HMGCR was 0.3 (95% confidence interval, 0.18-0.51) and among statin users with the T/T genotype was 0.66 (95% confidence interval, 0.41-1.06; P-interaction = 0.0012).0.0013572092010HMGCR575352778AT
rs12654264204039971917EEF1A2umls:C1527249BeFreeCompared with nonusers, the unadjusted odds ratio of CRC among statin users with the A/A genotype of rs12654264 in HMGCR was 0.3 (95% confidence interval, 0.18-0.51) and among statin users with the T/T genotype was 0.66 (95% confidence interval, 0.41-1.06; P-interaction = 0.0012).0.0013572092010HMGCR575352778AT
rs127332852174970951094ADIPOR1umls:C0009402BeFreeWe conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) in ADIPOR1 are the protective factors for CRC, while that rs266729G/C and G allele of ADIPOQ are the risk factors for colon cancer after excluding rectal cancer cases.0.0024429772011ADIPOR11202952912CT
rs127332852174970951094ADIPOR1umls:C1527249BeFreeWe conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) in ADIPOR1 are the protective factors for CRC, while that rs266729G/C and G allele of ADIPOQ are the risk factors for colon cancer after excluding rectal cancer cases.0.0048100092011ADIPOR11202952912CT
rs1279471424562971120227CYP2R1umls:C1527249BeFreeA nominally significant association was detected between CRC and the SNP rs12794714 in the vitamin D 25-hydroxylase gene CYP2R1 (p = 0.019), a SNP that has previously been associated with serum vitamin D levels.0.0002714422014CYP2R11114892029GA
rs1279471424562971120227CYP2R1umls:C0009402BeFreeA nominally significant association was detected between CRC and the SNP rs12794714 in the vitamin D 25-hydroxylase gene CYP2R1 (p = 0.019), a SNP that has previously been associated with serum vitamin D levels.0.0002714422014CYP2R11114892029GA
rs12904241757721942EFNA1umls:C1527249BeFreers12904 polymorphism in the 3'UTR of EFNA1 is associated with colorectal cancer susceptibility in a Chinese population.0.0005428842014EFNA1;SLC50A11155134221GA
rs12904241757721942EFNA1umls:C0009402BeFreers12904 polymorphism in the 3'UTR of EFNA1 is associated with colorectal cancer susceptibility in a Chinese population.0.0005428842014EFNA1;SLC50A11155134221GA
rs129172420381625976TIPARPumls:C1527249BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0005428842013MGMT10129708019CT
rs1291718006925142PARP1umls:C1527249BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.010629842007MGMT10129708019CT
rs12917180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007MGMT10129708019CT
rs12917180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007MGMT10129708019CT
rs12917180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007MGMT10129708019CT
rs129172420381625976TIPARPumls:C0009402BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0005428842013MGMT10129708019CT
rs12917166339204255MGMTumls:C0009402BeFreeO6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).0.0143864192006MGMT10129708019CT
rs12917180069254255MGMTumls:C1527249BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0333226752007MGMT10129708019CT
rs12917166339202099ESR1umls:C1527249BeFreeOur results suggest that the common Leu84Phe and Ile143Val polymorphisms in MGMT influence risk of colorectal cancer in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.0.0121825472006MGMT10129708019CT
rs12917166339202099ESR1umls:C0009402BeFreeOur results suggest that the common Leu84Phe and Ile143Val polymorphisms in MGMT influence risk of colorectal cancer in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.0.0038001862006MGMT10129708019CT
rs12917180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007MGMT10129708019CT
rs12917180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007MGMT10129708019CT
rs12917166339204255MGMTumls:C1527249BeFreeO6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).0.0333226752006MGMT10129708019CT
rs12917242038164255MGMTumls:C1527249BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0333226752013MGMT10129708019CT
rs12917180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007MGMT10129708019CT
rs1291718006925142PARP1umls:C0009402BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0032573022007MGMT10129708019CT
rs12917180069254255MGMTumls:C0009402BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0143864192007MGMT10129708019CT
rs12917242038164255MGMTumls:C0009402BeFreeIn conclusion, this meta-analysis suggests that the PARP-1 rs1136410: T > C polymorphism is a susceptibility factor for GI cancers, but the variant allele of MGMT rs12917: C > T polymorphism appears to be a protective factor for colorectal cancer.0.0143864192013MGMT10129708019CT
rs12953717212218124092SMAD7umls:C1527249BeFreeTwo previous genome-wide association studies identified three single nucleotide polymorphisms (SNPs) (rs4939827, rs12953717 and rs4464148) in SMAD7 to be associated with colorectal cancer in a Western population.0.1623674712011SMAD71848927559CT
rs12953717239498814092SMAD7umls:C1527249BeFreeSMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.0.1623674712013SMAD71848927559CT
rs12953717212218124092SMAD7umls:C0009402BeFreeTwo previous genome-wide association studies identified three single nucleotide polymorphisms (SNPs) (rs4939827, rs12953717 and rs4464148) in SMAD7 to be associated with colorectal cancer in a Western population.0.0092290242011SMAD71848927559CT
rs12953717182319134092SMAD7umls:C1527249BeFreeRecently we have demonstrated variation in SMAD7, defined by the single nucleotide polymorphism rs12953717, to be strongly associated with risk of colorectal cancer.0.1623674712008SMAD71848927559CT
rs12953717193573494092SMAD7umls:C1527249BeFreeTwo recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.0.1623674712009SMAD71848927559CT
rs12953717239498814092SMAD7umls:C0009402BeFreeSMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.0.0092290242013SMAD71848927559CT
rs12953717182319134092SMAD7umls:C0009402BeFreeRecently we have demonstrated variation in SMAD7, defined by the single nucleotide polymorphism rs12953717, to be strongly associated with risk of colorectal cancer.0.0092290242008SMAD71848927559CT
rs12953717193573494092SMAD7umls:C0009402BeFreeTwo recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.0.0092290242009SMAD71848927559CT
rs129972437525690ACVR1umls:C0009402BeFreeWe observed that compared with A carriers (AA + AG), the GG genotype of rs12997:ACVR1 is associated with a significantly higher risk of CRC (OR = 1.52, 95% confidence interval (95% CI) = 1.04-2.21, P = 0.031), particularly in nonsmokers with a higher OR of 1.63 (95% CI = 1.04-2.55, P = 0.032).0.0002714422013ACVR12157736845AG
rs129972437525690ACVR1umls:C1527249BeFreeWe observed that compared with A carriers (AA + AG), the GG genotype of rs12997:ACVR1 is associated with a significantly higher risk of CRC (OR = 1.52, 95% confidence interval (95% CI) = 1.04-2.21, P = 0.031), particularly in nonsmokers with a higher OR of 1.63 (95% CI = 1.04-2.55, P = 0.032).0.0002714422013ACVR12157736845AG
rs13098279232400384292MLH1umls:C0009402BeFreeWe previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients.0.0823670322012LOC105377132337190967GA
rs13098279232400384292MLH1umls:C1527249BeFreeWe previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients.0.162012LOC105377132337190967GA
rs13181206494332068ERCC2umls:C0009402BeFreeOxidative stress, Helicobacter pylori, and OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln polymorphisms in a Turkish population with colorectal carcinoma.0.0104343432010ERCC2;KLC31945351661TA,G
rs13181173630132068ERCC2umls:C1527249BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0575035412007ERCC2;KLC31945351661TA,G
rs13181233172452068ERCC2umls:C0009402BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0104343432012ERCC2;KLC31945351661TA,G
rs13181212782437376NR1H2umls:C0009402BeFreeTo summarize published data on the association between polymorphisms of NER genes (ERCC1 and ERCC2) and responses to oxaliplatin-based chemotherapies, we carried out a meta-analysis of gastric and colorectal cancer for commonly studied polymorphisms ERCC1 rs11615C>T and ERCC2 rs13181T>G.0.0013572092011ERCC2;KLC31945351661TA,G
rs13181180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007ERCC2;KLC31945351661TA,G
rs13181215598362068ERCC2umls:C1527249BeFreeWe found that: (i) XPC C/A (i11) heterozygous variant is associated with increased risk of CRC [OR is 2.07 (95% CI 1.1391, 3.7782) P=0.038], (ii) XPD A18911C (Lys751Gln) is associated with decreased risk of CRC [OR=0.4497, (95% CI 0.2215, 0.9131) P=0.031] for an individual with at least one A allele at this locus.0.0575035412012ERCC2;KLC31945351661TA,G
rs13181233172457515XRCC1umls:C1527249BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0623894952012ERCC2;KLC31945351661TA,G
rs13181180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007ERCC2;KLC31945351661TA,G
rs13181173630137508XPCumls:C1527249BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0074484832007ERCC2;KLC31945351661TA,G
rs13181180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007ERCC2;KLC31945351661TA,G
rs13181173630137508XPCumls:C0009402BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0032573022007ERCC2;KLC31945351661TA,G
rs13181241571182068ERCC2umls:C1527249BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0575035412013ERCC2;KLC31945351661TA,G
rs13181180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007ERCC2;KLC31945351661TA,G
rs13181159142782068ERCC2umls:C0009402BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0104343432005ERCC2;KLC31945351661TA,G
rs13181233172457515XRCC1umls:C0009402BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0126818232012ERCC2;KLC31945351661TA,G
rs13181180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007ERCC2;KLC31945351661TA,G
rs13181180859992068ERCC2umls:C0009402BeFreeDetermination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.0.0104343432007ERCC2;KLC31945351661TA,G
rs13181233172452068ERCC2umls:C1527249BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0575035412012ERCC2;KLC31945351661TA,G
rs13181212782437376NR1H2umls:C1527249BeFreeTo summarize published data on the association between polymorphisms of NER genes (ERCC1 and ERCC2) and responses to oxaliplatin-based chemotherapies, we carried out a meta-analysis of gastric and colorectal cancer for commonly studied polymorphisms ERCC1 rs11615C>T and ERCC2 rs13181T>G.0.0013572092011ERCC2;KLC31945351661TA,G
rs13181206494337508XPCumls:C0009402BeFreeThe association of OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln polymorphisms and the susceptibility to colorectal carcinoma with or without oxidative stress were evaluated.0.0032573022010ERCC2;KLC31945351661TA,G
rs13181173630137507XPAumls:C0009402BeFreeWe determined the risk of colorectal cancer in association with the four polymorphisms XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn, and interactions between the polymorphisms and the environmental factors: smoking intensity, intake of alcohol, red meat, processed meat, fish and poultry, fruits and vegetables and dietary fibres, in relation to development of colorectal cancer in a study population of 405 colorectal cancer cases and a comparison group of 810 persons, nested within the Danish prospective cohort, Diet, Cancer and Health, of 57053 cohort members.0.0008143262007ERCC2;KLC31945351661TA,G
rs13181241571182068ERCC2umls:C0009402BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0104343432013ERCC2;KLC31945351661TA,G
rs13181241571187515XRCC1umls:C1527249BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0623894952013ERCC2;KLC31945351661TA,G
rs13181173630137507XPAumls:C1527249BeFreeWe determined the risk of colorectal cancer in association with the four polymorphisms XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn, and interactions between the polymorphisms and the environmental factors: smoking intensity, intake of alcohol, red meat, processed meat, fish and poultry, fruits and vegetables and dietary fibres, in relation to development of colorectal cancer in a study population of 405 colorectal cancer cases and a comparison group of 810 persons, nested within the Danish prospective cohort, Diet, Cancer and Health, of 57053 cohort members.0.0079154222007ERCC2;KLC31945351661TA,G
rs13181241571187515XRCC1umls:C0009402BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0126818232013ERCC2;KLC31945351661TA,G
rs13181215598362068ERCC2umls:C0009402BeFreeWe found that: (i) XPC C/A (i11) heterozygous variant is associated with increased risk of CRC [OR is 2.07 (95% CI 1.1391, 3.7782) P=0.038], (ii) XPD A18911C (Lys751Gln) is associated with decreased risk of CRC [OR=0.4497, (95% CI 0.2215, 0.9131) P=0.031] for an individual with at least one A allele at this locus.0.0104343432012ERCC2;KLC31945351661TA,G
rs13181180859992068ERCC2umls:C1527249BeFreeDetermination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.0.0575035412007ERCC2;KLC31945351661TA,G
rs13181173630132068ERCC2umls:C0009402BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0104343432007ERCC2;KLC31945351661TA,G
rs13181159142782068ERCC2umls:C1527249BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0575035412005ERCC2;KLC31945351661TA,G
rs13181180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007ERCC2;KLC31945351661TA,G
rs1329149197068451571CYP2E1umls:C0009402BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0040716282009CYP2E110133536297TC
rs1329149197068451571CYP2E1umls:C1527249GAD[A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.]0.0424870232009CYP2E110133536297TC
rs1329149197068451571CYP2E1umls:C1527249BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0424870232009CYP2E110133536297TC
rs132914919706845217ALDH2umls:C0009402BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0035287442009CYP2E110133536297TC
rs132914919706845217ALDH2umls:C1527249BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0248320322009CYP2E110133536297TC
rs133439542473774885415RHPN2umls:C1527249GWASCATIdentification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.0.1389362562015RHPN21933036982TC
rs13423872174970951094ADIPOR1umls:C0009402BeFreeWe conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) in ADIPOR1 are the protective factors for CRC, while that rs266729G/C and G allele of ADIPOQ are the risk factors for colon cancer after excluding rectal cancer cases.0.0024429772011ADIPOR11202945228TC
rs13423872529202151094ADIPOR1umls:C0009402BeFreeIn summary, the ADIPOR1 rs1342387 polymorphism is significantly associated with risk of colorectal cancer among individuals of Asian ancestry.0.0024429772015ADIPOR11202945228TC
rs13423872174970951094ADIPOR1umls:C1527249BeFreeWe conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) in ADIPOR1 are the protective factors for CRC, while that rs266729G/C and G allele of ADIPOQ are the risk factors for colon cancer after excluding rectal cancer cases.0.0048100092011ADIPOR11202945228TC
rs13423872529202151094ADIPOR1umls:C1527249BeFreeIn summary, the ADIPOR1 rs1342387 polymorphism is significantly associated with risk of colorectal cancer among individuals of Asian ancestry.0.0048100092015ADIPOR11202945228TC
rs1346044253555957486WRNumls:C1527249BeFreeHowever, no correlation was found between WRN Cys1367Arg polymorphism and prognosis in CRC patients.0.0034527992014WRN;LOC105379359831167138TC
rs1346044253555957486WRNumls:C0009402BeFreeHowever, no correlation was found between WRN Cys1367Arg polymorphism and prognosis in CRC patients.0.0010857672014WRN;LOC105379359831167138TC
rs1382131972354122110481HOXB13umls:C1527249BeFreeGermline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.0.0008143262013HOXB131748728343CT
rs1382131972354122110481HOXB13umls:C0009402BeFreeGermline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.0.0008143262013HOXB131748728343CT
rs1382131972329208210481HOXB13umls:C1527249BeFreeHOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.0.0008143262013HOXB131748728343CT
rs1382131972329208210481HOXB13umls:C0009402BeFreeHOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.0.0008143262013HOXB131748728343CT
rs14085621717000706472ATMumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0024429772006ATM11108293410TC
rs140856217170007064524MTHFRumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.1068727452006ATM11108293410TC
rs140856217170007064524MTHFRumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0263298622006ATM11108293410TC
rs14085621717000706472ATMumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0039956832006ATM11108293410TC
rs142616668253390332067ERCC1umls:C1527249BeFreeThe ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies.0.0483068552015ERCC1;PPP1R13L;CD3EAP1945407183CT
rs142616668253390332067ERCC1umls:C0009402BeFreeThe ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies.0.0086101952015ERCC1;PPP1R13L;CD3EAP1945407183CT
rs1456315253154305462POU5F1Bumls:C0009402BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0002714422015PRNCR18127091692TC
rs145631525315430101867536PRNCR1umls:C1527249BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0005428842015PRNCR18127091692TC
rs1456315253154305462POU5F1Bumls:C1527249BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0002714422015PRNCR18127091692TC
rs145631525315430101867536PRNCR1umls:C0009402BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0005428842015PRNCR18127091692TC
rs1476413238936184524MTHFRumls:C1527249BeFreeUsing a nondominant model, the AA genotype for MTHFR rs1476413 exhibited a marginally significant (OR = 1.56; 95% CI = 1.00-2.44) association with CRC.0.1068727452013MTHFR111792243CT
rs1476413238936184524MTHFRumls:C0009402BeFreeUsing a nondominant model, the AA genotype for MTHFR rs1476413 exhibited a marginally significant (OR = 1.56; 95% CI = 1.00-2.44) association with CRC.0.0263298622013MTHFR111792243CT
rs14870495625680555149233IL23Rumls:C1527249BeFreeThe haplotypes of IL-17A G197A/IL-17F T7488C and IL-23R were not significantly associated with CRC.0.0016286512015IL17A652187772AG
rs14870495625680555149233IL23Rumls:C0009402BeFreeThe haplotypes of IL-17A G197A/IL-17F T7488C and IL-23R were not significantly associated with CRC.0.0016286512015IL17A652187772AG
rs1497269762403839279695GALNT12umls:C1527249BeFreeIn case of R297W-GALNT12, prediction of highly deleterious effect and disruption in ionic interactions were anticipated with reduction in enzymatic activity, associated with bilateral breast cancer and primary colorectal cancers.0.0008143262013GALNT12998831929CT
rs1501299254897169370ADIPOQumls:C0009402BeFreeTo discuss the association between adiponectin (ADIPOQ) gene rs2241766 and rs1501299 polymorphisms and the risk of colorectal cancer, and to analyze the role of the interaction between these two loci and environmental factors in colorectal cancer pathogenesis.0.0035287442015ADIPOQ;ADIPOQ-AS13186853334GT
rs1501299254897169370ADIPOQumls:C1527249BeFreeTo discuss the association between adiponectin (ADIPOQ) gene rs2241766 and rs1501299 polymorphisms and the risk of colorectal cancer, and to analyze the role of the interaction between these two loci and environmental factors in colorectal cancer pathogenesis.0.0129968722015ADIPOQ;ADIPOQ-AS13186853334GT
rs1503185196726275795PTPRJumls:C0009402BeFreeCompared with the major homozygotes at the Arg326Gln SNP in PTPRJ, a likely homologue of the mouse SCC1 (susceptible to colon cancer), Arg/Gln or Gln/Gln genotypes exhibited an increased colorectal cancer risk with adjusted odds ratios (aOR) of 1.71 (P = 0.021) and 3.74 (P = 4.14 x 10(-4)), respectively.0.0010857672010PTPRJ1148125070GA
rs1503185196726275795PTPRJumls:C1527249BeFreeCompared with the major homozygotes at the Arg326Gln SNP in PTPRJ, a likely homologue of the mouse SCC1 (susceptible to colon cancer), Arg/Gln or Gln/Gln genotypes exhibited an increased colorectal cancer risk with adjusted odds ratios (aOR) of 1.71 (P = 0.021) and 3.74 (P = 4.14 x 10(-4)), respectively.0.0034527992010PTPRJ1148125070GA
rs150963282189921484524MTHFRumls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.1068727452008MTHFR111800285GT
rs150963282189921483576CXCL8umls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.0257223032008MTHFR111800285GT
rs150963282189921485742PTGS1umls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.0109012822008MTHFR111800285GT
rs156243025302443727677CASC8umls:C1527249BeFreeGenome-wide association studies have identified the SNP rs10505477 and SNP rs1562430 in CASC8 were associated with risk of the colorectal cancer (CRC) and breast cancer, respectively.0.0002714422014CASC8;CASC218127375606TC
rs156243025302443727677CASC8umls:C0009402BeFreeGenome-wide association studies have identified the SNP rs10505477 and SNP rs1562430 in CASC8 were associated with risk of the colorectal cancer (CRC) and breast cancer, respectively.0.0002714422014CASC8;CASC218127375606TC
rs15669721113667119391GSTO2umls:C1527249BeFreeAssociation between N142D genetic polymorphism of GSTO2 and susceptibility to colorectal cancer.0.0026384742011GSTO210104279427AG
rs157349623149980131ADH7umls:C1527249BeFreeHowever, the relationship between alcohol and CRC risk might be modulated by the rs1573496 (ADH7) polymorphism.0.0002714422012ADH7499428512CG
rs157349623149980131ADH7umls:C0009402BeFreeHowever, the relationship between alcohol and CRC risk might be modulated by the rs1573496 (ADH7) polymorphism.0.0002714422012ADH7499428512CG
rs1625649200911854255MGMTumls:C0009402BeFreeThe MGMT -535G>T polymorphism (rs1625649) was found to be correlated with PFS in patients with advanced colorectal cancer treated with oxaliplatin-based chemotherapy.0.0143864192010MGMT10129466667AC
rs1625649200911854255MGMTumls:C1527249BeFreeThe MGMT -535G>T polymorphism (rs1625649) was found to be correlated with PFS in patients with advanced colorectal cancer treated with oxaliplatin-based chemotherapy.0.0333226752010MGMT10129466667AC
rs1643659206158901719DHFRumls:C1527249BeFreeIn the log additive model, two linked (r(2) = 0.99) tagSNPs in the DHFR gene (rs1677693 and rs1643659) were associated with a significant decrease in colorectal cancer risk after correction for multiple testing (odds ratio, 0.87; 95% confidence interval, 0.71-0.94; P = 0.029; and odds ratio, 0.87; 95% confidence interval, 0.71-0.95; P = 0.034 for rs1677693 and rs1643659, respectively).0.0058198312010DHFR580639017TC
rs1643659206158901719DHFRumls:C0009402BeFreeIn the log additive model, two linked (r(2) = 0.99) tagSNPs in the DHFR gene (rs1677693 and rs1643659) were associated with a significant decrease in colorectal cancer risk after correction for multiple testing (odds ratio, 0.87; 95% confidence interval, 0.71-0.94; P = 0.029; and odds ratio, 0.87; 95% confidence interval, 0.71-0.95; P = 0.034 for rs1677693 and rs1643659, respectively).0.0010857672010DHFR580639017TC
rs166565023263487259217HSPA12Aumls:C1527249GWASCATGenome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.0.122013HSPA12A10116727589TC
rs1677693206158901719DHFRumls:C0009402BeFreeIn the log additive model, two linked (r(2) = 0.99) tagSNPs in the DHFR gene (rs1677693 and rs1643659) were associated with a significant decrease in colorectal cancer risk after correction for multiple testing (odds ratio, 0.87; 95% confidence interval, 0.71-0.94; P = 0.029; and odds ratio, 0.87; 95% confidence interval, 0.71-0.95; P = 0.034 for rs1677693 and rs1643659, respectively).0.0010857672010DHFR580640499GT
rs1677693206158901719DHFRumls:C1527249BeFreeIn the log additive model, two linked (r(2) = 0.99) tagSNPs in the DHFR gene (rs1677693 and rs1643659) were associated with a significant decrease in colorectal cancer risk after correction for multiple testing (odds ratio, 0.87; 95% confidence interval, 0.71-0.94; P = 0.029; and odds ratio, 0.87; 95% confidence interval, 0.71-0.95; P = 0.034 for rs1677693 and rs1643659, respectively).0.0058198312010DHFR580640499GT
rs16847024245629711591CYP24A1umls:C1527249BeFreeTwo SNPs, rs16847024 in the GC gene and rs6022990 in the CYP24A1 gene, were nominally associated with left-sided CRC (p = 0.015 and p = 0.018, respectively).0.0016286512014GC471784962CT
rs16847024245629711591CYP24A1umls:C0009402BeFreeTwo SNPs, rs16847024 in the GC gene and rs6022990 in the CYP24A1 gene, were nominally associated with left-sided CRC (p = 0.015 and p = 0.018, respectively).0.0016286512014GC471784962CT
rs16879334261086767298TYMSumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.1117586992015MTRR57891393CG
rs16879334261086767799PRDM2umls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0010857672015MTRR57891393CG
rs16879334261086767799PRDM2umls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0037242412015MTRR57891393CG
rs16879334261086765447PORumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0002714422015MTRR57891393CG
rs16879334261086765447PORumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0002714422015MTRR57891393CG
rs16879334261086767298TYMSumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0325730252015MTRR57891393CG
rs16879334261086764522MTHFD1umls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0150165172015MTRR57891393CG
rs16879334261086764552MTRRumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0355814252015MTRR57891393CG
rs16879334261086764522MTHFD1umls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0008143262015MTRR57891393CG
rs16879334261086764552MTRRumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0024429772015MTRR57891393CG
rs1689276622367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012NA8116618444AC
rs16892766223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012NA8116618444AC
rs1689276622367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012NA8116618444AC
rs16892766223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012NA8116618444AC
rs16892766223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012NA8116618444AC
rs1689276622367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012NA8116618444AC
rs16892766183729058667EIF3Humls:C1527249BeFreeIn addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P = 2.5 x 10(-13) overall; P = 6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P = 3.3 x 10(-18) overall; P = 9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H.0.0102824542008NA8116618444AC
rs1689276622367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012NA8116618444AC
rs16892766223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012NA8116618444AC
rs1689276622367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012NA8116618444AC
rs1689276622367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012NA8116618444AC
rs16892766183729058667EIF3Humls:C1527249GAD[In addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P = 2.5 x 10(-13) overall; P = 6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P = 3.3 x 10(-18) overall; P = 9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H.]0.0102824542008NA8116618444AC
rs168927662236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012NA8116618444AC
rs16892766183729058667EIF3Humls:C0009402BeFreeIn addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P = 2.5 x 10(-13) overall; P = 6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P = 3.3 x 10(-18) overall; P = 9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H.0.0008143262008NA8116618444AC
rs168927662236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012NA8116618444AC
rs16902094253154305462POU5F1Bumls:C0009402BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0002714422015CASC8;CASC218127308101AG
rs16902094253154305462POU5F1Bumls:C1527249BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0002714422015CASC8;CASC218127308101AG
rs1690209425315430101867536PRNCR1umls:C0009402BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0005428842015CASC8;CASC218127308101AG
rs1690209425315430101867536PRNCR1umls:C1527249BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0005428842015CASC8;CASC218127308101AG
rs16906252197348444255MGMTumls:C1527249BeFreeMGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.0.0333226752009MGMT10129467281CT
rs16906252197348444255MGMTumls:C0009402BeFreeMGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.0.0143864192009MGMT10129467281CT
rs16944231926173552IL1Aumls:C0009402BeFreeWe investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer.0.0010857672013IL1B2112837290AG
rs16944231926173552IL1Aumls:C1527249BeFreeWe investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer.0.0058198312013IL1B2112837290AG
rs1695217110922950GSTP1umls:C1527249BeFreeGSTP1 I105V polymorphism and susceptibility to colorectal cancer in Kashmiri population.0.0895004662012GSTP11167585218AG
rs1695120725472950GSTP1umls:C0009402BeFreeThe GSTP1 Ile(105)Val polymorphism is associated in a dose-dependent fashion with increased survival of patients with advanced colorectal cancer receiving 5-FU/oxaliplatin chemotherapy.0.0118674982002GSTP11167585218AG
rs16952161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012GSTP11167585218AG
rs169520207535373156GSTK1umls:C1527249BeFreeControversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.0.0076003722010GSTP11167585218AG
rs1695216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012GSTP11167585218AG
rs16952161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012GSTP11167585218AG
rs169520207535373156GSTK1umls:C0009402BeFreeControversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.0.0070574892010GSTP11167585218AG
rs1695238114882950GSTP1umls:C1527249BeFreeGSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.0.0895004662013GSTP11167585218AG
rs1695216185222950GSTP1umls:C0009402BeFreeWe also found that GSTP1 Ile105Val might modify the association between intake of poultry cooked with high temperature methods and CRC risk (p = 0.0035), a finding that was stronger among rectal cancer cases.0.0118674982012GSTP11167585218AG
rs1695216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012GSTP11167585218AG
rs1695174047452950GSTP1umls:C1527249BeFreeBased on the obtained protective effect of Ile/Val GSTP1 genotype, we could suggest that Ile(105)Val GSTP1 polymorphism may play some role in susceptibility to CRC.0.0895004662007GSTP11167585218AG
rs16952381148827306HPGDSumls:C1527249BeFreeMany studies have investigated the association between the Glutathione S transferase-P1 (GSTP1) Ile105Val polymorphism and colorectal cancer (CRC) susceptibility, but the results were conflicting.0.0122148842013GSTP11167585218AG
rs1695187974552950GSTP1umls:C0009402BeFreeGSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.0.0118674982008GSTP11167585218AG
rs1695216185222950GSTP1umls:C1527249BeFreeWe also found that GSTP1 Ile105Val might modify the association between intake of poultry cooked with high temperature methods and CRC risk (p = 0.0035), a finding that was stronger among rectal cancer cases.0.0895004662012GSTP11167585218AG
rs1695202075352950GSTP1umls:C0009402BeFreeControversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.0.0118674982010GSTP11167585218AG
rs16952381148827306HPGDSumls:C0009402BeFreeMany studies have investigated the association between the Glutathione S transferase-P1 (GSTP1) Ile105Val polymorphism and colorectal cancer (CRC) susceptibility, but the results were conflicting.0.0119434422013GSTP11167585218AG
rs1695216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012GSTP11167585218AG
rs169520207535133482SLCO6A1umls:C0009402BeFreeControversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.0.0070574892010GSTP11167585218AG
rs169520207535133482SLCO6A1umls:C1527249BeFreeControversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.0.0076003722010GSTP11167585218AG
rs1695202075352950GSTP1umls:C1527249BeFreeControversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.0.0895004662010GSTP11167585218AG
rs1695174047452950GSTP1umls:C0009402BeFreeIle105Val GSTP1 polymorphism and susceptibility to colorectal carcinoma in Bulgarian population.0.0118674982007GSTP11167585218AG
rs1695216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012GSTP11167585218AG
rs1695238114882950GSTP1umls:C0009402BeFreeGSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.0.0118674982013GSTP11167585218AG
rs1695120725472950GSTP1umls:C1527249BeFreeThe GSTP1 Ile(105)Val polymorphism is associated in a dose-dependent fashion with increased survival of patients with advanced colorectal cancer receiving 5-FU/oxaliplatin chemotherapy.0.0895004662002GSTP11167585218AG
rs1695217110922950GSTP1umls:C0009402BeFreeGSTP1 I105V polymorphism and susceptibility to colorectal cancer in Kashmiri population.0.0118674982012GSTP11167585218AG
rs1695187974552950GSTP1umls:C1527249BeFreeGSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.0.0895004662008GSTP11167585218AG
rs16969681251312001045CDX2umls:C0009402BeFreeThe intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.0.0122148842014NA1532700910CT
rs169696812165508926585GREM1umls:C1527249BeFreeNear GREM1, we found using fine-mapping that the previously-identified association between tagSNP rs4779584 and CRC actually resulted from two independent signals represented by rs16969681 (P = 5.33×10(-8)) and rs11632715 (P = 2.30×10(-10)).0.1256243342011NA1532700910CT
rs169696812513120026585GREM1umls:C0009402BeFreeThe intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.0.0032573022014NA1532700910CT
rs16969681251312006934TCF7L2umls:C0009402BeFreeThe intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.0.0114005592014NA1532700910CT
rs169696812513120026585GREM1umls:C1527249BeFreeThe intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.0.1256243342014NA1532700910CT
rs16969681251312006934TCF7L2umls:C1527249BeFreeThe intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.0.1358631812014NA1532700910CT
rs16969681251312001045CDX2umls:C1527249BeFreeThe intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.0.0134961492014NA1532700910CT
rs169696812165508926585GREM1umls:C0009402BeFreeNear GREM1, we found using fine-mapping that the previously-identified association between tagSNP rs4779584 and CRC actually resulted from two independent signals represented by rs16969681 (P = 5.33×10(-8)) and rs11632715 (P = 2.30×10(-10)).0.0032573022011NA1532700910CT
rs17217772225817034436MSH2umls:C1527249BeFreeThe role of one of the most frequently reported MMR gene VUS, MSH2 c.380A>G (p.Asn127Ser), is especially interesting because its concomitant defect with another variant could finally explain its recurrent occurrence in CRC patients.0.143788842012MSH2247410107AG,T
rs17217772225817034436MSH2umls:C0009402BeFreeThe role of one of the most frequently reported MMR gene VUS, MSH2 c.380A>G (p.Asn127Ser), is especially interesting because its concomitant defect with another variant could finally explain its recurrent occurrence in CRC patients.0.0632459562012MSH2247410107AG,T
rs1728199520971123942CD86umls:C0009402BeFreePolymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.0.0008143262011CD863122120794GC
rs1728199520971123942CD86umls:C1527249BeFreePolymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.0.0031813582011CD863122120794GC
rs17350795261086767298TYMSumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.1117586992015PRDM2113779144GA
rs17350795261086764522MTHFD1umls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0150165172015PRDM2113779144GA
rs17350795261086767298TYMSumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0325730252015PRDM2113779144GA
rs17350795261086765447PORumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0002714422015PRDM2113779144GA
rs17350795261086767799PRDM2umls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0010857672015PRDM2113779144GA
rs17350795261086765447PORumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0002714422015PRDM2113779144GA
rs17350795261086764552MTRRumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0355814252015PRDM2113779144GA
rs17350795261086767799PRDM2umls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0037242412015PRDM2113779144GA
rs17350795261086764552MTRRumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0024429772015PRDM2113779144GA
rs17350795261086764522MTHFD1umls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0008143262015PRDM2113779144GA
rs17453724836286745MYRFumls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014MYRF1161785208GT
rs1750801519344527030MLH3umls:C0009402BeFreeNo association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.0.0021715352004MLH31475047125GA
rs1750801519344527030MLH3umls:C1527249BeFreeNo association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.0.0116396632004MLH31475047125GA
rs17576206625544312MMP1umls:C0009402BeFreeThe aim of this study was to investigate the association of single-nucleotide polymorphism (SNP) at MMP-1 16071G/2G, MMP-7 181A/G, and MMP-9 279R/Q genes with CRC in the southwest Chinese Han population.0.0054288372010MMP92046011586AG
rs17576206625544318MMP9umls:C1527249BeFreeThe MMP-9 279R/Q alleles and genotypes may be associated with the risk of CRC in Han Chinese.0.02052132010MMP92046011586AG
rs17576206625544318MMP9umls:C0009402BeFreeThe MMP-9 279R/Q alleles and genotypes may be associated with the risk of CRC in Han Chinese.0.008686142010MMP92046011586AG
rs17576206625544312MMP1umls:C1527249BeFreeThe aim of this study was to investigate the association of single-nucleotide polymorphism (SNP) at MMP-1 16071G/2G, MMP-7 181A/G, and MMP-9 279R/Q genes with CRC in the southwest Chinese Han population.0.0267321252010MMP92046011586AG
rs17655215613902073ERCC5umls:C1527249BeFreeThe aim of this study was to investigate the associations between the APE1 Asp148Glu, hOGG1 Ser326Cys, XRCC1 Arg399Gln, XRCC3 Thr241Met, XPD Lys751Gln, XPG Asp1104His polymorphisms and CRC risk in Turkish population.0.0158308432011ERCC5;BIVM-ERCC513102875652GC
rs17655253320482073ERCC5umls:C1527249BeFreePrevious studies have reported that the Asp1104His polymorphism in Xeroderma Pigmentosum complementation group G (XPG) was associated with the susceptibility to colorectal cancer (CRC), although the results were inconsistent.0.0158308432014ERCC5;BIVM-ERCC513102875652GC
rs17655253320482073ERCC5umls:C0009402BeFreePrevious studies have reported that the Asp1104His polymorphism in Xeroderma Pigmentosum complementation group G (XPG) was associated with the susceptibility to colorectal cancer (CRC), although the results were inconsistent.0.0019000932014ERCC5;BIVM-ERCC513102875652GC
rs17655215613902073ERCC5umls:C0009402BeFreeThe aim of this study was to investigate the associations between the APE1 Asp148Glu, hOGG1 Ser326Cys, XRCC1 Arg399Gln, XRCC3 Thr241Met, XPD Lys751Gln, XPG Asp1104His polymorphisms and CRC risk in Turkish population.0.0019000932011ERCC5;BIVM-ERCC513102875652GC
rs17782313225112544160MC4Rumls:C1527249BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0029099162012NA1860183864TC
rs177823132251125479047KCTD15umls:C1527249BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0002714422012NA1860183864TC
rs177823132251125479047KCTD15umls:C0009402BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0002714422012NA1860183864TC
rs17782313225112544160MC4Rumls:C0009402BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0005428842012NA1860183864TC
rs17824591238936184522MTHFD1umls:C1527249BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0150165172013MTHFD11464420993GA
rs17824591238936184522MTHFD1umls:C0009402BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0008143262013MTHFD11464420993GA
rs17824591238936187298TYMSumls:C1527249BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.1117586992013MTHFD11464420993GA
rs17824591238936187298TYMSumls:C0009402BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0325730252013MTHFD11464420993GA
rs178646782482227454575UGT1A10umls:C0009402BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014UGT1A10;UGT1A82233635964TA
rs178646782482227454575UGT1A10umls:C1527249BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014UGT1A10;UGT1A82233635964TA
rs1799782180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007XRCC11943553422GA
rs1799782210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010XRCC11943553422GA
rs1799782180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007XRCC11943553422GA
rs1799782188067527515XRCC1umls:C0009402BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0126818232008XRCC11943553422GA
rs1799782210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010XRCC11943553422GA
rs1799782216129987515XRCC1umls:C0009402BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0126818232011XRCC11943553422GA
rs1799782238572817515XRCC1umls:C1527249BeFreeThe present meta-analysis suggests that the XRCC1 Arg194Trp polymorphism may modify the risk for CRC, particularly colon cancer.0.0623894952013XRCC11943553422GA
rs1799782188067527515XRCC1umls:C1527249BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0623894952008XRCC11943553422GA
rs1799782180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007XRCC11943553422GA
rs1799782216129987515XRCC1umls:C1527249BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0623894952011XRCC11943553422GA
rs1799782238572817515XRCC1umls:C0009402BeFreeThe present meta-analysis suggests that the XRCC1 Arg194Trp polymorphism may modify the risk for CRC, particularly colon cancer.0.0126818232013XRCC11943553422GA
rs1799782210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010XRCC11943553422GA
rs1799782180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007XRCC11943553422GA
rs1799782210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010XRCC11943553422GA
rs1799793173630132068ERCC2umls:C1527249BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0575035412007ERCC21945364001CT
rs1799793180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007ERCC21945364001CT
rs1799793173630137508XPCumls:C0009402BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0032573022007ERCC21945364001CT
rs1799793173630132068ERCC2umls:C0009402BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0104343432007ERCC21945364001CT
rs1799793173630137507XPAumls:C0009402BeFreeWe determined the risk of colorectal cancer in association with the four polymorphisms XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn, and interactions between the polymorphisms and the environmental factors: smoking intensity, intake of alcohol, red meat, processed meat, fish and poultry, fruits and vegetables and dietary fibres, in relation to development of colorectal cancer in a study population of 405 colorectal cancer cases and a comparison group of 810 persons, nested within the Danish prospective cohort, Diet, Cancer and Health, of 57053 cohort members.0.0008143262007ERCC21945364001CT
rs1799793180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007ERCC21945364001CT
rs1799793180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007ERCC21945364001CT
rs1799793173630137507XPAumls:C1527249BeFreeWe determined the risk of colorectal cancer in association with the four polymorphisms XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn, and interactions between the polymorphisms and the environmental factors: smoking intensity, intake of alcohol, red meat, processed meat, fish and poultry, fruits and vegetables and dietary fibres, in relation to development of colorectal cancer in a study population of 405 colorectal cancer cases and a comparison group of 810 persons, nested within the Danish prospective cohort, Diet, Cancer and Health, of 57053 cohort members.0.0079154222007ERCC21945364001CT
rs1799793173630137508XPCumls:C1527249BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0074484832007ERCC21945364001CT
rs1799793180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007ERCC21945364001CT
rs1799889214224084524MTHFRumls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.1068727452011SERPINE17101126430AG
rs1799889214224085054SERPINE1umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0109012822011SERPINE17101126430AG
rs1799889214224085054SERPINE1umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0040716282011SERPINE17101126430AG
rs1799889214224082147F2umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0052769482011SERPINE17101126430AG
rs1799889214224082147F2umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0005428842011SERPINE17101126430AG
rs1799889214224084524MTHFRumls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0263298622011SERPINE17101126430AG
rs1799930216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012NAT2818400593GA
rs17999302161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012NAT2818400593GA
rs1799930216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012NAT2818400593GA
rs1799930216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012NAT2818400593GA
rs1799930216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012NAT2818400593GA
rs17999302161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012NAT2818400593GA
rs1799931216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012NAT2818400860GA
rs1799931216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012NAT2818400860GA
rs1799931216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012NAT2818400860GA
rs17999312161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012NAT2818400860GA
rs1799931216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012NAT2818400860GA
rs17999312161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012NAT2818400860GA
rs1799963214224084524MTHFRumls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.1068727452011F21146739505GA
rs1799963214224082147F2umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0005428842011F21146739505GA
rs1799963214224084524MTHFRumls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0263298622011F21146739505GA
rs1799963214224082147F2umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0052769482011F21146739505GA
rs1799963214224085054SERPINE1umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0040716282011F21146739505GA
rs1799963214224085054SERPINE1umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0109012822011F21146739505GA
rs1799969169375025468PPARGumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0389906172006ICAM1;LOC1053722721910284116GA
rs1799969169375023576CXCL8umls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0067860472006ICAM1;LOC1053722721910284116GA
rs1799969169375027124TNFumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0366235852006ICAM1;LOC1053722721910284116GA
rs1799969169375027124TNFumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006ICAM1;LOC1053722721910284116GA
rs1799969169375023576CXCL8umls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0257223032006ICAM1;LOC1053722721910284116GA
rs1799969169375025468PPARGumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006ICAM1;LOC1053722721910284116GA
rs1799983217061634846NOS3umls:C1527249BeFreeThe effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population.0.0110967792012NOS37150999023TG
rs1799983217061634846NOS3umls:C0009402BeFreeThe effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population.0.0016286512012NOS37150999023TG
rs1799990205643465621PRNPumls:C0009402BeFreePrion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.0.0010857672010PRNP204699605AG
rs1799990205643465621PRNPumls:C1527249BeFreePrion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.0.0034527992010PRNP204699605AG
rs1800056170007064524MTHFRumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0263298622006ATM11108267276TC
rs1800056170007064524MTHFRumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.1068727452006ATM11108267276TC
rs180005617000706472ATMumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0039956832006ATM11108267276TC
rs180005617000706472ATMumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0024429772006ATM11108267276TC
rs180005717000706472ATMumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0039956832006ATM11108272729CG
rs1800057170007064524MTHFRumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.1068727452006ATM11108272729CG
rs180005717000706472ATMumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0024429772006ATM11108272729CG
rs1800057170007064524MTHFRumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0263298622006ATM11108272729CG
rs1800371204497977157TP53umls:C0009402BeFreeTP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.0.0847340642010TP53177676230GA
rs1800371204497977157TP53umls:C1527249BeFreeTP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.0.162010TP53177676230GA
rs1800440208781301545CYP1B1umls:C0009402BeFreeCarriers of variant Ser allele in codon 453 of cytochrome P450 1B1 (rs1800440) were at a significantly lower risk of colorectal cancer compared to carriers of the wild-type allele (adjusted odds ratio, aOR=0.68, CI=0.51-0.89, p=0.006).0.0032573022010CYP1B1238070996TG,C
rs1800440208781301545CYP1B1umls:C1527249BeFreeCarriers of variant Ser allele in codon 453 of cytochrome P450 1B1 (rs1800440) were at a significantly lower risk of colorectal cancer compared to carriers of the wild-type allele (adjusted odds ratio, aOR=0.68, CI=0.51-0.89, p=0.006).0.0298375382010CYP1B1238070996TG,C
rs1800449251124034015LOXumls:C1527249BeFreeLysyl oxidase rs1800449 polymorphism and cancer risk among Asians: evidence from a meta-analysis and a case-control study of colorectal cancer.0.0019000932014LOX5122077513CT
rs1800449251124034015LOXumls:C0009402BeFreeLysyl oxidase rs1800449 polymorphism and cancer risk among Asians: evidence from a meta-analysis and a case-control study of colorectal cancer.0.0019000932014LOX5122077513CT
rs1800469248362867040TGFB1umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.1497179862014TGFB1;B9D21941354391AG
rs18004692483628680776B9D2umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014TGFB1;B9D21941354391AG
rs1800562129482853077HFEumls:C1527249BeFreeHeterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands).0.0161022852003HFE626092913GA
rs1800562235530283077HFEumls:C1527249BeFreeHFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.0.0161022852013HFE626092913GA
rs1800562129482853077HFEumls:C0009402BeFreeHeterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands).0.0019000932003HFE626092913GA
rs1800562232817413077HFEumls:C1527249BeFreeIn addition to hepatocellular cancer, HFE C282Y homozygotes are reported to have increased risk of colorectal cancer and breast cancer.0.0161022852013HFE626092913GA
rs1800562232817413077HFEumls:C0009402BeFreeIn addition to hepatocellular cancer, HFE C282Y homozygotes are reported to have increased risk of colorectal cancer and breast cancer.0.0019000932013HFE626092913GA
rs1800562200993043077HFEumls:C1527249BeFreeHFE C282Y homozygotes are at increased risk of breast and colorectal cancer.0.0161022852010HFE626092913GA
rs1800562200993043077HFEumls:C0009402BeFreeHFE C282Y homozygotes are at increased risk of breast and colorectal cancer.0.0019000932010HFE626092913GA
rs1800562235530283077HFEumls:C0009402BeFreeHFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.0.0019000932013HFE626092913GA
rs1800566222151481429CRYZumls:C0009402BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have a lower enzymatic activity, which may result in increased incidence of several kinds of carcinomas including colorectal cancer.0.0019000932012NQO11669711242GA
rs1800566223062491728NQO1umls:C1527249BeFreeContribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.0.034300162012NQO11669711242GA
rs1800566222151481728NQO1umls:C0009402BeFreeAssociation of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.0.0035287442012NQO11669711242GA
rs1800566222151481728NQO1umls:C1527249BeFreeAssociation of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.0.034300162012NQO11669711242GA
rs1800566167023801728NQO1umls:C1527249BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.0.034300162006NQO11669711242GA
rs1800566222151481429CRYZumls:C1527249BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have a lower enzymatic activity, which may result in increased incidence of several kinds of carcinomas including colorectal cancer.0.0021715352012NQO11669711242GA
rs1800566205939581728NQO1umls:C1527249BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.0.034300162010NQO11669711242GA
rs1800566241425281728NQO1umls:C0009402BeFreeMeta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.0.0035287442013NQO11669711242GA
rs1800566205939581429CRYZumls:C0009402BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.0.0019000932010NQO11669711242GA
rs1800566205939581429CRYZumls:C1527249BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.0.0021715352010NQO11669711242GA
rs1800566167023801728NQO1umls:C0009402BeFreeResults from our meta-analyses suggest that the variant NQO1 Pro187Ser genotype may affect individual susceptibility to lung, bladder, and colorectal cancer.0.0035287442006NQO11669711242GA
rs1800566205939581728NQO1umls:C0009402BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.0.0035287442010NQO11669711242GA
rs1800566241425281728NQO1umls:C1527249BeFreeMeta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.0.034300162013NQO11669711242GA
rs1800566223062491728NQO1umls:C0009402BeFreeContribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.0.0035287442012NQO11669711242GA
rs1800566167023801429CRYZumls:C1527249BeFreeNAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.0.0021715352006NQO11669711242GA
rs1800734222947704292MLH1umls:C0009402BeFreeWhen candidate SNPs were examined, our data did not support most of the previously reported associations with CRC susceptibility, an exception being an effect of the MLH1 promoter SNP -93G>A (rs1800734).0.0823670322012MLH1;EPM2AIP1336993455GA
rs1800734222947704292MLH1umls:C1527249BeFreeWhen candidate SNPs were examined, our data did not support most of the previously reported associations with CRC susceptibility, an exception being an effect of the MLH1 promoter SNP -93G>A (rs1800734).0.162012MLH1;EPM2AIP1336993455GA
rs1800734232400384292MLH1umls:C0009402BeFreeWe previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients.0.0823670322012MLH1;EPM2AIP1336993455GA
rs1800734232400384292MLH1umls:C1527249BeFreeWe previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients.0.162012MLH1;EPM2AIP1336993455GA
rs1800734209672084292MLH1umls:C1527249BeFreeWe previously identified an association between a mismatch repair gene, MLH1, promoter SNP (rs1800734) and microsatellite unstable (MSI-H) colorectal cancers (CRCs) in two samples.0.162010MLH1;EPM2AIP1336993455GA
rs1800795176944203569IL6umls:C1527249BeFreeData from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC.0.0358092592007IL6;LOC541472722727026CG
rs1800795176944203569IL6umls:C0009402BeFreeData from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC.0.0122148842007IL6;LOC541472722727026CG
rs1800796176944203569IL6umls:C0009402BeFreeData from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC.0.0122148842007IL6;LOC541472722726627GC
rs1800796176944203569IL6umls:C1527249BeFreeData from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC.0.0358092592007IL6;LOC541472722726627GC
rs1800871245570623586IL10umls:C0009402BeFreeWe found that rs1143634 in the interleukin-1β (IL1B) gene and rs1800871 in the interleukin-10 (IL10) gene were associated with increased risk for CRC in the Han Chinese.0.0059717212015IL101206773289AG
rs1800871245570623586IL10umls:C1527249BeFreeWe found that rs1143634 in the interleukin-1β (IL1B) gene and rs1800871 in the interleukin-10 (IL10) gene were associated with increased risk for CRC in the Han Chinese.0.0128013752015IL101206773289AG
rs1800872248892123586IL10umls:C0009402BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0059717212014IL101206773062TG
rs1800872248892123586IL10umls:C1527249BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0128013752014IL101206773062TG
rs1800872241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013IL101206773062TG
rs1800872241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013IL101206773062TG
rs1800872248892124609MYCumls:C1527249BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0113246142014IL101206773062TG
rs1800872248892124609MYCumls:C0009402BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0115960562014IL101206773062TG
rs1800896244461823553IL1Bumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0174594942014IL101206773552TC
rs1800896244461823586IL10umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0059717212014IL101206773552TC
rs1800896244461826647SOD1umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0016286512014IL101206773552TC
rs1800896244461823605IL17Aumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0054288372014IL101206773552TC
rs1800896244461823605IL17Aumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0057002792014IL101206773552TC
rs1800896244461827099TLR4umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.004343072014IL101206773552TC
rs1800896244461827099TLR4umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0082628082014IL101206773552TC
rs1800896244461823553IL1Bumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0032573022014IL101206773552TC
rs1800896244461823586IL10umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0128013752014IL101206773552TC
rs1800896244461826647SOD1umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0013572092014IL101206773552TC
rs1800947247618811401CRPumls:C1527249BeFreeGenotype CC of rs1800947 in the C-reactive protein gene may increase susceptibility to colorectal cancer: a meta-analysis.0.0056243342015CRP1159713648CT,G,A
rs1800947247618811401CRPumls:C0009402BeFreeGenotype CC of rs1800947 in the C-reactive protein gene may increase susceptibility to colorectal cancer: a meta-analysis.0.0032573022015CRP1159713648CT,G,A
rs1801131236266892073ERCC5umls:C1527249BeFreeMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.0.0158308432013MTHFR111794419TG
rs1801131236266894524MTHFRumls:C1527249BeFreeMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.0.1068727452013MTHFR111794419TG
rs1801131189921484524MTHFRumls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.1068727452008MTHFR111794419TG
rs1801131189921483576CXCL8umls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.0257223032008MTHFR111794419TG
rs1801131189921485742PTGS1umls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.0109012822008MTHFR111794419TG
rs1801131236266892073ERCC5umls:C0009402BeFreeMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.0.0019000932013MTHFR111794419TG
rs1801131236266894524MTHFRumls:C0009402BeFreeMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.0.0263298622013MTHFR111794419TG
rs1801133214224082147F2umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0052769482011MTHFR111796321GA
rs1801133214224084524MTHFRumls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0263298622011MTHFR111796321GA
rs1801133214224084524MTHFRumls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.1068727452011MTHFR111796321GA
rs1801133234370534524MTHFRumls:C1527249BeFreeThe 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.0.1068727452013MTHFR111796321GA
rs1801133214224082147F2umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0005428842011MTHFR111796321GA
rs1801133214224085054SERPINE1umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0109012822011MTHFR111796321GA
rs1801133234370534524MTHFRumls:C0009402BeFreeThe 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.0.0263298622013MTHFR111796321GA
rs1801133214224085054SERPINE1umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0040716282011MTHFR111796321GA
rs180115510756345324APCumls:C0009402BeFreeThe reported association between the APC I1307K mutation and colon cancer risk was supported by a correlation in these data between personal or family history of CRC or polyps and a gene mutation.0.0757322822000APC5112839514TA
rs180115511267860324APCumls:C0009402BeFreeTo this end, sequence analysis was carried out of the APC gene in order to identify any I1307K and E1317Q variants in 106 unselected cases and 88 hereditary/familial colorectal cancer cases including 22 cases of hereditary non-polyposis colorectal cancer (HNPCC) fulfilling the Amsterdam criteria.0.0757322822001APC5112839514TA
rs180115514578136324APCumls:C1527249BeFreeThe I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.0.242003APC5112839514TA
rs180115510938175324APCumls:C0009402BeFreeThe I1307K mutation of the APC gene is found in approximately 6% of the Ashkenazi Jewish population and is associated with elevated risk of colorectal cancer.0.0757322822000APC5112839514TA
rs180115516228836324APCumls:C1527249BeFreeThe APC I1307K mutation was detected in 78 colorectal cancer cases (8.7 percent) of the study population.0.242005APC5112839514TA
rs180115511551102324APCumls:C1527249BeFreeA missense mutation within the APC gene, I1307K, was described in Ashkenazi individuals at risk for colorectal cancer (CRC) and in the general population.0.242001APC5112839514TA
rs180115511354631324APCumls:C0009402BeFreeLack of an increased APC I1307K carrier rate suggests that this mutation does not account for the increased CRC susceptibility associated with IBD.0.0757322822001APC5112839514TA
rs18011559679945324APCumls:C0009402BeFreeAn APC gene sequence alteration, the I1307K allele, occurs in 6% of the Ashkenazi Jewish population and is reported to double the risk for colorectal cancer.0.0757322821998APC5112839514TA
rs180115598313554292MLH1umls:C0009402BeFreeI1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.0.0823670321998APC5112839514TA
rs18011559869602324APCumls:C0009402BeFreePrevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.0.0757322821999APC5112839514TA
rs180115516537703324APCumls:C1527249BeFreeHere, we used this design to evaluate inherited susceptibility to prostate cancer associated with APC I1307K using data from the Molecular Epidemiology of Colorectal Cancer study.0.242006APC5112839514TA
rs180115510938175324APCumls:C1527249BeFreeThe I1307K mutation of the APC gene is found in approximately 6% of the Ashkenazi Jewish population and is associated with elevated risk of colorectal cancer.0.242000APC5112839514TA
rs180115518343606324APCumls:C0009402BeFreeThis study seeks to determine whether there is any association of the I1307K, E1317Q and D1822V variants within the Adenomatous polyposis coli gene (APC) and risk to develop colorectal cancer in Tunisian population.0.0757322822009APC5112839514TA
rs18011559869603324APCumls:C1527249BeFreeThe I1307K polymorphism of the APC gene in colorectal cancer.0.241999APC5112839514TA
rs180115516875934324APCumls:C1527249BeFreeThe I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.0.242006APC5112839514TA
rs18011559973276324APCumls:C0009402BeFreeWe conclude that the APC I1307K variant leads to increased adenoma formation and directly contributes to 3%-4% of all Ashkenazi Jewish colorectal cancer.0.0757322821999APC5112839514TA
rs180115511159880324APCumls:C0009402BeFreeAPC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.0.0757322822001APC5112839514TA
rs18011559869602324APCumls:C1527249BeFreePrevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.0.241999APC5112839514TA
rs180115518343606324APCumls:C1527249BeFreeThis study seeks to determine whether there is any association of the I1307K, E1317Q and D1822V variants within the Adenomatous polyposis coli gene (APC) and risk to develop colorectal cancer in Tunisian population.0.242009APC5112839514TA
rs180115516537703324APCumls:C0009402BeFreeHere, we used this design to evaluate inherited susceptibility to prostate cancer associated with APC I1307K using data from the Molecular Epidemiology of Colorectal Cancer study.0.0757322822006APC5112839514TA
rs180115511159880324APCumls:C1527249BeFreeThe I1307K allele of the APC gene has been shown to confer a modestly elevated risk of colorectal cancer in the Ashkenazi Jewish population (relative risk, 1.5-1.7).0.242001APC5112839514TA
rs180115516228836324APCumls:C0009402BeFreeThe APC I1307K mutation was detected in 78 colorectal cancer cases (8.7 percent) of the study population.0.0757322822005APC5112839514TA
rs180115516195945324APCumls:C1527249BeFreeThis excess can partially be attributed to inherited factors that are over represented in this population, such as the APC variant I1307K, which is associated with a modest increase in colorectal cancer risk.0.242005APC5112839514TA
rs180115515516844324APCumls:C0009402BeFreeThe I1307K APC polymorphism/mutation is carried by 6-8% of Ashkenazim and increases the risk of colorectal cancer 1.5-2 fold.0.0757322822004APC5112839514TA
rs180115515929773324APCumls:C1527249BeFreeTwo APC germline mutations, E1317Q and I1307K, have been linked to colorectal cancer (CRC) risk.0.242005APC5112839514TA
rs18011559831355324APCumls:C0009402BeFreeI1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.0.0757322821998APC5112839514TA
rs180115510756345324APCumls:C1527249BeFreeThe reported association between the APC I1307K mutation and colon cancer risk was supported by a correlation in these data between personal or family history of CRC or polyps and a gene mutation.0.242000APC5112839514TA
rs180115510630180324APCumls:C0009402BeFreeA missense mutation in APC (I1307K) is associated with some familial colorectal cancer in Ashkenazic Jews.0.0757322821999APC5112839514TA
rs180115510343885324APCumls:C1527249BeFreeAn adenomatous polyposis coli (APC) gene variant (I1307K allele), which was recently reported in 1 in 17 Ashkenazi Jewish persons, may double the risk for colorectal cancer in that population.0.241999APC5112839514TA
rs18011559407954324APCumls:C1527249BeFreeThe I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.0.241997APC5112839514TA
rs180115510630180324APCumls:C1527249BeFreeA missense mutation in APC (I1307K) is associated with some familial colorectal cancer in Ashkenazic Jews.0.241999APC5112839514TA
rs18011559831355324APCumls:C1527249BeFreeI1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.0.241998APC5112839514TA
rs180115512822869324APCumls:C1527249BeFreeIn conclusion, the molecular pathways in CRC in I1307K APC mutation carriers are seemingly similar to those of sporadic cases, but a larger study is clearly needed.0.242003APC5112839514TA
rs180115516875934324APCumls:C0009402BeFreeThe I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.0.0757322822006APC5112839514TA
rs180115510555757324APCumls:C0009402BeFreeThe I1307K polymorphism in APC has been found to predispose to colorectal cancer in Ashkenazi Jews, and has recently been associated with an increased risk for breast cancer in the same population.0.0757322821999APC5112839514TA
rs180115511354631324APCumls:C1527249BeFreeLack of an increased APC I1307K carrier rate suggests that this mutation does not account for the increased CRC susceptibility associated with IBD.0.242001APC5112839514TA
rs180115517854661324APCumls:C1527249BeFreeHow the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.0.242007APC5112839514TA
rs180115598313554292MLH1umls:C1527249BeFreeI1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.0.161998APC5112839514TA
rs180115511720476324APCumls:C1527249BeFreePhenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.0.242001APC5112839514TA
rs18011559973276324APCumls:C1527249BeFreeWe conclude that the APC I1307K variant leads to increased adenoma formation and directly contributes to 3%-4% of all Ashkenazi Jewish colorectal cancer.0.241999APC5112839514TA
rs180115512822869324APCumls:C0009402BeFreeIn conclusion, the molecular pathways in CRC in I1307K APC mutation carriers are seemingly similar to those of sporadic cases, but a larger study is clearly needed.0.0757322822003APC5112839514TA
rs180115511551102324APCumls:C0009402BeFreeA missense mutation within the APC gene, I1307K, was described in Ashkenazi individuals at risk for colorectal cancer (CRC) and in the general population.0.0757322822001APC5112839514TA
rs180115516195945324APCumls:C0009402BeFreeThis excess can partially be attributed to inherited factors that are over represented in this population, such as the APC variant I1307K, which is associated with a modest increase in colorectal cancer risk.0.0757322822005APC5112839514TA
rs180115514578136324APCumls:C0009402BeFreeThe I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.0.0757322822003APC5112839514TA
rs180115515929773324APCumls:C0009402BeFreeTwo APC germline mutations, E1317Q and I1307K, have been linked to colorectal cancer (CRC) risk.0.0757322822005APC5112839514TA
rs180115515733272324APCumls:C0009402BeFreeWhile the I1307K APC mutation clearly confers an increased lifetime risk for colorectal cancer, there is a paucity of data on the natural history of colonic neoplasia in symptomatic and asymptomatic mutation carriers.0.0757322822005APC5112839514TA
rs180115515516844324APCumls:C1527249BeFreeThe I1307K APC polymorphism/mutation is carried by 6-8% of Ashkenazim and increases the risk of colorectal cancer 1.5-2 fold.0.242004APC5112839514TA
rs180115510343885324APCumls:C0009402BeFreeAn adenomatous polyposis coli (APC) gene variant (I1307K allele), which was recently reported in 1 in 17 Ashkenazi Jewish persons, may double the risk for colorectal cancer in that population.0.0757322821999APC5112839514TA
rs18011559869603324APCumls:C0009402BeFreeThe I1307K polymorphism of the APC gene in colorectal cancer.0.0757322821999APC5112839514TA
rs18011559679945324APCumls:C1527249BeFreeAn APC gene sequence alteration, the I1307K allele, occurs in 6% of the Ashkenazi Jewish population and is reported to double the risk for colorectal cancer.0.241998APC5112839514TA
rs180115517854661324APCumls:C0009402BeFreeHow the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.0.0757322822007APC5112839514TA
rs18011559407954324APCumls:C0009402BeFreeThe I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.0.0757322821997APC5112839514TA
rs180115511267860324APCumls:C1527249BeFreeTo this end, sequence analysis was carried out of the APC gene in order to identify any I1307K and E1317Q variants in 106 unselected cases and 88 hereditary/familial colorectal cancer cases including 22 cases of hereditary non-polyposis colorectal cancer (HNPCC) fulfilling the Amsterdam criteria.0.242001APC5112839514TA
rs180115510555757324APCumls:C1527249BeFreeThe I1307K polymorphism in APC has been found to predispose to colorectal cancer in Ashkenazi Jews, and has recently been associated with an increased risk for breast cancer in the same population.0.241999APC5112839514TA
rs180115515733272324APCumls:C1527249BeFreeWhile the I1307K APC mutation clearly confers an increased lifetime risk for colorectal cancer, there is a paucity of data on the natural history of colonic neoplasia in symptomatic and asymptomatic mutation carriers.0.242005APC5112839514TA
rs180116611267860324APCumls:C1527249BeFreeTo this end, sequence analysis was carried out of the APC gene in order to identify any I1307K and E1317Q variants in 106 unselected cases and 88 hereditary/familial colorectal cancer cases including 22 cases of hereditary non-polyposis colorectal cancer (HNPCC) fulfilling the Amsterdam criteria.0.242001APC5112839543GC
rs180116614578138324APCumls:C1527249BeFreeThe APC E1317Q variant in adenomatous polyps and colorectal cancers.0.242003APC5112839543GC
rs180116611267860324APCumls:C0009402BeFreeTo this end, sequence analysis was carried out of the APC gene in order to identify any I1307K and E1317Q variants in 106 unselected cases and 88 hereditary/familial colorectal cancer cases including 22 cases of hereditary non-polyposis colorectal cancer (HNPCC) fulfilling the Amsterdam criteria.0.0757322822001APC5112839543GC
rs180116615929773324APCumls:C1527249BeFreeTwo APC germline mutations, E1317Q and I1307K, have been linked to colorectal cancer (CRC) risk.0.242005APC5112839543GC
rs180116615929773324APCumls:C0009402BeFreeTwo APC germline mutations, E1317Q and I1307K, have been linked to colorectal cancer (CRC) risk.0.0757322822005APC5112839543GC
rs180116618343606324APCumls:C1527249BeFreeThis study seeks to determine whether there is any association of the I1307K, E1317Q and D1822V variants within the Adenomatous polyposis coli gene (APC) and risk to develop colorectal cancer in Tunisian population.0.242009APC5112839543GC
rs180116618343606324APCumls:C0009402BeFreeThis study seeks to determine whether there is any association of the I1307K, E1317Q and D1822V variants within the Adenomatous polyposis coli gene (APC) and risk to develop colorectal cancer in Tunisian population.0.0757322822009APC5112839543GC
rs1801270203639915063PAK3umls:C0009402BeFreeAssociation between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.0.0013572092010CDKN1A636684194CA,T
rs1801270203639915063PAK3umls:C1527249BeFreeAssociation between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.0.0013572092010CDKN1A636684194CA,T
rs1801278246962643667IRS1umls:C1527249BeFreeAssociation between IRS-1 Gly972Arg polymorphism and colorectal cancer risk.0.0142781372014IRS12226795828CT,G,A
rs1801278246962643667IRS1umls:C0009402BeFreeAssociation between IRS-1 Gly972Arg polymorphism and colorectal cancer risk.0.0029858612014IRS12226795828CT,G,A
rs1801280216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012NAT2818400344TC
rs1801280216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012NAT2818400344TC
rs18012802161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012NAT2818400344TC
rs1801280216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012NAT2818400344TC
rs1801280216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012NAT2818400344TC
rs18012802161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012NAT2818400344TC
rs180128224552298125ADH1Bumls:C0009402BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0019000932015PPARG312351626CG
rs1801282245522985468PPARGumls:C1527249BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0389906172015PPARG312351626CG
rs1801282169653925468PPARGumls:C0009402BeFreeMeat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.0.0111291172006PPARG312351626CG
rs1801282205966495468PPARGumls:C0009402BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0111291172010PPARG312351626CG
rs1801282169375025468PPARGumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0389906172006PPARG312351626CG
rs1801282169375027124TNFumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0366235852006PPARG312351626CG
rs1801282169375027124TNFumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006PPARG312351626CG
rs1801282128399427124TNFumls:C1527249BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0366235852003PPARG312351626CG
rs1801282161088325468PPARGumls:C1527249BeFreeInfluence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.0.0389906172005PPARG312351626CG
rs180128224552298125ADH1Bumls:C1527249BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0158308432015PPARG312351626CG
rs1801282161088325468PPARGumls:C0009402BeFreeInfluence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.0.0111291172005PPARG312351626CG
rs1801282158604375468PPARGumls:C0009402BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0111291172005PPARG312351626CG
rs18012822059664954512EXOSC4umls:C1527249BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0008143262010PPARG312351626CG
rs1801282128399427124TNFumls:C0009402BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0111291172003PPARG312351626CG
rs1801282169375023576CXCL8umls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0257223032006PPARG312351626CG
rs1801282205966495468PPARGumls:C1527249BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0389906172010PPARG312351626CG
rs18012821648953154512EXOSC4umls:C0009402BeFreeIn this study, we evaluated the association between colorectal cancer and specific tumor mutations and the Pro12Ala (P12A) PPARgamma polymorphism.0.0008143262006PPARG312351626CG
rs1801282169375023576CXCL8umls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0067860472006PPARG312351626CG
rs18012821586043754512EXOSC4umls:C0009402BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0008143262005PPARG312351626CG
rs18012821648953154512EXOSC4umls:C1527249BeFreeIn this study, we evaluated the association between colorectal cancer and specific tumor mutations and the Pro12Ala (P12A) PPARgamma polymorphism.0.0008143262006PPARG312351626CG
rs1801282245522985468PPARGumls:C0009402BeFreeThe current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.0.0111291172015PPARG312351626CG
rs1801282128399423576CXCL8umls:C1527249BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0257223032003PPARG312351626CG
rs18012822059664954512EXOSC4umls:C0009402BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0008143262010PPARG312351626CG
rs1801282128399423576CXCL8umls:C0009402BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0067860472003PPARG312351626CG
rs1801282169653925468PPARGumls:C1527249BeFreeMeat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.0.0389906172006PPARG312351626CG
rs1801282158604375468PPARGumls:C1527249BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0389906172005PPARG312351626CG
rs1801282169375025468PPARGumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006PPARG312351626CG
rs18012821586043754512EXOSC4umls:C1527249BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0008143262005PPARG312351626CG
rs1801394207263054552MTRRumls:C0009402BeFreeStudy results do not demonstrate an association between A66G MTRR polymorphism and CRC or BC in Romanian patients.0.0024429772010MTRR;FASTKD357870860AG
rs180139412020105102724560LOC102724560umls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0010857672002MTRR;FASTKD357870860AG
rs1801394262146474552MTRRumls:C1527249BeFreeA meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.0.0355814252015MTRR;FASTKD357870860AG
rs1801394207263054552MTRRumls:C1527249BeFreeStudy results do not demonstrate an association between A66G MTRR polymorphism and CRC or BC in Romanian patients.0.0355814252010MTRR;FASTKD357870860AG
rs1801394262146474552MTRRumls:C0009402BeFreeA meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.0.0024429772015MTRR;FASTKD357870860AG
rs1801394120201054524MTHFRumls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0263298622002MTRR;FASTKD357870860AG
rs180139412020105875CBSumls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0008143262002MTRR;FASTKD357870860AG
rs1801394120201054552MTRRumls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0355814252002MTRR;FASTKD357870860AG
rs1801394120201054552MTRRumls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0024429772002MTRR;FASTKD357870860AG
rs180139412020105875CBSumls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0129209272002MTRR;FASTKD357870860AG
rs180139412020105102724560LOC102724560umls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0008143262002MTRR;FASTKD357870860AG
rs1801394120201054524MTHFRumls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.1068727452002MTRR;FASTKD357870860AG
rs1802073204039156424SFRP4umls:C1527249BeFreeIn addition, homozygosity for the minor allele of SFRP4 P320T was significantly associated with rectal cancer risk (OR = 1.37, 95% CI, 1.06-1.79, P = 0.02) and early-stage CRC (OR = 1.33, 95% CI, 1.05-1.69, P = 0.02).0.0029099162010SFRP4737907562GT
rs1802073204039156424SFRP4umls:C0009402BeFreeIn addition, homozygosity for the minor allele of SFRP4 P320T was significantly associated with rectal cancer risk (OR = 1.37, 95% CI, 1.06-1.79, P = 0.02) and early-stage CRC (OR = 1.33, 95% CI, 1.05-1.69, P = 0.02).0.0008143262010SFRP4737907562GT
rs1805077203639915063PAK3umls:C1527249BeFreeAssociation between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.0.0013572092010PAK3X111123196CA
rs1805077203639915063PAK3umls:C0009402BeFreeAssociation between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.0.0013572092010PAK3X111123196CA
rs1805087227192224548MTRumls:C1527249BeFreeNo significant association was found between MTHFR A1298C and MTR A2756G polymorphisms and the risk of CRC.0.0424110792012MTR1236885200AG
rs1805087227192224548MTRumls:C0009402BeFreeNo significant association was found between MTHFR A1298C and MTR A2756G polymorphisms and the risk of CRC.0.0021715352012MTR1236885200AG
rs1805192128399423576CXCL8umls:C0009402BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0067860472003PPARG312379739CG
rs1805192128399423576CXCL8umls:C1527249BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0257223032003PPARG312379739CG
rs18051921586043754512EXOSC4umls:C1527249BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0008143262005PPARG312379739CG
rs1805192169375025468PPARGumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006PPARG312379739CG
rs1805192169653925468PPARGumls:C0009402BeFreeMeat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.0.0111291172006PPARG312379739CG
rs18051922059664954512EXOSC4umls:C1527249BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0008143262010PPARG312379739CG
rs1805192169375023576CXCL8umls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0257223032006PPARG312379739CG
rs1805192169375023576CXCL8umls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0067860472006PPARG312379739CG
rs1805192205966495468PPARGumls:C1527249BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0389906172010PPARG312379739CG
rs1805192169375027124TNFumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0366235852006PPARG312379739CG
rs18051921648953154512EXOSC4umls:C1527249BeFreeIn this study, we evaluated the association between colorectal cancer and specific tumor mutations and the Pro12Ala (P12A) PPARgamma polymorphism.0.0008143262006PPARG312379739CG
rs1805192158604375468PPARGumls:C0009402BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0111291172005PPARG312379739CG
rs1805192128399427124TNFumls:C1527249BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0366235852003PPARG312379739CG
rs1805192169375027124TNFumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006PPARG312379739CG
rs1805192205966495468PPARGumls:C0009402BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0111291172010PPARG312379739CG
rs1805192169653925468PPARGumls:C1527249BeFreeMeat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.0.0389906172006PPARG312379739CG
rs1805192128399427124TNFumls:C0009402BeFreeWe have studied the association between single nucleotide polymorphisms in the interleukin (IL)-6 (-174 G>C), IL8 (-251T>A), tumor necrosis factor alpha (-308G>A), and PPARG (Pro12Ala) genes and the risk of CRC in a group of 377 cases and 326 controls from Barcelona, Spain.0.0111291172003PPARG312379739CG
rs1805192161088325468PPARGumls:C0009402BeFreeInfluence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.0.0111291172005PPARG312379739CG
rs1805192161088325468PPARGumls:C1527249BeFreeInfluence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.0.0389906172005PPARG312379739CG
rs1805192158604375468PPARGumls:C1527249BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0389906172005PPARG312379739CG
rs1805192169375025468PPARGumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0389906172006PPARG312379739CG
rs18051922059664954512EXOSC4umls:C0009402BeFreeThis meta-analysis suggests that the Ala allele of the PPARgamma P12A polymorphism might be a protective factor for colorectal cancer, but a risk factor for gastric cancer.0.0008143262010PPARG312379739CG
rs18051921648953154512EXOSC4umls:C0009402BeFreeIn this study, we evaluated the association between colorectal cancer and specific tumor mutations and the Pro12Ala (P12A) PPARgamma polymorphism.0.0008143262006PPARG312379739CG
rs18051921586043754512EXOSC4umls:C0009402BeFreeIn this study we evaluated the association between the Pro12Ala (P12A) PPARgamma polymorphism and body mass index (BMI), waist-to-hip ratio (WHR), physical activity level, and energy intake and risk of colorectal cancer using data from a population-based, case-control study of colon cancer (1,577 cases and 1,971 controls) and rectal cancer (794 cases and 1,001 controls).0.0008143262005PPARG312379739CG
rs18625131927356856729RETNumls:C1527249BeFreeA trend to associate between the RETN SNP rs1862513 (C-420G) and CRC risk was observed (per allele OR 1.18, 95% confidence interval (0.99-1.40).0.005548392009RETN197668907CG
rs18625131927356856729RETNumls:C0009402BeFreeA trend to associate between the RETN SNP rs1862513 (C-420G) and CRC risk was observed (per allele OR 1.18, 95% confidence interval (0.99-1.40).0.0008143262009RETN197668907CG
rs1919314236775735460POU5F1umls:C0009402BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0019000932013HDAC9718100738AT
rs1919314236775739734HDAC9umls:C0009402BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0016286512013HDAC9718100738AT
rs1919314236775735460POU5F1umls:C1527249BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0019000932013HDAC9718100738AT
rs1919314236775739734HDAC9umls:C1527249BeFreeNo single nucleotide polymorphism (SNP) achieved a genome-wide significant P value; however, the most significantly associated SNPs were either previously associated with colorectal cancer in GWAS, such as rs10505477 in the gene POU5F1 [odds ratio (OR) = 0.87; 95% confidence interval (CI) 0.81-0.94; P = 4.4 × 10(-4)), or have been biologically linked to benign growths in other tissues, such as rs1919314 in the gene histone deacetylase 9 (OR = 1.32; 95% CI, 1.18-1.47; P = 1.1 × 10(-6)).0.0039956832013HDAC9718100738AT
rs1950902261086767298TYMSumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.1117586992015MTHFD11464415662AG
rs1950902261086764522MTHFD1umls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0008143262015MTHFD11464415662AG
rs1950902261086764552MTRRumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0355814252015MTHFD11464415662AG
rs1950902261086767799PRDM2umls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0037242412015MTHFD11464415662AG
rs1950902261086767799PRDM2umls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0010857672015MTHFD11464415662AG
rs1950902261086764522MTHFD1umls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0150165172015MTHFD11464415662AG
rs1950902261086765447PORumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0002714422015MTHFD11464415662AG
rs1950902261086764552MTRRumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0024429772015MTHFD11464415662AG
rs1950902261086767298TYMSumls:C0009402BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0325730252015MTHFD11464415662AG
rs1950902261086765447PORumls:C1527249BeFreeStatistically significant associations were observed between CRC risk and functionally defined candidate SNPs of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1; K134R), 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR; P450R), and PR domain containing 2 with ZNF domain (PRDM2; S450N) and a literature candidate SNP of thymidylate synthase (TYMS; g.676789A>T; nominal P < .05).0.0002714422015MTHFD11464415662AG
rs195763621655089652BMP4umls:C0009402BeFreeWe identified new, independent CRC predisposition SNPs close to BMP4 (rs1957636, P = 3.93×10(-10)) and BMP2 (rs4813802, P = 4.65×10(-11)).0.0038001862011LOC1053705071454093300TC
rs195763621655089652BMP4umls:C1527249BeFreeWe identified new, independent CRC predisposition SNPs close to BMP4 (rs1957636, P = 3.93×10(-10)) and BMP2 (rs4813802, P = 4.65×10(-11)).0.0132683142011LOC1053705071454093300TC
rs1979277251944386470SHMT1umls:C0009402BeFreeOtherwise, SHMT1 C1420T polymorphism may have a protective effect on colorectal cancer and Asian population.0.0010857672014SHMT11718328782GA
rs1979277251944386470SHMT1umls:C1527249BeFreeOtherwise, SHMT1 C1420T polymorphism may have a protective effect on colorectal cancer and Asian population.0.0105538952014SHMT11718328782GA
rs1979277234011046470SHMT1umls:C1527249BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.0105538952013SHMT11718328782GA
rs1979277234011047298TYMSumls:C0009402BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.0325730252013SHMT11718328782GA
rs1979277233225346470SHMT1umls:C1527249BeFreeA meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations.0.0105538952013SHMT11718328782GA
rs1979277234011046470SHMT1umls:C0009402BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.0010857672013SHMT11718328782GA
rs1979277233225346470SHMT1umls:C0009402BeFreeA meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations.0.0010857672013SHMT11718328782GA
rs1979277234011047298TYMSumls:C1527249BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.1117586992013SHMT11718328782GA
rs1989969240757991045CDX2umls:C1527249BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0134961492013VDR1247884227AT,G,C
rs1989969240757991045CDX2umls:C0009402BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0122148842013VDR1247884227AT,G,C
rs2020872186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008MLH1;EPM2AIP1336993641AG
rs20208721861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008MLH1;EPM2AIP1336993641AG
rs202087218619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008MLH1;EPM2AIP1336993641AG
rs20208721861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008MLH1;EPM2AIP1336993641AG
rs20208721861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008MLH1;EPM2AIP1336993641AG
rs20208721861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008MLH1;EPM2AIP1336993641AG
rs2020872186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008MLH1;EPM2AIP1336993641AG
rs2020872186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008MLH1;EPM2AIP1336993641AG
rs20208721861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008MLH1;EPM2AIP1336993641AG
rs20208721861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008MLH1;EPM2AIP1336993641AG
rs202087218619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008MLH1;EPM2AIP1336993641AG
rs2020872186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008MLH1;EPM2AIP1336993641AG
rs2020872186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008MLH1;EPM2AIP1336993641AG
rs2020872186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008MLH1;EPM2AIP1336993641AG
rs2020872186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008MLH1;EPM2AIP1336993641AG
rs2020872186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008MLH1;EPM2AIP1336993641AG
rs202087218619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008MLH1;EPM2AIP1336993641AG
rs20208721861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008MLH1;EPM2AIP1336993641AG
rs20208721861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008MLH1;EPM2AIP1336993641AG
rs202087218619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008MLH1;EPM2AIP1336993641AG
rs202150291186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008LIPC1558560941CT
rs202150291186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008LIPC1558560941CT
rs2021502911861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008LIPC1558560941CT
rs2021502911861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008LIPC1558560941CT
rs202150291186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008LIPC1558560941CT
rs20215029118619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008LIPC1558560941CT
rs2021502911861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008LIPC1558560941CT
rs20215029118619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008LIPC1558560941CT
rs202150291186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008LIPC1558560941CT
rs202150291186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008LIPC1558560941CT
rs2021502911861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008LIPC1558560941CT
rs2021502911861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008LIPC1558560941CT
rs2021502911861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008LIPC1558560941CT
rs2021502911861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008LIPC1558560941CT
rs2021502911861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008LIPC1558560941CT
rs202150291186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008LIPC1558560941CT
rs202150291186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008LIPC1558560941CT
rs20215029118619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008LIPC1558560941CT
rs202150291186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008LIPC1558560941CT
rs20215029118619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008LIPC1558560941CT
rs2031920235952201571CYP2E1umls:C1527249BeFreeAssociations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.0.0424870232013CYP2E110133526341CT
rs2031920235952201571CYP2E1umls:C0009402BeFreeAssociations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.0.0040716282013CYP2E110133526341CT
rs20417241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013PTGS2;PACERR1186681189CG
rs20417241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013PTGS2;PACERR1186681189CG
rs20541224197143596IL13umls:C0009402BeFreePatients carrying the TCF7L2_rs7903146_T allele had an increased risk of CRC (P(trend) = 0.02), whereas patients harboring the IL13_rs20541_T allele had a reduced risk (P(trend) = 0.02).0.0010857672012IL135132660272AG
rs20541224197143596IL13umls:C1527249BeFreePatients carrying the TCF7L2_rs7903146_T allele had an increased risk of CRC (P(trend) = 0.02), whereas patients harboring the IL13_rs20541_T allele had a reduced risk (P(trend) = 0.02).0.0010857672012IL135132660272AG
rs20668441735190064127NOD2umls:C0009402BeFreeNo evidence for association of NOD2 R702W and G908R with colorectal cancer.0.0046145122007NOD21650712015CT
rs20668441578531864127NOD2umls:C1527249BeFreeThree common NOD2 mutations -- 3020insC, G908R and R702W -- have been shown to be associated with chronic inflammatory disease such as Crohn's disease, the 3020insC also with human malignancy colorectal cancer.0.0256463582005NOD21650712015CT
rs20668441735190064127NOD2umls:C1527249BeFreeNo evidence for association of NOD2 R702W and G908R with colorectal cancer.0.0256463582007NOD21650712015CT
rs20668441578531864127NOD2umls:C0009402BeFreeThree common NOD2 mutations -- 3020insC, G908R and R702W -- have been shown to be associated with chronic inflammatory disease such as Crohn's disease, the 3020insC also with human malignancy colorectal cancer.0.0046145122005NOD21650712015CT
rs20668451578531864127NOD2umls:C0009402BeFreeThree common NOD2 mutations -- 3020insC, G908R and R702W -- have been shown to be associated with chronic inflammatory disease such as Crohn's disease, the 3020insC also with human malignancy colorectal cancer.0.0046145122005NOD21650722629GC,T
rs20668451735190064127NOD2umls:C0009402BeFreeNo evidence for association of NOD2 R702W and G908R with colorectal cancer.0.0046145122007NOD21650722629GC,T
rs20668451735190064127NOD2umls:C1527249BeFreeNo evidence for association of NOD2 R702W and G908R with colorectal cancer.0.0256463582007NOD21650722629GC,T
rs20668451578531864127NOD2umls:C1527249BeFreeThree common NOD2 mutations -- 3020insC, G908R and R702W -- have been shown to be associated with chronic inflammatory disease such as Crohn's disease, the 3020insC also with human malignancy colorectal cancer.0.0256463582005NOD21650722629GC,T
rs2066865214224085054SERPINE1umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0109012822011FGG4154604124GA
rs2066865214224084524MTHFRumls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.1068727452011FGG4154604124GA
rs2066865214224082147F2umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0005428842011FGG4154604124GA
rs2066865214224084524MTHFRumls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0263298622011FGG4154604124GA
rs2066865214224085054SERPINE1umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0040716282011FGG4154604124GA
rs2066865214224082147F2umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0052769482011FGG4154604124GA
rs207060024248547177AGERumls:C1527249BeFreeIn conclusion, the RAGE gene Gly82Ser polymorphism may confer not only an increased risk of CRC but also an increased invasion of CRC in the Chinese population.0.0002714422013AGER632183666CT
rs20764852135126110537UBDumls:C0009402BeFreeCarriage of the minor allele of UBD I68T was significantly associated with advanced stages of CRC and with CRC below 65 years of age (OR, 1.23; 95% CI, 1.04-1.45; p = 0.02 and OR, 1.32; 95% CI, 1.05-1.67; p = 0.02, respectively).0.0002714422010UBD629556175AG,C
rs20764852135126110537UBDumls:C1527249BeFreeCarriage of the minor allele of UBD I68T was significantly associated with advanced stages of CRC and with CRC below 65 years of age (OR, 1.23; 95% CI, 1.04-1.45; p = 0.02 and OR, 1.32; 95% CI, 1.05-1.67; p = 0.02, respectively).0.0002714422010UBD629556175AG,C
rs2167270248450323952LEPumls:C1527249BeFreeThese findings suggest that the LEP A19G (rs2167270) genetic polymorphism may decrease the susceptibility to cancers in colorectal cancer and non-Hodgkin's lymphoma, when assuming a homozygote codominant model and a recessive genetic model among Latin American population.0.0088056922014LEP7128241296GA
rs2167270248450323952LEPumls:C0009402BeFreeThese findings suggest that the LEP A19G (rs2167270) genetic polymorphism may decrease the susceptibility to cancers in colorectal cancer and non-Hodgkin's lymphoma, when assuming a homozygote codominant model and a recessive genetic model among Latin American population.0.0040716282014LEP7128241296GA
rs21714921861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008CPA47130310900GT
rs217149218619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008CPA47130310900GT
rs2171492186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008CPA47130310900GT
rs2171492186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008CPA47130310900GT
rs2171492186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008CPA47130310900GT
rs21714921861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008CPA47130310900GT
rs217149218619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008CPA47130310900GT
rs21714921861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008CPA47130310900GT
rs2171492186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008CPA47130310900GT
rs2171492186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008CPA47130310900GT
rs2171492186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008CPA47130310900GT
rs2171492186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008CPA47130310900GT
rs21714921861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008CPA47130310900GT
rs217149218619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008CPA47130310900GT
rs21714921861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008CPA47130310900GT
rs21714921861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008CPA47130310900GT
rs21714921861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008CPA47130310900GT
rs2171492186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008CPA47130310900GT
rs21714921861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008CPA47130310900GT
rs217149218619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008CPA47130310900GT
rs222793519945966641BLMumls:C0009402BeFreeAlthough none of them showed a significant association with CRC, the association of BLM P868L with rectal cancer risk requires further investigation.0.0008143262010BLM1590782869CG,T
rs222793519945966641BLMumls:C1527249BeFreeAlthough none of them showed a significant association with CRC, the association of BLM P868L with rectal cancer risk requires further investigation.0.005548392010BLM1590782869CG,T
rs2227983218969921956EGFRumls:C1527249BeFreeThe EGFR R521K polymorphism influences the risk to develop colorectal cancer.0.1081323492010EGFR755161562GA,C,T
rs2227983218969921956EGFRumls:C0009402BeFreeThe EGFR R521K polymorphism influences the risk to develop colorectal cancer.0.082010EGFR755161562GA,C,T
rs2228000253555957508XPCumls:C0009402BeFreeIndividuals with variant genotypes of XPC Ala499Val appeared to be associated with the increased risk of CRC.0.0032573022014XPC314158387GA
rs2228000243853047508XPCumls:C1527249BeFreeXPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.0.0074484832013XPC314158387GA
rs2228000243853047508XPCumls:C0009402BeFreeXPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.0.0032573022013XPC314158387GA
rs2228000253555957508XPCumls:C1527249BeFreeIndividuals with variant genotypes of XPC Ala499Val appeared to be associated with the increased risk of CRC.0.0074484832014XPC314158387GA
rs2228001249479367508XPCumls:C1527249BeFreeXPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.0.0074484832014XPC314145949GT
rs2228001173630137507XPAumls:C0009402BeFreeWe determined the risk of colorectal cancer in association with the four polymorphisms XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn, and interactions between the polymorphisms and the environmental factors: smoking intensity, intake of alcohol, red meat, processed meat, fish and poultry, fruits and vegetables and dietary fibres, in relation to development of colorectal cancer in a study population of 405 colorectal cancer cases and a comparison group of 810 persons, nested within the Danish prospective cohort, Diet, Cancer and Health, of 57053 cohort members.0.0008143262007XPC314145949GT
rs2228001173630137508XPCumls:C0009402BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0032573022007XPC314145949GT
rs2228001173630137507XPAumls:C1527249BeFreeWe determined the risk of colorectal cancer in association with the four polymorphisms XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn, and interactions between the polymorphisms and the environmental factors: smoking intensity, intake of alcohol, red meat, processed meat, fish and poultry, fruits and vegetables and dietary fibres, in relation to development of colorectal cancer in a study population of 405 colorectal cancer cases and a comparison group of 810 persons, nested within the Danish prospective cohort, Diet, Cancer and Health, of 57053 cohort members.0.0079154222007XPC314145949GT
rs2228001243853047508XPCumls:C0009402BeFreeXPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.0.0032573022013XPC314145949GT
rs2228001173630137508XPCumls:C1527249BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0074484832007XPC314145949GT
rs2228001173630132068ERCC2umls:C0009402BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0104343432007XPC314145949GT
rs2228001173630132068ERCC2umls:C1527249BeFreeXPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.0.0575035412007XPC314145949GT
rs2228001206494337508XPCumls:C0009402BeFreeThe association of OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln polymorphisms and the susceptibility to colorectal carcinoma with or without oxidative stress were evaluated.0.0032573022010XPC314145949GT
rs2228001243853047508XPCumls:C1527249BeFreeXPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.0.0074484832013XPC314145949GT
rs2228001249479367508XPCumls:C0009402BeFreeXPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.0.0032573022014XPC314145949GT
rs2228262186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008THBS11539589977AG
rs2228262186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008THBS11539589977AG
rs22282621861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008THBS11539589977AG
rs22282621861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008THBS11539589977AG
rs2228262186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008THBS11539589977AG
rs22282621861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008THBS11539589977AG
rs22282621861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008THBS11539589977AG
rs2228262186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008THBS11539589977AG
rs2228262186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008THBS11539589977AG
rs222826218619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008THBS11539589977AG
rs222826218619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008THBS11539589977AG
rs22282621861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008THBS11539589977AG
rs222826218619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008THBS11539589977AG
rs222826218619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008THBS11539589977AG
rs2228262186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008THBS11539589977AG
rs22282621861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008THBS11539589977AG
rs22282621861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008THBS11539589977AG
rs2228262186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008THBS11539589977AG
rs22282621861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008THBS11539589977AG
rs2228262186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008THBS11539589977AG
rs2228570240757991045CDX2umls:C1527249BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0134961492013VDR1247879112AT,G,C
rs2228570240757991045CDX2umls:C0009402BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0122148842013VDR1247879112AT,G,C
rs2229080156464291630DCCumls:C0009402BeFreeNo association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer.0.013029212004DCC1852906232CG
rs2229080156464291630DCCumls:C1527249BeFreeNo association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer.0.0140390322004DCC1852906232CG
rs222999515824157324APCumls:C1527249BeFreeAPC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.0.242005APC5112843098GA
rs222999515824157324APCumls:C0009402BeFreeAPC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.0.0757322822005APC5112843098GA
rs2234922224157912052EPHX1umls:C0009402BeFreeWe investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates.0.0021715352013EPHX11225838705AG,T
rs2234922224157912052EPHX1umls:C1527249BeFreeWe investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates.0.0326715092013EPHX11225838705AG,T
rs2236225151225974522MTHFD1umls:C1527249BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0150165172004MTHFD11464442127GA
rs2236225151225972346FOLH1umls:C1527249BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0081868632004MTHFD11464442127GA
rs2236225151225974522MTHFD1umls:C0009402BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0008143262004MTHFD11464442127GA
rs2236225151225972346FOLH1umls:C0009402BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0010857672004MTHFD11464442127GA
rs2240308168209358313AXIN2umls:C1527249BeFreeThese results suggest that the AXIN2 Pro50Ser SNP is associated with development of lung cancer as a protective SNP, while an association between the AXIN2 SNP and risk of colorectal cancer and of head and neck cancer was not observed.0.0050814512006AXIN21765558473GA
rs2240308168209358313AXIN2umls:C0009402BeFreeThese results suggest that the AXIN2 Pro50Ser SNP is associated with development of lung cancer as a protective SNP, while an association between the AXIN2 SNP and risk of colorectal cancer and of head and neck cancer was not observed.0.0029858612006AXIN21765558473GA
rs2241766254897169370ADIPOQumls:C1527249BeFreeTo discuss the association between adiponectin (ADIPOQ) gene rs2241766 and rs1501299 polymorphisms and the risk of colorectal cancer, and to analyze the role of the interaction between these two loci and environmental factors in colorectal cancer pathogenesis.0.0129968722015ADIPOQ;ADIPOQ-AS13186853103TG
rs2241766254897169370ADIPOQumls:C0009402BeFreeTo discuss the association between adiponectin (ADIPOQ) gene rs2241766 and rs1501299 polymorphisms and the risk of colorectal cancer, and to analyze the role of the interaction between these two loci and environmental factors in colorectal cancer pathogenesis.0.0035287442015ADIPOQ;ADIPOQ-AS13186853103TG
rs2273535170037826790AURKAumls:C1527249BeFreeCase-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele.0.0116396632006AURKA2056386485AT
rs2273535170037822011MARK2umls:C1527249BeFreeRecently, homozygosity for T91A single-nucleotide polymorphism (SNP) in the serine/threonine kinase (STK15) gene, which generates the substitution F31I has been proposed to increase the risk of a number of tumours including colorectal cancer (CRC).0.0016286512006AURKA2056386485AT
rs2273535170037826790AURKAumls:C0009402BeFreeCase-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele.0.0016286512006AURKA2056386485AT
rs2273535170037822011MARK2umls:C0009402BeFreeRecently, homozygosity for T91A single-nucleotide polymorphism (SNP) in the serine/threonine kinase (STK15) gene, which generates the substitution F31I has been proposed to increase the risk of a number of tumours including colorectal cancer (CRC).0.0019000932006AURKA2056386485AT
rs2273697232329021244ABCC2umls:C1527249BeFreeThe correlation of G1249A ABCC2 polymorphism with the development of colorectal cancer (CRC) and poor prognosis was evaluated in patients who were treated with fluorouracil/-leucovorin (FL) plus oxaliplatin (FOLFOX-4).0.0081868632013ABCC21099804058GA
rs2273697232329021244ABCC2umls:C0009402BeFreeThe correlation of G1249A ABCC2 polymorphism with the development of colorectal cancer (CRC) and poor prognosis was evaluated in patients who were treated with fluorouracil/-leucovorin (FL) plus oxaliplatin (FOLFOX-4).0.0013572092013ABCC21099804058GA
rs2275913244461826647SOD1umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0013572092014IL17A652186235GA
rs2275913244461823586IL10umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0059717212014IL17A652186235GA
rs2275913244461827099TLR4umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0082628082014IL17A652186235GA
rs2275913244461826647SOD1umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0016286512014IL17A652186235GA
rs2275913244461823605IL17Aumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0057002792014IL17A652186235GA
rs2275913244461823553IL1Bumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0174594942014IL17A652186235GA
rs2275913244461823553IL1Bumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0032573022014IL17A652186235GA
rs2275913244461823605IL17Aumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0054288372014IL17A652186235GA
rs2275913244461827099TLR4umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.004343072014IL17A652186235GA
rs2275913244461823586IL10umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0128013752014IL17A652186235GA
rs2276466248616462072ERCC4umls:C0009402BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.0008143262014ERCC41613949318CG
rs2276466248616462072ERCC4umls:C1527249BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.005548392014ERCC41613949318CG
rs2295080257764752475MTORumls:C0009402BeFreeFunctional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.0.0051573962014MTOR111262571GT
rs2295080257764752475MTORumls:C1527249BeFreeFunctional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.0.0046145122014MTOR111262571GT
rs2298881248616462072ERCC4umls:C0009402BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.0008143262014ERCC11945423658CA
rs2298881248616462072ERCC4umls:C1527249BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.005548392014ERCC11945423658CA
rs2308237182681144255MGMTumls:C1527249BeFreeOf note, the MGMT Lys(178)Arg (rs2308237) SNP, in linkage disequilibrium with the previously reported MGMT Ile(143)Val SNP, had an inverse association with colorectal cancer risk (MGMT Lys(178)Arg: odds ratio, 0.52; 95% confidence interval, 0.35-0.78; unadjusted P(trend) = 0.0003 for the additive model; gene-based test global P = 0.00003).0.0333226752008NA3191728221-TA
rs2308237182681144255MGMTumls:C0009402BeFreeOf note, the MGMT Lys(178)Arg (rs2308237) SNP, in linkage disequilibrium with the previously reported MGMT Ile(143)Val SNP, had an inverse association with colorectal cancer risk (MGMT Lys(178)Arg: odds ratio, 0.52; 95% confidence interval, 0.35-0.78; unadjusted P(trend) = 0.0003 for the additive model; gene-based test global P = 0.00003).0.0143864192008NA3191728221-TA
rs2308318201925664255MGMTumls:C0009402BeFreeHowever, there was a significant association between two polymorphisms in MGMT with sporadic colorectal cancer: Arg128Gln (OR, 5.53; 95% CI) and Gly160Arg (OR, 3.04; 95% CI).0.0143864192009MGMT;LOC10537855910129766851GA
rs2308318201925664255MGMTumls:C1527249BeFreeHowever, there was a significant association between two polymorphisms in MGMT with sporadic colorectal cancer: Arg128Gln (OR, 5.53; 95% CI) and Gly160Arg (OR, 3.04; 95% CI).0.0333226752009MGMT;LOC10537855910129766851GA
rs2308321166339202099ESR1umls:C1527249BeFreeOur results suggest that the common Leu84Phe and Ile143Val polymorphisms in MGMT influence risk of colorectal cancer in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.0.0121825472006MGMT;LOC10537855910129766800AG
rs2308321166339204255MGMTumls:C0009402BeFreeO6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).0.0143864192006MGMT;LOC10537855910129766800AG
rs2308321182681144255MGMTumls:C1527249BeFreeOf note, the MGMT Lys(178)Arg (rs2308237) SNP, in linkage disequilibrium with the previously reported MGMT Ile(143)Val SNP, had an inverse association with colorectal cancer risk (MGMT Lys(178)Arg: odds ratio, 0.52; 95% confidence interval, 0.35-0.78; unadjusted P(trend) = 0.0003 for the additive model; gene-based test global P = 0.00003).0.0333226752008MGMT;LOC10537855910129766800AG
rs2308321166339202099ESR1umls:C0009402BeFreeOur results suggest that the common Leu84Phe and Ile143Val polymorphisms in MGMT influence risk of colorectal cancer in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.0.0038001862006MGMT;LOC10537855910129766800AG
rs2308321166339204255MGMTumls:C1527249BeFreeO6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).0.0333226752006MGMT;LOC10537855910129766800AG
rs2308321182681144255MGMTumls:C0009402BeFreeOf note, the MGMT Lys(178)Arg (rs2308237) SNP, in linkage disequilibrium with the previously reported MGMT Ile(143)Val SNP, had an inverse association with colorectal cancer risk (MGMT Lys(178)Arg: odds ratio, 0.52; 95% confidence interval, 0.35-0.78; unadjusted P(trend) = 0.0003 for the additive model; gene-based test global P = 0.00003).0.0143864192008MGMT;LOC10537855910129766800AG
rs2308327182681144255MGMTumls:C0009402BeFreeOf note, the MGMT Lys(178)Arg (rs2308237) SNP, in linkage disequilibrium with the previously reported MGMT Ile(143)Val SNP, had an inverse association with colorectal cancer risk (MGMT Lys(178)Arg: odds ratio, 0.52; 95% confidence interval, 0.35-0.78; unadjusted P(trend) = 0.0003 for the additive model; gene-based test global P = 0.00003).0.0143864192008MGMT;LOC10537855910129766906AG
rs2308327182681144255MGMTumls:C1527249BeFreeOf note, the MGMT Lys(178)Arg (rs2308237) SNP, in linkage disequilibrium with the previously reported MGMT Ile(143)Val SNP, had an inverse association with colorectal cancer risk (MGMT Lys(178)Arg: odds ratio, 0.52; 95% confidence interval, 0.35-0.78; unadjusted P(trend) = 0.0003 for the additive model; gene-based test global P = 0.00003).0.0333226752008MGMT;LOC10537855910129766906AG
rs2337107249698654092SMAD7umls:C0009402BeFreeLack of influence of the SMAD7 gene rs2337107 polymorphism on risk of colorectal cancer in an Iranian population.0.0092290242015SMAD71848932953CT
rs2337107249698654092SMAD7umls:C1527249BeFreeLack of influence of the SMAD7 gene rs2337107 polymorphism on risk of colorectal cancer in an Iranian population.0.1623674712015SMAD71848932953CT
rs240780186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008ASCC36100516271GC
rs2407801861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008ASCC36100516271GC
rs2407801861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008ASCC36100516271GC
rs2407801861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008ASCC36100516271GC
rs240780186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008ASCC36100516271GC
rs240780186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008ASCC36100516271GC
rs240780186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008ASCC36100516271GC
rs240780186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008ASCC36100516271GC
rs2407801861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008ASCC36100516271GC
rs2407801861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008ASCC36100516271GC
rs24078018619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008ASCC36100516271GC
rs240780186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008ASCC36100516271GC
rs240780186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008ASCC36100516271GC
rs24078018619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008ASCC36100516271GC
rs24078018619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008ASCC36100516271GC
rs2407801861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008ASCC36100516271GC
rs2407801861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008ASCC36100516271GC
rs24078018619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008ASCC36100516271GC
rs240780186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008ASCC36100516271GC
rs2407801861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008ASCC36100516271GC
rs2414191861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008PSMB9632856171GC,A
rs2414191861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008PSMB9632856171GC,A
rs2414191861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008PSMB9632856171GC,A
rs24141918619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008PSMB9632856171GC,A
rs241419186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008PSMB9632856171GC,A
rs2414191861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008PSMB9632856171GC,A
rs241419186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008PSMB9632856171GC,A
rs2414191861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008PSMB9632856171GC,A
rs241419186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008PSMB9632856171GC,A
rs241419186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008PSMB9632856171GC,A
rs24141918619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008PSMB9632856171GC,A
rs241419186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008PSMB9632856171GC,A
rs241419186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008PSMB9632856171GC,A
rs24141918619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008PSMB9632856171GC,A
rs241419186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008PSMB9632856171GC,A
rs2414191861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008PSMB9632856171GC,A
rs241419186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008PSMB9632856171GC,A
rs24141918619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008PSMB9632856171GC,A
rs2414191861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008PSMB9632856171GC,A
rs2414191861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008PSMB9632856171GC,A
rs242327924836286171472SRSF10P2umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014NA207831703TC
rs242327923263487171472SRSF10P2umls:C1527249GWASCATGenome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.0.122013NA207831703TC
rs2424913209600501789DNMT3Bumls:C0009402BeFreeAmong 609 CRC cases and 1,663 subcohort members of the Netherlands Cohort Study on diet and cancer (n = 120,852), we estimated CRC risk according to methyl donor intake across genotypes of folate metabolizing enzymes and methyltransferases.Although diet-gene interactions were not statistically significant, methionine intake was inversely associated with CRC among subjects having both common rs2424913 and rs406193 DNMT3B C > T genotypes (highest versus lowest tertile: RR = 0.44; p (trend) = 0.05).0.0032573022011DNMT3B2032786453CT
rs2424913209600501789DNMT3Bumls:C1527249BeFreeAmong 609 CRC cases and 1,663 subcohort members of the Netherlands Cohort Study on diet and cancer (n = 120,852), we estimated CRC risk according to methyl donor intake across genotypes of folate metabolizing enzymes and methyltransferases.Although diet-gene interactions were not statistically significant, methionine intake was inversely associated with CRC among subjects having both common rs2424913 and rs406193 DNMT3B C > T genotypes (highest versus lowest tertile: RR = 0.44; p (trend) = 0.05).0.012725432011DNMT3B2032786453CT
rs24273082473774881928CABLES2umls:C1527249GWASCATIdentification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.0.122015CABLES22062394395CT
rs25487159142787515XRCC1umls:C1527249BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0623894952005XRCC11943551574TC
rs25487231887037515XRCC1umls:C1527249BeFreeThe meta-analysis suggests that the XRCC1 Arg399Gln polymorphism is associated with increased risk of CRC.0.0623894952013XRCC11943551574TC
rs25487219711037515XRCC1umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0623894952011XRCC11943551574TC
rs25487159142787517XRCC3umls:C1527249BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0285562732005XRCC11943551574TC
rs25487241571187515XRCC1umls:C0009402BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0126818232013XRCC11943551574TC
rs25487159142782068ERCC2umls:C1527249BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0575035412005XRCC11943551574TC
rs25487180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007XRCC11943551574TC
rs25487188067527515XRCC1umls:C1527249BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0623894952008XRCC11943551574TC
rs25487259211337515XRCC1umls:C0009402BeFreeAssociation of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.0.0126818232016XRCC11943551574TC
rs25487188067527515XRCC1umls:C0009402BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0126818232008XRCC11943551574TC
rs25487241571187515XRCC1umls:C1527249BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0623894952013XRCC11943551574TC
rs25487233172457515XRCC1umls:C0009402BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0126818232012XRCC11943551574TC
rs25487250246287515XRCC1umls:C0009402BeFreeAPE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.0.0126818232014XRCC11943551574TC
rs25487242248517515XRCC1umls:C1527249BeFreeHowever, we did not observe a significant association between XRCC1 Arg399Gln polymorphism and hazard for PFS and OS for gastric and colorectal cancer patients in all tested models.0.0623894952013XRCC11943551574TC
rs25487210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010XRCC11943551574TC
rs25487180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007XRCC11943551574TC
rs25487159142787515XRCC1umls:C0009402BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0126818232005XRCC11943551574TC
rs25487159142782068ERCC2umls:C0009402BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0104343432005XRCC11943551574TC
rs25487233172452068ERCC2umls:C0009402BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0104343432012XRCC11943551574TC
rs25487243776057515XRCC1umls:C1527249BeFreeThe XRCC1 Arg399Gln gene polymorphism and risk of colorectal cancer: a study in Kashmir.0.0623894952014XRCC11943551574TC
rs25487219711037515XRCC1umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0126818232011XRCC11943551574TC
rs25487242248517515XRCC1umls:C0009402BeFreeHowever, we did not observe a significant association between XRCC1 Arg399Gln polymorphism and hazard for PFS and OS for gastric and colorectal cancer patients in all tested models.0.0126818232013XRCC11943551574TC
rs25487219711037157TP53umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.162011XRCC11943551574TC
rs25487255823187515XRCC1umls:C1527249BeFreeXRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.0.0623894952015XRCC11943551574TC
rs25487159142787517XRCC3umls:C0009402BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0048859542005XRCC11943551574TC
rs25487237127787515XRCC1umls:C1527249BeFreeXRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.0.0623894952012XRCC11943551574TC
rs25487216129987515XRCC1umls:C1527249BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0623894952011XRCC11943551574TC
rs25487216129987515XRCC1umls:C0009402BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0126818232011XRCC11943551574TC
rs25487180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007XRCC11943551574TC
rs25487180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007XRCC11943551574TC
rs25487255823187515XRCC1umls:C0009402BeFreeXRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.0.0126818232015XRCC11943551574TC
rs25487180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007XRCC11943551574TC
rs25487219711037157TP53umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0847340642011XRCC11943551574TC
rs25487180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007XRCC11943551574TC
rs25487210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010XRCC11943551574TC
rs25487210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010XRCC11943551574TC
rs25487233172457515XRCC1umls:C1527249BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0623894952012XRCC11943551574TC
rs25487237127787515XRCC1umls:C0009402BeFreeXRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.0.0126818232012XRCC11943551574TC
rs25487250246287515XRCC1umls:C1527249BeFreeAPE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.0.0623894952014XRCC11943551574TC
rs25487210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010XRCC11943551574TC
rs25487243776057515XRCC1umls:C0009402BeFreeThe XRCC1 Arg399Gln gene polymorphism and risk of colorectal cancer: a study in Kashmir.0.0126818232014XRCC11943551574TC
rs25487231887037515XRCC1umls:C0009402BeFreeThe meta-analysis suggests that the XRCC1 Arg399Gln polymorphism is associated with increased risk of CRC.0.0126818232013XRCC11943551574TC
rs25487241571182068ERCC2umls:C1527249BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0575035412013XRCC11943551574TC
rs25487241571182068ERCC2umls:C0009402BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0104343432013XRCC11943551574TC
rs25487259211337515XRCC1umls:C1527249BeFreeAssociation of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.0.0623894952016XRCC11943551574TC
rs25487233172452068ERCC2umls:C1527249BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0575035412012XRCC11943551574TC
rs25489210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010XRCC11943552260CT,G
rs25489210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010XRCC11943552260CT,G
rs25489210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010XRCC11943552260CT,G
rs25489210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010XRCC11943552260CT,G
rs2665802190645442688GH1umls:C1527249BeFreeA common polymorphism in the GH1 gene, rs2665802, was previously shown to be associated with lower IGF-I levels and decreased colorectal cancer (CRC) risk.0.0113682212008GH11763917670AT
rs2665802190645442688GH1umls:C0009402BeFreeA common polymorphism in the GH1 gene, rs2665802, was previously shown to be associated with lower IGF-I levels and decreased colorectal cancer (CRC) risk.0.0021715352008GH11763917670AT
rs266729188272099370ADIPOQumls:C0009402BeFreeThe SNP rs266729, which tags the 5' flanking region of the ADIPOQ gene, is associated with decreased colorectal cancer risk.0.0035287442008ADIPOQ3186841685CG
rs2667292174970951094ADIPOR1umls:C0009402BeFreeWe conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) in ADIPOR1 are the protective factors for CRC, while that rs266729G/C and G allele of ADIPOQ are the risk factors for colon cancer after excluding rectal cancer cases.0.0024429772011ADIPOQ3186841685CG
rs266729188272099370ADIPOQumls:C1527249BeFreeThe SNP rs266729, which tags the 5' flanking region of the ADIPOQ gene, is associated with decreased colorectal cancer risk.0.0129968722008ADIPOQ3186841685CG
rs2667292174970951094ADIPOR1umls:C1527249BeFreeWe conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) in ADIPOR1 are the protective factors for CRC, while that rs266729G/C and G allele of ADIPOQ are the risk factors for colon cancer after excluding rectal cancer cases.0.0048100092011ADIPOQ3186841685CG
rs27361002287837581037CLPTM1Lumls:C0009402BeFreeThe rs2736100 association demonstrates an influence of variation at 5p15.33 on CRC risk and further evidence that the 5p15.33 (TERT-CLPTM1L) locus has pleiotropic effects (reflecting generic or lineage-specific effects) on cancer risk.0.0002714422012TERT51286401CA
rs2736100228783757015TERTumls:C0009402BeFreeThe TERT variant rs2736100 is associated with colorectal cancer risk.0.0048859542012TERT51286401CA
rs2736100228783757015TERTumls:C1527249BeFreeThe TERT variant rs2736100 is associated with colorectal cancer risk.0.0032573022012TERT51286401CA
rs27361002287837581037CLPTM1Lumls:C1527249BeFreeThe rs2736100 association demonstrates an influence of variation at 5p15.33 on CRC risk and further evidence that the 5p15.33 (TERT-CLPTM1L) locus has pleiotropic effects (reflecting generic or lineage-specific effects) on cancer risk.0.0002714422012TERT51286401CA
rs27372139438556955MEPEumls:C0009402BeFreeThe frequency of the C/C rs2737 genotype was much lower in patients who developed colorectal cancer below the age of 45 years than in individuals over age 45 years (10.8% versus 26.6%, P = 0.039).0.0035287442011CDK5RAP31747981705TC
rs27372139438556955MEPEumls:C1527249BeFreeThe frequency of the C/C rs2737 genotype was much lower in patients who developed colorectal cancer below the age of 45 years than in individuals over age 45 years (10.8% versus 26.6%, P = 0.039).0.0027144192011CDK5RAP31747981705TC
rs2853533238936187298TYMSumls:C0009402BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0325730252013TYMS;TYMSOS18658064GC
rs2853533238936184522MTHFD1umls:C1527249BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0150165172013TYMS;TYMSOS18658064GC
rs2853533238936187298TYMSumls:C1527249BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.1117586992013TYMS;TYMSOS18658064GC
rs2853533238936184522MTHFD1umls:C0009402BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0008143262013TYMS;TYMSOS18658064GC
rs28930073151848984292MLH1umls:C1527249BeFreeThe MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.0.162004MLH1337007004GC
rs28930073159910644292MLH1umls:C1527249BeFreeGenetic testing for the MLH1 D132H allele exclusively is therefore unlikely to be cost effective for genetic risk assessment in American population-based and clinic-based colorectal cancer and endometrial cancer patients.0.162005MLH1337007004GC
rs28930073159910644292MLH1umls:C0009402BeFreeGenetic testing for the MLH1 D132H allele exclusively is therefore unlikely to be cost effective for genetic risk assessment in American population-based and clinic-based colorectal cancer and endometrial cancer patients.0.0823670322005MLH1337007004GC
rs28930073151848984292MLH1umls:C0009402BeFreeThe MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.0.0823670322004MLH1337007004GC
rs291016425519012406938MIR146Aumls:C0009402BeFreeOur findings suggest that the rs2910164 polymorphism in pre-miRNA, miR-146a may be associated with the risk of CRC.0.0035287442016LOC285628;MIR146A5160485411CG
rs291016424136745406938MIR146Aumls:C1527249BeFreeMiR-146a (rs2910164 G > C) polymorphism is associated with CRC susceptibility and histological differentiation in Chinese Han population.0.0038001862013LOC285628;MIR146A5160485411CG
rs291016424247819406938MIR146Aumls:C1527249BeFreeWe found that the miR-146a polymorphism rs2910164 might significantly increase the susceptibility of digestive tumors, in particular for esophageal cancer and colorectal cancers.0.0038001862013LOC285628;MIR146A5160485411CG
rs291016424399071406938MIR146Aumls:C1527249BeFreeEffects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.0.0038001862013LOC285628;MIR146A5160485411CG
rs291016424136745406938MIR146Aumls:C0009402BeFreeMiR-146a (rs2910164 G > C) polymorphism is associated with CRC susceptibility and histological differentiation in Chinese Han population.0.0035287442013LOC285628;MIR146A5160485411CG
rs291016424399071406938MIR146Aumls:C0009402BeFreeEffects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.0.0035287442013LOC285628;MIR146A5160485411CG
rs291016425283877406938MIR146Aumls:C0009402BeFreeEffect of a common genetic variant microRNA-146a rs2910164 on colorectal cancer: a meta-analysis.0.0035287442015LOC285628;MIR146A5160485411CG
rs291016425519012406938MIR146Aumls:C1527249BeFreeOur findings suggest that the rs2910164 polymorphism in pre-miRNA, miR-146a may be associated with the risk of CRC.0.0038001862016LOC285628;MIR146A5160485411CG
rs291016423898084406938MIR146Aumls:C0009402BeFreeA miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer.0.0035287442013LOC285628;MIR146A5160485411CG
rs291016423898084406938MIR146Aumls:C1527249BeFreeA miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer.0.0038001862013LOC285628;MIR146A5160485411CG
rs291016425283877406938MIR146Aumls:C1527249BeFreeEffect of a common genetic variant microRNA-146a rs2910164 on colorectal cancer: a meta-analysis.0.0038001862015LOC285628;MIR146A5160485411CG
rs2946834231800203479IGF1umls:C0009402BeFreeRecently, IGF-1 single nucleotide polymorphisms (SNPs), especially variant rs2946834, have been associated with poor clinical outcome in patients with colorectal cancer.0.0076003722013LOC10536994212102394036AG
rs2946834231800203479IGF1umls:C1527249BeFreeRecently, IGF-1 single nucleotide polymorphisms (SNPs), especially variant rs2946834, have been associated with poor clinical outcome in patients with colorectal cancer.0.033094842013LOC10536994212102394036AG
rs299412251125479047KCTD15umls:C1527249BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0002714422012NA1933818627AG
rs29941225112544160MC4Rumls:C0009402BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0005428842012NA1933818627AG
rs299412251125479047KCTD15umls:C0009402BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0002714422012NA1933818627AG
rs29941225112544160MC4Rumls:C1527249BeFreeRisk alleles for two obesity SNPs were associated with colorectal cancer risk--KCTD15 rs29941 [odds ratio (OR) for C allele = 0.90, 95% confidence interval (CI) 0.83-0.98; p = 0.01] and MC4R rs17782313 (OR for C allele = 1.12, 95% CI 1.02-1.22; p = 0.02).0.0029099162012NA1933818627AG
rs3024505248892123586IL10umls:C0009402BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0059717212014NA1206766559GA
rs3024505241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013NA1206766559GA
rs3024505248892123586IL10umls:C1527249BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0128013752014NA1206766559GA
rs3024505241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013NA1206766559GA
rs3024505248892124609MYCumls:C1527249BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0113246142014NA1206766559GA
rs3024505248892124609MYCumls:C0009402BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0115960562014NA1206766559GA
rs3106189239405586892TAPBPumls:C1527249BeFreeFinally, we determined that rs3106189, localized to the 5' UTR of antigen presenting tapasin binding protein (TAPBP), and rs1052918, localized to the 3' UTR of transcription factor 3 (TCF3), were associated with overall survival of CRC patients.0.0002714422013TAPBP;ZBTB22633314225CT
rs3106189239405586929TCF3umls:C1527249BeFreeTargeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients.0.0010857672013TAPBP;ZBTB22633314225CT
rs3106189239405586929TCF3umls:C0009402BeFreeTargeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients.0.0010857672013TAPBP;ZBTB22633314225CT
rs3106189239405586892TAPBPumls:C0009402BeFreeFinally, we determined that rs3106189, localized to the 5' UTR of antigen presenting tapasin binding protein (TAPBP), and rs1052918, localized to the 3' UTR of transcription factor 3 (TCF3), were associated with overall survival of CRC patients.0.0002714422013TAPBP;ZBTB22633314225CT
rs31427723052130389421LIN28Bumls:C0009402BeFreeWe find that LIN28B rs314277 is associated with significant recurrence of colorectal cancer in Stage II disease, which may have translational therapeutic implications.0.0005428842012LIN28B6104959787AC
rs31427723052130389421LIN28Bumls:C1527249BeFreeWe find that LIN28B rs314277 is associated with significant recurrence of colorectal cancer in Stage II disease, which may have translational therapeutic implications.0.0005428842012LIN28B6104959787AC
rs320682418619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DKK31111964514TC
rs32068241861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008DKK31111964514TC
rs3206824186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DKK31111964514TC
rs32068241861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008DKK31111964514TC
rs3206824186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DKK31111964514TC
rs32068241861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008DKK31111964514TC
rs32068241861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DKK31111964514TC
rs32068241861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DKK31111964514TC
rs32068241861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DKK31111964514TC
rs320682418619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008DKK31111964514TC
rs320682418619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DKK31111964514TC
rs3206824186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008DKK31111964514TC
rs32068241861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008DKK31111964514TC
rs320682418619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DKK31111964514TC
rs3206824186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008DKK31111964514TC
rs3206824186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008DKK31111964514TC
rs3206824186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008DKK31111964514TC
rs32068241861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008DKK31111964514TC
rs3206824186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DKK31111964514TC
rs3206824186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008DKK31111964514TC
rs3212986248616462072ERCC4umls:C0009402BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.0008143262014ERCC1;CD3EAP1945409478CA
rs3212986248616462072ERCC4umls:C1527249BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.005548392014ERCC1;CD3EAP1945409478CA
rs321781023266556894CCND2umls:C1527249GWASCATWe also provided evidence for an association between colorectal tumor risk and polymorphisms in laminin gamma 1 (this is the second gene in the laminin family to be associated with colorectal cancers), cyclin D2 (which encodes for cyclin D2), and T-box 3 (which encodes a T-box transcription factor and is a target of Wnt signaling to β-catenin).0.1205428842013CCND2124279105CT
rs321790123266556894CCND2umls:C1527249GWASCATWe also provided evidence for an association between colorectal tumor risk and polymorphisms in laminin gamma 1 (this is the second gene in the laminin family to be associated with colorectal cancers), cyclin D2 (which encodes for cyclin D2), and T-box 3 (which encodes a T-box transcription factor and is a target of Wnt signaling to β-catenin).0.1205428842013CCND2124296223AG
rs3219145180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007PARP11226363128TG,C
rs3219145180069254255MGMTumls:C0009402BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0143864192007PARP11226363128TG,C
rs3219145180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007PARP11226363128TG,C
rs321914518006925142PARP1umls:C0009402BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0032573022007PARP11226363128TG,C
rs3219145180069254255MGMTumls:C1527249BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0333226752007PARP11226363128TG,C
rs3219145180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007PARP11226363128TG,C
rs3219145180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007PARP11226363128TG,C
rs3219145180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007PARP11226363128TG,C
rs321914518006925142PARP1umls:C1527249BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.010629842007PARP11226363128TG,C
rs3219145180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007PARP11226363128TG,C
rs3219489188235664595MUTYHumls:C0009402BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.0276870712008MUTYH145331833CG
rs321948918823566328APEX1umls:C1527249BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.0119111052008MUTYH145331833CG
rs3219489188235664595MUTYHumls:C1527249BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.1055276842008MUTYH145331833CG
rs321948918823566328APEX1umls:C0009402BeFreeAssociation of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.0.0027144192008MUTYH145331833CG
rs342455112473774851474LIMA1umls:C1527249GWASCATIdentification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.0.122015LIMA11250179650GC
rs34743033234011047298TYMSumls:C1527249BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.1117586992013NANANANANA
rs34743033234011046470SHMT1umls:C0009402BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.0010857672013NANANANANA
rs34743033234011046470SHMT1umls:C1527249BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.0105538952013NANANANANA
rs34743033234011047298TYMSumls:C0009402BeFreeResults for other variants varied across individual studies; in our meta-analyses we observed some evidence for SHMT 1420C>T (rs1979277) ((odds ratio) OR = 0.85; 95% confidence interval (CI) = 0.73-1.00 for TT v. CC) and TYMS 5' 28 bp repeat (rs34743033) and CRC risk (OR = 0.84; 95% CI = 0.75-0.94 for 2R/3R v. 3R/3R and OR = 0.82; 95% CI = 0.69-0.98 for 2R/2R v. 3R/3R).0.0325730252013NANANANANA
rs351855160127242264FGFR4umls:C1527249BeFreeFGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.0.0045385672005FGFR45177093242GA
rs351855160127242264FGFR4umls:C0009402BeFreeFGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.0.0027144192005FGFR45177093242GA
rs3544762228240023199GSE1umls:C0009402BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012NUP210313316486AG
rs3544762228240023199GSE1umls:C1527249BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012NUP210313316486AG
rs3544762228240023225NUP210umls:C1527249BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012NUP210313316486AG
rs3544762228240023225NUP210umls:C0009402BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012NUP210313316486AG
rs35502531247433844292MLH1umls:C0009402BeFreeThe MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals.0.0823670322014NANANANANA
rs35502531247433844292MLH1umls:C1527249BeFreeThe MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals.0.162014NANANANANA
rs35502531224262354292MLH1umls:C1527249BeFreeWe also reviewed the literature concerning MLH1 K618A in families with colorectal cancer.0.162012NANANANANA
rs35502531224262354292MLH1umls:C0009402BeFreeWe also reviewed the literature concerning MLH1 K618A in families with colorectal cancer.0.0823670322012NANANANANA
rs361863212395043977LIFRumls:C0009402BeFreeCytotoxicity analyses showed that all RKO and HCT116 CRC clones transfected with the G allele at LIFR rs3729740 and the C allele at ISX rs361863 were more sensitive to cetuximab regimens than those with the A and T allele, respectively (P ≤ 0.001-0.024).0.0005428842011ISX2235067169AG
rs361863212395043977LIFRumls:C1527249BeFreeCytotoxicity analyses showed that all RKO and HCT116 CRC clones transfected with the G allele at LIFR rs3729740 and the C allele at ISX rs361863 were more sensitive to cetuximab regimens than those with the A and T allele, respectively (P ≤ 0.001-0.024).0.0005428842011ISX2235067169AG
rs3713739822414503557599WDR48umls:C1527249BeFreeImportantly, we found a WDR48 somatic mutation (L580F) that is defective in stabilizing PHLPP1 in colorectal cancers, supporting a WDR48 role in tumor suppression.0.0002714422014WDR48339091696AT
rs3713739822414503523239PHLPP1umls:C1527249BeFreeImportantly, we found a WDR48 somatic mutation (L580F) that is defective in stabilizing PHLPP1 in colorectal cancers, supporting a WDR48 role in tumor suppression.0.0008143262014WDR48339091696AT
rs3729740212395043977LIFRumls:C1527249BeFreeCytotoxicity analyses showed that all RKO and HCT116 CRC clones transfected with the G allele at LIFR rs3729740 and the C allele at ISX rs361863 were more sensitive to cetuximab regimens than those with the A and T allele, respectively (P ≤ 0.001-0.024).0.0005428842011LIFR538496535CT
rs3729740212395043977LIFRumls:C0009402BeFreeCytotoxicity analyses showed that all RKO and HCT116 CRC clones transfected with the G allele at LIFR rs3729740 and the C allele at ISX rs361863 were more sensitive to cetuximab regimens than those with the A and T allele, respectively (P ≤ 0.001-0.024).0.0005428842011LIFR538496535CT
rs3732040882161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012SLC38A11246209126CT
rs373204088216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012SLC38A11246209126CT
rs373204088216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012SLC38A11246209126CT
rs373204088216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012SLC38A11246209126CT
rs373204088216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012SLC38A11246209126CT
rs3732040882161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012SLC38A11246209126CT
rs37356842060261154905CYP2W1umls:C0009402BeFreeCYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk.0.0008143262010CYP2W1;C7orf507985219GA
rs37356842060261154905CYP2W1umls:C1527249BeFreeCYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk.0.0031813582010CYP2W1;C7orf507985219GA
rs3750824201925664255MGMTumls:C0009402BeFreeHowever, there was a significant association between two polymorphisms in MGMT with sporadic colorectal cancer: Arg128Gln (OR, 5.53; 95% CI) and Gly160Arg (OR, 3.04; 95% CI).0.0143864192009MGMT10129759310GA
rs3750824201925664255MGMTumls:C1527249BeFreeHowever, there was a significant association between two polymorphisms in MGMT with sporadic colorectal cancer: Arg128Gln (OR, 5.53; 95% CI) and Gly160Arg (OR, 3.04; 95% CI).0.0333226752009MGMT10129759310GA
rs3757417250795148460TPST1umls:C0009402BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0002714422014TPST1766360270TG
rs375741725079514124220ZG16Bumls:C1527249BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0005428842014TPST1766360270TG
rs375741725079514124220ZG16Bumls:C0009402BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0005428842014TPST1766360270TG
rs3757417250795148460TPST1umls:C1527249BeFreeThe current study provides evidence that the TPST1 rs3757417T>G and PAUF rs12373A>C polymorphisms are possible prognostic biomarkers for patients with colorectal cancer.0.0002714422014TPST1766360270TG
rs37615482541605350943FOXP3umls:C0009402BeFreeAssociation of FoxP3 rs3761548 polymorphism with susceptibility to colorectal cancer in the Chinese population.0.004343072014FOXP3X49261784GT
rs37615482541605350943FOXP3umls:C1527249BeFreeAssociation of FoxP3 rs3761548 polymorphism with susceptibility to colorectal cancer in the Chinese population.0.0046145122014FOXP3X49261784GT
rs3775291212391677098TLR3umls:C0009402BeFreeMore importantly, among 582 followed up patients the SNP rs3775291 in the toll-like receptor 3 (TLR-3) gene was associated with CRC specific survival (150 events).0.0005428842011TLR34186082920CT,G
rs3775291212391677098TLR3umls:C1527249BeFreeMore importantly, among 582 followed up patients the SNP rs3775291 in the toll-like receptor 3 (TLR-3) gene was associated with CRC specific survival (150 events).0.0005428842011TLR34186082920CT,G
rs377655174216185225743PTGS2umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0941805312012PTGS21186678374GA
rs377655174216185225743PTGS2umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0513025142012PTGS21186678374GA
rs3776551742161852281539SLC38A1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012PTGS21186678374GA
rs377655174216185221545CYP1B1umls:C1527249BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0298375382012PTGS21186678374GA
rs3776551742161852281539SLC38A1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0103147912012PTGS21186678374GA
rs377655174216185221545CYP1B1umls:C0009402BeFreeWe conducted a family-based case-control study to investigate the association between polymorphisms in carcinogen metabolism genes (CYP1A2 -154A>C, CYP1B1 Leu432Val, CYP2E1 -1054C>T, GSTP1 Ile105Val, PTGS2 5UTR -765, EPHX1 Tyr113His, NAT2 Ile114Thr, NAT2 Arg197Gln and NAT2 Gly286Glu) and CRC risk.0.0032573022012PTGS21186678374GA
rs380284225766683120376COLCA2umls:C1527249BeFreeThe CRC-associated eQTL rs3802842 was associated with the expression of C11orf93 (COLCA2).0.1210857672015COLCA2;COLCA111111300984CA
rs380284222367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012COLCA2;COLCA111111300984CA
rs3802842223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012COLCA2;COLCA111111300984CA
rs3802842223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012COLCA2;COLCA111111300984CA
rs380284222367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012COLCA2;COLCA111111300984CA
rs380284225766683120376COLCA2umls:C0009402BeFreeThe CRC-associated eQTL rs3802842 was associated with the expression of C11orf93 (COLCA2).0.0010857672015COLCA2;COLCA111111300984CA
rs380284218372901399948COLCA1umls:C1527249GWASCATGenome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.0.1252769482008COLCA2;COLCA111111300984CA
rs380284222367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012COLCA2;COLCA111111300984CA
rs38028422236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012COLCA2;COLCA111111300984CA
rs380284222367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012COLCA2;COLCA111111300984CA
rs380284222367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012COLCA2;COLCA111111300984CA
rs380284224836286399948COLCA1umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.1252769482014COLCA2;COLCA111111300984CA
rs38028422236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012COLCA2;COLCA111111300984CA
rs3802842223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012COLCA2;COLCA111111300984CA
rs380284223266556399948COLCA1umls:C1527249GWASCATIdentification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.0.1252769482013COLCA2;COLCA111111300984CA
rs380284223266556120376COLCA2umls:C1527249GWASCATIdentification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.0.1210857672013COLCA2;COLCA111111300984CA
rs380284221761138120376COLCA2umls:C1527249GWASCATMeta-analysis of new genome-wide association studies of colorectal cancer risk.0.1210857672012COLCA2;COLCA111111300984CA
rs380284224836286120376COLCA2umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.1210857672014COLCA2;COLCA111111300984CA
rs3802842223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012COLCA2;COLCA111111300984CA
rs380284218372901120376COLCA2umls:C1527249GWASCATGenome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.0.1210857672008COLCA2;COLCA111111300984CA
rs380284222367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012COLCA2;COLCA111111300984CA
rs380284221761138399948COLCA1umls:C1527249GWASCATMeta-analysis of new genome-wide association studies of colorectal cancer risk.0.1252769482012COLCA2;COLCA111111300984CA
rs380318517449901115761ARL11umls:C1527249BeFreeAssociation of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.0.0079154222007ARL111349630889TC
rs3803185218195674163MCCumls:C1527249BeFreeThe rs3803185 variant was not significantly associated with CRC risk in an external cohort (MCC-Spain), but it still showed some borderline significance in the pooled analysis of both cohorts (OR = 1.08, 95% CI = 0.98-1.18, P-value = 0.09, log-additive 0, 1, 2 alleles).0.0029858612011ARL111349630889TC
rs380318517449901115761ARL11umls:C0009402BeFreeAssociation of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.0.0008143262007ARL111349630889TC
rs3803185218195674163MCCumls:C0009402BeFreeThe rs3803185 variant was not significantly associated with CRC risk in an external cohort (MCC-Spain), but it still showed some borderline significance in the pooled analysis of both cohorts (OR = 1.08, 95% CI = 0.98-1.18, P-value = 0.09, log-additive 0, 1, 2 alleles).0.0035287442011ARL111349630889TC
rs3813867235952201571CYP2E1umls:C1527249BeFreeAssociations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.0.0424870232013CYP2E110133526101GC
rs3813867235952201571CYP2E1umls:C0009402BeFreeAssociations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.0.0040716282013CYP2E110133526101GC
rs38249992263475510714POLD3umls:C1527249GWASCATCommon variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.0.1202714422012POLD31174634505TG
rs383412924465592841CASP8umls:C0009402BeFreeAssociation between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study.0.0046145122013CASP82201232809AGTAAG-
rs383412924465592841CASP8umls:C1527249BeFreeAssociation between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study.0.0111727242013CASP82201232809AGTAAG-
rs3856806189921485468PPARGumls:C1527249BeFreeOn the contrary, two other SNPs, PLA2G2A c.435+230C>T and PPARG c.1431C>T (p.His477His), were associated with a decrease in CRC risk.0.0389906172008PPARG312434058CT
rs3856806189921485320PLA2G2Aumls:C1527249BeFreeOn the contrary, two other SNPs, PLA2G2A c.435+230C>T and PPARG c.1431C>T (p.His477His), were associated with a decrease in CRC risk.0.0060912732008PPARG312434058CT
rs386425447156464291630DCCumls:C1527249BeFreeNo association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer.0.0140390322004NANANANANA
rs386425447156464291630DCCumls:C0009402BeFreeNo association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer.0.013029212004NANANANANA
rs3864484891519344527030MLH3umls:C1527249BeFreeNo association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.0.0116396632004NANANANANA
rs3864484891519344527030MLH3umls:C0009402BeFreeNo association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.0.0021715352004NANANANANA
rs386493716219711037157TP53umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0847340642011NANANANANA
rs386493716219711037157TP53umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.162011NANANANANA
rs386493716159142787517XRCC3umls:C0009402BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0048859542005NANANANANA
rs386493716250246287515XRCC1umls:C0009402BeFreeAPE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.0.0126818232014NANANANANA
rs386493716233172457515XRCC1umls:C0009402BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0126818232012NANANANANA
rs386493716259211337515XRCC1umls:C1527249BeFreeAssociation of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.0.0623894952016NANANANANA
rs386493716216129987515XRCC1umls:C0009402BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0126818232011NANANANANA
rs386493716219711037515XRCC1umls:C1527249BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0623894952011NANANANANA
rs386493716159142787517XRCC3umls:C1527249BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0285562732005NANANANANA
rs386493716243776057515XRCC1umls:C1527249BeFreeThe XRCC1 Arg399Gln gene polymorphism and risk of colorectal cancer: a study in Kashmir.0.0623894952014NANANANANA
rs386493716180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007NANANANANA
rs386493716237127787515XRCC1umls:C0009402BeFreeXRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.0.0126818232012NANANANANA
rs386493716219711037515XRCC1umls:C0009402BeFreeAssociation between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.0.0126818232011NANANANANA
rs386493716210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010NANANANANA
rs386493716180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007NANANANANA
rs386493716242248517515XRCC1umls:C1527249BeFreeHowever, we did not observe a significant association between XRCC1 Arg399Gln polymorphism and hazard for PFS and OS for gastric and colorectal cancer patients in all tested models.0.0623894952013NANANANANA
rs386493716255823187515XRCC1umls:C0009402BeFreeXRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.0.0126818232015NANANANANA
rs386493716159142782068ERCC2umls:C1527249BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0575035412005NANANANANA
rs386493716231887037515XRCC1umls:C1527249BeFreeThe meta-analysis suggests that the XRCC1 Arg399Gln polymorphism is associated with increased risk of CRC.0.0623894952013NANANANANA
rs386493716242248517515XRCC1umls:C0009402BeFreeHowever, we did not observe a significant association between XRCC1 Arg399Gln polymorphism and hazard for PFS and OS for gastric and colorectal cancer patients in all tested models.0.0126818232013NANANANANA
rs386493716255823187515XRCC1umls:C1527249BeFreeXRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.0.0623894952015NANANANANA
rs386493716216129987515XRCC1umls:C1527249BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0623894952011NANANANANA
rs386493716188067527515XRCC1umls:C1527249BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0623894952008NANANANANA
rs386493716241571182068ERCC2umls:C1527249BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0575035412013NANANANANA
rs386493716159142782068ERCC2umls:C0009402BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0104343432005NANANANANA
rs386493716233172457515XRCC1umls:C1527249BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0623894952012NANANANANA
rs386493716180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007NANANANANA
rs386493716180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007NANANANANA
rs386493716241571182068ERCC2umls:C0009402BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0104343432013NANANANANA
rs386493716188067527515XRCC1umls:C0009402BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0126818232008NANANANANA
rs386493716241571187515XRCC1umls:C0009402BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0126818232013NANANANANA
rs386493716243776057515XRCC1umls:C0009402BeFreeThe XRCC1 Arg399Gln gene polymorphism and risk of colorectal cancer: a study in Kashmir.0.0126818232014NANANANANA
rs386493716210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010NANANANANA
rs386493716237127787515XRCC1umls:C1527249BeFreeXRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.0.0623894952012NANANANANA
rs386493716159142787515XRCC1umls:C0009402BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0126818232005NANANANANA
rs386493716210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010NANANANANA
rs386493716180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007NANANANANA
rs386493716233172452068ERCC2umls:C0009402BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0104343432012NANANANANA
rs386493716231887037515XRCC1umls:C0009402BeFreeThe meta-analysis suggests that the XRCC1 Arg399Gln polymorphism is associated with increased risk of CRC.0.0126818232013NANANANANA
rs386493716233172452068ERCC2umls:C1527249BeFreeAssociation between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.0.0575035412012NANANANANA
rs386493716250246287515XRCC1umls:C1527249BeFreeAPE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.0.0623894952014NANANANANA
rs386493716159142787515XRCC1umls:C1527249BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0623894952005NANANANANA
rs386493716210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010NANANANANA
rs386493716241571187515XRCC1umls:C1527249BeFreeLys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.0.0623894952013NANANANANA
rs386493716259211337515XRCC1umls:C0009402BeFreeAssociation of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.0.0126818232016NANANANANA
rs386493716180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007NANANANANA
rs38652655118006925142PARP1umls:C1527249BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.010629842007NANANANANA
rs386526551180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007NANANANANA
rs386526551180069257515XRCC1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0623894952007NANANANANA
rs386526551180069254255MGMTumls:C1527249BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0333226752007NANANANANA
rs386526551166339204255MGMTumls:C0009402BeFreeO6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).0.0143864192006NANANANANA
rs386526551166339202099ESR1umls:C1527249BeFreeOur results suggest that the common Leu84Phe and Ile143Val polymorphisms in MGMT influence risk of colorectal cancer in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.0.0121825472006NANANANANA
rs386526551180069257515XRCC1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0126818232007NANANANANA
rs386526551166339202099ESR1umls:C0009402BeFreeOur results suggest that the common Leu84Phe and Ile143Val polymorphisms in MGMT influence risk of colorectal cancer in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.0.0038001862006NANANANANA
rs386526551180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007NANANANANA
rs38652655118006925142PARP1umls:C0009402BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0032573022007NANANANANA
rs386526551180069254255MGMTumls:C0009402BeFreeWe observed a positive association between the PARP codon 940 Lys/Arg and Arg/Arg genotypes and colorectal cancer risk [odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.1-3.1], and an inverse association between the MGMT codon 84 Leu/Phe or Phe/Phe genotypes and colon cancer risk (OR, 0.6; 95% CI, 0.3-0.9), but not rectal cancer (test of heterogeneity by tumor site, P=0.027).0.0143864192007NANANANANA
rs386526551166339204255MGMTumls:C1527249BeFreeO6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).0.0333226752006NANANANANA
rs386526551180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007NANANANANA
rs386526551180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007NANANANANA
rs3865450441899600511200CHEK2umls:C1527249BeFreeThe CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.0.0262651862009NANANANANA
rs3865450442371394711200CHEK2umls:C1527249BeFreeThis meta-analysis demonstrates that the CHEK2 I157T variant was an important cancer gene, which increases cancer risk, especially in breast and colorectal cancer in Caucasian, and the bioinformatic analysis showed this change was mainly attributed to the decreased hydrophobicity of CHEK2 157T.0.0262651862013NANANANANA
rs3865450442371394711200CHEK2umls:C0009402BeFreeThis meta-analysis demonstrates that the CHEK2 I157T variant was an important cancer gene, which increases cancer risk, especially in breast and colorectal cancer in Caucasian, and the bioinformatic analysis showed this change was mainly attributed to the decreased hydrophobicity of CHEK2 157T.0.0070574892013NANANANANA
rs386545044229011701111CHEK1umls:C0009402BeFreeThe cell cycle checkpoint kinase 2 (CHEK2) gene I157T variant may be associated with an increased risk of colorectal cancer, but it is unclear whether the evidence is sufficient to recommend testing for the mutation in clinical practice.0.0016286512012NANANANANA
rs3865450442229477011200CHEK2umls:C1527249BeFreeRare variants in CHEK2 (I157T and possibly del1100C) also appear to be associated with CRC risk.0.0262651862012NANANANANA
rs386545044229011701111CHEK1umls:C1527249BeFreeThe cell cycle checkpoint kinase 2 (CHEK2) gene I157T variant may be associated with an increased risk of colorectal cancer, but it is unclear whether the evidence is sufficient to recommend testing for the mutation in clinical practice.0.0042671252012NANANANANA
rs3865450442290117011200CHEK2umls:C0009402BeFreeThe CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.0.0070574892012NANANANANA
rs3865450442229477011200CHEK2umls:C0009402BeFreeRare variants in CHEK2 (I157T and possibly del1100C) also appear to be associated with CRC risk.0.0070574892012NANANANANA
rs3865450441899600511200CHEK2umls:C0009402BeFreeThe CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.0.0070574892009NANANANANA
rs3865450441681602111200CHEK2umls:C1527249BeFreeCHEK2 I157T associates with familial and sporadic colorectal cancer.0.0262651862006NANANANANA
rs3865450442252156211200CHEK2umls:C0009402BeFreeOur result demonstrate for the first time that CHEK2 1100delC, IVS2+1G>A and I157T mutations have not been agenetic susceptibility factor for CRC in the Turkish population.0.0070574892012NANANANANA
rs3865450442252156211200CHEK2umls:C1527249BeFreeOur result demonstrate for the first time that CHEK2 1100delC, IVS2+1G>A and I157T mutations have not been agenetic susceptibility factor for CRC in the Turkish population.0.0262651862012NANANANANA
rs3865450442290117011200CHEK2umls:C1527249BeFreeThe CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.0.0262651862012NANANANANA
rs3865450441681602111200CHEK2umls:C0009402BeFreeCHEK2 I157T associates with familial and sporadic colorectal cancer.0.0070574892006NANANANANA
rs3865450442065872811200CHEK2umls:C1527249BeFreeCHEK2 I157T and colorectal cancer in Bulgaria.0.0262651862010NANANANANA
rs3865450442065872811200CHEK2umls:C0009402BeFreeCHEK2 I157T and colorectal cancer in Bulgaria.0.0070574892010NANANANANA
rs386545546188067527515XRCC1umls:C0009402BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0126818232008NANANANANA
rs386545546180069252068ERCC2umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0104343432007NANANANANA
rs386545546210371067515XRCC1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0623894952010NANANANANA
rs386545546210371064968OGG1umls:C1527249BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0296420412010NANANANANA
rs386545546180069254968OGG1umls:C0009402BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0062431632007NANANANANA
rs386545546216129987515XRCC1umls:C1527249BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0623894952011NANANANANA
rs386545546210371064968OGG1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0062431632010NANANANANA
rs386545546238572817515XRCC1umls:C1527249BeFreeThe present meta-analysis suggests that the XRCC1 Arg194Trp polymorphism may modify the risk for CRC, particularly colon cancer.0.0623894952013NANANANANA
rs386545546180069252068ERCC2umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0575035412007NANANANANA
rs386545546216129987515XRCC1umls:C0009402BeFreeNo association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.0.0126818232011NANANANANA
rs386545546180069254968OGG1umls:C1527249BeFreeIn the present study, we investigated the role in colorectal cancer of single-nucleotide polymorphisms in five DNA repair genes: XRCC1 (Arg(194)Trp and Arg(399)Gln), PARP (Val(762)Ala, Lys(940)Arg), XPD (Asp(312)Asn, Lys(751)Gln), OGG1 (Ser(326)Cys), and MGMT (Leu(84)Phe).0.0296420412007NANANANANA
rs386545546188067527515XRCC1umls:C1527249BeFreeNo association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.0.0623894952008NANANANANA
rs386545546238572817515XRCC1umls:C0009402BeFreeThe present meta-analysis suggests that the XRCC1 Arg194Trp polymorphism may modify the risk for CRC, particularly colon cancer.0.0126818232013NANANANANA
rs386545546210371067515XRCC1umls:C0009402BeFreeUsing a family-based study, we investigated the role of polymorphisms in 4 BER genes (APEX1 Gln51His, Asp148Glu; OGG1 Ser236Cys; PARP Val742Ala; and XRCC1 Arg194Trp, Arg280His, Arg399Gln) as potential CRC risk factors and modifiers of the association between diets high in red meat or poultry and CRC risk.0.0126818232010NANANANANA
rs386545580224596151545CYP1B1umls:C1527249BeFreeCYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.0.0298375382012NANANANANA
rs386545580224596151545CYP1B1umls:C0009402BeFreeCYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.0.0032573022012NANANANANA
rs386545618170007064524MTHFRumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.1068727452006NANANANANA
rs386545618170007064524MTHFRumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0263298622006NANANANANA
rs38654561817000706472ATMumls:C0009402BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0024429772006NANANANANA
rs38654561817000706472ATMumls:C1527249BeFreeFurther SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L [OR=1.48; 95% confidence interval (CI): 1.06-2.07] and P1054R (OR=1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95% CI: 0.69-0.97).0.0039956832006NANANANANA
rs38655629324248547177AGERumls:C1527249BeFreeIn conclusion, the RAGE gene Gly82Ser polymorphism may confer not only an increased risk of CRC but also an increased invasion of CRC in the Chinese population.0.0002714422013NANANANANA
rs386559608186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008NANANANANA
rs386559608186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008NANANANANA
rs3865596081861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008NANANANANA
rs3865596081861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008NANANANANA
rs3865596081861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008NANANANANA
rs386559608186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008NANANANANA
rs3865596081861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008NANANANANA
rs38655960818619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008NANANANANA
rs386559608186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008NANANANANA
rs386559608186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008NANANANANA
rs38655960818619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008NANANANANA
rs386559608186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008NANANANANA
rs38655960818619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008NANANANANA
rs3865596081861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008NANANANANA
rs3865596081861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008NANANANANA
rs38655960818619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008NANANANANA
rs3865596081861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008NANANANANA
rs386559608186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008NANANANANA
rs386559608186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008NANANANANA
rs3865596081861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008NANANANANA
rs386561660243853047508XPCumls:C1527249BeFreeXPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.0.0074484832013NANANANANA
rs386561660243853047508XPCumls:C0009402BeFreeXPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.0.0032573022013NANANANANA
rs386561660253555957508XPCumls:C0009402BeFreeIndividuals with variant genotypes of XPC Ala499Val appeared to be associated with the increased risk of CRC.0.0032573022014NANANANANA
rs386561660253555957508XPCumls:C1527249BeFreeIndividuals with variant genotypes of XPC Ala499Val appeared to be associated with the increased risk of CRC.0.0074484832014NANANANANA
rs386596027172242357157TP53umls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0847340642007NANANANANA
rs386596027172242357157TP53umls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.162007NANANANANA
rs386596027160545676041RNASELumls:C0009402BeFreeArg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.0.0008143262005NANANANANA
rs386596027172242356041RNASELumls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0031813582007NANANANANA
rs386596027160545676041RNASELumls:C1527249BeFreeArg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.0.0031813582005NANANANANA
rs386596027172242356041RNASELumls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0008143262007NANANANANA
rs391957213828703309HSPA5umls:C1527249BeFreeGRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.0.0021715352011HSPA5;GAPVD19125241745TC
rs391957213828703309HSPA5umls:C0009402BeFreeGRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.0.0021715352011HSPA5;GAPVD19125241745TC
rs391957238189653309HSPA5umls:C1527249BeFreeThese data provide the first evidence that GRP78 rs391957 and rs430397 polymorphisms could serve as markers to predict the risk of CRC.0.0021715352013HSPA5;GAPVD19125241745TC
rs391957238189653309HSPA5umls:C0009402BeFreeThese data provide the first evidence that GRP78 rs391957 and rs430397 polymorphisms could serve as markers to predict the risk of CRC.0.0021715352013HSPA5;GAPVD19125241745TC
rs39750744412020105875CBSumls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0008143262002MTHFR111794407TG
rs397507444178556934524MTHFRumls:C1527249BeFreeInfluence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.0.1068727452007MTHFR111794407TG
rs397507444120201054524MTHFRumls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0263298622002MTHFR111794407TG
rs397507444196697694524MTHFRumls:C1527249BeFreeAssociation of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.0.1068727452010MTHFR111794407TG
rs397507444120201054524MTHFRumls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.1068727452002MTHFR111794407TG
rs397507444120201054552MTRRumls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0355814252002MTHFR111794407TG
rs397507444188047024524MTHFRumls:C0009402BeFreeCertain common polymorphisms within the MTHFR gene (C677T, A1298C) result in reduced enzymatic activity and have been associated with reduced risk for a variety of cancers such as acute lymphocytic leukemia, lung and colorectal cancer.0.0263298622008MTHFR111794407TG
rs397507444170890704524MTHFRumls:C1527249BeFreeDifferent roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis.0.1068727452007MTHFR111794407TG
rs397507444227192224548MTRumls:C1527249BeFreeNo significant association was found between MTHFR A1298C and MTR A2756G polymorphisms and the risk of CRC.0.0424110792012MTHFR111794407TG
rs397507444201938474524MTHFRumls:C1527249BeFreeWe aimed to test the hypothesis that C677T and A1298C variants of MTHFR predispose to microsatellite instable (MSI) colorectal cancer.0.1068727452010MTHFR111794407TG
rs397507444188047024524MTHFRumls:C1527249BeFreeCertain common polymorphisms within the MTHFR gene (C677T, A1298C) result in reduced enzymatic activity and have been associated with reduced risk for a variety of cancers such as acute lymphocytic leukemia, lung and colorectal cancer.0.1068727452008MTHFR111794407TG
rs397507444155465094524MTHFRumls:C0009402BeFreeMethylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study.0.0263298622004MTHFR111794407TG
rs397507444227192224548MTRumls:C0009402BeFreeNo significant association was found between MTHFR A1298C and MTR A2756G polymorphisms and the risk of CRC.0.0021715352012MTHFR111794407TG
rs397507444170890704524MTHFRumls:C0009402BeFreeDifferent roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis.0.0263298622007MTHFR111794407TG
rs397507444252920544524MTHFRumls:C1527249BeFreeMethylenetetrahydrofolate reductase gene germ-line C677T and A1298C SNPs are associated with colorectal cancer risk in the Turkish population.0.1068727452015MTHFR111794407TG
rs397507444200768184524MTHFRumls:C0009402BeFreeC677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer.0.0263298622009MTHFR111794407TG
rs397507444178556934524MTHFRumls:C0009402BeFreeInfluence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.0.0263298622007MTHFR111794407TG
rs397507444155465094524MTHFRumls:C1527249BeFreeMethylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study.0.1068727452004MTHFR111794407TG
rs39750744412020105875CBSumls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0129209272002MTHFR111794407TG
rs397507444261110494524MTHFRumls:C0009402BeFreeMethylenetetrahydrofolate reductase C677T and A1298C polymorphisms and fluorouracil-based treatment in Taiwan colorectal cancer.0.0263298622015MTHFR111794407TG
rs397507444261110494524MTHFRumls:C1527249BeFreeMethylenetetrahydrofolate reductase C677T and A1298C polymorphisms and fluorouracil-based treatment in Taiwan colorectal cancer.0.1068727452015MTHFR111794407TG
rs397507444196697694524MTHFRumls:C0009402BeFreeAssociation of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.0.0263298622010MTHFR111794407TG
rs397507444201938474524MTHFRumls:C0009402BeFreeWe aimed to test the hypothesis that C677T and A1298C variants of MTHFR predispose to microsatellite instable (MSI) colorectal cancer.0.0263298622010MTHFR111794407TG
rs39750744412020105102724560LOC102724560umls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0008143262002MTHFR111794407TG
rs397507444200768184524MTHFRumls:C1527249BeFreeC677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer.0.1068727452009MTHFR111794407TG
rs39750744412020105102724560LOC102724560umls:C1527249BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0010857672002MTHFR111794407TG
rs397507444120201054552MTRRumls:C0009402BeFreeThis population-based case-control study was designed to investigate the interrelationships between polymorphisms in the methylenetetrahydrofolate (MTHFR C677T and A1298C) gene and other genes (MTR A2756G; MTRR A66G and CBS 844ins68), intake of B-vitamins and colorectal cancer risk (CRC).0.0024429772002MTHFR111794407TG
rs397507444252920544524MTHFRumls:C0009402BeFreeMethylenetetrahydrofolate reductase gene germ-line C677T and A1298C SNPs are associated with colorectal cancer risk in the Turkish population.0.0263298622015MTHFR111794407TG
rs406193198436711789DNMT3Bumls:C0009402BeFreeThe MTR 2756GG genotype was associated with increased colorectal cancer risk (incidence rate ratio, 1.58; P = 0.04), and inverse associations were observed among women carrying DNMT3b C-->T (rs406193; incidence rate ratio, 0.72; P = 0.04) or EHMT2 G-->A (rs535586; incidence rate ratio, 0.76; P = 0.05) polymorphisms.0.0032573022009NA2032811837TC
rs406193209600501789DNMT3Bumls:C1527249BeFreeAmong 609 CRC cases and 1,663 subcohort members of the Netherlands Cohort Study on diet and cancer (n = 120,852), we estimated CRC risk according to methyl donor intake across genotypes of folate metabolizing enzymes and methyltransferases.Although diet-gene interactions were not statistically significant, methionine intake was inversely associated with CRC among subjects having both common rs2424913 and rs406193 DNMT3B C > T genotypes (highest versus lowest tertile: RR = 0.44; p (trend) = 0.05).0.012725432011NA2032811837TC
rs406193198436711789DNMT3Bumls:C1527249BeFreeThe MTR 2756GG genotype was associated with increased colorectal cancer risk (incidence rate ratio, 1.58; P = 0.04), and inverse associations were observed among women carrying DNMT3b C-->T (rs406193; incidence rate ratio, 0.72; P = 0.04) or EHMT2 G-->A (rs535586; incidence rate ratio, 0.76; P = 0.05) polymorphisms.0.012725432009NA2032811837TC
rs406193209600501789DNMT3Bumls:C0009402BeFreeAmong 609 CRC cases and 1,663 subcohort members of the Netherlands Cohort Study on diet and cancer (n = 120,852), we estimated CRC risk according to methyl donor intake across genotypes of folate metabolizing enzymes and methyltransferases.Although diet-gene interactions were not statistically significant, methionine intake was inversely associated with CRC among subjects having both common rs2424913 and rs406193 DNMT3B C > T genotypes (highest versus lowest tertile: RR = 0.44; p (trend) = 0.05).0.0032573022011NA2032811837TC
rs4143094247438402625GATA3umls:C1527249GWASCATGenome-wide diet-gene interaction analyses for risk of colorectal cancer.0.122014GATA3;LOC105376502108047173TG
rs419598231926173552IL1Aumls:C1527249BeFreeWe investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer.0.0058198312013IL1RN2113129630TC
rs419598231926173552IL1Aumls:C0009402BeFreeWe investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer.0.0010857672013IL1RN2113129630TC
rs430397238189653309HSPA5umls:C0009402BeFreeThese data provide the first evidence that GRP78 rs391957 and rs430397 polymorphisms could serve as markers to predict the risk of CRC.0.0021715352013HSPA59125238840CT
rs430397238189653309HSPA5umls:C1527249BeFreeThese data provide the first evidence that GRP78 rs391957 and rs430397 polymorphisms could serve as markers to predict the risk of CRC.0.0021715352013HSPA59125238840CT
rs4444235223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012NA1453944201TC
rs44442352236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012NA1453944201TC
rs444423525647270652BMP4umls:C0009402BeFreeOur findings demonstrated that BMP4-rs4444235 is a risk factor associated with increased CRC and CRA susceptibility, but these associations vary in different ethnic populations.0.0038001862014NA1453944201TC
rs4444235223634409787DLGAP5umls:C0009402BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012NA1453944201TC
rs44442352236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012NA1453944201TC
rs4444235223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012NA1453944201TC
rs444423522367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012NA1453944201TC
rs444423519011631652BMP4umls:C1527249GAD[We identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).]0.0132683142008NA1453944201TC
rs444423522367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012NA1453944201TC
rs444423522158048652BMP4umls:C0009402BeFreeAllele-specific expression studies in CRC cell lines heterozygous for rs4444235 showed significantly increased expression of bone morphogenetic protein-4 (BMP4) associated with the risk allele (P<0.001).0.0038001862012NA1453944201TC
rs444423524932582652BMP4umls:C1527249BeFreeThe common variant rs4444235 near BMP4 confers genetic susceptibility of colorectal cancer: an updated meta-analysis based on a comprehensive statistical strategy.0.0132683142014NA1453944201TC
rs4444235223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012NA1453944201TC
rs444423525647270652BMP4umls:C1527249BeFreeOur findings demonstrated that BMP4-rs4444235 is a risk factor associated with increased CRC and CRA susceptibility, but these associations vary in different ethnic populations.0.0132683142014NA1453944201TC
rs4444235223634409787DLGAP5umls:C1527249BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012NA1453944201TC
rs444423522367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012NA1453944201TC
rs444423524932582652BMP4umls:C0009402BeFreeThe common variant rs4444235 near BMP4 confers genetic susceptibility of colorectal cancer: an updated meta-analysis based on a comprehensive statistical strategy.0.0038001862014NA1453944201TC
rs444423522367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012NA1453944201TC
rs444423522363440509ATP5C1umls:C0009402BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012NA1453944201TC
rs444423522363440509ATP5C1umls:C1527249BeFreeWe observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples.0.0002714422012NA1453944201TC
rs444423522367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012NA1453944201TC
rs4444235223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012NA1453944201TC
rs444423522158048652BMP4umls:C1527249BeFreeAllele-specific expression studies in CRC cell lines heterozygous for rs4444235 showed significantly increased expression of bone morphogenetic protein-4 (BMP4) associated with the risk allele (P<0.001).0.0132683142012NA1453944201TC
rs444423519011631652BMP4umls:C1527249BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0132683142008NA1453944201TC
rs444423522367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012NA1453944201TC
rs444423519011631652BMP4umls:C0009402BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0038001862008NA1453944201TC
rs4444903215672711950EGFumls:C1527249BeFreeEffect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.0.0266125732012EGF4109912954AG
rs4444903215672711950EGFumls:C0009402BeFreeEffect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.0.0108576752012EGF4109912954AG
rs4464148212218124092SMAD7umls:C1527249BeFreeTwo previous genome-wide association studies identified three single nucleotide polymorphisms (SNPs) (rs4939827, rs12953717 and rs4464148) in SMAD7 to be associated with colorectal cancer in a Western population.0.1623674712011SMAD71848932662TC
rs4464148193573494092SMAD7umls:C0009402BeFreeTwo recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.0.0092290242009SMAD71848932662TC
rs4464148212218124092SMAD7umls:C0009402BeFreeTwo previous genome-wide association studies identified three single nucleotide polymorphisms (SNPs) (rs4939827, rs12953717 and rs4464148) in SMAD7 to be associated with colorectal cancer in a Western population.0.0092290242011SMAD71848932662TC
rs4464148193573494092SMAD7umls:C1527249BeFreeTwo recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.0.1623674712009SMAD71848932662TC
rs45955215824157324APCumls:C1527249BeFreeAPC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.0.242005APC5112841059TA
rs45955215824157324APCumls:C0009402BeFreeAPC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.0.0757322822005APC5112841059TA
rs45955217556698324APCumls:C1527249BeFreeThe D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons.0.242007APC5112841059TA
rs45955218343606324APCumls:C0009402BeFreeThis study seeks to determine whether there is any association of the I1307K, E1317Q and D1822V variants within the Adenomatous polyposis coli gene (APC) and risk to develop colorectal cancer in Tunisian population.0.0757322822009APC5112841059TA
rs45955218343606324APCumls:C1527249BeFreeThis study seeks to determine whether there is any association of the I1307K, E1317Q and D1822V variants within the Adenomatous polyposis coli gene (APC) and risk to develop colorectal cancer in Tunisian population.0.242009APC5112841059TA
rs45955217556698324APCumls:C0009402BeFreeThe D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons.0.0757322822007APC5112841059TA
rs4596225818362965GTF2H1umls:C1527249BeFreeRs7356 in RPA2 and rs4596 in GTF2H1 were associated with colorectal cancer risk.0.0010857672012GTF2H11118366581GC
rs45962258183684172POLR1Bumls:C0009402BeFreeRs7356 in RPA2 and rs4596 in GTF2H1 were associated with colorectal cancer risk.0.0002714422012GTF2H11118366581GC
rs4596225818362965GTF2H1umls:C0009402BeFreeRs7356 in RPA2 and rs4596 in GTF2H1 were associated with colorectal cancer risk.0.0013572092012GTF2H11118366581GC
rs45962258183684172POLR1Bumls:C1527249BeFreeRs7356 in RPA2 and rs4596 in GTF2H1 were associated with colorectal cancer risk.0.0002714422012GTF2H11118366581GC
rs463196224968322894CCND2umls:C1527249BeFreeWe found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population.0.1205428842014CCND2-AS1124263966AG
rs463196224968322894CCND2umls:C0009402BeFreeWe found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population.0.0002714422014CCND2-AS1124263966AG
rs4659744206158904548MTRumls:C0009402BeFreeThese two linked (r(2) = 0.99) tagSNPs and one tagSNP in the MTR gene (rs4659744) were significantly associated with reduced colorectal cancer risk only among individuals not using multivitamin supplements.0.0021715352010MTR1236896158GC
rs4659744206158904548MTRumls:C1527249BeFreeThese two linked (r(2) = 0.99) tagSNPs and one tagSNP in the MTR gene (rs4659744) were significantly associated with reduced colorectal cancer risk only among individuals not using multivitamin supplements.0.0424110792010MTR1236896158GC
rs477958422367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012NA1532702555TC
rs47795842165508926585GREM1umls:C0009402BeFreeNear GREM1, we found using fine-mapping that the previously-identified association between tagSNP rs4779584 and CRC actually resulted from two independent signals represented by rs16969681 (P = 5.33×10(-8)) and rs11632715 (P = 2.30×10(-10)).0.0032573022011NA1532702555TC
rs477958422367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012NA1532702555TC
rs4779584180842926447SCG5umls:C0009402BeFreeIn a large series of colorectal cancer cases and controls, SNPs near GREM1 and SCG5 were strongly associated with increased CRC risk (for rs4779584, P = 4.44 x 10(-14)).0.0005428842008NA1532702555TC
rs477958422367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012NA1532702555TC
rs4779584238756894092SMAD7umls:C1527249BeFreeAmong the European CRC-susceptibility SNPs, rs4939827 in SMAD7 was associated with a significant decreased risk of Korean CRC (age-/gender-adjusted odds ratio [95% confidence interval]: additive model, 0.67 [95% CI, 0.47-0.95]; dominant model, 0.59 [95% CI, 0.39-0.91]). rs4779584 and rs10795668 were associated with CRC risk in females and males, respectively.0.1623674712013NA1532702555TC
rs477958422367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012NA1532702555TC
rs47795842458699726585GREM1umls:C1527249BeFreeGREM1-SCG5 rs4779584 polymorphisms may increase the risk of developing colorectal cancer.0.1256243342014NA1532702555TC
rs477958422367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012NA1532702555TC
rs47795842165508926585GREM1umls:C1527249BeFreeNear GREM1, we found using fine-mapping that the previously-identified association between tagSNP rs4779584 and CRC actually resulted from two independent signals represented by rs16969681 (P = 5.33×10(-8)) and rs11632715 (P = 2.30×10(-10)).0.1256243342011NA1532702555TC
rs477958422367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012NA1532702555TC
rs4779584180842926447SCG5umls:C1527249BeFreeIn a large series of colorectal cancer cases and controls, SNPs near GREM1 and SCG5 were strongly associated with increased CRC risk (for rs4779584, P = 4.44 x 10(-14)).0.0005428842008NA1532702555TC
rs47795842458699726585GREM1umls:C0009402BeFreeGREM1-SCG5 rs4779584 polymorphisms may increase the risk of developing colorectal cancer.0.0032573022014NA1532702555TC
rs4779584223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012NA1532702555TC
rs47795842236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012NA1532702555TC
rs4779584223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012NA1532702555TC
rs4779584223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012NA1532702555TC
rs4779584223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012NA1532702555TC
rs4779584245869976447SCG5umls:C0009402BeFreeGREM1-SCG5 rs4779584 polymorphisms may increase the risk of developing colorectal cancer.0.0005428842014NA1532702555TC
rs4779584245869976447SCG5umls:C1527249BeFreeGREM1-SCG5 rs4779584 polymorphisms may increase the risk of developing colorectal cancer.0.0005428842014NA1532702555TC
rs4779584238756894092SMAD7umls:C0009402BeFreeAmong the European CRC-susceptibility SNPs, rs4939827 in SMAD7 was associated with a significant decreased risk of Korean CRC (age-/gender-adjusted odds ratio [95% confidence interval]: additive model, 0.67 [95% CI, 0.47-0.95]; dominant model, 0.59 [95% CI, 0.39-0.91]). rs4779584 and rs10795668 were associated with CRC risk in females and males, respectively.0.0092290242013NA1532702555TC
rs47795842236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012NA1532702555TC
rs481380221655089652BMP4umls:C0009402BeFreeWe identified new, independent CRC predisposition SNPs close to BMP4 (rs1957636, P = 3.93×10(-10)) and BMP2 (rs4813802, P = 4.65×10(-11)).0.0038001862011NA206718948TG
rs481380221655089652BMP4umls:C1527249BeFreeWe identified new, independent CRC predisposition SNPs close to BMP4 (rs1957636, P = 3.93×10(-10)) and BMP2 (rs4813802, P = 4.65×10(-11)).0.0132683142011NA206718948TG
rs4848306241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013NA2112840530GA
rs4848306241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013NA2112840530GA
rs48493032474384055289ACOXLumls:C1527249GWASCATGenome-wide diet-gene interaction analyses for risk of colorectal cancer.0.122014ACOXL2110970905CT
rs486907160545676041RNASELumls:C0009402BeFreeArg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.0.0008143262005RNASEL1182585422CT
rs486907172242357157TP53umls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.162007RNASEL1182585422CT
rs486907172242356041RNASELumls:C1527249BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0031813582007RNASEL1182585422CT
rs486907172242356041RNASELumls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0008143262007RNASEL1182585422CT
rs486907160545676041RNASELumls:C1527249BeFreeArg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.0.0031813582005RNASEL1182585422CT
rs486907172242357157TP53umls:C0009402BeFreeWe have previously reported that the common, functionally different variants Arg72Pro in p53 and Arg462Gln in RNASEL are associated with the age of disease onset of colorectal cancer in Lynch syndrome patients.0.0847340642007RNASEL1182585422CT
rs491951022606253693193MIR608umls:C0009402BeFreers4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer.0.0008143262012SEMA4G;MIR60810100975021CG
rs491951022606253693193MIR608umls:C1527249BeFreers4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer.0.0008143262012SEMA4G;MIR60810100975021CG
rs4925386209724403911LAMA5umls:C1527249GWASCATMeta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.0.1202714422010LAMA52062345988TC
rs4938723231837477157TP53umls:C1527249BeFreeWe aimed to investigate the association between miR-34b/c rs4938723 and TP53 Arg72Pro polymorphisms and the risk of CRC.0.162013BTG4;MIR34B;MIR34C11111511840TC
rs4938723231837477157TP53umls:C0009402BeFreeWe aimed to investigate the association between miR-34b/c rs4938723 and TP53 Arg72Pro polymorphisms and the risk of CRC.0.0847340642013BTG4;MIR34B;MIR34C11111511840TC
rs4939827193573494092SMAD7umls:C0009402BeFreeTwo recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.0.0092290242009SMAD71848927093TC
rs493982722367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012SMAD71848927093TC
rs4939827212422604092SMAD7umls:C1527249BeFreeMoreover, we found cumulative effects of three genetic factors (rs7758229, rs6983267, and rs4939827 in SMAD7) and one environmental factor (alcohol drinking) which appear to increase CRC risk approximately twofold.0.1623674712011SMAD71848927093TC
rs4939827179344614092SMAD7umls:C1527249GWASCATA genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk.0.1623674712007SMAD71848927093TC
rs4939827240660934092SMAD7umls:C1527249BeFreeSMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population.0.1623674712013SMAD71848927093TC
rs4939827240660934092SMAD7umls:C0009402BeFreeSMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population.0.0092290242013SMAD71848927093TC
rs4939827217611384092SMAD7umls:C1527249GWASCATMeta-analysis of new genome-wide association studies of colorectal cancer risk.0.1623674712012SMAD71848927093TC
rs493982722367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012SMAD71848927093TC
rs4939827232665564092SMAD7umls:C1527249GWASCATIdentification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.0.1623674712013SMAD71848927093TC
rs4939827179344614092SMAD7umls:C1527249GAD[A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk.]0.1623674712007SMAD71848927093TC
rs4939827238756894092SMAD7umls:C1527249BeFreeAmong the European CRC-susceptibility SNPs, rs4939827 in SMAD7 was associated with a significant decreased risk of Korean CRC (age-/gender-adjusted odds ratio [95% confidence interval]: additive model, 0.67 [95% CI, 0.47-0.95]; dominant model, 0.59 [95% CI, 0.39-0.91]). rs4779584 and rs10795668 were associated with CRC risk in females and males, respectively.0.1623674712013SMAD71848927093TC
rs493982722367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012SMAD71848927093TC
rs4939827223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012SMAD71848927093TC
rs4939827193573494092SMAD7umls:C1527249BeFreeTwo recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.0.1623674712009SMAD71848927093TC
rs493982722367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012SMAD71848927093TC
rs4939827212422604092SMAD7umls:C0009402BeFreeMoreover, we found cumulative effects of three genetic factors (rs7758229, rs6983267, and rs4939827 in SMAD7) and one environmental factor (alcohol drinking) which appear to increase CRC risk approximately twofold.0.0092290242011SMAD71848927093TC
rs49398272236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012SMAD71848927093TC
rs4939827238756894092SMAD7umls:C0009402BeFreeAmong the European CRC-susceptibility SNPs, rs4939827 in SMAD7 was associated with a significant decreased risk of Korean CRC (age-/gender-adjusted odds ratio [95% confidence interval]: additive model, 0.67 [95% CI, 0.47-0.95]; dominant model, 0.59 [95% CI, 0.39-0.91]). rs4779584 and rs10795668 were associated with CRC risk in females and males, respectively.0.0092290242013SMAD71848927093TC
rs4939827223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012SMAD71848927093TC
rs4939827212218124092SMAD7umls:C1527249BeFreeTwo previous genome-wide association studies identified three single nucleotide polymorphisms (SNPs) (rs4939827, rs12953717 and rs4464148) in SMAD7 to be associated with colorectal cancer in a Western population.0.1623674712011SMAD71848927093TC
rs4939827212218124092SMAD7umls:C0009402BeFreeTwo previous genome-wide association studies identified three single nucleotide polymorphisms (SNPs) (rs4939827, rs12953717 and rs4464148) in SMAD7 to be associated with colorectal cancer in a Western population.0.0092290242011SMAD71848927093TC
rs49398272236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012SMAD71848927093TC
rs493982722367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012SMAD71848927093TC
rs493982722367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012SMAD71848927093TC
rs4939827183729014092SMAD7umls:C1527249GWASCATGenome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.0.1623674712008SMAD71848927093TC
rs4939827223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012SMAD71848927093TC
rs4939827223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012SMAD71848927093TC
rs49483172483628680114BICC1umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014BICC11058811675CT
rs4986790239498807099TLR4umls:C0009402BeFreePositive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.0.004343072013TLR49117713024AG
rs4986790168791997099TLR4umls:C0009402BeFreeIn conclusion, we report an association of microsatelite GT polymorphisms of TLR2 gene and Asp299Gly polymorphism of the TLR4 gene with sporadic colorectal cancer among Croatians.0.004343072006TLR49117713024AG
rs4986790244461823553IL1Bumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0174594942014TLR49117713024AG
rs4986790168791997099TLR4umls:C1527249BeFreeIn conclusion, we report an association of microsatelite GT polymorphisms of TLR2 gene and Asp299Gly polymorphism of the TLR4 gene with sporadic colorectal cancer among Croatians.0.0082628082006TLR49117713024AG
rs4986790244461826647SOD1umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0016286512014TLR49117713024AG
rs4986790244461826647SOD1umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0013572092014TLR49117713024AG
rs4986790244461827099TLR4umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0082628082014TLR49117713024AG
rs4986790244461823586IL10umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0128013752014TLR49117713024AG
rs4986790244461823553IL1Bumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0032573022014TLR49117713024AG
rs4986790239498807099TLR4umls:C1527249BeFreePositive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.0.0082628082013TLR49117713024AG
rs4986790244461823605IL17Aumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0054288372014TLR49117713024AG
rs4986790244461827099TLR4umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.004343072014TLR49117713024AG
rs4986790244461823586IL10umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0059717212014TLR49117713024AG
rs4986790244461823605IL17Aumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0057002792014TLR49117713024AG
rs4986791244461823605IL17Aumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0057002792014TLR49117713324CT
rs4986791244461823586IL10umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0059717212014TLR49117713324CT
rs4986791239498807099TLR4umls:C0009402BeFreePositive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.0.004343072013TLR49117713324CT
rs4986791244461827099TLR4umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.004343072014TLR49117713324CT
rs4986791244461823553IL1Bumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0032573022014TLR49117713324CT
rs4986791244461827099TLR4umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0082628082014TLR49117713324CT
rs4986791244461826647SOD1umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0013572092014TLR49117713324CT
rs4986791244461823605IL17Aumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0054288372014TLR49117713324CT
rs4986791244461826647SOD1umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0016286512014TLR49117713324CT
rs4986791244461823553IL1Bumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0174594942014TLR49117713324CT
rs4986791239498807099TLR4umls:C1527249BeFreePositive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.0.0082628082013TLR49117713324CT
rs4986791244461823586IL10umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0128013752014TLR49117713324CT
rs4988453241548724615MYD88umls:C1527249BeFreeMYD88 rs4988453, a SNP that maps to a promoter region shared with the acetyl coenzyme-A acyl-transferase-1 (ACAA1), was associated with decreased survival of patients with colorectal cancer and altered transcriptional activity of the proximal genes.0.0010857672014ACAA1;MYD88338137763CA
rs4988453241548724615MYD88umls:C0009402BeFreeMYD88 rs4988453, a SNP that maps to a promoter region shared with the acetyl coenzyme-A acyl-transferase-1 (ACAA1), was associated with decreased survival of patients with colorectal cancer and altered transcriptional activity of the proximal genes.0.0010857672014ACAA1;MYD88338137763CA
rs49884532415487230ACAA1umls:C0009402BeFreeMYD88 rs4988453, a SNP that maps to a promoter region shared with the acetyl coenzyme-A acyl-transferase-1 (ACAA1), was associated with decreased survival of patients with colorectal cancer and altered transcriptional activity of the proximal genes.0.0002714422014ACAA1;MYD88338137763CA
rs49884532415487230ACAA1umls:C1527249BeFreeMYD88 rs4988453, a SNP that maps to a promoter region shared with the acetyl coenzyme-A acyl-transferase-1 (ACAA1), was associated with decreased survival of patients with colorectal cancer and altered transcriptional activity of the proximal genes.0.0002714422014ACAA1;MYD88338137763CA
rs4998557244461826647SOD1umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0013572092014SOD12131662579GA
rs4998557244461823553IL1Bumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0174594942014SOD12131662579GA
rs4998557244461823605IL17Aumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0057002792014SOD12131662579GA
rs4998557244461827099TLR4umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.004343072014SOD12131662579GA
rs4998557244461826647SOD1umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0016286512014SOD12131662579GA
rs4998557244461823586IL10umls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0059717212014SOD12131662579GA
rs4998557244461823553IL1Bumls:C0009402BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0032573022014SOD12131662579GA
rs4998557244461823605IL17Aumls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0054288372014SOD12131662579GA
rs4998557244461827099TLR4umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0082628082014SOD12131662579GA
rs4998557244461823586IL10umls:C1527249BeFreeA case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85).0.0128013752014SOD12131662579GA
rs521921602532221895JAZF1umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011KCNJ111117388025TC
rs5219216025328549LGR5umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0046145122011KCNJ111117388025TC
rs521921602532221895JAZF1umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011KCNJ111117388025TC
rs5219216025323767KCNJ11umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011KCNJ111117388025TC
rs5219216025327103TSPAN8umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011KCNJ111117388025TC
rs5219216025323767KCNJ11umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011KCNJ111117388025TC
rs5219216025328549LGR5umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0048859542011KCNJ111117388025TC
rs5219216025327103TSPAN8umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011KCNJ111117388025TC
rs5275235318635743PTGS2umls:C0009402BeFreeAn association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.0.0513025142013PTGS21186673926AG
rs5275235318635743PTGS2umls:C1527249BeFreeAn association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.0.0941805312013PTGS21186673926AG
rs5275241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013PTGS21186673926AG
rs5275241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013PTGS21186673926AG
rs5277248707485743PTGS2umls:C0009402BeFreeThe prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/ COX2) rs5277 polymorphism does not influence risk of colorectal cancer in an Iranian population.0.0513025142015PTGS2;PACERR1186679065CT,G
rs5277248707485743PTGS2umls:C1527249BeFreeThe prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/ COX2) rs5277 polymorphism does not influence risk of colorectal cancer in an Iranian population.0.0941805312015PTGS2;PACERR1186679065CT,G
rs535586198436711789DNMT3Bumls:C0009402BeFreeThe MTR 2756GG genotype was associated with increased colorectal cancer risk (incidence rate ratio, 1.58; P = 0.04), and inverse associations were observed among women carrying DNMT3b C-->T (rs406193; incidence rate ratio, 0.72; P = 0.04) or EHMT2 G-->A (rs535586; incidence rate ratio, 0.76; P = 0.05) polymorphisms.0.0032573022009EHMT2631892560TC
rs535586198436711789DNMT3Bumls:C1527249BeFreeThe MTR 2756GG genotype was associated with increased colorectal cancer risk (incidence rate ratio, 1.58; P = 0.04), and inverse associations were observed among women carrying DNMT3b C-->T (rs406193; incidence rate ratio, 0.72; P = 0.04) or EHMT2 G-->A (rs535586; incidence rate ratio, 0.76; P = 0.05) polymorphisms.0.012725432009EHMT2631892560TC
rs5498169375023576CXCL8umls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0067860472006ICAM1;ICAM4;LOC1053722721910285007AG
rs5498198220193383ICAM1umls:C0009402BeFreePolymorphisms of the ICAM-1 exon 6 (E469K) are associated with differentiation of colorectal cancer.0.0021715352009ICAM1;ICAM4;LOC1053722721910285007AG
rs5498198220193383ICAM1umls:C1527249BeFreePolymorphisms of the ICAM-1 exon 6 (E469K) are associated with differentiation of colorectal cancer.0.0069055992009ICAM1;ICAM4;LOC1053722721910285007AG
rs5498169375023576CXCL8umls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0257223032006ICAM1;ICAM4;LOC1053722721910285007AG
rs5498169375025468PPARGumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006ICAM1;ICAM4;LOC1053722721910285007AG
rs5498169375027124TNFumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0366235852006ICAM1;ICAM4;LOC1053722721910285007AG
rs5498169375025468PPARGumls:C1527249BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0389906172006ICAM1;ICAM4;LOC1053722721910285007AG
rs5498169375027124TNFumls:C0009402BeFreeWe studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.0.0111291172006ICAM1;ICAM4;LOC1053722721910285007AG
rs56053615154491734968OGG1umls:C1527249BeFreeMutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.0.0296420412004OGG139751845GA,T
rs56053615154491734968OGG1umls:C0009402BeFreeMutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.0.0062431632004OGG139751845GA,T
rs5788189921485742PTGS1umls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.0109012822008PTGS19122381513CA
rs5788189921484524MTHFRumls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.1068727452008PTGS19122381513CA
rs5788189921483576CXCL8umls:C1527249BeFreeThree SNPs were shown to increase CRC risk: PTGS1 c.639C>A (p.Gly213Gly), IL8 c.-352T>A, and MTHFR c.1286A>C (p.Ala429Glu).0.0257223032008PTGS19122381513CA
rs59336232665566926TBX3umls:C1527249GWASCATWe also provided evidence for an association between colorectal tumor risk and polymorphisms in laminin gamma 1 (this is the second gene in the laminin family to be associated with colorectal cancers), cyclin D2 (which encodes for cyclin D2), and T-box 3 (which encodes a T-box transcription factor and is a target of Wnt signaling to β-catenin).0.1202714422013TBX312114678547TA
rs5985214224082147F2umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0052769482011F13A166318562CT,A
rs5985214224084524MTHFRumls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0263298622011F13A166318562CT,A
rs5985214224085054SERPINE1umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0040716282011F13A166318562CT,A
rs5985214224084524MTHFRumls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.1068727452011F13A166318562CT,A
rs5985214224085054SERPINE1umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0109012822011F13A166318562CT,A
rs5985214224082147F2umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0005428842011F13A166318562CT,A
rs6022990245629711591CYP24A1umls:C1527249BeFreeTwo SNPs, rs16847024 in the GC gene and rs6022990 in the CYP24A1 gene, were nominally associated with left-sided CRC (p = 0.015 and p = 0.018, respectively).0.0016286512014CYP24A12054158993AG
rs6022990245629711591CYP24A1umls:C0009402BeFreeTwo SNPs, rs16847024 in the GC gene and rs6022990 in the CYP24A1 gene, were nominally associated with left-sided CRC (p = 0.015 and p = 0.018, respectively).0.0016286512014CYP24A12054158993AG
rs6025214224085054SERPINE1umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0040716282011F51169549811CT
rs6025214224082147F2umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0052769482011F51169549811CT
rs6025214224084524MTHFRumls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0263298622011F51169549811CT
rs6025214224085054SERPINE1umls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0109012822011F51169549811CT
rs6025214224084524MTHFRumls:C1527249BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.1068727452011F51169549811CT
rs6025214224082147F2umls:C0009402BeFreeFactor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study.0.0005428842011F51169549811CT
rs60380712061054153904MYO3Aumls:C1527249BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0026384742010NA20584433CT
rs6038071206105411459CSNK2A2umls:C0009402BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0005428842010NA20584433CT
rs60380712061054153904MYO3Aumls:C0009402BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0002714422010NA20584433CT
rs6038071206105411457CSNK2A1umls:C1527249BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0029099162010NA20584433CT
rs6038071206105411459CSNK2A2umls:C1527249BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0005428842010NA20584433CT
rs6038071206105411457CSNK2A1umls:C0009402BeFreeTwo other unreported SNPs, rs6038071, 40 kb upstream of CSNK2A1 (casein kinase 2, alpha 1 polypeptide) and an intronic marker in MYO3A (myosin IIIA), rs11014993, associated with CRC only in the familial CRC cases (P = 2.5 x 10(-3), recessive model, and P = 2.7 x 10(-4), dominant model).0.0008143262010NA20584433CT
rs61764370242821493845KRASumls:C1527249BeFreeUsing site-specific homologous recombination, we inserted the rs61764370:T>G KRAS gene variant in the colorectal cancer cell line SW48 (SW48 +SNP) and assessed the cellular and biochemical phenotype.0.162013KRAS1225207290AC
rs61764370242821493845KRASumls:C0009402BeFreeUsing site-specific homologous recombination, we inserted the rs61764370:T>G KRAS gene variant in the colorectal cancer cell line SW48 (SW48 +SNP) and assessed the cellular and biochemical phenotype.0.0823670322013KRAS1225207290AC
rs61886492151225972346FOLH1umls:C0009402BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0010857672004FOLH11149164722GA
rs61886492151225972346FOLH1umls:C1527249BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0081868632004FOLH11149164722GA
rs61886492151225974522MTHFD1umls:C0009402BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0008143262004FOLH11149164722GA
rs61886492151225974522MTHFD1umls:C1527249BeFreeWe examined whether polymorphisms in these genes, i.e., cSHMT L474F, MTHFD1 R653Q and GCPII H475Y, modify the risk of CRC in the prospective Physicians' Health Study.0.0150165172004FOLH11149164722GA
rs6375044795261674292MLH1umls:C0009402BeFreeIn a search for germline mutations in the DNA mismatch repair genes hMSH2 and hMLH1 in Chinese patients with colorectal cancer we identified a novel missense mutation (V384D) in exon 12 of the hMLH1 gene in 4 out of 26 individuals.0.0823670321998MLH1337025749TA
rs6375044795261674436MSH2umls:C0009402BeFreeIn a search for germline mutations in the DNA mismatch repair genes hMSH2 and hMLH1 in Chinese patients with colorectal cancer we identified a novel missense mutation (V384D) in exon 12 of the hMLH1 gene in 4 out of 26 individuals.0.0632459561998MLH1337025749TA
rs6375044795261674292MLH1umls:C1527249BeFreeIn a search for germline mutations in the DNA mismatch repair genes hMSH2 and hMLH1 in Chinese patients with colorectal cancer we identified a novel missense mutation (V384D) in exon 12 of the hMLH1 gene in 4 out of 26 individuals.0.161998MLH1337025749TA
rs6375044795261674436MSH2umls:C1527249BeFreeIn a search for germline mutations in the DNA mismatch repair genes hMSH2 and hMLH1 in Chinese patients with colorectal cancer we identified a novel missense mutation (V384D) in exon 12 of the hMLH1 gene in 4 out of 26 individuals.0.143788841998MLH1337025749TA
rs63750875174146044436MSH2umls:C1527249BeFreeSingle-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.0.143788842007MSH2247475171GC
rs63750875174146044436MSH2umls:C0009402BeFreeSingle-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.0.0632459562007MSH2247475171GC
rs63750875186746564436MSH2umls:C1527249BeFreeGenetic counseling and testing for the MSH2 A636P mutation is indicated for Ashkenazi Jewish women with an endometrial cancer, especially if the cancer is detected before the age of 70 years in women with a personal or family history of colorectal cancer.0.143788842008MSH2247475171GC
rs63750875186746564436MSH2umls:C0009402BeFreeGenetic counseling and testing for the MSH2 A636P mutation is indicated for Ashkenazi Jewish women with an endometrial cancer, especially if the cancer is detected before the age of 70 years in women with a personal or family history of colorectal cancer.0.0632459562008MSH2247475171GC
rs63751310201679754292MLH1umls:C1527249BeFreeR659X mutation in the MLH1 gene in hereditary non-polyposis colorectal cancer(HNPCC) in an Indian extended family.0.162010MLH1337048595CT
rs63751310201679754292MLH1umls:C0009402BeFreeR659X mutation in the MLH1 gene in hereditary non-polyposis colorectal cancer(HNPCC) in an Indian extended family.0.0823670322010MLH1337048595CT
rs64642112470618958508KMT2Cumls:C1527249BeFreeThe strongest association with CRC risk and survival was found for MLL3 (rs6464211, OR 1.50, p = 0.002, dominant model; HR 2.12, p = 0.020, recessive model).0.0008143262014KMT2C7152176768CT
rs64642112470618958508KMT2Cumls:C0009402BeFreeThe strongest association with CRC risk and survival was found for MLL3 (rs6464211, OR 1.50, p = 0.002, dominant model; HR 2.12, p = 0.020, recessive model).0.0005428842014KMT2C7152176768CT
rs64716123263487100996485C5orf66umls:C1527249GWASCATGenome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.0.122013C5orf665135163402CA
rs64716124836286100996485C5orf66umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014C5orf665135163402CA
rs6498486248616462072ERCC4umls:C1527249BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.005548392014ERCC4;LOC1053710931613919809AC
rs6498486248616462072ERCC4umls:C0009402BeFreeWe investigated the association between polymorphisms in excision repair cross-complementation group 1 (ERCC1) (rs3212986, rs2298881 and rs11615) and xeroderma pigmentosum-complementation group F (XPF) (rs2276466 and rs6498486) and risk of colorectal cancer.0.0008143262014ERCC4;LOC1053710931613919809AC
rs662256845295444PON1umls:C0009402BeFreeAssociation of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.0.0005428842015PON1795308134TC
rs662256845295444PON1umls:C1527249BeFreeAssociation of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.0.0029099162015PON1795308134TC
rs67119706845217ALDH2umls:C0009402BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0035287442009ALDH212111803962GA
rs67119706845217ALDH2umls:C1527249BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0248320322009ALDH212111803962GA
rs671197068451571CYP2E1umls:C1527249BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0424870232009ALDH212111803962GA
rs671197068451571CYP2E1umls:C0009402BeFreeA novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.0.0040716282009ALDH212111803962GA
rs67289402482227454575UGT1A10umls:C0009402BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014MROH2A2233780518GA
rs67289402482227454575UGT1A10umls:C1527249BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014MROH2A2233780518GA
rs67491583224295954609MYCumls:C0009402BeFreeCharacterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.0.0115960562012CASC8;CCAT28127401987GA-
rs67491583224295954609MYCumls:C1527249BeFreeCharacterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.0.0113246142012CASC8;CCAT28127401987GA-
rs689466241949233586IL10umls:C1527249BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0128013752013PTGS2;PACERR1186681619TC
rs689466241949233586IL10umls:C0009402BeFreeThe polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons.0.0059717212013PTGS2;PACERR1186681619TC
rs69645871861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008AKAP9792001306GT
rs6964587186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008AKAP9792001306GT
rs69645871861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008AKAP9792001306GT
rs696458718619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008AKAP9792001306GT
rs69645871861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008AKAP9792001306GT
rs696458718619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008AKAP9792001306GT
rs6964587186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008AKAP9792001306GT
rs696458718619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008AKAP9792001306GT
rs69645871861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008AKAP9792001306GT
rs69645871700070610142AKAP9umls:C0009402BeFreeOne SNP AKAP9 M463I remained significantly associated with CRC risk after stringent adjustment for multiple testing.0.0005428842006AKAP9792001306GT
rs69645871861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008AKAP9792001306GT
rs6964587186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008AKAP9792001306GT
rs69645871861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008AKAP9792001306GT
rs69645871861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008AKAP9792001306GT
rs6964587186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008AKAP9792001306GT
rs696458718619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008AKAP9792001306GT
rs6964587186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008AKAP9792001306GT
rs69645871861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008AKAP9792001306GT
rs69645871700070610142AKAP9umls:C1527249BeFreeOne SNP AKAP9 M463I remained significantly associated with CRC risk after stringent adjustment for multiple testing.0.0029099162006AKAP9792001306GT
rs6964587186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008AKAP9792001306GT
rs6964587186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008AKAP9792001306GT
rs6964587186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008AKAP9792001306GT
rs6983267248892123586IL10umls:C0009402BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0059717212014CASC8;CCAT28127401060GT
rs6983267224295956934TCF7L2umls:C0009402BeFreeIn our previous work, we showed that the colorectal cancer (CRC) risk variant rs6983267 at 8q24 resides within a TCF4 binding site at the MYC-335 enhancer, with the risk allele G having a stronger binding capacity and Wnt responsiveness.0.0114005592012CASC8;CCAT28127401060GT
rs698326721242260101805488CCAT2umls:C1527249GWASCATCommon variant in 6q26-q27 is associated with distal colon cancer in an Asian population.0.1202714422011CASC8;CCAT28127401060GT
rs6983267243171746934TCF7L2umls:C0009402BeFreeThe single nucleotide polymorphism (SNP) rs6983267 on chromosome 8q24 is a CRC susceptibility locus that affects binding activity of transcription factor 7 like-2 (TCF7L2) to CTNNB1, thereby altering expression of target oncogenes, including MYC.0.0114005592014CASC8;CCAT28127401060GT
rs6983267248892124609MYCumls:C0009402BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0115960562014CASC8;CCAT28127401060GT
rs698326722367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012CASC8;CCAT28127401060GT
rs6983267248892124609MYCumls:C1527249BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0113246142014CASC8;CCAT28127401060GT
rs6983267229763784609MYCumls:C0009402BeFreeThe rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.0.0115960562013CASC8;CCAT28127401060GT
rs6983267223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012CASC8;CCAT28127401060GT
rs6983267253154305462POU5F1Bumls:C1527249BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0002714422015CASC8;CCAT28127401060GT
rs698326724836286101805488CCAT2umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.1202714422014CASC8;CCAT28127401060GT
rs6983267206968994609MYCumls:C1527249BeFreeA region spanning the single nucleotide polymorphism rs6983267, which lies within a MYC enhancer and confers colorectal cancer risk in humans, represented one of many co-occupied sites.0.0113246142010CASC8;CCAT28127401060GT
rs6983267243171744609MYCumls:C1527249BeFreeThe single nucleotide polymorphism (SNP) rs6983267 on chromosome 8q24 is a CRC susceptibility locus that affects binding activity of transcription factor 7 like-2 (TCF7L2) to CTNNB1, thereby altering expression of target oncogenes, including MYC.0.0113246142014CASC8;CCAT28127401060GT
rs69832672236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012CASC8;CCAT28127401060GT
rs698326718372905101805488CCAT2umls:C1527249GWASCATA genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.0.1202714422008CASC8;CCAT28127401060GT
rs6983267215672711950EGFumls:C1527249BeFreeEffect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.0.0266125732012CASC8;CCAT28127401060GT
rs69832672236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012CASC8;CCAT28127401060GT
rs6983267253154305462POU5F1Bumls:C0009402BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0002714422015CASC8;CCAT28127401060GT
rs6983267215672711950EGFumls:C0009402BeFreeEffect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.0.0108576752012CASC8;CCAT28127401060GT
rs6983267248892123586IL10umls:C1527249BeFreeWe found indications that aspirin interacted with rs6983267 close to MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs interacted with rs3024505 and rs1800872 in or close to IL10 (encoding IL-10) in preventing CRC.0.0128013752014CASC8;CCAT28127401060GT
rs6983267229763784609MYCumls:C1527249BeFreeThe rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.0.0113246142013CASC8;CCAT28127401060GT
rs698326725315430101867536PRNCR1umls:C0009402BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0005428842015CASC8;CCAT28127401060GT
rs698326722367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012CASC8;CCAT28127401060GT
rs698326725315430101867536PRNCR1umls:C1527249BeFreeThese included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).0.0005428842015CASC8;CCAT28127401060GT
rs6983267206968994609MYCumls:C0009402BeFreeA region spanning the single nucleotide polymorphism rs6983267, which lies within a MYC enhancer and confers colorectal cancer risk in humans, represented one of many co-occupied sites.0.0115960562010CASC8;CCAT28127401060GT
rs6983267243171744609MYCumls:C0009402BeFreeThe single nucleotide polymorphism (SNP) rs6983267 on chromosome 8q24 is a CRC susceptibility locus that affects binding activity of transcription factor 7 like-2 (TCF7L2) to CTNNB1, thereby altering expression of target oncogenes, including MYC.0.0115960562014CASC8;CCAT28127401060GT
rs6983267212422604092SMAD7umls:C0009402BeFreeMoreover, we found cumulative effects of three genetic factors (rs7758229, rs6983267, and rs4939827 in SMAD7) and one environmental factor (alcohol drinking) which appear to increase CRC risk approximately twofold.0.0092290242011CASC8;CCAT28127401060GT
rs6983267243171741499CTNNB1umls:C0009402BeFreeAspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.0.0105862332014CASC8;CCAT28127401060GT
rs698326722367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012CASC8;CCAT28127401060GT
rs698326722367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012CASC8;CCAT28127401060GT
rs6983267223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012CASC8;CCAT28127401060GT
rs6983267195616074609MYCumls:C0009402BeFreeThe 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.0.0115960562009CASC8;CCAT28127401060GT
rs6983267223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012CASC8;CCAT28127401060GT
rs698326717618284101805488CCAT2umls:C1527249GWASCATA genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21.0.1202714422007CASC8;CCAT28127401060GT
rs6983267212422604092SMAD7umls:C1527249BeFreeMoreover, we found cumulative effects of three genetic factors (rs7758229, rs6983267, and rs4939827 in SMAD7) and one environmental factor (alcohol drinking) which appear to increase CRC risk approximately twofold.0.1623674712011CASC8;CCAT28127401060GT
rs6983267223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012CASC8;CCAT28127401060GT
rs698326723266556101805488CCAT2umls:C1527249GWASCATIdentification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.0.1202714422013CASC8;CCAT28127401060GT
rs698326722367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012CASC8;CCAT28127401060GT
rs6983267224295956934TCF7L2umls:C1527249BeFreeIn our previous work, we showed that the colorectal cancer (CRC) risk variant rs6983267 at 8q24 resides within a TCF4 binding site at the MYC-335 enhancer, with the risk allele G having a stronger binding capacity and Wnt responsiveness.0.1358631812012CASC8;CCAT28127401060GT
rs6983267195616074609MYCumls:C1527249BeFreeThe 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.0.0113246142009CASC8;CCAT28127401060GT
rs698326722367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012CASC8;CCAT28127401060GT
rs6983267243171746934TCF7L2umls:C1527249BeFreeThe single nucleotide polymorphism (SNP) rs6983267 on chromosome 8q24 is a CRC susceptibility locus that affects binding activity of transcription factor 7 like-2 (TCF7L2) to CTNNB1, thereby altering expression of target oncogenes, including MYC.0.1358631812014CASC8;CCAT28127401060GT
rs6983267243171741499CTNNB1umls:C1527249BeFreeAspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.0.1421499512014CASC8;CCAT28127401060GT
rs70401724836286283050ZMIZ1-AS1umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.122014ZMIZ1-AS11079059375AG
rs7098052228240023199GSE1umls:C1527249BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012GSE11685672958GA
rs7098052228240023199GSE1umls:C0009402BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012GSE11685672958GA
rs7098052228240023225NUP210umls:C0009402BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012GSE11685672958GA
rs7098052228240023225NUP210umls:C1527249BeFreeStatistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).0.0002714422012GSE11685672958GA
rs712239753733845KRASumls:C0009402BeFreeA let-7 KRAS rs712 polymorphism increases colorectal cancer risk.0.0823670322013KRAS1225209618AC
rs712239753733845KRASumls:C1527249BeFreeA let-7 KRAS rs712 polymorphism increases colorectal cancer risk.0.162013KRAS1225209618AC
rs7121164670862778GNASumls:C0009402BeFreeWe have recently shown that TT genotypes of the GNAS1 T393C polymorphism display increased transcription of Galphas and a more favorable clinical course in bladder and colorectal cancer patients compared both with TC or CC genotypes.0.0016286512006GNAS2058903752CT
rs7121164670862778GNASumls:C1527249BeFreeWe have recently shown that TT genotypes of the GNAS1 T393C polymorphism display increased transcription of Galphas and a more favorable clinical course in bladder and colorectal cancer patients compared both with TC or CC genotypes.0.0034527992006GNAS2058903752CT
rs7121160338192778GNASumls:C0009402BeFreeGNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.0.0016286512005GNAS2058903752CT
rs7121171863572778GNASumls:C0009402BeFreeWe have recently shown that genotypes of the single nucleotide polymorphism (SNP) T393C in the gene GNAS1 are associated with survival of patients suffering from bladder, renal cell and colorectal carcinoma.0.0016286512007GNAS2058903752CT
rs7121160338192778GNASumls:C1527249BeFreeGNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.0.0034527992005GNAS2058903752CT
rs713017324256810341032C11orf53umls:C0009402BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0002714422014C11orf5311111283347AC
rs713017324256810120376COLCA2umls:C0009402BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0010857672014C11orf5311111283347AC
rs713017324256810399948COLCA1umls:C0009402BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0005428842014C11orf5311111283347AC
rs713017324256810120376COLCA2umls:C1527249BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.1210857672014C11orf5311111283347AC
rs713017324256810341032C11orf53umls:C1527249BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.0026384742014C11orf5311111283347AC
rs713017324256810399948COLCA1umls:C1527249BeFreeThese data imply that rs10891246 and rs7130173 are functional SNPs mapping to 11q23.1 and that C11orf53, C11orf92 and C11orf93 represent novel candidate target genes involved in CRC etiology.0.1252769482014C11orf5311111283347AC
rs71972521952639115426UHRF2umls:C1527249BeFreeFurthermore, NIRF is immediately adjacent to the single nucleotide polymorphism rs719725, which is reportedly associated with the risk of colorectal cancer.0.0005428842011NA96365683AC
rs71972521952639115426UHRF2umls:C0009402BeFreeFurthermore, NIRF is immediately adjacent to the single nucleotide polymorphism rs719725, which is reportedly associated with the risk of colorectal cancer.0.0005428842011NA96365683AC
rs7229639244489864092SMAD7umls:C1527249GWASCATGenome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians.0.1623674712013SMAD71848924606AG
rs7229639248362864092SMAD7umls:C1527249GWASCATLarge-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.0.1623674712014SMAD71848924606AG
rs731236240757991045CDX2umls:C0009402BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0122148842013VDR;LOC1053697491247844974AG
rs731236240757991045CDX2umls:C1527249BeFreeUnadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132).0.0134961492013VDR;LOC1053697491247844974AG
rs733769302473774826585GREM1umls:C1527249GWASCATIdentification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.0.1256243342015GREM1;LOC1001313151532720301AG
rs7337693024737748100131315LOC100131315umls:C1527249GWASCATIdentification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.0.122015GREM1;LOC1001313151532720301AG
rs743554229392285894RAF1umls:C1527249BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0038001862012GALK1;ITGB41775758167GA
rs743554229392283691ITGB4umls:C0009402BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0005428842012GALK1;ITGB41775758167GA
rs743554229392283691ITGB4umls:C1527249BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0005428842012GALK1;ITGB41775758167GA
rs743554229392285894RAF1umls:C0009402BeFreeWe found that the AA genotype of the rs743554 polymorphism in the ITGB4 gene and the T allele of the rs1051208 polymorphism of the RAF1 gene were associated with the risk of CRC in females; however, after Bonferroni's correction we found that they were non-significant.0.0038001862012GALK1;ITGB41775758167GA
rs74837985209376341559CYP2C9umls:C1527249BeFreeThe CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.99) genotypes were associated with decreased risk, and the GSTM1-K173N-CG (AOR = 1.99, 95% CI: 1.21, 3.25) genotype was associated with an increased risk of colorectal cancer.0.0372100762010NANANANANA
rs74837985209376341543CYP1A1umls:C0009402BeFreeThe CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.99) genotypes were associated with decreased risk, and the GSTM1-K173N-CG (AOR = 1.99, 95% CI: 1.21, 3.25) genotype was associated with an increased risk of colorectal cancer.0.0073289312010NANANANANA
rs74837985209376341543CYP1A1umls:C1527249BeFreeThe CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.99) genotypes were associated with decreased risk, and the GSTM1-K173N-CG (AOR = 1.99, 95% CI: 1.21, 3.25) genotype was associated with an increased risk of colorectal cancer.0.0715102362010NANANANANA
rs74837985209376342944GSTM1umls:C1527249BeFreeThe CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.99) genotypes were associated with decreased risk, and the GSTM1-K173N-CG (AOR = 1.99, 95% CI: 1.21, 3.25) genotype was associated with an increased risk of colorectal cancer.0.0943864192010NANANANANA
rs74837985209376342944GSTM1umls:C0009402BeFreeThe CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.99) genotypes were associated with decreased risk, and the GSTM1-K173N-CG (AOR = 1.99, 95% CI: 1.21, 3.25) genotype was associated with an increased risk of colorectal cancer.0.0141149772010NANANANANA
rs74837985209376341559CYP2C9umls:C0009402BeFreeThe CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.99) genotypes were associated with decreased risk, and the GSTM1-K173N-CG (AOR = 1.99, 95% CI: 1.21, 3.25) genotype was associated with an increased risk of colorectal cancer.0.0038001862010NANANANANA
rs749072232400384292MLH1umls:C1527249BeFreeWe previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients.0.162012LRRFIP2337054533TC
rs749072232400384292MLH1umls:C0009402BeFreeWe previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients.0.0823670322012LRRFIP2337054533TC
rs7553007237551783845KRASumls:C0009402BeFreeFurthermore, the CRP SNP rs7553007 (hazard ratio [HR] = 1.101; 95% confidence interval [CI] = 1.011-1.200; P = 0.027) and KRAS/BRAF mutations (HR = 2.377; 95% CI = 1.293-4.368; P = 0.005) remained predictive for the CSS of CRC patients with synchronous liver metastasis in multivariate analysis.0.0823670322013NA1159728759GA
rs755300723755178140913PPIAP10umls:C1527249BeFreeWe aimed to determine the impact of the CRP-specific single nucleotide polymorphism (SNP) rs7553007 in liver metastasis on the CRC-specific survival (CSS) of patients after colorectal liver metastasectomy.0.0013572092013NA1159728759GA
rs7553007237551783845KRASumls:C1527249BeFreeFurthermore, the CRP SNP rs7553007 (hazard ratio [HR] = 1.101; 95% confidence interval [CI] = 1.011-1.200; P = 0.027) and KRAS/BRAF mutations (HR = 2.377; 95% CI = 1.293-4.368; P = 0.005) remained predictive for the CSS of CRC patients with synchronous liver metastasis in multivariate analysis.0.162013NA1159728759GA
rs755300723755178140913PPIAP10umls:C0009402BeFreeWe aimed to determine the impact of the CRP-specific single nucleotide polymorphism (SNP) rs7553007 in liver metastasis on the CRC-specific survival (CSS) of patients after colorectal liver metastasectomy.0.0013572092013NA1159728759GA
rs75781532482227454575UGT1A10umls:C0009402BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014MROH2A2233777511CT
rs75781532482227454575UGT1A10umls:C1527249BeFreeUGT1A haplotype analysis found that the T-G haplotype in UGT1A10 exon 1 (block 2: rs17864678, rs10929251) decreased cancer risk for the colon [proximal (OR = 0.28, 95% CI = 0.11–0.69) and for the distal colon (OR = 0.32, 95% CI = 0.12–0.91)], and that the C-T-G haplotype in the 3′ region flanking the UGT1A shared exons (block 11: rs7578153, rs10203853, rs6728940) increased CRC risk in males (OR = 2.56, 95% CI = 1.10–5.95).0.0002714422014MROH2A2233777511CT
rs7578597216025328549LGR5umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0046145122011THADA243505684TC
rs7578597216025323767KCNJ11umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011THADA243505684TC
rs7578597216025323767KCNJ11umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011THADA243505684TC
rs7578597216025328549LGR5umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0048859542011THADA243505684TC
rs757859721602532221895JAZF1umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011THADA243505684TC
rs7578597216025327103TSPAN8umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011THADA243505684TC
rs757859721602532221895JAZF1umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011THADA243505684TC
rs7578597216025327103TSPAN8umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011THADA243505684TC
rs763289802182114427306HPGDSumls:C1527249BeFreeHematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.0.0122148842012HPGDS494299521CT
rs763289802182114427306HPGDSumls:C0009402BeFreeHematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.0.0119434422012HPGDS494299521CT
rs76378025296730112744IL17Fumls:C1527249BeFreeThe results of this study indicate that the 7488T>C (rs763780) in the IL-17F gene may be correlated with increased risk of CRC.0.0010857672014IL17F;LOC105375088652236941TC
rs76378025296730112744IL17Fumls:C0009402BeFreeThe results of this study indicate that the 7488T>C (rs763780) in the IL-17F gene may be correlated with increased risk of CRC.0.0010857672014IL17F;LOC105375088652236941TC
rs7754840224197146934TCF7L2umls:C1527249BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.1358631812012CDKAL1620661019GC,T
rs77548402241971454901CDKAL1umls:C0009402BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0002714422012CDKAL1620661019GC,T
rs77548402241971454901CDKAL1umls:C1527249BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0002714422012CDKAL1620661019GC,T
rs7754840224197146934TCF7L2umls:C0009402BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0114005592012CDKAL1620661019GC,T
rs7758229212422606581SLC22A3umls:C1527249GWASCATCommon variant in 6q26-q27 is associated with distal colon cancer in an Asian population.0.1235287442011SLC22A36160419220GT
rs7758229212422604092SMAD7umls:C0009402BeFreeMoreover, we found cumulative effects of three genetic factors (rs7758229, rs6983267, and rs4939827 in SMAD7) and one environmental factor (alcohol drinking) which appear to increase CRC risk approximately twofold.0.0092290242011SLC22A36160419220GT
rs7758229235550066581SLC22A3umls:C1527249BeFreeA recent genome-wide association study has identified a new genetic variant rs7758229 in SLC22A3 for colorectal cancer susceptibility in a Japanese population, but it is unknown whether this newly identified variant is associated with colorectal cancer in other populations, including the Chinese population.0.1235287442013SLC22A36160419220GT
rs7758229212422604092SMAD7umls:C1527249BeFreeMoreover, we found cumulative effects of three genetic factors (rs7758229, rs6983267, and rs4939827 in SMAD7) and one environmental factor (alcohol drinking) which appear to increase CRC risk approximately twofold.0.1623674712011SLC22A36160419220GT
rs7758229235550066581SLC22A3umls:C0009402BeFreeA recent genome-wide association study has identified a new genetic variant rs7758229 in SLC22A3 for colorectal cancer susceptibility in a Japanese population, but it is unknown whether this newly identified variant is associated with colorectal cancer in other populations, including the Chinese population.0.0038001862013SLC22A36160419220GT
rs7775174201702487FRZBumls:C1527249BeFreeThe functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk.0.0029099162007FRZB2182834857GT,C,A
rs7775174201702487FRZBumls:C0009402BeFreeThe functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk.0.0005428842007FRZB2182834857GT,C,A
rs7873784197600277099TLR4umls:C0009402BeFreeTwo CRP haplotypes (global p = 0.04) and TLR4 tagSNPs (rs7873784, rs11536891), but not TLR4 haplotypes, were associated with colorectal cancer.0.004343072009TLR49117716658GA,C
rs7873784197600277099TLR4umls:C1527249BeFreeTwo CRP haplotypes (global p = 0.04) and TLR4 tagSNPs (rs7873784, rs11536891), but not TLR4 haplotypes, were associated with colorectal cancer.0.0082628082009TLR49117716658GA,C
rs79031462241971454901CDKAL1umls:C1527249BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0002714422012TCF7L210112998590CT
rs7903146224197146934TCF7L2umls:C1527249BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.1358631812012TCF7L210112998590CT
rs7903146224197143596IL13umls:C0009402BeFreePatients carrying the TCF7L2_rs7903146_T allele had an increased risk of CRC (P(trend) = 0.02), whereas patients harboring the IL13_rs20541_T allele had a reduced risk (P(trend) = 0.02).0.0010857672012TCF7L210112998590CT
rs79031462241971454901CDKAL1umls:C0009402BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0002714422012TCF7L210112998590CT
rs7903146224197143596IL13umls:C1527249BeFreePatients carrying the TCF7L2_rs7903146_T allele had an increased risk of CRC (P(trend) = 0.02), whereas patients harboring the IL13_rs20541_T allele had a reduced risk (P(trend) = 0.02).0.0010857672012TCF7L210112998590CT
rs7903146224197146934TCF7L2umls:C0009402BeFreeA further analysis revealed gender-specific effects: the TCF7L2_rs7903146_T allele was associated with an increased risk of CRC in women (P(trend) = 0.003) but not in men (P(interaction) = 0.06); the LTA_rs1041981_A allele was associated with a decreased risk for CRC in women (P(trend) = 0.02), with an opposite effect in men (P(trend) = 0.05; P(interaction) = 0.002); the CDKAL1_rs7754840_C allele was associated with a decreased risk for CRC in men (P(trend) = 0.03), with no effect in women (P(interaction) = 0.03).0.0114005592012TCF7L210112998590CT
rs791148825977444596BCL2umls:C0009402BeFreeIn summary, our results show that rs7911488 C-allelic pre-miR-1307 binds to MBNL1 and infers with Dicer processing, leading to reduced miR-1307 and increased Bcl2 expression, thus representing an important process in the initiation of CRC.0.016015072015USMG5;MIR130710103394332AG
rs7911488259774444154MBNL1umls:C0009402BeFreeIn summary, our results show that rs7911488 C-allelic pre-miR-1307 binds to MBNL1 and infers with Dicer processing, leading to reduced miR-1307 and increased Bcl2 expression, thus representing an important process in the initiation of CRC.0.0002714422015USMG5;MIR130710103394332AG
rs791148825977444596BCL2umls:C1527249BeFreeIn summary, our results show that rs7911488 C-allelic pre-miR-1307 binds to MBNL1 and infers with Dicer processing, leading to reduced miR-1307 and increased Bcl2 expression, thus representing an important process in the initiation of CRC.0.0124863262015USMG5;MIR130710103394332AG
rs7911488259774444154MBNL1umls:C1527249BeFreeIn summary, our results show that rs7911488 C-allelic pre-miR-1307 binds to MBNL1 and infers with Dicer processing, leading to reduced miR-1307 and increased Bcl2 expression, thus representing an important process in the initiation of CRC.0.0002714422015USMG5;MIR130710103394332AG
rs791148825977444100302174MIR1307umls:C0009402BeFreeIn summary, our results show that rs7911488 C-allelic pre-miR-1307 binds to MBNL1 and infers with Dicer processing, leading to reduced miR-1307 and increased Bcl2 expression, thus representing an important process in the initiation of CRC.0.0002714422015USMG5;MIR130710103394332AG
rs791148825977444100302174MIR1307umls:C1527249BeFreeIn summary, our results show that rs7911488 C-allelic pre-miR-1307 binds to MBNL1 and infers with Dicer processing, leading to reduced miR-1307 and increased Bcl2 expression, thus representing an important process in the initiation of CRC.0.0002714422015USMG5;MIR130710103394332AG
rs7961581216025327103TSPAN8umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011NA1271269322CT
rs7961581216025328549LGR5umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0048859542011NA1271269322CT
rs796158121602532221895JAZF1umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011NA1271269322CT
rs7961581216025328549LGR5umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0046145122011NA1271269322CT
rs7961581216025323767KCNJ11umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011NA1271269322CT
rs796158121602532221895JAZF1umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011NA1271269322CT
rs7961581216025327103TSPAN8umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011NA1271269322CT
rs7961581216025323767KCNJ11umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011NA1271269322CT
rs8003379238936187298TYMSumls:C0009402BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0325730252013MTHFD11464406881AC
rs8003379238936184522MTHFD1umls:C0009402BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0008143262013MTHFD11464406881AC
rs8003379238936187298TYMSumls:C1527249BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.1117586992013MTHFD11464406881AC
rs8003379238936184522MTHFD1umls:C1527249BeFreeUsing a dominant model for the variant allele, several SNPs were significantly associated with CRC including MTHFD1 rs8003379 (OR = 1.65; 95% CI = 1.00-2.73) and rs17824591 (OR = 1.98; 95% CI = 1.14-3.41) and the TYMS rs2853533 SNP (OR = 1.38; 95% CI = 1.05-1.80).0.0150165172013MTHFD11464406881AC
rs81767462494122528ABOumls:C0009402BeFreeThe rs1047781 (chr19- FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9- ABO) was associated with the regional lymph metastasis in the CRC patients.0.0002714422014ABO9133255935GT,A
rs81767462494122528ABOumls:C1527249BeFreeThe rs1047781 (chr19- FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9- ABO) was associated with the regional lymph metastasis in the CRC patients.0.0002714422014ABO9133255935GT,A
rs8330612513948525801GCAumls:C1527249BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0002714422014VEGFA643769749CT
rs833061199045587422VEGFAumls:C1527249GAD[The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer.]0.0535289262010VEGFA643769749CT
rs8330612513948525801GCAumls:C0009402BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0002714422014VEGFA643769749CT
rs833061251394852321FLT1umls:C1527249BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0021715352014VEGFA643769749CT
rs833061251394852321FLT1umls:C0009402BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0029858612014VEGFA643769749CT
rs854560256845295444PON1umls:C1527249BeFreeAssociation of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.0.0029099162015PON1795316772AC,G,N,T
rs854560256845295444PON1umls:C0009402BeFreeAssociation of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.0.0005428842015PON1795316772AC,G,N,T
rs861539241666047517XRCC3umls:C0009402BeFreeAssociation of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the Polish population.0.0048859542014KLC1;XRCC314103699416GA
rs861539246877797517XRCC3umls:C1527249BeFreeNo association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.0.0285562732014KLC1;XRCC314103699416GA
rs861539258247487517XRCC3umls:C0009402BeFreeAssociation between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.0.0048859542016KLC1;XRCC314103699416GA
rs861539255200787517XRCC3umls:C1527249BeFreeXRCC3 Thr241Met gene polymorphism and risk of colorectal cancer in Kashmir: a case control study.0.0285562732015KLC1;XRCC314103699416GA
rs861539241666047517XRCC3umls:C1527249BeFreeAssociation of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the Polish population.0.0285562732014KLC1;XRCC314103699416GA
rs861539246877797517XRCC3umls:C0009402BeFreeNo association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.0.0048859542014KLC1;XRCC314103699416GA
rs861539162719547517XRCC3umls:C0009402BeFreeThe association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.0.0048859542005KLC1;XRCC314103699416GA
rs861539255200787517XRCC3umls:C0009402BeFreeXRCC3 Thr241Met gene polymorphism and risk of colorectal cancer in Kashmir: a case control study.0.0048859542015KLC1;XRCC314103699416GA
rs861539258247487517XRCC3umls:C1527249BeFreeAssociation between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.0.0285562732016KLC1;XRCC314103699416GA
rs861539235045537517XRCC3umls:C0009402BeFreeAssociation between XRCC3 Thr241Met polymorphism and colorectal cancer risk.0.0048859542013KLC1;XRCC314103699416GA
rs861539159142782068ERCC2umls:C1527249BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0575035412005KLC1;XRCC314103699416GA
rs861539159142787515XRCC1umls:C0009402BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0126818232005KLC1;XRCC314103699416GA
rs861539159142787517XRCC3umls:C0009402BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0048859542005KLC1;XRCC314103699416GA
rs861539162719547517XRCC3umls:C1527249BeFreeThe association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.0.0285562732005KLC1;XRCC314103699416GA
rs861539159142787517XRCC3umls:C1527249BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0285562732005KLC1;XRCC314103699416GA
rs861539235045537517XRCC3umls:C1527249BeFreeAssociation between XRCC3 Thr241Met polymorphism and colorectal cancer risk.0.0285562732013KLC1;XRCC314103699416GA
rs861539159142787515XRCC1umls:C1527249BeFreeOur results suggest that the XRCC1 Arg399Gln polymorphism may contribute to the risk of early-onset colorectal cancer and the XRCC3 Thr241Met polymorphism may modify the risk for meat-associated colorectal cancer.0.0623894952005KLC1;XRCC314103699416GA
rs861539159142782068ERCC2umls:C0009402BeFreeThis hospital-based case-control study examined whether polymorphic DNA repair genes: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, play a role in the susceptibility to colorectal cancer.0.0104343432005KLC1;XRCC314103699416GA
rs86474521602532221895JAZF1umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011JAZF1728140937TC
rs864745216025328549LGR5umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0046145122011JAZF1728140937TC
rs864745216025328549LGR5umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0048859542011JAZF1728140937TC
rs86474521602532221895JAZF1umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011JAZF1728140937TC
rs864745216025323767KCNJ11umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011JAZF1728140937TC
rs864745216025327103TSPAN8umls:C0009402BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011JAZF1728140937TC
rs864745216025327103TSPAN8umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0005428842011JAZF1728140937TC
rs864745216025323767KCNJ11umls:C1527249BeFreeFour type 2 diabetes SNPs were associated with colorectal cancer risk: rs7578597 (THADA), rs864745 (JAZF1), rs5219 (KCNJ11) and rs7961581 (TSPAN8, LGR5).0.0002714422011JAZF1728140937TC
rs9282861121650386817SULT1A1umls:C1527249BeFreeAssociation of the SULT1A1 R213H polymorphism with colorectal cancer.0.0353099832002SULT1A1;NPIPB81628606193CT
rs9282861216951806817SULT1A1umls:C0009402BeFreeLack of association of SULT1A1 R213H polymorphism with colorectal cancer: a meta-analysis.0.0021715352011SULT1A1;NPIPB81628606193CT
rs9282861216951806817SULT1A1umls:C1527249BeFreeLack of association of SULT1A1 R213H polymorphism with colorectal cancer: a meta-analysis.0.0353099832011SULT1A1;NPIPB81628606193CT
rs9282861121650386817SULT1A1umls:C0009402BeFreeAssociation of the SULT1A1 R213H polymorphism with colorectal cancer.0.0021715352002SULT1A1;NPIPB81628606193CT
rs932335240612673290HSD11B1umls:C1527249BeFreeA variant (rs932335) in the HSD11B1 gene is associated with colorectal cancer in a Chinese population.0.0002714422014HSD11B1;LOC1019301141209732389GC
rs932335240612673290HSD11B1umls:C0009402BeFreeA variant (rs932335) in the HSD11B1 gene is associated with colorectal cancer in a Chinese population.0.0002714422014HSD11B1;LOC1019301141209732389GC
rs934418196581595CCND1umls:C1527249GAD[The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.]0.067546892008CCND11169648142GA
rs943818619730170506DHX36umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DHX363154301098GC
rs9438186197305698PSMB9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DHX363154301098GC
rs9438186197307057THBS1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0019000932008DHX363154301098GC
rs943818619730270AMPD1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DHX363154301098GC
rs94381861973010142AKAP9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DHX363154301098GC
rs9438186197304292MLH1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.162008DHX363154301098GC
rs943818619730170506DHX36umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008DHX363154301098GC
rs94381861973027122DKK3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008DHX363154301098GC
rs94381861973051200CPA4umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DHX363154301098GC
rs94381861973051200CPA4umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008DHX363154301098GC
rs94381861973010973ASCC3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0002714422008DHX363154301098GC
rs943818619730270AMPD1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DHX363154301098GC
rs9438186197305698PSMB9umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DHX363154301098GC
rs94381861973027122DKK3umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0008143262008DHX363154301098GC
rs9438186197304292MLH1umls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0823670322008DHX363154301098GC
rs9438186197303990LIPCumls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008DHX363154301098GC
rs9438186197307057THBS1umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0066341572008DHX363154301098GC
rs94381861973010973ASCC3umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0026384742008DHX363154301098GC
rs94381861973010142AKAP9umls:C1527249BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0029099162008DHX363154301098GC
rs9438186197303990LIPCumls:C0009402BeFreeTen non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with colorectal cancer risk in a comprehensive, array based study (AKAP9 M463I, DKK3 G335R, AMPD1 Q12X, LIPC L356F, PSMB9 V32I, THBS1 N700S, CA6 S90G, ASCC3 C1995S, DHX36 S416C and CPA4 G303C) were re-evaluated in the present study based on 626 German familial non-HNPCC colorectal cancer patients and 736 healthy controls.0.0005428842008DHX363154301098GC
rs9513070251394852321FLT1umls:C0009402BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0029858612014FLT11328305702GA
rs9513070251394852321FLT1umls:C1527249BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0021715352014FLT11328305702GA
rs95130702513948525801GCAumls:C0009402BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0002714422014FLT11328305702GA
rs95130702513948525801GCAumls:C1527249BeFreeThe VEGFA rs833061 SNP is associated with the ORR, and the FLT1 rs9513070 SNP and FLT1 GCA haplotypes are associated with PFS and OS in advanced CRC patients treated with cytotoxic chemotherapy plus bevacizumab.0.0002714422014FLT11328305702GA
rs961253223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012NA206423634CA
rs96125319011631652BMP4umls:C1527249BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0132683142008NA206423634CA
rs9612532236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012NA206423634CA
rs96125322367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012NA206423634CA
rs96125322367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012NA206423634CA
rs96125319011631652BMP4umls:C0009402BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0038001862008NA206423634CA
rs96125322367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012NA206423634CA
rs96125322367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012NA206423634CA
rs96125322367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012NA206423634CA
rs961253223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012NA206423634CA
rs961253223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012NA206423634CA
rs9612532236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012NA206423634CA
rs961253223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012NA206423634CA
rs96125322367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012NA206423634CA
rs992921822367214999CDH1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1712927162012CDH11668787043GA
rs992921822367214650BMP2umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0016286512012CDH11668787043GA
rs992921822367214652BMP4umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0132683142012CDH11668787043GA
rs992921822367214652BMP4umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0038001862012CDH11668787043GA
rs99292182236721426585GREM1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0032573022012CDH11668787043GA
rs9929218223672144092SMAD7umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1623674712012CDH11668787043GA
rs9929218223672148667EIF3Humls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0008143262012CDH11668787043GA
rs9929218223634408996NOL3umls:C1527249BeFreeThe colorectal cancer low risk allele (A) for rs9929218 at 16q22.1 was associated with a significant decrease in expression of both NOL3 (q = 0.017) and DDX28 (q = 0.046) in the adjacent normal colon tissue samples.0.0008143262012CDH11668787043GA
rs9929218223634408996NOL3umls:C0009402BeFreeThe colorectal cancer low risk allele (A) for rs9929218 at 16q22.1 was associated with a significant decrease in expression of both NOL3 (q = 0.017) and DDX28 (q = 0.046) in the adjacent normal colon tissue samples.0.0008143262012CDH11668787043GA
rs992921822367214999CDH1umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0076003722012CDH11668787043GA
rs9929218223672148667EIF3Humls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0102824542012CDH11668787043GA
rs992921819011631652BMP4umls:C0009402BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0038001862008CDH11668787043GA
rs9929218223672144092SMAD7umls:C0009402BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0092290242012CDH11668787043GA
rs992921822367214650BMP2umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.0039956832012CDH11668787043GA
rs992921819011631652BMP4umls:C1527249BeFreeWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.0132683142008CDH11668787043GA
rs99292182236344055794DDX28umls:C0009402BeFreeThe colorectal cancer low risk allele (A) for rs9929218 at 16q22.1 was associated with a significant decrease in expression of both NOL3 (q = 0.017) and DDX28 (q = 0.046) in the adjacent normal colon tissue samples.0.0002714422012CDH11668787043GA
rs992921819011631999CDH1umls:C1527249GWASCATWe identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)).0.1712927162008CDH11668787043GA
rs99292182236344055794DDX28umls:C1527249BeFreeThe colorectal cancer low risk allele (A) for rs9929218 at 16q22.1 was associated with a significant decrease in expression of both NOL3 (q = 0.017) and DDX28 (q = 0.046) in the adjacent normal colon tissue samples.0.0002714422012CDH11668787043GA
rs99292182236721426585GREM1umls:C1527249BeFreeWe used meta-analysis of an efficient empirical-Bayes estimator to detect potential multiplicative interactions between each of the SNPs [rs16892766 at 8q23.3 (EIF3H/UTP23), rs6983267 at 8q24 (MYC), rs10795668 at 10p14 (FLJ3802842), rs3802842 at 11q23 (LOC120376), rs4444235 at 14q22.2 (BMP4), rs4779584 at 15q13 (GREM1), rs9929218 at 16q22.1 (CDH1), rs4939827 at 18q21 (SMAD7), rs10411210 at 19q13.1 (RHPN2), and rs961253 at 20p12.3 (BMP2)] and select major CRC risk factors (sex, body mass index, height, smoking status, aspirin/nonsteroidal anti-inflammatory drug use, alcohol use, and dietary intake of calcium, folate, red meat, processed meat, vegetables, fruit, and fiber).0.1256243342012CDH11668787043GA
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:25)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
9136131188rs8176749CTrs8176749249412252.59E-23NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176749-AResearch Support, Non-U.S. Gov'tGABO
9136131322rs8176746GTrs8176746249412256.10E-24NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176746-AResearch Support, Non-U.S. Gov'tC,AABO
9136131415rs8176743CTrs8176743249412251.82E-23NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176743-AResearch Support, Non-U.S. Gov'tGABO
9136131461rs8176741GArs8176741249412252.00E-24NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176741-AResearch Support, Non-U.S. Gov'tCABO
9136131905rs7873522TCrs7873522249412255.12E-12NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs7873522-GResearch Support, Non-U.S. Gov'tCABO
9136132617rs8176725GArs8176725249412256.61E-11NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176725-AResearch Support, Non-U.S. Gov'tCABO
9136132754rs8176722CArs8176722249412251.17E-23NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176722-AResearch Support, Non-U.S. Gov'tGABO
9136132873rs8176720TCrs8176720249412257.38E-12NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8176720-GResearch Support, Non-U.S. Gov'tGABO
9136149399rs507666GA,C,Trs507666249412257.39E-19NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs507666-AResearch Support, Non-U.S. Gov'tGABO
9136154168rs579459TCrs579459249412254.44E-19NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs579459-GResearch Support, Non-U.S. Gov'tCNA
9136155359rs7030248GArs7030248249412254.00E-15NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs7030248-GResearch Support, Non-U.S. Gov'tGNA
195830302rs778809GArs778809249412252.16E-08NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs778809-GResearch Support, Non-U.S. Gov'tGFUT6
195832209rs778805GArs778805249412251.77E-08NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs778805-GResearch Support, Non-U.S. Gov'tCFUT6
195839746rs3760776GArs3760776249412252.06E-13NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs3760776-AResearch Support, Non-U.S. Gov'tTFUT6
195841356rs3760775GTrs3760775249412258.00E-19NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs3760775-AResearch Support, Non-U.S. Gov'tCFUT6
195851801rs2306969AGrs2306969249412253.00E-08NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs2306969-AResearch Support, Non-U.S. Gov'tGFUT3
1949095278rs3786749TCrs3786749249412251.00E-10NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs3786749-AResearch Support, Non-U.S. Gov'tCSULT2B1
1949117104rs433852CTrs433852249412255.00E-08NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs433852-AResearch Support, Non-U.S. Gov'tCNA
1949118371rs2292342GArs2292342249412257.00E-12NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs2292342-AResearch Support, Non-U.S. Gov'tGRPL18
1949136651rs12608544GArs12608544249412252.00E-12NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs12608544-AResearch Support, Non-U.S. Gov'tGDBP
1949144790rs11880333CTrs11880333249412255.00E-12NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs11880333-AResearch Support, Non-U.S. Gov'tTCA11
1949152955rs8111500GArs8111500249412254.00E-09NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs8111500-GResearch Support, Non-U.S. Gov'tGSEC1
1949206631rs1047781ATrs1047781249412251.00E-56NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs1047781-AResearch Support, Non-U.S. Gov'tAFUT2
1949254504rs2071699GArs2071699249412253.00E-10NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs2071699-AResearch Support, Non-U.S. Gov'tCFUT1
2142698907rs441810AGrs441810249412252.00E-08NANANA1,999 Chinese ancestry individualsChinese(1999)ALL(1999)ASN(1999)ALL(1999)Elevated serum carcinoembryonic antigen levelsHPOID:0200063Colorectal polypsDOID:9256colorectal cancerNANANANAHereditary nonpolyposis colorectal tumorrs441810-GResearch Support, Non-U.S. Gov'tGFAM3B
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)